Upload your Midyear 2012 video clips and win www.ashp.org/midyearvideo

where is…CareerPharm’s Personnel Bayside C, Level 1Placement Service (PPS)If you’re not looking here, you’re not looking!Sunday, December 2 – Wednesday, December 5The Personnel Placement Service (PPS) is a national pharmacyrecruiting event that takes place annually at ASHP’sMidyear Clinical Meeting. PPS is the only event that is dedicatedto putting top pharmacy talent in front of the mostemployers in one location.Who should participate?CareerPharm’s PPS is an excellent event for any pharmacistseeking a position or employer recruiting for positions in a hospitalor health system:u Residents (PGY-1 and PGY-2)u Fellowsu Pharmacy Practitioners (Staff and Clinical Positions)Participation in PPS includes:u Job and resume posting(s) on our website http://www.careerpharm.com.u Job and resume search functionality to find job seekers oremployers that match your desired criteria.u A place to conduct interviews and meeting space for potentialemployers and job seekers. (Employers are assigned a spaceto conduct interviews.)u Computer terminals to continue searching, communicatingand scheduling interviews.PPS Hours:Sunday – Wednesday7:30am – 5:00pmCity InfoMandalay Bay Hotel LobbyEverything you need from dinner reservations, to show reservations,shopping and more can be found at www.visitlasvegas.com. Look around, have fun, and enjoy your stay in Vegas!The Mandalay Bay’s Concierge is also available to assist youwith world-class dining, shopping, and entertainment arrangements.The Concierge Desk is located in the Mandalay BayHotel Lobby and can be reached by dialing 74760 from anyMandalay Bay house phone or at (702) 632-4760.Coat and Baggage Check Bayside A, Level 1SundayMonday – TuesdayWednesdayThursday7:30am – 5:30pm7:30am – 6:30pm7:30am – 5:30pm8:30am – 4:30pmExhibit Program Shoreline AB, Level 2Immerse yourself in an exhibit hall featuring the latest productdevelopments and technological advancements in hospital andhealth-system pharmacy. The ASHP Midyear Clinical Meeting& Exhibition includes a vast exhibit program which allows youthe opportunity to compare products, attend demonstrationsand have questions answered from over 300 companies, bothdomestic and international.A full listing of the exhibiting companies can be found in theExhibitor Yellow Pages, available in the registration bag and atthe entrance of the Exhibit Hall. You can also view the listingson the ASHP Mobile Midyear app.Exhibit Hall Hours:Monday – TuesdayWednesday11:00am – 3:00pm11:00am – 2:00pmViva the Midyear!6 47th ASHP Midyear Clinical Meeting and ExhibitionFollow ASHP at @ashpofficial: Use #ashpmidyearGet rocking and read and write tweets about interestingthings you see or hear. Share pictures of things yousee. Set up meetings with friends old and new.You will experience the meeting at a differentlevel and feel like you are everywhere!There will also be aTwitter contest withprizes!

where is…Theme Center Exhibit Hall, Booth 1373While in the Exhibit Hall, make sure to stop by ASHP’sAdvance Your Career Theme Center! Learn more about thePhORCAS (Pharmacy Online Residency CentralizedApplication) system, ASHP’s CareerPharm offerings andASHP’s specialty certification preparatory and recertificationproducts. Test your interview savvy in a mock interview sessionor get feedback from an experienced practitioner on yourCurriculum Vitae (CV). Stop by, grab a light snack, and learnmore about these ASHP initiatives that will assist you inadvancing your career.Headquarters Office Surf F, Level 2Contact ASHP staff at ASHP Headquarters.Lost and Found Surf F, Level 2Lost and Found is located in the ASHP Headquarters Officeduring meeting hours. Afterwards, attendees may callMandalay Bay Lost & Found at 77995.Meeting Info Center Bayside Foyer, Level 1Do you have a question about The Midyear 2012? Need helpwith your CE processing or finding a session room? Stop byMeeting Info for the answers.The Spot for First-TimersExhibit Hall,and New Members Booth 2521New to ASHP and The Midyear? If so, we have The Spot foryou! Located within the Exhibit Hall, The Spot is an areareserved especially for first-time attendees and new membersto meet with colleagues and relax while visiting 300+ exhibitingcompanies!Meeting Info Center Hours:SaturdaySunday – WednesdayThursday12:00pm – 5:00pm7:30am – 5:00pm8:30am – 4:00pmFirst Aid Station Level 1(Across from Bayside A and B)First Aid is accessible by calling Mandalay Bay Securityu Dispatch from any in-house phone located throughout theConvention Center.u Pick up any in-house phone and dial 77911. From a cellphone, call (702) 632-7911.u Request first aid service and state your location.Food ConcessionsFood and beverage outlets and concession stands are availablein the South Convention Center, including the Exhibit Hall duringopen hours. There are also a variety of restaurants locatedwithin the Mandalay Bay Hotel, just steps away from theConvention Center.Future Meetings Bayside Foyer, Level 1Stop by the Future Meetings area for information on upcomingASHP meetings and conferences, and pick up a small give-a-wayor two.Membership Information Center Bayside Foyer, Level 1Get the most out of ASHP membershipLearn how to access the professional resources and educationaltools you need to grow in your continually-evolvingcareer. Stop by and learn about the opportunities for involvementwith ASHP. Meet members of the ASHP Forum andSection Executive Committees, and hear how to best utilizeyour benefits and network with peers. Not yet a member? Joinor renew your ASHP membership. Member ribbons for yourbadge can be picked up at Membership Information.Membership Information Center Hours:SaturdaySunday – WednesdayThursday12:00pm – 5:00pm7:30am – 5:00pm8:30am – 12:00pmRemember to mark your calendars for:2013 ASHP Summer Meeting & ExhibitionMinneapolis, MinnesotaJune 1-5, 201348th Midyear Clinical Meeting & ExhibitionOrlando, FloridaDecember 8-12, 2013Make note of our future meeting city partners on pages 12 and 13.What is ASHP Connect? It’s our “private” social network thatlets you connect with your colleagues and is loaded with excitingfeatures that will make participating in discussions moreconvenient and rewarding. Network with colleagues and fellowattendees of the meeting and stay up-to-date on the latestinformation about The Midyear in the ASHP Connect MidyearCommunity. Stop by the Membership Information Center to getacquainted—the conversations have already started! Join athttp://connect.ashp.org to join in.Network ConnectionsStay connected! There are four locations of individual computerworkstations to access email, record your CE online, printhandouts, and complete a session evaluation:Station #1 Bayside Foyer, Level 1Station #2 Breakers Registration, Level 2Station #3 Jasmine Registration, Level 3,8 47th ASHP Midyear Clinical Meeting and ExhibitionStation #4 Mandalay Bay Foyer, Level 2(beginning Tuesday morning)

Orchid Event Solutions Mandalay Bay Foyer, Level 2(Formerly The Housing Connection)ASHP’s official housing company is available to assist registrantswith hotel related matters the hotels are unable toanswer. Registrants may also call Orchid Event Solutionsdirectly at (877) 505-0675. Agents are available Monday-Fridayfrom 7:00am – 6:00pm, MST.Hours:Saturday and Sunday7:30am – 4:00pmWe would like to thank APPPharmaceuticals for theirsponsorship of the hotel keycards.Speaker Preview Room Surf D, Level 2The Speaker Preview Room has computers available for presenterswho want preview their slides or practice their presentation.Hours:Saturday – WednesdayThursday7:30am – 5:00pm8:30am – 3:00pmWi-Fi AccessMandalay Bay South Convention Center offers complimentaryWi-Fi access in the windowed alcove areas on Levels 2 & 3. Toensure fast speeds for all attendees, please limit your usage to15 minutes.Recharging StationsStation #1 Bayside Foyer, Level 1Station #2 Mandalay Bay Foyer, Level 2Station #3 Palm Foyer, Level 3Station #4 MGM Grand Conference Center, Level 1Network, relax, and recharge mobile phones, laptops or any ofyour portable mobile devices.We would like to thank Forest Pharmaceuticals for their sponsorshipof the recharging stations.Residency Showcase Bayside B, Level 1For an up-to-date list of residency programs, go to http://www.ashp.org/residencyshowcase/floorplans.aspx or view on theASHP Mobile Midyear app. Printed listings will be available atthe Showcase.Hours:MondayTuesday1:00pm – 4:00pm8:00am – 11:00am1:00pm – 4:00pmNew and Improved!Get the most out of The Midyear withyour smartphone or tablet. Users cancreate their own custom schedule, seeWhat’s On Now, browse the exhibits,receive timely announcements, viewhandouts, and much more. Availablefor Android TM andiPhone ® , or fromyour mobilebrowser atwww.ashp.org/mobilemidyear.Shuttle Bus ServiceSouth Convention Center(near Shark Reef)For your convenience, shuttle buses will provide transportationSaturday through Thursday between the Mandalay BayConvention Center and all official Midyear hotels except Luxorand THEhotel, as they are within walking distance of MandalayBay. Shuttle service will also be provided for the WednesdayEvening Event taking place at Mandalay Bay.For a complete shuttle schedule, please refer to page 130.The shuttle schedule is subject to change based on usageand traffic/weather conditions. Please check the MidyearNews & Views daily for updates to the schedule.Note: ASHP does not provide transportation between eveningsymposia and social events supported by the pharmaceuticalindustry, universities, and other organizations.47th ASHP Midyear Clinical Meeting and Exhibition 9

where is…THEhotelhacienda avenuemandalaybaytheatershoppesATmandalayplacehouseof bluesturfclubbartramentrancefrank sinatra driveEVENTS CENTEROpening Sessionself-PArk GArAGENORTHCONVENTIONCENTERProductTheater(Sunday)SymposiaEducationalSessionsLUPOmizuyaredwhitechina bluegrillFLEURstripsteakredsquarebordergrillaureoleBAYSIDEBUFFETeyecandyc A S I N OTOMANDALAY BAY HOTELTHEhotelLUXORnoodleshopRAFFLESCAFESHUTTLE STOPDrop-off/PickuporchidLOUNGEfourseasonslas vegas boulevardSOUTHCONVENTIONCENTERRegistrationEducationalSessionsExhibitsCareer Pharm’sPPSResidencyShowcase &PostersSEE DETAIL, OPPOSITE PAGE ashark reefaquariumconvention center parkingmandalay bay driverUssel road10 47th ASHP Midyear Clinical Meeting and Exhibition

ORLANDO WELCOMES BACKTHE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS IN 2013!We look forward to hosting the 48 th ASHPMidyear Clinical Meeting & ExhibitionDecember 8-12, 2013.Visit Orlando ®Orange County Convention Centerng Forward to Seeing You In Anaheim in 2014!occc.netOrlandoMeetingInfo.comAnaheim is proud to host ASHP in2014!You’ll feel like you are Walking onSunshine while networking in ourcampus environment under sunnyskies and palm trees! After hours,experience world class dining,entertainment and nightlife, allwithin walking distance at TheShops at Anaheim GardenWalkand Downtown Disney® District.We are looking forward to your return every 4 years!ASHP Midyear ClinicalMeeting and ExhibitionAnaheim Convention CenterDec 7 - 11, 201412 47th ASHP Midyear Clinical Meeting and Exhibition

education informationself-appraisal or plan. For more information go to http://connect.ashp.org/midyear2012/Education/GeneralEducationInformation.Audio-Synched PresentationsWith so many education sessions to choose from, it’s impossibleto catch them all . . . or can you? The full-meeting registrationfee includes access to all available audio-synchededucational session presentations. Download the sessionsyou’ve missed from the ASHP CE Center and “attend” at yourleisure. Log in at http://ce.ashp.org and click on Meetings.Note: CE is not available with audio-synched presentations.Educational Session HandoutsHandouts for educational sessions will be available online twoweeks prior to the meeting. If you would like to print handoutsfor the sessions you plan to attend, please do so before arrivingat the meeting. We also encourage you to follow along onyour smartphone or tablet. Handouts are available at www.ashp.org/mobilemidyear.Management Case StudiesFind out how your peers are meeting today’s administrativechallenges by discussing actual cases in pharmacy management.Each presentation focuses on one pharmacy department’sadministrative steps and decision-making processes, orplanning and implementing a new program, or resolving anadministrative problem. Cases may be presented by an individualor a team and will consist of a 20-minute case summary followedby a brief period of questions, answers, and discussion.Pearl SessionsThe object of each Pearl presentation is to convey one idea,concept, or fact that has been useful in day-to-day practice,and may not be widely known, understood, published, ortaught. Among the categories of Pearls this year are: Safetyand Quality, Management, Clinical, Informatics, EmergencyMedicine and, for students, Career Pearls and Clinical Pearlsfor Students.PostersPoster sessions encourage registrants to informally discusscurrent projects in pharmacy practice with colleagues. This isyour opportunity to pick up ideas from hundreds of successfulprograms that have worked in other healthcare systems. CE isNOT offered for poster sessions.Poster MentorsYou’re Needed! You’re Wanted! You’re INVITED—to be aPoster Mentor. Share an hour of your time with Student orResident poster presenters during The Midyear and you’ll begiving a much-needed boost to the rising stars of our profession.Stop by the Poster Hall during any one of the Student orResident Poster sessions and ask about being a mentor at thePoster Information booth.For a listing of Professional Posters and scheduled times forother poster presentations see page 87.Keeping track of your Continuing Pharmacy Education credits is about to get much easier!ASHP will soon help you manage your CPE reporting requirementsusing CPE Monitor—a national, centralized inventory of CPE credits.CPE Monitor is a powerful new system developed by The AccreditationCouncil for Pharmacy Education (ACPE) and the National Associationof Boards of Pharmacy (NABP), and will allow you 24/7access to your CPE credits —wherever you’ve earnedthem—all in one place! That means no morepaper copies of CPE statements to state boards!Create your e-Profile in CPE Monitor by followingthese three easy steps:1. Go to www.nabp.net2. Click on the Programs tab, then on CPE Monitor3. Set up your e-Profile and get your e-Profile IDDon’t delay—implementation is just around the corner.1647th HPAJ111_AJHP-EDS_1-2Ad.indd ASHP Midyear Clinical Meeting 1 and Exhibition5/18/11 1:48:42 PM

SUNDAYmeeting-at-a-glancesundayCONTINUEDTIME SESSION/EVENT ROOM PAGE CE CODE12:30pm – 2:00pm a Cardiology Jasmine B, Level 3 4812:30pm – 2:00pm a Hematology/Oncology Jasmine F, Level 3 4812:30pm – 5:00pm a The ASHP Federal Forum Mandalay Bay L, 54— — — — — —Viva Federal Pharmacy: The Future is Now Level 21:00pm – 2:00pm New and Prospective Pharmacy Technician Lagoon G, Level 2 46Training Program Directors and Instructors Meeting1:00pm – 2:00pm Applying for Residency Accreditation— Palm A, Level 3 46Finding the Pathway and Taking the Right Steps1:00pm – 2:00pm ResiTrak Update 2012 Banyan C, Level 3 461:00pm – 3:50pm Clinical Skills Competition Final Round Presentations Breakers E, Level 2 411:00pm – 4:00pm a State Affiliate Volunteer Conference Lagoon F, Level 2 261:30pm – 3:00pm a Making Students Indispensable: Level 2 54— — — — — —Involving Students in Patient Care Roles Mandalay Bay D,1:30pm – 3:00pm a Medication Informatics — Measuring Success Lagoon H, Level 2 482:00pm – 3:00pm New Pharmacy Technician Training Standard: Lagoon G, Level 2 46Open Forum2:00pm – 3:00pm Transition of Care: Future Residency Opportunities? Banyan C, Level 3 462:00pm – 4:00pm a More Creative Techniques to Engage Mandalay Bay B, 55— — — — — —Your Audience in Active Learning Level 22:00pm – 5:00pm a Satellite Symposia See Listing 83— — — — — —2:00pm – 5:00pm a Ambulatory Care Intensive Study B Islander Ballroom F, 33Lower Level,North Conv Ctr2:30pm – 4:00pm a Psychopharmacy/Neurology Jasmine B, Level 3 482:30pm – 4:00pm a Women’s Health Lagoon L, Level 2 492:30pm – 4:00pm a Immunology/Transplant Jasmine F, Level 3 493:00pm – 5:30pm Residency Program Directors and Preceptors South Seas J, 46Town Hall & PhORCAS update Level 35:00pm – 7:00pm a ASHP Foundation Donor Match Reception South Pacific D, 27Lower Level,North Conv Ctr5:30pm – 7:00pm a ASHP Best Practices Award in Islander Ballroom G, 27Health-System Pharmacy Poster ReceptionLower Level,North Conv Ctr5:30pm – 7:00pm Awards Ceremony and Student Society Showcase Mandalay Bay H, 41Level 25:30pm – 8:00pm a Satellite Symposia See Listing 83— — — — — —1847th ASHP Midyear Clinical Meeting and Exhibition

D E C E M B E RM3 mondaya CE Programa Special Eventa Networking SessionAmbulatory CareTIME SESSION/EVENT ROOM PAGE CE CODE6:15am–8:30am a Satellite Symposia See Listing 83— — — — — —6:30am–9:00am Veterans Affairs Residency Open Forum Banyan C, Level 3 467:30am–9:00am a 340B Program Update: Transitioning Mandalay Bay D, 55— — — — — —from Access to Integrity Level 27:30am–5:00pm CareerPharm’s PPS Bayside C, Level 1 68:15am–9:15am Student Posters Bayside B, Level 1 879:30am–11:00am a Opening Session and Keynote Mandalay Bay 28Events Center11:00am–3:00pm a EXHIBIT PROGRAM Shoreline AB, 6Level 211:15am–12:15pm a Pharmacy Technician Meet and Greet Jasmine B, Level 3 27Networking Session11:15am–12:15pm a Current Issues for Ambulatory Care Pharmacists: Lagoon H, Level 2 49Provider Status, Collaborative Practice, Health-Homes,and Billing for Services11:15am–12:15pm a IV Workflow Software – Implementation and Mandalay Bay D, 49Change Management Level 211:15am–12:15pm a Clinical/Quality Dashboards and the Jasmine F, Level 3 49Business Case for Pharmacy Services11:15am–12:30pm a ASHP-PAC Drug Shortages Victory Celebration Breakers E, Level 2 2711:15am–12:45pm ACPE Update 2012 Banyan C, Level 3 5511:15am–12:45pm a Big Ideas for Small and Rural Hospitals Palm H, Level 3 4911:15am–12:45pm a Pharmacoeconomics and Drug Mandalay Bay F, 50Policy Development Level 211:15am–12:45pm a Pain Management Reef D, Level 2 5011:15am–12:45pm a Nutrition Support Mandalay Bay J, 50Level 211:15am–12:45pm a Geriatrics Lagoon G, Level 2 5011:15am–12:45pm a Preceptor Skills Development Mandalay Bay L, 50Level 211:15am–5:30pm Student Programming See Listing 5011:30am–12:30pm Student Posters Bayside B, Level 1 8711:30am–1:00pm a Task Force on Organizational Structure South Seas B, 27Town Hall Meeting Level 311:30am–1:30pm a Midday Symposia See Listing 85— — — — — —1:00pm – 4:00pm Residency Showcase Bayside B, Level 1 91:30pm – 3:00pm a The Art of Precepting: It’s Not as Easy as it Looks Banyan C, Level 3 55— — — — — —2:00pm – 3:00pm a Process Improvement Essentials for South Seas H, 55— — — — — —Pharmacy Technicians Level 32:00pm – 3:30pm a The Emily Jerry Story: Lessons Learned from South Seas D, 55— — — — — —a Fatal Medication Error Level 32:00pm – 3:30pm a Pain, Sedation, and Delirium in the ICU: Breakers C, Level 2 56— — — — — —Cutting-Edge UpdatesMONDAY CONTINUES >MMONDAY47th ASHP Midyear Clinical Meeting and Exhibition19

MTIME SESSION/EVENT ROOM PAGE CE CODEmeeting-at-a-glancemondayCONTINUED2:00pm – 3:30pm a Domo Arigato, Mr. Roboto: Mandalay Bay L, 56— — — — — —Advancing Technician Roles Through IV Room Level 2Technology & Quality Assurance2:00pm – 3:30pm a What is the Pharmacy Enterprise? A Framework Reef D, Level 2 56— — — — — —for Success and for the Future of the Profession2:00pm – 3:30pm a Expecting the Unexpected: South Seas J, 56— — — — — —Treatment of Opiate Dependence in Pregnancy Level 32:00pm – 4:00pm a Are You Prepared? Mandalay Bay F, 56— — — — — —Excelling in Joint Commission Surveys Level 22:00pm – 4:00pm a Safety & Quality Pearls 2012 South Seas E, 57— — — — — —Level 32:00pm – 4:00pm a A ‘Bloody’ Debate — Mandalay Bay H, 57— — — — — —Which Agent is Best to Prevent Stroke in a Level 2Treatment Naive Atrial Fibrillation Patient?2:00pm – 4:00pm a Update in Emergency Department Practice: Mandalay Bay D, 58— — — — — —Service Optimization & Collaborative Practice Level 22:00pm – 4:00pm a Emerging Strategies for Neonatal Infections Mandalay Bay J, 58— — — — — —Level 22:00pm – 4:30pm Professional Posters Bayside B, Level 1 872:00pm – 5:00pm a Perspectives on International Collaboration South Seas B, 58— — — — — —in Pharmacy Education featuring the Level 3Donald E. Francke Medal Lecture3:00pm – 4:00pm a Optimizing Medication Safety: South Seas H, 58— — — — — —The Role of Pharmacy Technicians Level 33:00pm – 5:00pm a How to Establish Specialty Pharmacy Services Mandalay Bay B, 59— — — — — —in Your Health System: Experience from the Field Level 23:00pm – 5:00pm a Debates in Therapeutics 2012 Lagoon K, Level 2 59— — — — — —3:30pm – 5:00pm a Multi-Hospital Health System Pharmacy Reef D, Level 2 50Leaders and Executives3:45pm – 5:00pm a Replaced by Technology: Could the EMR South Pacific D, 59— — — — — —Materially Reduce the Role of the Pharmacist?Lower Level,North Conv Ctr4:00pm – 5:00pm a Management Case Studies A: Parts 1 & 2 South Pacific J, 59— — — — — —Lower Level,North Conv Ctr4:00pm – 5:00pm a Antimicrobial Safety: Spare the Kidneys South Pacific F, 60— — — — — —Lower Level,North Conv Ctr4:00pm – 5:00pm a Medical Marijuana: Rational Medicine South Seas D, 60— — — — — —or Potential Medication Misadventure? Level 34:00pm – 5:00pm a Transplant Pharmacy: Paving the Way Banyan C, Level 3 60— — — — — —to a Practice Model of Excellence4:00pm – 5:00pm a Hitting the Trifecta: Improving Safety and Quality Mandalay Bay L, 60— — — — — —Without Breaking the Budget Level 24:00pm – 5:00pm a Bring It On! Alternative Opinions Breakers C, Level 2 60— — — — — —on a Controversial Pain Topic4:30pm – 5:00pm a Management Case Studies B South Seas J, Level 3 61— — — — — —4:30pm – 5:00pm a Donald E. Francke Medal Lecture South Seas B, Level 3 274:45pm – 5:45pm Community Pharmacy Residency Open Forum Lagoon H, Level 2 472047th ASHP Midyear Clinical Meeting and Exhibition

D E C E M B E RTIME SESSION/EVENT ROOM PAGE CE CODE4:45pm – 5:45pm Regional Residency Conference Planners Meeting Palm C, Level 3 475:15pm – 6:15pm a Medication Safety Issues and Best Practices South Pacific J, 51Lower Level,North Conv Ctr5:15pm – 6:15pm a Who’s on First? Developing a Playbook for South Pacific D, 51Optimizing Transitions of CareLower Level,North Conv Ctr5:15pm – 6:15pm a International Registrants Gathering and Reception Jasmine B, Level 3 285:15pm – 6:30pm a Infectious Diseases South Pacific F, 51Lower Level,North Conv CtrMOṆTUESDAY5:30pm – 7:30pm a Satellite Symposia See Listing 83— — — — — —4 tuesdaya CE Programa Special Eventa Networking SessionAmbulatory CareTTIME SESSION/EVENT ROOM PAGE CE CODE6:15am–7:45am a Satellite Symposia See Listing 84— — — — — —7:00am–8:00am a Home Infusion Palm H, Level 3 517:30am–5:00pm CareerPharm’s PPS Bayside C, Level 1 68:00am–9:00am a Management Case Studies F: Parts 1 & 2 South Seas H, 61— — — — — —Level 38:00am–9:00am a Is Natural Better? Reef D, Level 2 61— — — — — —Nutraceuticals in the Treatment of Pain8:00am–9:15am a Productivity and Benchmarking: Breakers C, Level 2 61— — — — — —More than Just Doses Dispensed8:00am–9:30am a PGY1s, PGY2s, and Students, Oh My! Mandalay Bay J, 62— — — — — —Tools for Effective Precepting and Training Level 28:00am–9:30am a Critical Updates in Pediatrics, Part 1: Mandalay Bay B, 62— — — — — —Guidelines on UTI, Pneumonia, and Cardiovascular Risk Level 28:00am–10:00am a Innovations in Drug Information Practice Banyan C, Level 3 62— — — — — —and Research 20128:00am–10:00am a First Do No Harm: Prevention, Detection & Mandalay Bay F, 62— — — — — —Management of Drug-Induced Diseases Level 28:00am–11:00am a Oncology Pharmacy Specialty Sessions 2012: South Seas B, 63— — — — — —Advanced Topics in Practice Part 1 Level 38:00am–11:00am Residency Showcase Bayside B, Level 1 98:15am–9:15am a Hepatitis C in 2012: The Clinical Pharmacist’s South Seas J, 63— — — — — —Role in Successful Treatment Level 38:30am–9:30am a Strategies for Reducing Anesthesia Mandalay Bay D, 64— — — — — —Medication Errors Level 29:00am–10:00am Ask the Pharmacy Residency Accreditation Lagoon H, Level 2 47Surveyors Roundtable Discussion9:00am–11:00am a Management Pearls 2012 South Seas E, 64— — — — — —Level 3TUESDAY CONTINUES >M47th ASHP Midyear Clinical Meeting and Exhibition21

TTIME SESSION/EVENT ROOM PAGE CE CODEmeeting-at-a-glance2247th ASHP Midyear Clinical Meeting and ExhibitiontuesdayCONTINUED9:00am–11:00am a Ambulatory Guideline Roulette: Place Your Bets South Seas D, 64— — — — — —Level 39:15am–11:00am a Success Strategies for Implementing Mandalay Bay L, 65— — — — — —an Electronic Health Record Level 29:30am–10:30am a Management Case Studies G: Parts 1 & 2 South Seas H, 65— — — — — —Level 39:30am–11:00am a Bet on Red: New Challenges and Mandalay Bay H, 65— — — — — —Therapies for Bleeding Level 29:30am–11:00am a What You Need to Know to Get Started: Reef D, Level 2 65— — — — — —Opportunities in Medical Writing9:45am–11:00am a Immunizing Inpatients: South Seas J, 66— — — — — —Evidence Plus Effort Equals Optimization Level 310:00am–11:00am a Management Case Studies C: Parts 1 & 2 Mandalay Bay D, 66— — — — — —Level 210:00am–11:00am a Incorporating REMS into Your Daily Clinical Practice Mandalay Bay J, 66— — — — — —Level 210:00am–11:00am a Gram-Negative Infections and the Emergence Lagoon K, Level 2 66— — — — — —of Resistance: Is One Drug Enough?11:00am–12:30pm a Advancing the Role of Pharmacy Technicians Lagoon I, Level 2 51in Future Pharmacy Practice –The Role of CREST and Standardization11:00am–3:00pm EXHIBIT PROGRAM Shoreline AB, Level 2 611:15am–12:15pm a Developing Informal Leaders Mandalay Bay D, 51to Drive Practice Model Advancement Level 211:15am–12:30pm a Ambulatory Care Pharmacist Reimbursement Reef D, Level 2 52Opportunities: Hospital-Based, Physician-Basedand Retail Pharmacy-Based11:15am–12:30pm a The Pharmacist and Meaningful Use Palm H, Level 3 5211:15am–12:30pm a Special Poster Session Bayside Foyer, 87Introducing an Emergency Pharmacist into Your Level 1Institution: An ASHP Patient Care Impact Program TM 201211:15am–12:45pm a Clinical Leadership Lagoon G, Level 2 5211:15am–12:45pm a Anticoagulation Mandalay Bay F, 52Level 211:15am–12:45pm a Emergency Medicine Breakers C, Level 2 5211:30am–12:30pm Student Posters Bayside B, Level 1 8711:30am - 1:00pm BPS Open Hearing on Critical Care and Pediatric South Seas B, Level 3 28Pharmacy Specialty Petitions11:30am–1:00pm Pharmacy Forecast 2013-2017: Banyan C, Level 3 66Strategic Planning Advice for PharmacyDepartments in Hospitals and Health Systems11:30am–1:30pm a Midday Symposia See Listing 85— — — — — —12:00pm – 1:30pm a Pharmacy Practice Experiences: Student and Lagoon H, Level 2 52Preceptor Partnerships to Maximize the Interactions1:00pm – 4:00pm Residency Showcase Bayside B, Level 1 91:00pm – 5:30pm Student Programming See Listing 402:00pm – 3:00pm a Clostridium Difficile Infections: South Seas D, 68— — — — — —New Drugs and New Strategies Level 32:00pm – 3:00pm Ask the Pharmacy Residency Accreditation Lagoon H, Level 2 47Surveyors Roundtable Discussion

TIME SESSION/EVENT ROOM PAGE CE CODE2:00pm – 3:15pm a Are You Ready? Preparing and Responding to Codes Mandalay Bay D, 67— — — — — —Level 22:00pm – 3:30pm a Critical Roles for Certified Pharmacy Technicians South Seas J, 67— — — — — —in Practice Model Change Level 32:00pm – 3:30pm a Improving Patient Outcomes: South Seas E, 67— — — — — —Highlights from the ASHP-APhA Medication Level 3Management in Care Transitions ProjectTTUESDAYT2:00pm – 4:30pm Professional Posters Bayside B, Level 1 872:00pm – 3:30pm a Help, I Can’t Afford My Drugs! Banyan C, Level 3 67— — — — — —Emerging Opportunities in Caring for Indigent Patients2:00pm – 3:45pm a Advancing Pharmacy Practice & Medication Safety Mandalay Bay L, 67— — — — — —Through Medical Device Integration Level 22:00pm – 4:00pm a Preparing for 2013 — Congress, Agencies, and the Mandalay Bay J, 68— — — — — —States: What’s in Store for Health-System Pharmacy Level 22:00pm – 4:00pm a Clinical Pearls 2012 Mandalay Bay H, 68— — — — — —Level 22:00pm – 4:00pm a Soothing the Savage Beast: Mandalay Bay F, 70— — — — — —Vignettes in Complicated Pain Management Level 22:00pm – 5:00pm a Developing Ambulatory Care Clinical Services: Reef D, Level 2 70— — — — — —Financial Incentives and Service Value2:00pm – 5:00pm a Oncology Pharmacy Specialty Sessions 2012: South Seas B, 69— — — — — —Advanced Topics in Practice Part 2 Level 33:00pm – 4:00pm a Antibiotic Stewardship: Get on Board South Seas D, 68— — — — — —Before We Drown in Bacterial Resistance Level 33:00pm – 5:00pm a Corporate Pharmacy: Managing Pharmacy Breakers C, Level 2 70— — — — — —Across an Integrated Multi-Hospital Network3:30pm – 5:00pm a Management Case Studies H: Parts 1, 2 & 3 South Seas H, 70— — — — — —Level 33:30pm – 5:00pm a Compounding Conundrums: Outsourcing Lagoon K, Level 2 71— — — — — —Shortages, Clean Room Design, and Hazardous Drugs3:30pm – 5:00pm a Critical Updates in Pediatrics, Part 2: Mandalay Bay B, 71— — — — — —CHF, Cystic Fibrosis, and Traumatic Brain Injury Level 24:00pm – 5:00pm a Management Case Studies D: Parts 1 & 2 South Pacific D, 71— — — — — —Lower Level,North Conv Ctr4:00pm – 5:00pm a Management Case Studies E: Parts 1 & 2 South Seas J, Level 3 72— — — — — —4:00pm – 5:00pm a Providing Care Beyond Cure: Mandalay Bay F, 72— — — — — —Transitioning Patients to Palliative Care Level 24:00pm – 5:00pm a Integrated Precepting: Maximizing Learning Mandalay Bay L, 72— — — — — —for Both Students and Residents Level 24:00pm – 5:00pm a Therapy Updates: The Risks and Benefits Banyan C, Level 3 72— — — — — —of Immunosuppression in the Modern Era4:00pm – 5:00pm a Crisis in Medical Mycology: South Seas D, 68— — — — — —The Urgent Need to Adjust Antifungal Breakpoints Level 34:45pm – 5:45pm Managed Care Residency Open Forum Breakers F, Level 2 475:15pm – 6:30pm a Critical Care Banyan C, Level 3 535:15pm – 6:30pm a Primary Care/Pharmacotherapy Lagoon H, Level 2 535:30pm – 7:00pm a Satellite Symposia See Listing 84— — — — — —8:00pm – Midnight Students’ Night Out Cathouse 43Boutique Nightclub47th ASHP Midyear Clinical Meeting and Exhibition23

D E C E M B E R5 wednesdayTIME SESSION/EVENT ROOM PAGE CE CODE6:15am–7:45am a Satellite Symposia See Listing 84— — — — — —7:30am–5:00pm CareerPharm’s PPS Bayside C, Level 1 68:00am–9:30am a Management Case Studies I: Parts 1, 2 & 3 Banyan C, Level 3 72— — — — — —8:00am–9:30am a Management Case Studies L: Parts 1, 2 & 3 South Seas B, 73— — — — — —Level 38:00am–9:30am a Case-Based Approach to Insulin Initiation Reef D, Level 2 73— — — — — —and Intensification8:00am–9:30am a PPMI, IT, & Automation: How to Develop Mandalay Bay L, 74— — — — — —a Medication-Use System Strategic Plan Level 28:00am–9:30am a A Compounding Tragedy - A National Response Breakers C, Level 2 73— — — — — —8:00am–9:45am a Emergency Medicine Pearls 2012 South Seas E, 74— — — — — —Level 38:00am–9:45am a Lytes Off in Vegas! The Acute Management Mandalay Bay B, 74— — — — — —of Potassium and Calcium Disorders Level 28:00am–9:45am a Innovative Practice: Sustainable Approaches Mandalay Bay J, 74— — — — — —for Reducing 30-Day Hospital Readmissions Level 28:00am–9:45am a Transforming Care: Results from the Partnership South Seas J, 75— — — — — —for Patients Initiative Level 38:00am–9:45am a Residency Precepting: Strategies Worth Sharing Mandalay Bay D, 75— — — — — —Level 28:00am–9:45am a Troubled Teen 101: Topics in Adolescent Psychiatry South Seas H, 75— — — — — —Level 38:00am–9:45am a From Drug Shortage to Order Entry Error South Seas D, 75— — — — — —to Device Failure: Managing a TPN Event Level 3in a Large Health System8:30am–9:30am a Resisting Inertia: Lagoon K, Level 2 76— — — — — —Approaches to Managing Resistant Hypertension8:30am–9:30am Resident Posters Bayside B, Level 1 8710:00am–11:00am a Spotlight on Science — Nanotechnology in Medicine: Mandalay Bay F, 30— — — — — —How Very Tiny Solutions can Impact Big Problems Level 210:00am–11:00am Resident Posters Bayside B, Level 1 8711:00am–12:30pm a OR/Anesthesiology Lagoon G, Level 2 5311:00am–2:00pm EXHIBIT PROGRAM Shoreline AB, Level 2 611:15am - 12:30pm a Informatics in Pharmacy Practice Experiences Lagoon H, Level 2 5311:30am–12:30pm Resident Posters Bayside B, Level 1 8711:30am–1:30pm a Midday Symposia See Listing 86— — — — — —1:00pm – 2:00pm Resident Posters Bayside B, Level 1 872:00pm – 3:00pm a Management Case Studies J: Parts 1 & 2 Banyan C, Level 3 76— — — — — —2:00pm – 3:00pm a Strategies to Create a More Collaborative Workplace Mandalay Bay J, 76— — — — — —Level 22:00pm – 3:30pm a The Tortoise and the Hare of Chronic Kidney Disease: Mandalay Bay L, 76— — — — — —Slowing Disease Progression Level 22:00pm – 3:30pm a 2012 ASHP National Survey Results: South Seas H, 77— — — — — —Implications and Trends for Today’s Practice Level 32:00pm – 3:30pm a Hot Topics in Emergency Medicine South Seas D, 77— — — — — —Level 32447th ASHP Midyear Clinical Meeting and Exhibitiona CE Programa Special Eventa Networking SessionAmbulatory Care

TIME SESSION/EVENT ROOM PAGE CE CODE2:00pm – 3:30pm a Top Ten Medication Safety Issues Lagoon K, Level 2 77— — — — — —Related to Hospital Accreditation Standards2:00pm – 3:45pm a Reimbursement 2013: South Seas J, 77— — — — — —Unique and Compelling Opportunities Level 32:00pm – 4:00pm a Transitioning Through ADHD: Pharmacotherapeutic Reef D, Level 2 77— — — — — —Management from Childhood to Adulthood2:00pm – 4:00pm a Informatics Pearls 2012: Bytes of Informatics South Seas E, 78— — — — — —Level 32:00pm – 4:00pm a A Smooth Transition: Mandalay Bay B, 78— — — — — —Moving Pain Management from Here to There Level 22:30pm – 3:30pm Resident Posters Bayside B, Level 1 872:30pm – 4:30pm a Evidence Based Approaches to Breakers C, Level 2 79— — — — — —Pharmacokinetic Dilemmas 20123:00pm – 5:00pm a Beers, Antihypertensives, and Medical Home: South Seas B, 79— — — — — —An Update in Geriatric Practice Level 33:30pm – 4:30pm a Management Case Studies K: Parts 1 & 2 Banyan C, Level 3 79— — — — — —3:30pm – 5:00pm a Driving Quality with Real-Time Dashboards Mandalay Bay J, 79— — — — — —Level 24:00pm – 5:00pm a Antimicrobial Dosing in Obesity: Mandalay Bay D, 80— — — — — —Finding the Holy Scale Level 24:00pm – 5:00pm a Antipsychotics for the Non-Psychiatric Pharmacist: South Seas H, 80— — — — — —Across the Ages Level 37:45pm – 10:00pm a Wednesday Evening Event (ticket required) Mandalay Bay F, 31Level 2WWEḌD E C E M B E R6 thursdaya CE Programa Special Eventa Networking SessionAmbulatory CareTIME SESSION/EVENT ROOM PAGE CE CODE9:00am–11:00am a Hot off the Press... Mandalay Bay L, 80— — — — — —New Hypertension and Dyslipidemia Guidelines Level 29:00am–11:45am a Problem Solving 101: Reef D, Level 2 80— — — — — —Why Going Back to Basics Yields Better Results9:30am–11:30am a Strategies Worth Sharing: Practice Innovations Mandalay Bay J, 80— — — — — —Level 29:30am–11:30am a Controversial ICU Prophylactic Drug Therapies: Mandalay Bay D, 81— — — — — —Playing With a Royal Flush or Bluffing On a Busted Hand Level 212:05pm – 1:50pm a Thursday Networking Luncheon (ticket required) Mandalay Bay F, 31Level 22:00pm – 4:00pm a Advanced Topics: Mandalay Bay J, 81— — — — — —Treating Your Patient with Novel Oral Anticoagulants Level 22:15pm – 3:30pm a Frontline Pharmacists Make a Difference for Patients Mandalay Bay D, 81— — — — — —Level 22:15pm – 4:00pm a Office Anthropology: Reef D, Level 2 81— — — — — —New Ways to Approach Team Conflict for Better Results2:30pm – 4:00pm a Optimizing Antimicrobial Therapy for Mandalay Bay L, 81— — — — — —Gram-Negative Infections Level 2TTHURSDAY47th ASHP Midyear Clinical Meeting and Exhibition25

SPECiAL EVEnTS & ACTivitiESAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.SunDAY, DECEMBER 28:30am – 10:00am South Seas D, Level 3a First-Time Attendee Welcome Event andSelf-Guided ToursNew to The Midyear meeting? We know it can seem overwhelmingat first but fear not! This informal first-timer orientationwill give you insider tips on how to make the most of TheMidyear experience and a chance to meet your fellow attendees.Learn what The Midyear 2012 has to offer, how the OnsiteProgram can help you maximize your experience, what youcan expect in the Exhibit Hall, which events you won’t want tomiss, the benefits of ASHP membership and more.10:15am – 11:10am South Seas D, Level 3a First Time Attendee Welcome KeynoteFeaturing: Brad Nieder, MD – The Healthy Humorist ®Laughter is the Best MedicineDr. Brad is unique. (After all, how many physicians doyou know who can make you laugh?) He’s beendescribed as Jerry Seinfeld or Ray Romano...withan “MD.” Always a fan of standup comedy andimprovisation, Dr. Brad became a founding memberof the SIMPS improv troupe while attendingStanford University. During medical school atthe University of Colorado, he frequently performedstandup comedy throughout Denver forboth live audiences ... and cadavers. He thenmoved on to the Medical College of Virginia forhis residency. He still traverses the country, but heonce again lives in Denver, a general practitioner bytraining who some would say is really a specialist inHealthy Humor. And while he has NOT been published in theNew England Journal of Medicine, he has co-authored the bookHumor Me, which features his popular poem of wellness advice.And he has a CD and DVD, too! And some pretty cool T-shirts!Those hotshot academic physicians can’t say that!10:30am – 12:00pm Palm B, Level 3a Quality Advocates information ExchangeCollaborating on Improving Healthcare QualityMeet like-minded members who are passionate about improvingthe quality of pharmacy services in healthcare. See how otherpractitioners are incorporating quality improvement measuresinto health-system pharmacy dashboards. Discuss the creationand accumulation of pharmacy-sensitive quality measures thatcan be used to gauge outcomes related to medication therapymanagement.Discussion Topics:u Consider current pharmacy-sensitive accountability measuresu Discuss gaps in measurement and opportunity to addressimprovementu Understand how other members have overcome barriers intheir journey toward quality improvementThe Quality Advocates Information Exchange is an informalmeeting coordinated by ASHP’s Practice Development Divisionto inform the attendees on ASHP’s work on quality measuresand performance improvement.12:30pm – 2:00pm Mandalay Bay L, Level 2a The 2012 ASHP Federal ForumWelcome EventFeaturing Keynote Speaker:Carey “Vixen” LohrenzPracticing in healthcare is a high pressureenvironment with no room for mistakes.You are cordially invited by our colleaguesin Federal Pharmacy for a special openingceremony and motivational keynotespeaker, Carey Lohrenz.The opening ceremony includes thePresentation of the Colors and the NationalAnthem. ASHP President Kathryn R. Schultz,PharmD, MPH, FASHP and ASHP ChiefExecutive Officer Paul Abramowitz, PharmD,FASHP share thoughtful remarks.Our keynote speaker, Carey Lohrenz knows what it takes towin in one of the highest pressure, extreme environments imaginable:in the cockpit at Mach 2. As the first female F-14 TomcatFighter Pilot in the U.S. Navy, having flown missions worldwideas a combat-mission-ready United States Navy pilot, Lohrenzis used to working in fast moving, dynamic environments, whereinconsistent execution can generate catastrophic results. Carey’slessons learned about high performing teams and leadershipare applicable to our evolving pharmacy practice.1:00pm – 4:00pm Lagoon F, Level 2a State Affiliate Volunteer ConferenceHow State Affiliates Can Foster Changeand Move Practice ForwardAn annual event during The Midyear, the State Affiliate VolunteerConference is an opportunity to focus on important issues forstate organizations and to network with fellow affiliate leaders.Successful implementation of new pharmacy practice modelsrequires action on the part of state affiliate organizations, theirleaders, their members and even their non-members. These newpharmacy models will require change in how health-system pharmaciesoperate and how they work with patients. Fostering thechange process is a special challenge at the individual institutionlevel and also for the state affiliate organization. This challengecan be daunting or overwhelming to many pharmacy directorsand practitioners. However, it is critical that these changes occur.This interactive session will be divided into two segments. Inthe first, Max D. Ray, Pharm.D., M.S., L.H.D. (Hon.), Professorof Pharmaceutical Sciences, at the University of Tennessee,Memphis, will outline the need for change models. In the second,Thomas S. Thielke, M.S., FASHP, FFIP, RPh, EmeritusProfessor and Associate Director, Office of Global HealthUniversity of Wisconsin School of Pharmacy will presentselected case studies on how affiliate organizations can2647th ASHP Midyear Clinical Meeting and Exhibition

facilitate change in their states and will also facilitate severalroundtable discussion groups to develop plans for creatingchange within your state.5:00pm – 7:00pmSouth Pacific D, Lower Level,Mandalay Bay North Convention Centera ASHP Foundation Donor Match ReceptionThis reception is an opportunity to gather with ASHPFoundation staff, Board members and contributors to celebratethe year’s accomplishments and to maximize your own giftsupporting the Foundation’s mission of improving the healthand well-being of patients in health systems through appropriate,safe and effective medication use. A sponsor will matchdollar for dollar all donations made at the reception. We hopeto see you there!5:30pm – 7:00pmIslander Ballroom G, Lower Level,Mandalay Bay North Convention Centera ASHP Best Practices Award in Health-System Pharmacy Poster ReceptionThis poster reception will honor the awardees of the 2012ASHP Best Practices Award in Health-System Pharmacy. Thesix awardees will present posters of programs that have beennationally recognized to demonstrate best practices in healthsystempharmacy, especially in those areas that significantlyimprove the quality of patient care. Join us in honoring theaward recipients and discussing their programs with them.For additional information about this award program, visit www.ashp.org/menu/AboutUs/Awards/BestPracticesAward.aspx.Awarded by the American Society of Health-SystemPharmacists and sponsored by Amgen.MonDAY, DECEMBER 39:30am – 11:00amMandalay Bay Events Centera Opening SessionThe doors to the Event Center will open at 8:00am and seatingfor the Opening Session will begin at this time. Please planahead as this will be a very popular session. For more informationand important tips on attending the Opening Session, referto page 29.11:15am – 12:15pm Jasmine B, Level 3a Pharmacy Technician Meet and greetNetworking SessionJoin other technician attendees and kick off The Midyear 2012greeting colleagues and making new friends.11:15am – 12:30pm Breakers E, Level 2a ASHP-PAC Drug Shortages VictoryCelebrationJoin ASHP-PAC to celebrate our successful advocacy efforts toaddress the ongoing issue of drug shortages! Hear stories ofinvolvement in grassroots advocacy from the ASHP memberswhose efforts led to the passage and enactment of the “Foodand Drug Safety and Innovation Act of 2012.” Plus, ASHP’sgovernment affairs staff will share how our victory on drugshortages can help us achieve even more for the profession.To RSVP or for more information, go to www.ashp.org/pac.11:30am – 1:00pm South Seas B, Level 3a Task Force on organizational StructureTown Hall MeetingASHP desires to ensure that ASHP’s membership structureand governance keeps pace with the changing times, remainsrelevant and responsive to the needs of its members, and continuesto be a leader in preparing members for the continuingevolution of practice. ASHP has formed a Task Force onOrganizational Structure to propose to the Board of Directorsspecific recommendations regarding membership structure andgovernance as well as the ASHP policy development process.Attend the Town Hall Meeting to learn more about the TaskForce process and have opportunities to influence its direction.2:00pm – 5:00pm South Seas B, Level 3a Perspectives on internationalCollaboration in Pharmacy EducationFeaturing the Donald E. Francke Medal LectureThe lectures in this educational session will cover the followingtopics: major factors causing variability in the nature of pharmacyeducation around the world; the main reasons that collegesof pharmacy are interested in international collaborations;success factors in establishing cross-border collaborations inpharmacy education; and worldwide efforts to foster improvementin pharmacy education. The session will conclude withthe Donald E. Francke Medal Lecture.Donald E. Francke Medalist, Henri R. Manasse, Jr., Ph.D,Sc.D., FFIP, Retired ASHP Chief Executive Officer/ExecutiveVice President and current Professional Secretary of theInternational Pharmaceutical Federation (FIP), will present alecture titled, “Perspectives on the Global Evolution andDevelopment of Pharmacy.” The Donald E. Francke Medal wasestablished to honor individuals who have made significantinternational contributions to hospital pharmacy.All attendees of this session are invited to join Dr. Manasseafter his lecture to offer congratulations at a special receptionfor International Registrants. The reception is an opportunity tonetwork with your friends and colleagues from around theworld. Light refreshments will be served.For more information on this session see page 58.Donald E. Francke Medalist,Henri R. Manasse, Jr., PhD, ScD, FFIPHenri R. Manasse, Jr. was Executive VicePresident and Chief Executive Officer ofthe American Society of Health-SystemPharmacists (ASHP) from July 1, 1997until January 1, 2012 when he served asExecutive Vice President and ChiefExecutive Officer Emeritus through June30, 2012. He received his Bachelor ofScience degree in pharmacy from theUniversity of Illinois at the Medical Center, aMaster of Arts degree in educational psychologyfrom Loyola University of Chicago, and a Ph.D.in pharmacy administration from the University of Minnesota.Prior to joining ASHP, Dr. Manasse was Vice President forHealth Sciences, The University of Iowa, and Chairman of theBoard of the University of Iowa Health System. He previouslyserved as interim Vice Chancellor for Health Services,University of Illinois at Chicago Medical Center.continues >47th ASHP Midyear Clinical Meeting and Exhibition27

special events & activitiesHis previous positions include dean, professor of pharmacyadministration, and professor of health professions educationat the College of Pharmacy, University of Illinois at Chicago.He has adjunct professor appointments at the University ofIowa, and the University of Maryland, and most recently wasappointed Visiting Professor at the Peking Union MedicalCollege Hospital in Beijing, China and Honorary Professor atNottingham University, England. In 1996 he was elected to theInstitute of Medicine of the National Academy of Sciences, andis the 2007 recipient of the Harvey A.K. Whitney LectureAward. In 2012, he was awarded the prestigious Donald E.Francke Medal and Lectureship reflecting his work in internationalpharmacy.In 2005, Dr. Manasse was elected as the ProfessionalSecretary of the Board of Pharmaceutical Practice of theInternational Pharmaceutical Federation (FIP), and was nameda 2008 FIP Fellow. He continues in his elected position asProfessional Secretary of the International PharmaceuticalFederation (FIP) and expanded his work in FIPEd, a strategicinitiative of FIP in global reform of pharmacy education. He isalso engaged in academic pursuits at the University of Illinoisat Chicago, College of Pharmacy as Professor and DeanEmeritus and serves the Joint Commission International (JCI)as a member of the Steering Committee on Patient Safety.5:15pm – 6:15pm Jasmine B, Level 3a International Registrants gathering andReceptionInternational registrants are invited to join their colleagues andfriends from around the world at this special reception. It is theperfect opportunity to network and enjoy light hors d’oeuvres ina casual setting.TUESDAY, DECEMBER 411:30am - 1:00pm South Seas B, Level 3a BPS open Hearing on Critical Care andPediatric Pharmacy Specialty PetitionsThe Board of Pharmacy Specialties (BPS) (www.bpsweb.org)will conduct an opening hearing on the petitions to recognizepediatric pharmacy and critical care pharmacy as specialtieswithin the profession. This open hearing is part of the publiccomment period where BPS will solicit input from the pharmacyprofession, other health professions, third-party payers, andthe public in support of or in opposition to these petitions. TheBPS Board of Directors will consider the comments from thishearing in their deliberations along with the evidence presentedby the petitioning organizations to meet the criteria to recognizea new pharmacy specialty.9:30am – 11:00amOpening SESSionKeynote Speakera President Bill ClintonFounder of the William J. ClintonFoundation and 42nd Presidentof the United States of America“Embracing ourCommon Humanity”Mandalay Bay Events CenterPresident Clinton served the UnitedStates for eight years during a time ofunprecedented prosperity and change. Now,President Clinton is a powerful voice for progress aroundthe world as he shares his unique insights and observationswith audiences around the world. President Clinton’s publicspeeches describe the challenge of globalization, emphasizeour growing interdependence, and point the waytoward a common future based on shared goals and values.William Jefferson Clinton, the first Democratic presidentin six decades to be elected twice, led the U.S. to the longesteconomic expansion in American history, including thecreation of more than 22 million jobs.After leaving the White House, President Clinton establishedthe William J. Clinton Foundation with the mission toimprove global health, strengthen economies, promotehealthier childhoods, and protect the environment by fosteringpartnerships among governments, businesses, nongovernmentalorganizations (NGOs), and private citizens to turngood intentions into measurable results. Today the Foundationhas staff and volunteers around the world working to improvelives through several initiatives, including the Clinton HealthAccess Initiative, which is helping 4.5 million people livingwith HIV/AIDS access lifesaving drugs. The Clinton ClimateInitiative, the Clinton Development Initiative, and the ClintonGiustra Sustainable Growth Initiative — are applying a business-orientedapproach to fight climate change worldwideand to promote sustainable economic growth in Africa andLatin America. In the U.S., the Foundation is working tocombat the alarming rise in childhood obesity through theAlliance for a Healthier Generation, and is helping individualsand families succeed and to increase small businessgrowth in underserved communities through the ClintonEconomic Opportunity Initiative. Established in 2005, theClinton Global Initiative brings together global leaders todevise and implement innovative solutions to some of theworld’s most pressing issues. So far, more than 2,100Clinton Global Initiative commitments have improved thelives of 400 million people in 180 nations.In addition to his Foundation work, President Clinton hasjoined with former President George H.W. Bush three times –after the 2004 tsunami in South Asia, Hurricane Katrina in2005, and Hurricane Ike in 2008, and with President GeorgeW. Bush in Haiti in the aftermath of the 2010 earthquake.The Clinton Foundation also supports economic growth, jobcreation, and sustainability in Haiti.President Clinton was born on August 19, 1946, in Hope,Arkansas. He and his wife Secretary Hillary Rodham Clintonhave one daughter, Chelsea, and live in Chappaqua, N.Y.2847th ASHP Midyear Clinical Meeting and Exhibition

!TiPS FoR ATTEnding THE oPEning SESSionWe encourage you to consider the following tips for attending this popular session.For the most up-to-the-minute information, download the Mobile Midyear App or visit www.ashp.org/midyear2012.a Plan Aheadu Plan to register and pick up your badge before Monday morning to avoid the rush.u Badges are required; no one will be admitted who is not registered and wearing their badge.a Arrive Earlyu On Monday morning, shuttle buses will start running at 6:30am. Allow for extra travel time to the Mandalay BayEvents Center. Please note: Entrances into the Events Center, as well as areas adjacent to entrances, mustremain clear until Monday morning at 6:30am. In addition, the casino area adjacent to the Events Center entrancemust remain clear at all times.u Doors open at 8:00am and registrants will be directed to seats by ushers.u Space in the Events Center is limited and seats will be available on a first-come basis.u Saving seats for others or sitting end-of-aisle with empty seats in-between will not be permitted.u Those arriving after capacity is reached will be directed to overflow seating where a live audio/video version ofthe presentation will be shown.a Follow Directionsu ASHP staff and volunteers will be stationed in and around the Events Center to direct traffic flow and assist attendees.a Presidential AddressASHP President, Kathryn R. Schultz, PharmD, MPH, FASHP,Director of Pharmacy, HealthEast Bethesda Hospital, St. Paul, MNKathryn R. Schultz, PharmD, MPH, FASHP is Director of Pharmacy at HealthEast Bethesda Hospital in St. Paul,Minnesota. Dr. Schultz has 30 years of experience in hospital, home care, ambulatory, and community pharmacypractice. She received her Pharm.D. and a Masters degree in public health from the University of Minnesota.In her current role, Schultz has transformed the pharmacy practice model at Bethesda, increasing decentralizedservices, interdisciplinary team participation, and direct patient contact for pharmacists; advancing interntraining; and promoting greater responsibility for technicians.ASHP involvement includes member, Board of Directors and committee appointments including ASHP Awards (chair)and Treasurer Nominations. She chaired the Commission on Affiliate Relations and served as a Minnesota Delegate.Schultz was elected MSHP and CMSHP President and chaired numerous MSHP councils and committees. She received the MSHPOutstanding Student Award, Outstanding Pharmacist Award, and Hallie Bruce Memorial Lecture Award (MSHP’s highest honor).a CEo Award for Staff ExcellencePresented by ASHP CEO, Paul W. Abramowitz, PharmD, FASHP.The CEO Award for Staff Excellence recognizes an individual staff member who, in addition to performing all his/her normal jobduties with excellence, has also demonstrated exceptional initiative in contributing to ASHP. Specifically, this award recognizes astaff member who has provided an outstanding contribution by leading and/or developing a project of significant value for ASHPand/or has demonstrated sustained excellence over time to the advancement of ASHP.Joseph Hill, Director, Federal Legislative Affairs, Government Affairs DivisionDiane McCleskey, Director, eLearning and Logistics, Office of Resources Developmenta Acknowledgement of the Donald E. Francke MedalistHenri R. Manasse, Jr., PhD, ScD, FFIPFor more information see page 27.a ASHP Board of Directors AwardsHonorary MembershipA.J.M. (Ton) Hoek, MSc PharmacistA.J.M. (Ton) Hoek, CEO and General Secretary, International Pharmaceutical Federation (FIP), will be presented posthumouslywith the Honorary Membership Award at the Opening General Session.Mr. Hoek took the helm of FIP in 1999 and since that time brought the Federation to entirely new levels of developmentand accomplishments, especially in solidifying key global partnerships like that with the World Health Organization(WHO) and in incorporating FIP as a Founding Partner in the World Health Professions Alliance (WHPA). His efforts inextending FIP’s outreach and impact not only elevated FIP to the position of an influential global stakeholder in medicinesand health, but raised the image of the pharmacist as a healthcare provider around the world.The FIP is the global federation of 127 national organizations of pharmacists and pharmaceutical scientists, with itsmission to improve global health by: advancing pharmacy practice and science, to enable better discovery, development,access to and safe use of appropriate, cost-effective, and quality medicines worldwide. The FIP, founded in 1912, is a NonGovernmental Organization in official relation with the World Health Organization in Geneva since 1948.Ton Hoek was recently named an Officer in Order of Orange-Nassau, a royal declaration bestowed by the Queen of the Netherlands.He passed away after a brave battle with cancer. His wife, Dr. Wijnandien Hoek-Scholten will accept the award on his behalf.continues >47th ASHP Midyear Clinical Meeting and Exhibition29

special events & activitiesOPEning SESSion continuedASHP AWARD For Distinguished Leadership in Health-System Pharmacy PracticeJanet Silvester, RPh, MBA, FASHPJanet Silvester is the Director of Pharmacy and Emergency Services at Martha Jefferson Hospital in Charlottesville, VA.Janet holds a B.S. in Pharmacy from the Medical College of Virginia (MCV), Virginia Commonwealth University(VCU), a Masters in Business Administration from James Madison University, and is currently completing herDoctor of Pharmacy through Creighton University. Janet has spent 33 years in the hospital and has worked toadvance pharmacy practice by deploying an integrated, decentralized practice model for pharmacists toimprove medication related outcomes. In this model, distribution is highly automated and is managed largelyby well trained technicians.Janet is past president of both the American Society of Health-System Pharmacists (ASHP) and theVirginia Society of Health-System Pharmacists (VSHP). Janet also served on the ASHP Research andEducation Foundation Board and as Vice Chair for two years. Janet was Chair of the ASHP EVP SearchCommittee and was a voting participant in the ASHP Pharmacy Practice Model Summit. Janet is ImmediatePast Chair of the Virginia Pharmacy Congress, an organization of Virginia pharmacy stakeholders formed duringher VSHP presidency in 1998. Janet serves as a VSHP representative to that organization which has beenworking to expand scope of practice for pharmacists in Virginia. Janet serves on the Dean’s National AdvisoryCouncil for the VCU School of Pharmacy and as Chair for three years. She has received several honors, includingVSHP’s Pharmacist of the Year, RD Anderson Distinguished Leadership Award, and the Pharmacy Alumnus Service Award from theMCV Alumni Association.ASHP Board of Directors’ AWARD of HonorJune L. Dahl, PhDJune L. Dahl is Professor of Neuroscience at the University of Wisconsin School of Medicine and Public Health inMadison where she has taught second and fourth year medical students and graduate students in the Molecularand Cellular Pharmacology program. She received a PhD in physical chemistry and spent several years inbasic research before directing her attention to pain management. While serving as Chair of the WisconsinControlled Substances Board, she co-founded the Wisconsin Cancer Pain Initiative (later the WisconsinPain Initiative) whose goal was to systematically address the barriers responsible for the inadequate treatmentof pain. For many years, she served as Director of the Alliance of State Pain Initiatives, a network ofstate-based organizations whose mission was to promote pain relief nationwide. She has been involved ina variety of educational and quality improvement efforts to make pain management a priority in the nation’shealth care system. She worked with the Joint Commission to put pain assessment and management intothe standards used to accredit the nation’s healthcare organizations. She facilitated development of the firstcore curriculum for Pain Resource Nurses. She has served as a member of the editorial boards of Pain, theJournal of Pain, and the Journal of Opioid Management. She received a distinguished Teaching Award from theUniversity of Wisconsin as well as awards from the Wisconsin Medical Society, the American Pain Society, theAmerican Cancer Society, and the American Society for Pain Management Nursing.a ASHP Research and Education Foundation 2012 Award for Excellencein Medication-Use SafetyPresented by Diane B. Ginsburg, MS, RPh, FASHPSupported by a grant from the Cardinal Health Foundation.WEDnESDAY, DECEMBER 510:00am – 11:00am Mandalay Bay F, Level 2a Spotlight on ScienceNanotechnology in Medicine: How Very Tiny Solutionscan Impact Big ProblemsFeatured Speaker: Mansoor M. Amiji, PhD, RPhCo-Director, Nanomedicine Education and ResearchConsortium, School of Pharmacy, Bouve College of HealthSciences, Northeastern UniversityDr. Amiji is currently the Distinguished Professor and Chairman ofthe Department of Pharmaceutical Sciences and Co-Director ofNortheastern University NanomedicineEducation and Research Consortium (NERC)at Northeastern University in Boston, MA.NERC oversees a doctoral training grant inNanomedicine Science and Technologythat was co-funded by the NationalInstitutes of Health (NIH) and the NationalScience Foundation (NSF). Dr. Amijireceived the BS degree in Pharmacy fromNortheastern University in 1988 and aPhD in Pharmaceutical Sciences fromPurdue University in 1992.His research is focused on developmentof biocompatible materials from natural and3047th ASHP Midyear Clinical Meeting and Exhibition

synthetic polymers, target-specific drug and gene delivery systemsfor cancer and infectious diseases, and nanotechnologyapplications for medical diagnosis, imaging, and therapy. Hisresearch has received over $15 million in sustained fundingfrom the NIH, NSF, private foundations, and corporations.Dr. Amiji teaches in the professional pharmacy program andin the graduate programs of Pharmaceutical Science, Biotechnology,and Nanomedicine. He has published four books andover 200 book chapters, peer-reviewed articles, and conferenceproceedings. He has received a number of awards including theNSTI Award for Outstanding Contributions towards the Advancementof Nanotechnology, Microtechnology, and Biotechnologyin 2006 and the AAPS Fellowship and AAPS MeritoriousManuscript Award in 2007.The following awards will also be presented:u ASHP Research and Education Foundation 2012Literature Awardsu ASHP Research and Education Foundation 2012 Awardfor Sustained Contributions to the Literature of PharmacyPractice, presented to Dr. Mary H. H. Ensom, BS Pharm,PharmD, Professor, Pharmaceutical Sciences, University ofBritish Columbia and Clinical Pharmacy Specialist, Children’sand Women’s Centre of British ColumbiaFor more information on this session see page 76.7:45pm – 10:00pm Mandalay Bay F, Level 2a Wednesday Evening EventFeatured Entertainer: Jeff Tracta…CelebrityImpressionist/Comedian/SingerSee him first at The Midyear 2012! Jeff Tracta hasbecome the most sought-after impressionist in theworld today. With an array of over 100 spot-onimpressions, Jeff pays tribute to over fifty yearsof music, comedy, and pop culture. From themost current music artists -- the Black EyedPeas, Eminem, and Lady Gaga -- to legendaryicons such as Bob Dylan, Billy Joel, and EltonJohn -- and comedy tributes including AdamSandler, George Lopez, Joan Rivers, RayRomano, Chris Rock, Jeff Foxworthy, and theentire cast of Family Guy -- Jeff’s show has somethingfor everyone. But Tracta takes impressionismto an entirely new level. Cutting-edge technologyallows Jeff to transform himself into a galaxy of stars right infront of you. His multimedia experience is wowing audiencesaround the world.The Los Angeles Times calls him, “Hilarious! A comicgenius, Tracta is superb.”The show is designed as an after dinner event and final opportunityto have fun with colleagues and friends in a casual setting.Doors open at 7:45pm. Show begins at 8:30pm.Ticket InfoA ticket is required for entrance into the show and entitles theholder to one (1) free drink! A ticket is included in the full registrationfee, one-day Wednesday/Thursday, and exhibitor registration.Additional tickets can be purchased at the Ticket Salescounter in the Registration area (Mandalay Bay Foyer, Level2). Tickets are $30 and must be purchased no later than3:00pm on Wednesday. There are no refunds for this event.THURSDAY, DECEMBER 612:05pm – 1:50pm Mandalay Bay F, Level 2a Thursday networking LuncheonFeatured Speaker: Robyn BenincasaExtreme Performance:Why Winners WinWhat are the five most commonattributes of people who makea lifelong habit of winning?Robyn Benincasa – New York TimesBest-Selling Author and WorldChampion Adventure Racer – acceptsfull blame for inspiring people to doinsane things like climb Mount Kilimanjaro,run their first triathlon, start their own adventureracing teams, or start their own businesses.This is, after all, who she is and what shedoes: Robyn Benincasa inspires people to do amazing things.Benincasa has made an art form of extreme performanceby competing and winning at the highest levels of sport andbusiness. Revered as one of “California’s Fittest Women”, shespent her youth competing at the state and national level ingymnastics, diving, cross country, and judo in which shebecame a national champion. Soon after earning a Marketingdegree from Arizona State University, Robyn “started at the top’Fortune 500 pharmaceutical company where she earned theprestigious “Rookie of the Year” award.She has biked through jungles in Borneo, climbedHimalayan giants in Nepal, trekked across lava fields in Fiji,rafted rapids in Chile - and racked up multiple world championshiptitles along the way. In her spare time, Robyn, is a full-timefirefighter in San Diego, on the nation’s first all-female crew.NBC, ABC, CNN, ESPN, USA Network, Discovery Channel,Outdoor Life Network, PBS and FOX have all featured Robynand her amazing accomplishments. Add to those networkcredits editorials in Fast Company, Sport Illustrated, Vogue,Corporate & Incentive Travel, The New York Times, Outside,and Harper’s Bazaar.Robyn recently set a new Guinness World Record for paddling.“The biggest, strongest, and fastest competitors are notguaranteed a successful finish. It’s the teams that truly understandinterdependence, have empathy for one another, sharecommon ideals, manage adversity well, and check their egosat the start line that win these races.”Ticket InfoA ticket is required for entrance into the Luncheon and isincluded in the full registration fee. Additional tickets can bepurchased at the Ticket Sales counter in the Registration area(Mandalay Bay Foyer, Level 2). Tickets are $40 and must bepurchased no later than Monday at 3:00pm. There are norefunds for this event.Doors open at 12:05pm. Lunch service is based on availabilityafter 12:20pm.ASHP wishes to thank the city of Orlando, location of TheMidyear 2013, for partneringwith us as a cohostof Thursday’sLuncheon.47th ASHP Midyear Clinical Meeting and Exhibition31

PRE-MEETing WORKSHOPSAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.Unless otherwise noted, the following applies to all workshops:Pre-registration required. On-site registration may notavailable. Refreshments and lunch included for all full-dayworkshops unless otherwise noted.SATURDAY, DECEMBER 18:00am – 5:00pma Residency Learning System (RLS)ACPE Program #204-000-11-291-L04P8.0 Contact Hours / Application-basedFaculty: Margaret Chrymko, BS, PharmD; Kate Farthing,PharmD, BCPS; Katrin S. Fulginiti, BS Pharm, MGA; AnneLesko, PharmD; Kimberly M. Mattox, PharmD; William A.Miller, PharmD, FASHP; Steven Pass, PharmD, FCCM; BethB. Phillips, PharmD, BCPS; David J. Warner, PharmDRoom Assignments:RLS A: PGY1 New Programs Lagoon I, Level 2RLS B: PGY1 Existing Programs Lagoon L, Level 2RLS C: PGY2 New and Lagoon F, Level 2Existing ProgramsLearning Objectives:u Define a residency program’s purpose, structure, outcomes,goals, objectives, and learning experiences, and how to customizethem for individual residents.u Designate appropriate learning activities for given objectivesand learning experiences.u Apply skills for giving criteria-based assessment feedbackand designing assessment strategies for specified learningexperiences.u In given cases, apply effective precepting skills including useof appropriate preceptor teaching roles and monitoring residentprogress.u Identify elements of an effective residency quality improvementprogram, including preceptor development plans.8:00am – 12:00pm Lagoon H, Level 2a Design Your Residency Program forSuccess: Residency Learning System (RLS)for Programs Starting Within a Year32ACPE Program #204-000-12-230-L04P4.0 Contact Hours / Application-basedFaculty: Wayne F. Conrad, PharmDPlease note: Lunch not includedLearning Objectives:u Determine, in examples, if components of a residency program(purpose statements, selection of elective outcomes,program structure) meet accreditation standards, and commonreasons they don’t.u Assign goals to learning experiences in a manner that facilitateseffective teaching and evaluation.47th ASHP Midyear Clinical Meeting and Exhibitionu Determine appropriate learning activities for specified learningexperiences and objectives.u Describe accreditation requirements for assessment, customization,clinical teaching and program quality improvement.8:00am – 5:00pm Mandalay Bay D, Level 2a PharmPrep Live! A Board Review WorkshopOn-site Registration Fee: $90Faculty: Lawrence J. Cohen, PharmD, BCPP, FASHP; DianeB. Ginsburg, MS, RPh, FASHP; Charles W. Jastram, Jr.,PharmD, FASHP; James A. Karboski, PharmD; Jason M.Vaughn, PhD; John L. Woon, PharmD, FASHPPlease note: Lunch not included. Participants will receive afree 15-month access to ASHP’s PharmPrep Online—a $75value! Don’t forget to bring a calculator!Preparing for the Pharmacy Board Exam? We’ve got the workshopfor you! Ask around—faculty, advisors, and workshopalum will all agree that this is the “must attend” board review ofthe year. The editors of ASHP’s PharmPrep Interactive Case-Based Board Review bring the text to life at a full-day workshopto help you prepare for the board examination to become alicensed pharmacist. The workshop will incorporate evidencebasedapproaches to decision making and important diseasestates you are likely to encounter on the board exam.SunDAY, DECEMBER 27:30am – 5:00pm South Seas H, Level 3a 340B University TMOffered by Apexus, manager of the 340B Prime VendorProgram for the HRSA Office of Pharmacy AffairsACPE Program #221-999-11-051-L04P8.0 Contact Hours / Knowledge-basedFaculty: Christopher A. Hatwig, MS, RPh, FASHPACPE Credit: ProCE, Inc. is accredited by the AccreditationCouncil for Pharmacy Education as a provider of continuingpharmacy education. Statements of credit can be receivedonline at www.proce.com/340buniversity/December2012 at theconclusion of the workshop. Participants must complete anonline program evaluation in order to receive pharmacy CEcredit. No partial credit will be given.Apexus, manager of the 340B Prime Vendor Program forthe HRSA Office of Pharmacy Affairs, is offering a comprehensivereview of the 340B Drug Pricing Program. The goal of theprogram is to provide an understanding of the 340B drug pricingprogram, its development, implementation and policies surroundingits utilization.340B University will provide you with many opportunitiesfor hands-on, practical advice to help with program implementation,including: learning innovative strategies to reduce costs,remaining compliant and improving care. There will be opportunitiesto participate in small breakout sessions, to get theadvice from industry leaders, and to network with peers!continues >For presenter affiliations see Presenter Index

SUPER SunDAY: Ambulatory Care Review Course intensives9:30am – 12:30pma Ambulatory Care intensive Study AIslander Ballroom F, Lower Level, North Convention CenterACPE Program #0204-9999-12-989-L01-P3.0 Contact Hours / Application-basedFaculty: Amie Taggart Blaszczyk, PharmD,CGP, BCPS, FASCP; Joel Marrs, PharmD, BCPS, AQ-Cardiology, CLS; Stuart Haines,PharmD, BCPS, BCACPPlease note: Lunch not includedLearning Objectives:u Compare and contrast the updated American Geriatric Society Beers Criteria from previously published versions.u Analyze landmark clinical trials considered in the development of hypertensive guidelines.u Discuss the most recent dyslipidemia guidelines and clinical trials and the applications to practice.BCACP Recertification:This session is part of the ASHP/APhA professional development program for recertification of Board Certified Ambulatory CarePharmacists (BCACP) approved by the Board of Pharmacy Specialties (BPS). In the session room, you must register as a participantfor the recertification program.To earn recertification credit from the BCACP Recertification Intensive Study, BCACPs must attend the entire three hour sessionand successfully complete the online assessment by the deadline. Only completed tests will be eligible for credit; no partial orincomplete tests will be processed. The recertification exam fee is $50. After the Midyear Clinical Meeting, program participants willreceive email instructions to purchase and access the test. The recertification exam must be completed by May 31, 2013.2:00pm – 5:00pma Ambulatory Care intensive Study BIslander Ballroom F, Lower Level, North Convention CenterACPE Program #0204-9999-12-990-L01-P3.0 Contact Hours / Application-basedFaculty: Kelly Epplen, PharmD, BCACP; Ian McNicholl, PharmD, FCCP, BCPS (AQ-ID), AAHIVE; Mary Roederer, PharmD, BCPSPlease note: Lunch not includedLearning Objectives:u Compare and contrast updates made to the ACCP Consensus Guidelines for Antithrombotic Therapy and describe resultantpractice changes.u Design and justify an evidence based hepatitis C treatment plan including the management of adverse effects.u Analyze the recent literature, benefits, and clinical applications of pharmacogenomic testing.BCACP Recertification:This session is part of the ASHP/APhA professional development program for recertification of Board Certified Ambulatory CarePharmacists (BCACP) approved by the Board of Pharmacy Specialties (BPS). In the session room, you must register as a participantfor the recertification program.To earn recertification credit from the BCACP Recertification Intensive Study, BCACPs must attend the entire three hour sessionand successfully complete the online assessment by the deadline. Only completed tests will be eligible for credit; no partial orincomplete tests will be processed. The recertification exam fee is $50. After the Midyear Clinical Meeting, program participants willreceive email instructions to purchase and access the test. The recertification exam must be completed by May 31, 2013.Note: BCACPs may participate in the BCACP Recertification Intensive Study as many times as they wish throughout their 7-yearcertification cycle to attain the required recertification credit.For more information on the ASHP/APhA professional development program for recertification of Board Certified Ambulatory CarePharmacists (BCACP) go to www.ashp.org/certifications.For more information on BPS’ recertification requirements go to http://www.bpsweb.org/pdfs/2012_Recertification_Guide.pdfFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition33

pre-meeting workshopsLearning Objectives:u Describe the history, intent and statutory principals of the340B program.u Outline the process for addressing 340B policy and the maintenanceof integrity of the 340B Program participation.u List methods to optimize the value of 340B Prime VendorProgram services.u Describe the role of the manufacturer, wholesaler, prime vendorand entity in 340B pricing integrity.8:00am – 5:00pm Breakers B, Level 2a Basic Statistics: A non-ThreateningApproach to the Use of Statistics inClinical Trials 2012ACPE Program #204-000-12-245-L04P8.0 Contact Hours / Application-basedFaculty: James E. De Muth, PhDLearning Objectives:u Define statistical terms commonly encountered in theliterature.u List various graphic and numeric methods for presentingdescriptive statistics.u Discuss the major type of variables and define the generalrule of probability in inferential statistics.u Select the appropriate statistical test given the type of datapresented.u Evaluate example problems to identify the type of variablesinvolved and the most appropriate statistical test(s) to use.8:30am - 11:30am Lagoon I, Level 2a How to Start a Residency: Practical Toolsfor initiating a Pharmacy ResidencyTraining ProgramFaculty: Heath R. Jennings, PharmD, BCPSPlease note: Lunch not includedLearning Objectives:u Describe the benefits and summarize requirements forstarting a residency program that meets ASHP accreditationstandards.u Describe approaches taken by organizations with successfulnew residency programs.u Assess your organization’s readiness to start a residency.u Develop a plan to prepare your organization to start a residencyprogram.u Define challenges to starting a residency program, and strategiesfor meeting those challenges.1:30pm – 4:30pm Lagoon I, Level 2a Expanding a Residency ProgramWorkshopACPE Program #204-000-11-135-L04P3.0 Contact Hours / Application-basedFaculty: Leslie Kenney, BS Pharm, BCPS; Thomas W. Woller,MS, FASHPPlease note: Lunch not includedLearning Objectives:u Describe benefits of expanding your existing residencyprogram.u Describe approaches taken by organizations that successfullyexpanded their residency programs.u Identify challenges to expanding your residency program.u Develop strategies for meeting challenges of expanding yourresidency program.u Develop a preliminary plan to prepare your organization toexpand its residency program.ACPE Program #204-000-11-134-L04P3.0 Contact Hours / Application-based3447th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

Great eXPECTATionS LiVEfoR nEW PRACTitionERSAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.SATURDAY, DECEMBER 1 –SunDAY, DECEMBER 2Are you in your first five years of pharmacy practice? You’reprobably still finding your way – and your concerns, needs, andinterests aren’t the same as those of your colleagues who areseasoned practitioners.That’s why Great eXpectations Live– developed by ASHP toaddress the unique needs of new practitioners – is now a partof The Midyear Clinical Meeting. As a conference-within-a conference,Great eXpectations Live is the place for you to exploreworkplace challenges, mentorship, and clinical issues in anencouraging, motivational atmosphere.Best of all, entry into Great eXpectations Live is included inyour full Midyear registration fee!Ensure your success. Spend your weekend in Great eXpectationsLive, and see your way to a great future.a SATURDAY: Career ManagementFrom navigating hospital politics, to publishing your work, to conquering a certification exam, heaven knows you’re in over your headwhen it comes to advancing your career. Learn tips and tricks that your colleagues have used to not only make your career more successful,but more rewarding too.South Seas B, Level 38:30am – 10:30am10:45am – 12:15pm12:15pm – 1:15pm1:15pm – 2:30pm2:45pm – 3:45pm3:45pm – 4:00pm4:00pm – 5:00pmStarting Your Career as a Pharmacy Faculty MemberWhat’s Your Definition of Clinical Pharmacy Leadership? Empowering Yourself for AdvancementLunch on OwnHow to Succeed in Pharmacy without Really Trying: Expanding Your Professional Presencethrough Leading and WritingThe Secret Sauce of Professional Presence: Make Yourself Stand OutNetworking Energy Break There is no better time to meet fellow residents and new practitionersthan here. Flex your networking skills while learning interesting and helpful information. We’llprovide the energizing snacks for you to network network network!So You Wanna Be a Preceptor: Vital Tips and Tricks to Becoming the Best Preceptor You Can BeFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition35

u Identify steps necessary to advance clinical leadership roles.u List potential challenges for new practitioners to advancingclinically as a leader.Clinical Leadership: Early Steps and Challenges, Jason J.Schafer, PharmD, BCPSClinical Advancement: Establishing Yourself as a ClinicalLeader, Debra Goff, PharmD, FCCP1:15pm – 2:30pm South Seas B, Level 3a How to Succeed in Pharmacy WithoutReally Trying: Expanding Your ProfessionalPresence through Leading and WritingPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-302-L04PLevel of Content: General Interest1.25 Contact Hours/Application-basedProgram Chair/Moderator: Eric Wombwell, PharmD, BCPSLearning Objectives:u Design an individualized plan for leadership enhancement.u Identify daily practice responsibilities that can be easily convertedto a publishable manuscript.u Evaluate opportunities to increase involvement in leadershipand authorship activities which exist in your current practice.Importance of Professional Presence, Eric Wombwell,PharmD, BCPS; Karen Berger, PharmD, BCPSLeaders Education: Learning to Lead, Eric Wombwell,PharmD, BCPSAuthorship: You CAN Do It, Karen Berger, PharmD, BCPS2:45pm – 3:45pm South Seas B, Level 3a The Secret Sauce of Professional Presence:Make Yourself Stand outPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-303-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedPresenter: Deborah A. DeNure, BSLearning Objectives:u List ways to make a positive first impression.u Explain how social media influences professional presence.u Describe memorable verbal and non-verbal clues that canhelp or hurt how you are perceived.3:45pm – 4:00pm South Seas B, Level 3a Networking Energy BreakThere is no better time to meet fellow residents and new practitionersthan here. Flex your networking skills while learninginteresting and helpful information. We’ll provide the energizingsnacks for you to network network network!4:00pm – 5:00pm South Seas B, Level 3a So You Wanna Be a Preceptor:Vital Tips and Tricks to Becoming theBest Preceptor You Can BePlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-304-L04PLevel of Content: General Interest1.0 Contact Hours/Application-basedProgram Chair/Moderator: Asad E. Patanwala, PharmD,BCPSLearning Objectives:u Apply the socratic method of teaching to precepting studentsand residents.u Name characteristics of an exemplary rotation site and howto implement them in your setting.u Design a strategy for effective one-on-one teaching interactionsin your health care setting.Old Dog, New Tricks, Brian L. Erstad, PharmD, FASHPNew Dog, Old Tricks, Asad E. Patanwala, PharmD, BCPSSunDAY, DECEMBER 28:00am – 9:00am South Seas E, Level 3a Why a PIC isn’t a PICC, andOther Things You Should KnowAbout Lines, Drains, and TubesPlanned in cooperation with the ASHP New PractitionersForum and the ASHP Section of Ambulatory Care PractitionersActivity #204-000-12-305-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Carol J. Rollins, MS, PharmDLearning Objectives:u Interpret the chest radiograph report of vascular access tiplocation and identify it as central or peripheral placement.u Determine if a specific medication or therapy is appropriate toadminister via the available vascular access device.u Describe the typical use of various drains, such as JacksonPratt, or tubing.PIC vs PICC: Deciphering the Radiology Report, AmandaShearin, PharmDWhat’s the Vascular Access? Which Medication? Carol J.Rollins, MS, PharmDLines, Drains, and Tubes, Carol J. Rollins, MS, PharmD8:00am – 9:30am South Seas B, Level 3a Drug Literature Evaluation: Beyond theRandomized, Controlled Clinical TrialPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-310-L04PLevel of Content: Intermediate1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Robert D. Beckett, PharmD, BCPSLearning Objectives:u Interpret key components of commonly encountered studydesigns.u Assess the biostatistical methods used in commonly encounteredstudy designs.u Evaluate a piece of drug literature for appropriateness,strengths, limitations, and impact on practice.Noninferiority Trials, Lindsay Davison, PharmDPhamacoeconomic Analyses, Robert D. Beckett, PharmD, BCPSMeta-Analyses, Jean Cunningham, PharmD, BCPSFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition37

great eXpectations live SunDAY, DECEMBER 2continued9:15am – 10:15am South Seas E, Level 3a Ensuring Your Future: Developing a newPractice or Expanding a Current onePlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-306-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedPresenter: Sara J. White, MSLearning Objectives:u Evaluate unmet medication use needs as possible new orexpanded practice opportunities.u Develop a service vision based on those identified unmetneeds.u Describe the process to assess the feasibility, garner theneeded support and ultimately implement the practice.9:45am – 11:45am South Seas B, Level 3a Pain Management in the Critically-IllPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-311-L01PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Brian L. Erstad, PharmD, FASHPLearning Objectives:u Describe common mistakes practitioners make in the assessmentand treatment of pain in the critically-ill.u Name appropriate pain assessment techniques to be usedinthe ED and ICU.u Apply the correct techniques and treatment principles togiven patient cases.Pain Management in the ED, Asad E. Patanwala, PharmD,BCPSPain Management in the ICU, Brian L. Erstad, PharmD, FASHPIntegrated Pain Management, John J. Radosevich, PharmD10:30am – 12:30pm South Seas E, Level 3a Stop the Bleeding: Updates in HemophiliaManagement and Development of aFactor Stewardship ProgramPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-307-L04PLevel of Content: Intermediate2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Lindsey B. Poppe, PharmD, MSLearning Objectives:u Develop an appropriate treatment regimen for a hemophiliapatient given the patient specific parameters.u Evaluate the process for multidisciplinary involvement inchanging the medication use process of factor products to continuousinfusion.u Recommend reasons for implementing a Factor StewardshipProgram.u Delineate patient-oriented and financial-oriented stewardshipmetrics.Update on Hemophilia Management, R. Donald Harvey,PharmD, FCCP, BCOPMultidisciplinary Approach to Using Continuous Infusionsof Factor VIII, IX, and VIII/von Willebrand Factor, Lindsey B.Poppe, PharmD, MSDevelopment of a Factor Stewardship Program, ScottSavage, PharmD, MSMetrics of Factor Stewardship, Lindsey B. Poppe, PharmD, MS1:00pm – 3:00pm South Seas B, Level 3a Therapeutic Dilemmas in PK/PD,Pneumonia and Multi-Drug Resistance:Crossroads Between iD and iCUPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-312-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Simon W. Lam, PharmD, BCPSLearning Objectives:u Identify antibiotic pharmacokinetic differences in critically illpatients and the development of dosing regimens to meet pharmacodynamicgoals.u Apply recent evidence in hospital acquired pneumonia,healthcare associated pneumonia, and ventilator associatedpneumonia to optimize patient pharmacotherapy.u Evaluate the epidemiological trends, risk factors, and treatmentsof multi-drug resistant gram negative pathogens.u Assess the role of early antifungal therapy in critically illpatients.Antimicrobial Pharmacokinetics/Pharmacodynamics inCritically Ill Patients, Meghan Jeffres, PharmDUpdates in HAP, HCAP, and VAP, Garrett W. Schramm,PharmD, BCPSTreatment and Risk Factors of Multi-Drug Resistant GramNegative Pathogens, Christine J. Kubin, PharmD, BCPS(AQ-ID)Role of Early Antifungal Therapy in Critically Ill Patients:Risk Factors and Treatment Options, Simon W. Lam,PharmD, BCPS1:45pm – 3:15pm South Seas E, Level 3a Superbugs! Clinical Controversies in theManagement of Multiple-Drug ResistantBacteriaPlanned in cooperation with the ASHP New Practitioners ForumActivity #204-000-12-308-L01PLevel of Content: Advanced1.5 Contact Hours/Application-basedProgram Chair/Moderator: Rachel Chambers, PharmDLearning Objectives:u Apply recent literature on colistin safety and dosing to thecare of an individual patient.u Interpret the literature comparing carbapenems and noncarbapenembeta-lactams for the treatment of ESBL producingenterobacteriaceae.u Given an individual patient case, develop a rational, costeffective antimicrobial regimen for the management of methicillinresistant Staphylococcus aureus (MRSA) bacteremia.Colistin Dosing: Beans versus Bugs! Rachel Chambers,PharmDAre Carbapenems Always the Drug of Choice for Extended3847th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

Spectrum Beta-Lactamase (EBSL) Producers? Jason M.Pogue, PharmD, BCPS-IDMRSA Bacteremia with Elevated Vancomycin MIC’s: IsDaptomycin Really Superior? Molly E. Steed, PharmD3:00pm – 3:15pm South Seas B, Level 3a Networking Energy BreakThere is no better time to meet fellow residents and new practitionersthan here. Flex your networking skills while learninginteresting and helpful information. We’ll provide the energizingsnacks for you to network network network!3:15pm – 3:30pm South Seas E, Level 3a Networking Energy BreakThere is no better time to meet fellow residents and new practitionersthan here. Flex your networking skills while learninginteresting and helpful information. We’ll provide the energizingsnacks for you to network network network!3:15pm – 5:00pm South Seas B, Level 3a How to Recognize and Treat Drug-Induced Disorders Caused by HypertonicSaline, Linezolid, and other MedicationsPlanned in cooperation with the ASHP New Practitioners Forumand the ASHP Section of Clinical Specialists and ScientistsActivity #204-000-12-313-L01PLevel of Content: Intermediate1.75 Contact Hours/Application-basedProgram Chair: Freddy M. Creekmore, PharmD, BCPSModerator: David Cluck, PharmDLearning Objectives:u Recognize when a patient is suffering from one of the discusseddrug-induced disorders.u Evaluate patients’ drug regimens to discover the most likelymedication that is causing a drug- induced disorder.u Prevent or reduce the likelihood of the disorder recurring inpatients or occurring in other patients.u Develop a treatment plan to manage the disorder.Central Pontine Myelinolysis, Tyson Brooks, PharmD, BCPSDrug-Induced Thrombotic Microangiopathy, Anne Ormerod,PharmDDrug-Induced Rash with Eosinophilia and SystemicSyndrome, Nicole Bohm, PharmDSerotonin Syndrome, David Cluck, PharmD3:30pm – 5:00pm South Seas E, Level 3a New oral Anticoagulants: A Balancing ActBetween Safety and EfficacyPlanned in cooperation with the ASHP New Practitioners Forumand the ASHP Section of Clinical Specialists and ScientistsActivity #204-000-12-309-L01PLevel of Content: Advanced1.5 Contact Hours/Knowledge-basedProgram Chair: Joel C. Marrs, PharmD, BCPSModerator: Matthew Strum, PharmD, BCACPLearning Objectives:u Describe safety data comparing the bleeding risk betweenwarfarin, dabigatrin, and rivaroxaban.u Compare anticoagulation reversibility practices between warfarin,dabigatran, and rivaroxaban.u Describe stroke prevention data in patients with nonvalvularatrial fibrillation treated with warfarin, dabigatrin, orrivaroxaban.u Determine optimal practices for the safe use of new oralanticoagulants in the inpatient setting and the transition to outpatientsetting.Safety and Efficacy Analysis of New Oral Anticoagulantsversus Warfarin, Carrie Oliphant, PharmD, BCPS (AQCardiology)Comparison of Reversibility Practices for New OralAnticoagulants versus Warfarin, James B. Groce, III,PharmD, CACPOptimal Management of New Oral Anticoagulants duringTransitions between the Inpatient and Outpatient Setting,Daniel M. Witt, PharmD, BCPSFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition39

ASHP PHARMACY STUDENTFORUM PRogRAMMingAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.SATURDAY, DECEMBER 17:00am – 6:00pm Breakers E, Level 2a Clinical Skills CompetitionSemi-Final Round(Closed session)Sponsored by the ASHP Research and Education FoundationIt’s the battle of the best and brightest. Winning teams from thePreliminary Round (school-level) competitions at each collegeof pharmacy will compete in the Semi-Final round at thenational level, showcasing their clinical skills and knowledge.8:00am – 5:00pm Mandalay Bay D, Level 2a ASHP’s PharmPrep Live!A Board Review Workshop(Separate fee required. Registration is limited.Lunch is on your own.)Preparing for the Pharmacy Board Exam? We’ve got the workshopfor you! Ask around—faculty, advisors, and workshop alumwill all agree that this is the “must attend” board review of theyear. The editors of ASHP’s PharmPrep Interactive Case-BasedBoard Review bring the text to life at a full-day workshop to helpyou prepare for the board examination to become a licensedpharmacist. The workshop will incorporate evidence-basedapproaches to decision making and important disease statesyou are likely to encounter on the board exam. Participants willreceive a free 15-month access to ASHP’s PharmPrepOnline—a $75 value! Don’t forget to bring a calculator!SunDAY, DECEMBER 27:00am – 8:30ama Pharmacy Student ForumAdvisory group Meetings(Closed session by invitation only)Advisory Groups will meet in the following locations:u Admiral Boardroom, Level 3u Commanders Boardroom, Level 3u Explorer Boardroom, Level 3u Outrigger Boardroom, Level 3u Voyager Boardroom, Level 38:30am – 10:00am Lagoon L, Level 2a SSHP Leaders WorkshopAre you a current officer or emerging leader in your StudentSociety of Health-System Pharmacy (SSHP)? If so, thenplease plan to join other student leaders from across the nationto network, share, and reapply best practices from fundraisingto programming.4047th ASHP Midyear Clinical Meeting and ExhibitionPresenters: Thomas Achey, PharmD Candidate, AuburnUniversity, and Vice Chair, Pharmacy Student Forum ExecutiveCommittee, Helena, AL; Thomas Lupton, PharmDCandidate, University of Kansas, and Member, PharmacyStudent Forum Executive Committee, Lawrence, KS10:00am – 11:20am South Seas D, Level 3a Pharmacy Student Forum openingSessionModerator: Lisa Scherkenbach, PharmD Candidate,University of Minnesota, and Chair, Pharmacy Student ForumExecutive Committee, St. Paul, MNJoin your fellow ASHP Pharmacy Student Forum members tokick off The Midyear! This session will start with a lot of excitementas the top 10 finalist teams from the national ClinicalSkills Competition are announced!As an added bonus, you will be entertained and inspired by ourkeynote speaker, Brad Nieder, MD, as he gives you a dose ofhumor and advice. Don’t miss it!Laughter is the Best MedicineDr. Brad is unique. (After all, how many physiciansdo you know who can make you laugh?) He’sbeen described as Jerry Seinfeld or RayRomano...with an “MD.” Always a fan ofstandup comedy and improvisation, Dr.Brad became a founding member ofthe SIMPS improv troupe whileattending Stanford University. Duringmedical school at the University ofColorado, he frequently performedstandup comedy throughout Denverfor both live audiences ... and cadavers.He then moved on to the MedicalCollege of Virginia for his residency. Hestill traverses the country, but he onceagain lives in Denver, a general practitionerby training who some would say is really a specialistin Healthy Humor. And while he has NOT been publishedin the New England Journal of Medicine, he hasco-authored the book Humor Me, which features his popularpoem of wellness advice. And he has a CD and DVD, too! Andsome pretty cool T-shirts! Those hotshot academic physicianscan’t say that!11:30am – 12:30pma Residency Training PrimerCome learn the basics of residency training and how it canbenefit your career. These concurrent sessions will answer allthe questions you may have-from should I do a residency, allthe way to how to apply, and the basics of the match.“Residency Training 101: Should I Do a Residency?” is for studentswho have decisions to make about the residency pathand “Residency Training 102: Navigating the ApplicationProcess” is for those who have full confidence that a residencyis for them! It’s never too early to start preparing, and it is never

too late to get a few last minute tips, so stop by to find out whatyou can do to improve your residency prospects.Residency Training 101: South Seas J, Level 3Should I Do a Residency?Presenter: David Warner, PharmD, Associate Chief PharmacyOfficer, Duke University Hospital Department of Pharmacy,Durham, NCResidency Training 102: South Seas D, Level 3Navigating the Application ProcessPresenter: Sarah Boyd, PharmD, BCPS, Pharmacy ClinicalCoordinator, St. John’s Regional Medical Center, Joplin, MO1:00pm – 3:50pm Breakers E, Level 2a Clinical Skills CompetitionFinal Round PresentationsSponsored by the ASHP Research and Education FoundationIt’s the battle of the best and brightest. On Saturday, winningteams from the Preliminary Round (school level) competitionsat each college of pharmacy competed in the Semi-Final Roundat the national level, showcasing their clinical skills and knowledge.If you think you’ve got what it takes to be a champion inyour pharmacy school or maybe even at the Clinical SkillsCompetition next year, check out the Final Round presentationsfrom the top ten finalist teams. You are invited to stop in as anobserver and get a good idea of what it takes to be a nationalfinalist in the Clinical Skills Competition and enjoy the range ofpresentations at this inspiring and impressive session. Stickaround following the presentations for the case review with thenational case writer.1:30pm – 2:30pm South Seas D, Level 3a Mysteries of “The Match”Are you interested in a residency but afraid of “The Match”?Don’t be! Come learn how the pharmacy residency matchingservice works, learn strategies to successfully navigate throughthe Match, and get tips on what to do if you don’t match. Dispelthe rumor suggesting the Match is a scary process.Presenter: Mary Hess, PharmD, FASHP, FCCM, FCCP,Associate Dean, Student Affairs, Jefferson School of Pharmacy,Thomas Jefferson University, Philadelphia, PA; Lea Eiland,PharmD, BCPS, FASHP, Associate Clinical Professor &Associate Department Head of Pharmacy Practice; AuburnUniversity Harrison School of Pharmacy, Huntsville, AL2:30pm – 3:15pm South Seas D, Level 3a PhORCAS: The new CentralizedApplication System for PharmacyResidenciesPhORCAS is the new Pharmacy Online Centralized ApplicationService. Come to this session to learn about the new processand how it will save you time in the residency application process.You’ll also have an opportunity to ask questions aboutthis new service.Presenters: Robert Montgomery, Liaison International, LLC;Brendan Reichert, MS, RPh, Assistant Director of Med UseInformatics, The Johns Hopkins Hospital, Baltimore, MD3:15pm – 4:45pm South Seas D, Level 3a Make a Lasting impression: EvaluatingYour interview SkillsInterviews in your near future? There could be in a matter ofmonths as you pursue an internship, residency or other careeroptions, so be ready to make a lasting impression. This workshopincludes role-play and live examples of common interviewformats and questions you may encounter.Note: This workshop builds on the Webinar presentation“Interview Preparation: an Overview” (available at www.ashp.org/students) where you will learn about interview formats andhow to develop your personal interview strategy. It is stronglyrecommended that you view the Webinar prior to attending theworkshop, but not mandatory!Moderator: Mary Hess, PharmD, FASHP, FCCM, FCCP,Associate Dean, Student Affairs, Jefferson School of Pharmacy,Thomas Jefferson University, Philadelphia, PAFacilitators: Catherine Bourg, PharmD, BCPS, BCACP,Clinical Assistant Professor, University of Georgia College ofPharmacy, Athens, GA; Anthony C. Kessels, PharmD,BCPS, FASHP, Manager of Medication Safety, Barnes-JewishHospital, St. Louis, MO; Beth Bryles Phillips, PharmD,FCCP, BCPS, PGY2 Ambulatory Care Residency ProgramDirector and Clinical Professor, University of Georgia College ofPharmacy, Athens, GA; Jason J. Schafer, PharmD, BCPS,AAHIVP, Assistant Professor Pharmacy Practice, JeffersonSchool of Pharmacy, Thomas Jefferson University, Philadelphia, PAParticipants: Michelle Blair, PharmD, PGY 1 PharmacyResident, Billings Clinic, Billings, MT; Shelly King McIntire,PharmD, PGY2 Ambulatory Care Resident, University ofGeorgia and Charlie Norwood VA Medical Center, Athens, GA;Saranyu Selvanathan, PharmD, PGY1 Pharmacy Resident,Thomas Jefferson University Hospital, Philadelphia, PA; RyanMarkham, PharmD, PGY1 Resident, Oregon Health & ScienceUniversity (OHSU) Hospitals and Clinics5:30pm – 7:00pm Mandalay Bay H, Level 2a Awards Ceremony andStudent Society ShowcasePlease join us for an evening to recognize and celebrate theaccomplishments of our ASHP student leaders. StudentSocieties of Health-System Pharmacy (SSHPs) will spotlighttheir achievements in the annual Student Society Showcase.Take this opportunity to learn about best practices from SSHPsacross the nation and find out how you can reapply their successfulevent on your campus! Stick around to cheer on therecipients of the ASHP Student Leadership Award, ASHPFoundation Student Research Award, and of course, you don’twant to miss the announcement of the Clinical SkillsCompetition winners.Emcees: Samar Chakar, PharmD Candidate, University ofNew England College of Pharmacy, and Member, PharmacyStudent Forum Executive Committee, Lawrence, MA; JacalynJones, PharmD Candidate, Northeast Ohio Medical UniversityCollege of Pharmacy, Pharmacy Student Forum ExecutiveCommittee, Rootstown, OH47th ASHP Midyear Clinical Meeting and Exhibition41

pharmacy student forum programmingMonDAY, DECEMBER 38:15am – 9:15am Bayside B, Level 1a Student Poster Session11:15am – 12:45pm Mandalay Bay B, Level 2a Career Pearls: Days in the Lives ofHealth-System PharmacistsUndecided about your career path? From clinical to management,informatics to ambulatory care — the options seem endless!Hear from 12 pharmacists who work in every aspect ofhospital and health-system pharmacy practice to learn moreabout what a day-in-the-life is like. Take away informationabout careers you have interest in but never took the time tolearn about-you may even find something you never knew existed.Moderator: Thomas Lupton, PharmD Candidate, Universityof Kansas, and Member, Pharmacy Student Forum ExecutiveCommittee, LawrencePresentations:Group 111:20am – 12:00pmu Pediatric Specialist: Sherry Luedtke, PharmD, FPPAG,Associate Professor, Pharmacy Practice, Texas Tech HSCSchool of Pharmacy, Amarillo, TXu Medication Safety: Amanda E. Prusch, PharmD, BCPS,Clinical Pharmacy Specialist-Medication Safety, LancasterGeneral Health, Lancaster, PAu Small/Rural Hospital Practice: Debbie Cameron Sisson,RPh, MS, PharmD, Clinical Pharmacist, St Luke’s Hospital andAssistant Professor, University of Minnesota College ofPharmacy, Duluth, MNu Management and Administration: Michael Nnadi,PharmD, MHS, Corporate Vice President /Chief PharmacyOfficer, Novant Health, Winston-Salem, NCu OR/Anesthesia Specialist: Eric L. Chernin, RPh,Pharmaceutical Care Specialist-OR Pharmacy, SarasotaMemorial Hospital, Sarasota, FLu Informatics: Elizabeth Breeden, DPh, MS, AssistantProfessor, Department of Pharmacy Practice Director, Masterof Health Care Informatics Program, Lipscomb College ofPharmacy, Nashville, TNGroup 212:05pm – 12:45pmu Ambulatory Care: Mary Ann Kliethermes, BS, PharmD,Vice-Chair Ambulatory Care, Associate Professor, MidwesternUniversity Chicago College of Pharmacy, Downer’s Grove, ILu Oncology Specialist: Bradley Burton, PharmD, BCOP,CACP, Clinical Pharmacy Specialist- Medical Oncology, TheJohns Hopkins Hospital, Baltimore, MDu Critical Care Specialist: Stacey Folse, PharmD, MPH,BCPS, Medical ICU Clinical Pharmacy Specialist EmoryUniversity Hospital, Atlanta, GAu Emergency Medicine Specialist: Melinda J. Ortmann,PharmD, BCPS, Clinical Pharmacy Specialist - EmergencyMedicine, The Johns Hopkins Hospital, Baltimore, MDu Academia: Kelly M. Smith, PharmD, BCPS, FASHP, FCCP,Associate Dean, Academic and Student Affairs AssociateProfessor, Department of Pharmacy Practice and Science,University of Kentucky College of Pharmacy, Lexington, KYu Emerging Sciences-Pharmacogenomics: Kristine Crews,PharmD, BCPS, Translational Research Laboratory Directorand Director, PGY2 Pharmacogenetics Residency Program,Pharmaceutical Sciences Department, St. Jude Children’sResearch Hospital, Memphis, TN11:30am – 12:30pm Bayside B, Level 1a Student Poster Session1:00pm – 2:30pm Mandalay Bay B, Level 2a Fundamental Strategies to Secure aResidency: getting a Head Start as P1-P3In the tough competition for post graduate positions, how canyou stand out? After this presentation you will have fundamentaltips, a timeline, and answers to some of the questions youmay have, including: When do I start planning my residencysearch strategy? How can I set up a plan and task list to keepmyself on target for success as early as a P1 student? Howcan I excel in the interview process? You will receive candidadvice, and guidance that will be directly applicable to yourhunt for a post graduate residency or fellowship. You will beable to follow an outline of what you will need to do as a studentduring the P1 to P3 years in order to successfully prepareyourself for the residency or fellowship application process.There is no ultimate guarantee of securing a post graduatetraining program. However, session presenter JoshuaCaballero, Pharm.D., BCPP, Associate Professor at NovaSoutheastern University is one of the faculty that put together acourse that helped their students achieve an 83% residencyacceptance rate, compared to the national average of 60% inthe most recent match, making this one of the most successfulresidency preparation programs in the nation!Presenter: Joshua Caballero, PharmD, BCPP, AssociateProfessor, Nova Southeastern University College of PharmacyModerator: Samar Chakar, PharmD Candidate, University ofNew England College of Pharmacy, and Member, PharmacyStudent Forum Executive Committee, Lawrence, MAa Residency ShowcaseMonday, December 3:Tuesday, December 4:Bayside B, Level 11:00pm – 4:00pm8:00am – 11:00am1:00pm – 4:00pmThe Residency Showcase is for individuals pursuing residencypositions in 2013-14. Make the rounds all in oneplace – and save money and time. The Residency Showcaseis set up for your convenience, allowing you to meet with representativesfrom hundreds of programs across the country.Remember, the Showcase is continued on Tuesday, but eachprogram will only be available during one of the three timeslots so plan ahead! Business dress is recommended.For those students interested in visiting the ResidencyShowcase but who will not be pursuing a residency in 2013-14,please wait until the last hour to enter the Showcase. Be courteous– do not engage programs in a discussion at this pointas this prevents them from talking to those pursuing residencypositions next year! We recommend attending the studenteducational sessions on Monday and Tuesday designedexclusively for P1-P3 students.u Fundamental Strategies to Secure a Residency: Getting aHead Start as P1-P3u Effective CV and Resume Writing4247th ASHP Midyear Clinical Meeting and Exhibition

4:30pm – 5:30pm Mandalay Bay D, Level 2a Dollars and good SenseThe days of living off student loans and fast food are coming toan end. You are entering the real world of working professionals…andthe real world of mortgages, debt, bills, and investmentopportunities. This popular session will help you manageyour finances and learn strategies to help you handle your currentresponsibilities while planning for the future!Speakers: Eric Truvillion, Financial Representative andFinancial Advisor, New England Financial, Tampa, FL; AlonzoBarnes, Jr., Financial Representative, New England Financial,Tampa, FLModerator: Thomas Achey, PharmD Candidate, AuburnUniversity, and Vice Chair, Pharmacy Student Forum ExecutiveCommittee, Helena, ALTUESDAY, DECEMBER 47:00am – 9:00am Lagoon G, Level 2a SSHP Faculty Advisor Breakfast Workshop(Closed session by invitation only)Presenter: Diana L. Dabdub, Director, ASHP PharmacyStudent Forum, Bethesda, MD8:00am – 11:00am Bayside B, Level 1a Residency ShowcaseFor more information see page 9.11:30am – 12:30pm Bayside B, Level 1a Student Poster Session1:00pm – 3:00pm Mandalay Bay B, Level 2a Effective CV and Resume WritingGetting ready to enter the pharmacy workforce? Before youknow it, potential employers will start requesting your CV orresume. Get real-world advice on how to market your skillseffectively. Learn important tips about preparing your CV andresume and how to avoid common mistakes.Presenter: Joseph Bonnarens, PhD, Associate Dean forStudent Affairs, Manchester University College of Pharmacy,Fort Wayne, INModerator: Jacob Thompson, PharmD, MS, AssociateDirector of Pharmacy, UHS Wilson Medical Center, JohnsonCity, NY1:00pm – 4:00pm Bayside B, Level 1a Residency ShowcaseFor more information see page 9.4:30pm – 5:30pm Mandalay Bay D, Level 2a Clinical Pearls for StudentsBased on the popular Clinical Pearls session for practicingpharmacists, the session is custom tailored for a student audience.Come hear the valuable lessons learned as new practitionersshare clinical pearls that can help you prepare forresidency training or entering practice.Moderator: Adam Pate, PharmD, Assistant Professor,University of Louisiana at Monroe College of Pharmacy,Monroe, LAPresentations:Making Sense of Alphabet Soup, the ABC’s ofChemotherapyJill M. Comeau, PharmD, BCOP, Assistant ProfessorHematology/Oncology, University of Louisiana at MonroeCollege of Pharmacy, Gratis Assistant Professor ofMedicine, Feist-Weiller Cancer Center and Bone MarrowTransplant Unit, LSUHSC-Shreveport, Shreveport, LADefense Against the Dark Arts: Approach to the ToxicPatientNadia Awad, PharmD,PGY-2 Emergency Medicine PharmacyResident, Robert Wood Johnson University Hospital andRutgers, The State University of New Jersey, New Brunswick, NJA Shot?....Or Not!: Oral Management of Type 2 DiabetesKristen Pate, PharmD, Clinical Assistant Professor, Universityof Louisiana at Monroe College of Pharmacy, Monroe, LAVTE Prophylaxis in Hospitalized PatientsSarah A. Johannes, PharmD, Health-System PharmacyAdministration Resident, University of North Carolina Hospitaland Clinics, Chapel Hill, NCMedications and QTc: The Myths, The Facts andPharmacist’s ResponsibilityClaire Markway, PharmD, PGY2 Pediatric PharmacyResident, St. Louis Children’s Hospital, St. Louis, MO8:00pm – MidnightCatHouse(located inside the Luxor Hotel)a Students’ night outParty with a purpose! After a long week of education programming,interview, poster presentations, and more; you need to kickback and relax. Join pharmacy student from across the countryfor a fun night out in Las Vegas. You must present your SNOticket (included with your registration badge) and be 21 years orolder with proper ID to enter. Shuttle service will not be provided.47th ASHP Midyear Clinical Meeting and Exhibition43

ProgRAMMing FoR SMALL & RURALHoSPiTAL PRACTITionERSAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.SunDAY, DECEMBER 28:00am – 9:00am Reef D, Level 2a Small and Rural KeynoteIncreasing Pharmacist’s Role in Small, RuralHospitals: The Time is Now!Planned in cooperation with the ASHP Section ofInpatient Care PractitionersActivity #204-000-12-317-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedPresenter: Lance W. Keilers, MBAModerator: Anthea Francis, RPh, PharmD, BSLearning Objectives:u Name the challenges facing small, rural hospitalsin improving medication management.u Identify current findings around patient safetyand the important role of the pharmacist in small,rural hospitals.u Describe local, state and federal initiatives aimed atincreasing the pharmacist’s role in small, rural hospitals.u Explain how to lead the way to better care, better health, andlower costs for our nation’s healthcare system.9:10am – 10:10am Reef D, Level 2a Drug Shortages: Survival Tacticsfor the Perfect StormPlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-318-L04P/204-000-12-318-L04TLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedPresenter: Deborah R. Saine, MS, RPh, FASHPLearning Objectives:u Describe the current status of drug shortages in the US andimplications for patient safety.u Outline six components of a framework for safe managementof drug shortages.u Explain how appropriate management of shortages can avoidpatient harm.10:20am – 11:20am Reef D, Level 2a Don’t Forget the Chronic Problems:DM, HTN, and COPD Update forSmall and Rural PracticePlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-324-L01PLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Lois Parker, BSPresenter: Wes C. Pitts, PharmD, BCPS4447th ASHP Midyear Clinical Meeting and ExhibitionLearning Objectives:u Summarize recent updates to clinical practice guidelines forthe management of diabetes, chronic obstructive pulmonarydisease (COPD), and hypertension.u Explain practical tips for management of diabetes, COPD,and hypertension in the small and/or rural acute care setting.u Explain strategies for medication management in the smalland/or rural acute care setting for the management of diabetes,COPD, and hypertension.11:30am – 12:30pm Reef D, Level 2a PPMi initiatives in Small and RuralHospitals: Success Stories that Movethe Profession ForwardPlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-323-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: John Worden, PharmD, MSLearning Objectives:u Describe results of PPMI self-assesment survey data andhow they compare to your institution.u Describe services that have been successfully implementedin small/rural hospitals and their applicability in your setting.u Illustrate the value of successfully implementing an identifiedPPMI service.PPMI Survey, Jeff Little, PharmD, MPHSuccess Story: Fairview Northland, Mark D. Nelson, RPhSuccess Story: Berlin Hospital, Craig W. Griffis, BS Pharm1:40pm – 2:40pm Reef D, Level 2a Positioning Remotely Delivered PharmacistCare in Small and Rural SettingsActivity #204-000-12-321-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Kelly Morrison, BALearning Objectives:u Develop how to determine when remote pharmacy servicescould be an alternative in your setting.u Explain how to develop a guidelines checklist to weighremote pharmacy service alternative delivery models.u Identify problematic areas and develop action plan forsuccess.Welcome & Introduction: Understanding Remote OrderProcessing Models, Kelly Morrison, BAPositioning Remote Pharmacy Services: EnablingMeaningful Use Technology, Richard F. Stomackin, BSPharmComplying with Regulatory and State Laws, Heidi Bragg,MBA, RPhFor presenter affiliations see Presenter Index

2:50pm – 3:50pm Reef D, Level 2a Small and Rural Hospital Success Stories:Strategies Worth SharingPlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-320-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: John Worden, PharmD, MSLearning Objectives:u Identify opportunities to improve pharmacy services in thesmall and rural setting.u Describe steps for implementation of one pharmacy improvementopportunity in a small and rural practice.u Discuss human resource opportunities that have been successfullyimplemented in the small and rural hospital.Driving Quality and Outcomes with CMS Data, Ann Carder,PharmDTapping into External Funding Resources, Denise Fields,PharmDHRSA PSPC Practice Site, Todd D. Lemke, PharmD, CDE4:00pm – 5:15pm Reef D, Level 2a Quality Assessment and Measurementin Small and Rural HospitalsPlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-322-L04PLevel of Content: Intermediate1.25 Contact Hours/Knowledge-basedProgram Chair/Moderator: Debra L. Cowan, PharmDLearning Objectives:u Explain differences in The Joint Commission and CMS standardsand requirements for small, rural, critical access hospitalsversus other hospitals.u Describe new programs such as NRHA quality measures andtheir impact in your setting.u Name specific examples of how to meet measures/standardsin an effort to improve patient outcomes.Check It Out: Joint Commission Standards andInspections for Small and Rural Hospitals, Jeannell Mansur,BS Pharm, PharmD, FASHPRural Relevant Quality Measures: Hope for Small, RuralHospitals, Brock Slabach, MPH, FACHEFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition45

PHARMACY RESiDEnCY & TECHnicianTRAining ACTivitiESAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.Pharmacy Technician Training Program Directors and instructorsSunDAY, DECEMBER 21:00pm – 2:00pm Lagoon G, Level 2a New and Prospective PharmacyTechnician Training Program Directorsand instructors MeetingAttending this session is one of the first steps for those contemplatingthe submission of an application for accreditation orwho have very recently submitted an application and havenever been through an accreditation site survey. The “nutsand-bolts”questions asked by program directors and instructorsabout recently established or newly developing programswill be discussed. Time permitting, other topics may include areview of the critical aspects of accreditation and commentaryResidency Program Directors and Preceptorson specific elements of the accreditation standards. Come andlearn the essentials for getting your pharmacy technician trainingprogram off to a good start!2:00pm – 3:00pm Lagoon G, Level 2a New Pharmacy Technician TrainingStandard: open ForumA perfect forum for pharmacy technician training program directorsand instructors to learn about hot issues that are happeningin pharmacy technician training program accreditation. Thisyear’s topic is sizzling! Come to the session and provide feedbackregarding the upcoming pharmacy technician training programaccreditation standard. The document will soon beleaving the draft stage so your comments are essential!SunDAY, DECEMBER 21:00pm – 2:00pm Palm A, Level 3a Applying for Residency Accreditation—Finding the Pathway and Takingthe Right StepsAttendance at this session should be one of the first steps forindividuals contemplating submission of an application forASHP-accreditation of a pharmacy residency. Criteria, steps,and timelines for applying for pre-candidate status and accreditation(candidate status) will be detailed. Come and learn theessentials for getting your program off to a good start!1:00pm – 2:00pm Banyan C, Level 3a ResiTrak Update 2012Did you know that you are now able to copy one resident’s scheduleto another in ResiTrak? Have you ever logged into ResiTrakand wished you could sort and organize your task list? Do notmiss out on this opportunity to see a review of all the improvementsand updates that occurred in ResiTrak this year. You willbe able to see demonstrations of the latest changes and gaininsight into maximizing your use of the system. Whether you area program director, preceptor, or resident that utilizes ResiTrak,your attendance at this session will definitely be beneficial!2:00pm – 3:00pm Banyan C, Level 3a Transition of Care: Future ResidencyOpportunities?Pharmacists are getting more involved in the continuity of careof patients from the acute care settings back to home. With thedevelopment of Accountable Care Organizations is this anopportunity for more advanced training, maybe even residencytraining to develop this area of expertise? Come hear theexperts and how they are developing programs to fill the needs4647th ASHP Midyear Clinical Meeting and Exhibitionfor now and the future for ensuring optimal patient care in thepharmacy practice model.3:00pm – 5:30pm South Seas J, Level 3a Residency Program Directors andPreceptors Town Hall & PhORCAS updateWhy will this Residency Preceptors Town Hall meeting be differentthan any other? Catch a perfect opportunity to gain all of thehot off of the press information regarding accreditation issuesfrom the Commission on Credentialing and ASHP related activities(residency expansion, critical factors, duty hours, and centralizedapplication services, to name a few). The first part ofthe session will be spent discussing updates from the Commissionon Credentialing by Janet Teeters, Director, AccreditationServices Division and Michelle McCarthy, Chair of the Commissionon Credentialing. Robert Montgomery, from Liaison International,will be a guest during the later part of the session. He’ll providethe group with the latest and greatest from PhORCAS(Pharmacy Online Residency Centralized Application Service).He’ll also be available to answer any questions that the grouphas regarding the centralized application service. This is aforum not to be missed! All current and future residency programs,preceptors, and residents are encouraged to attend.MonDAY, DECEMBER 36:30am – 9:00am Banyan C, Level 3a Veterans Affairs Residency open ForumThis open forum will provide an opportunity for residency programdirectors and preceptors to discuss issues concerningresidency training in the VA System with members of theVeterans Affairs, ASHP Commission on Credentialing, andASHP Accreditation Services Division staff. Come share thisexcellent opportunity to network with other practitioners in theVeterans Affairs environment!

1:00pm – 4:00pm Bayside B, Level 1a Residency ShowcaseFor more information see page 9.4:45pm – 5:45pm Lagoon H, Level 2a Community Pharmacy Residency openForumThis open forum will provide an opportunity for residency programdirectors and preceptors to discuss issues concerningcommunity pharmacy residency training with members of theASHP Commission on Credentialing, ASHP AccreditationServices Division staff, and APhA staff. Come share this excellentopportunity to network with other practitioners in the communitypharmacy arena.4:45pm – 5:45pm Palm C, Level 3a Regional Residency Conference PlannersMeetingThis meeting provides an opportunity for the planners of theresidency regional conferences to share ideas and discussissues to improve each regional residency conference.TUESDAY, DECEMBER 48:00am – 11:00am Bayside B, Level 1a Residency ShowcaseFor more information see page 9.9:00am – 10:00am Lagoon H, Level 2a Ask the Pharmacy Residency AccreditationSurveyors Roundtable DiscussionASHP Accreditation Services Division staff lead surveyors willbe available to answer any questions regarding starting a residencytraining program, getting ready for an accreditation surveyand more. Come out to a great session where you canspeak one-on-one with lead surveyors to get the informationthat you need. There are two sessions: 9:00-10:00am and2:00-3:00pm to accommodate the busy schedules of thoseexhibiting at the Residency Showcase.1:00pm – 4:00pm Bayside B, Level 1a Residency ShowcaseFor more information see page 9.2:00pm – 3:00pm Lagoon H, Level 2a Ask the Pharmacy Residency AccreditationSurveyors Roundtable Discussion(See above.)4:45pm – 5:45pm Breakers F, Level 2a Managed Care Residency open ForumThis open forum will provide an opportunity for pharmacy residencyprogram directors and preceptors to discuss issues concerningmanaged care residency issues with members of theASHP Commission on Credentialing, ASHP AccreditationServices Division staff, and AMCP staff. Come share this excellentopportunity to network with other practitioners in the managedcare pharmacy environment.47th ASHP Midyear Clinical Meeting and Exhibition47

PHARMACY PRACTiCE SECTionsAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.Sessions marked with this icon relate to ambulatory care.Networking SessionsSunDAY, DECEMBER 212:00pm – 1:30pm Mandalay Bay B, Level 2a Investigational Drug ServicesNetworking Session Hosted by the Section of Inpatient CarePractitionersFacilitator: Helen R. Tamer, PharmD, Clinical Pharmacist,Investigational Drug Service, University of Michigan Hospital,Clinical Assistant Professor, University of Michigan College ofPharmacy, Ann Arbor, MIInvestigational Drug Services Practitioners and interested personsshould attend this networking session to learn and discusscurrent issues and regulatory concerns in the IDS arena.Discussion Topics:u New Regulatory Guideline Update and Current Issuesu Research and Ethics – When Quest for Knowledge Conflictswith Patient Safety12:30pm – 2:00pm Lagoon L, Level 2a Pediatrics/NeonatalNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Jennifer Hamner, PharmD, Manager ofProfessional Development and Residency Program Director,Children’s Hospital Colorado, Aurora, CODiscussion Topics:u Management of Drug Shortages in Pediatricsu Chloral Hydrate Discontinuationu Off Label routes – Inhalation/Nebulization/Intrathecalu Management of Pediatric Appendicitisu Combination Narcotic Analgesics and Codeine12:30pm – 2:00pm Jasmine B, Level 3a CardiologyNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Christopher Betz, PharmD, BCPS, AssociateProfessor, Department of Clinical and Administrative Sciences,Sullivan University College of Pharmacy, Louisville, KYDiscussion Topics:u Anticoagulants in ACS and Atrial Fibrillation: What’s changed?u Dual Antiplatelet Therapy: Which path to choose?u The future of anticoagulant usage in heart failure: What didWARCEF tell us?u Cardiovascular Risk Reduction Guidelines 2012?12:30pm – 2:00pm Jasmine F, Level 3a Hematology/OncologyNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Bradley Burton, PharmD, BCOP, CACP, ClinicalPharmacy Specialist, Medical Oncology, The Johns HopkinsHospital, Baltimore, MDDiscussion Topics:u Drug Shortagesu Oral Chemotherapy Programsu Chemotherapy Order Set Developmentu Where do you work as a hematology/oncology pharmacist?Share your experiences1:30pm – 3:00pm Lagoon H, Level 2a Medication informatics – MeasuringSuccessNetworking Session Hosted by the Section of PharmacyInformatics and Technology Executive CommitteeFacilitators: Kevin Marvin, RPh, MS, FASHP, Kevin MarvinConsulting LLC, Burlington, VT; Sylvia Thomley, PharmD,MS, Director, IT Clinical Informatics, Sanford Health, SiouxFalls, SDDiscussion Topics:u What is success?u Why develop standard measures now?u Meaningful Use and Medication Related Measuresu Numerators and denominatorsu Breakout to discuss and identify measures in the followingareas: Inpatient operations and automation, Inpatient andAmbulatory Clinical practice, Clinical Decision Support, andPharmacy Informatics Education/Work Force2:30pm – 4:00pm Jasmine B, Level 3a Psychopharmacy/NeurologyNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Cherry W. Jackson, PharmD, BCPP, FASHP,Professor of Pharmacy, Auburn University, Auburn, ALDiscussion Topics:u Introduction to Psychiatry Residency Directors andCandidates interested in Networkingu Collaborative Practice Agreements for Psychiatric Pharmacistsu Starting New Clinical Programs in Psychiatric Facilitiesu Medicaid Prescription Limits in Psychiatry4847th ASHP Midyear Clinical Meeting and Exhibition

2:30pm – 4:00pm Lagoon L, Level 2a Women’s HealthNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Fancy G. Manton, PharmD, Clinical PharmacyCoordinator, Woman’s Hospital, Baton Rouge, LADiscussion Topics:u Drugs in Obstetrics (HIV, Contraception, and Labor Induction/Augmentationu Obstetrical Quality Initiatives (Reducing early elective inductions)u Cardiovascular Disease in Womenu Menopause and Related Conditions2:30pm – 4:00pm Jasmine F, Level 3a Immunology/TransplantNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Amy G. Krauss, PharmD, BCPS, ClinicalPharmacy Specialist, Solid Organ Transplant, MethodistUniversity Hospital, Memphis, TNDiscussion Topics:u Is Transplant on the path to becoming a BPS-certified specialty:an update?u “Novel” drug distribution avenues: the case of Campathu Immunosuppressant related REMs and recent labeling changesu Generic tacrolimus and mycophenolate products: what hasbeen your program’s experience?u Transplant Pharmacist Documentation: How is your programmeeting CMS “requirements”MonDAY, DECEMBER 311:15am – 12:15pm Mandalay Bay D, Level 2a IV Workflow Software – implementationand Change ManagementNetworking Session Hosted by the Section of PharmacyInformatics and Technology’s Advisory Group on PharmacyOperations AutomationFacilitators: Kavish Choudhary, PharmD, MS, Director,Pharmacy Support Services, University of Utah Hospitals &Clinics, Salt Lake City, UT; Brandon J. Ordway, PharmD, MS,Pharmacy Operations Manager, St. Joseph’s Hospital-HealthEast Care System, St. Paul, MNDiscussion Topicsu Quick overview of softwareu Implementation and installation – tips for successu Managing change for staff, focusing on techniciansu Assessment tools11:15am – 12:15pm Jasmine F, Level 3a Clinical/Quality Dashboards and theBusiness Case for Pharmacy ServicesNetworking Session Hosted by the Section of PharmacyPractice Managers’ Advisory Group on Pharmacy BusinessManagementFacilitator: Michael DeCoske, PharmD, BCPS, AssociateChief Pharmacy Officer, Ambulatory Services, Duke UniversityHospital, Durham, NCIn the face of increasing pressure to measure the value of pharmacyservices and to affect patient outcomes, discuss strategiesand solutions for measuring the work pharmacists performand illustrate in a meaningful way using dashboards.Discussion Topics:u Current successful strategies, brainstorm new measures anddiscuss how to get them implementedu Clinical quality dashboards currently used by memberinstitutionsu Strategize how metrics can be used to develop and marketnew and existing pharmacy services11:15am – 12:45pm Palm H, Level 3a Big ideas for Small and Rural HospitalsNetworking Session Hosted by the Section of Inpatient CarePractitioners’ Advisory Group on Small and Rural HospitalsFacilitator: Navy Chhay, PharmD, Director of PharmacyServices, Sauk Prairie Memorial Hospital & Clinics, Prairie duSac, WISmall and Rural Hospitals face many challenges to comply withfederal and state regulations while ensuring their patientsreceive safe and quality healthcare as their urban and academiccenter counterparts. Those interested in networking withcolleagues to address the issues facing practitioners who practicein rural and frontier areas of the country should scheduletime to attend this session.Discussion Topics:u The Role of Small and Rural Hospitals in Advancing NontraditionalResidency Programsu C-suite Buy-in to Fund Clinical Pharmacy Services in RuralInstitutions11:15am – 12:15pm Lagoon H, Level 2a Current issues for Ambulatory CarePharmacists: Provider Status,Collaborative Practice, Health-Homes,and Billing for ServicesNetworking Session Hosted by the Section of Ambulatory CarePractitioners’ Advisory Group on Clinical Practice AdvancementFacilitator: Laura M. Traynor, PharmD, BCPS, AssistantProfessor, Concordia University Wisconsin School of Pharmacyand Ambulatory Pharmacist, Columbia-St. Mary’s Hospital-Ozaukee, Mequon, WIDiscussion Topicsu Share the most current information about the quest for pharmacistprovider statusu Identify opportunities for pharmacists within health-homemodels of care and Accountable Care Organizationscontinues >47th ASHP Midyear Clinical Meeting and Exhibition49

coordinating the pharmacy enterprise across more than onehospital, multiple hospitals in different cities and states, andleading multiple different pharmacy service lines.Discussion Topics:u System organizational structures and effective communicationand outcomesu System Pharmacy and Therapeutics Committee and relatedcommittee managementu Efforts in meeting Value Based Purchasing and ACOsu Centralized programs and technologyu Market environment and issues facing multi-hospital healthsystem pharmacy leaders5:15pm – 6:15pmSouth Pacific J, Lower Level,North Convention Centera Medication Safety issues and BestPracticesNetworking Session Hosted by the Section of Inpatient CarePractitioners’ Advisory Group on Medication SafetyFacilitator: Dan Degnan, PharmD, MS, CPHQ, MedicationSafety Officer, Community Health Network, Carmel, INThis networking session is a must attend for practitioners whohave quality, risk management, medication safety responsibilities.Those who are medication safety experts or wish to networkwith them should attend as well.Discussion Topics:u National Patient Safety Initiatives – Update and tips for Prioritizing(Sequel to the Summer Meeting 2012 Networking Session)u MSOs – Who are we? What can we do? What are our issues?5:15pm – 6:15pmSouth Pacific D, Lower Level,North Convention Centera Who’s on First? Developing a Playbookfor optimizing Transitions of CareNetworking Session Hosted by the Section of PharmacyInformatics and Technology’s Advisory Group on AmbulatoryCare Informatics and the Section of Ambulatory CarePractitionersFacilitator: George A. Robinson, RPh, Senior ProductManager, FDB (First Databank, Inc.), Indianapolis, INDiscussion Topics:u Current barriersu Role of HIE and ACOsu What specific ambulatory pharmacy issues need to beaddressedu What are people doing now?5:15pm – 6:30pma Infectious DiseasesSouth Pacific F, Lower Level,North Convention CenterNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Jason J. Schafer, PharmD, BCPS, AAHIVP,Assistant Professor, Department of Pharmacy Practice, TheJefferson School of Pharmacy, Thomas Jefferson University,Philadelphia, PADiscussion Topics:u Antiretroviral Therapy for HIV Preventionu The Challenges of Starting and Stopping HIV Medicines inthe Hospitalu HIV and Primary Care – An Important Role for PharmacistsTUESDAY, DECEMBER 47:00am – 8:00am Palm H, Level 3a Home infusionNetworking Session Hosted by the Section of Ambulatory CarePractitioners’ Advisory Group on Home InfusionFacilitator: Donald J. Filibeck, PharmD, MBA, Dublin, OHDiscussion Topic:u New issues and fresh perspectives in the operational, regulatory,and clinical concerns of home infusion essentials11:00am – 12:30pm Lagoon I, Level 2a Advancing the Role of PharmacyTechnicians in Future Pharmacy Practice–The Role of CREST and StandardizationNetworking Session Hosted by the Section of Inpatient CarePractitioners’ Advisory Group on Pharmacy Support ServicesFacilitator: Trish Wegner, BS Pharm, PharmD, FASHP, Vice-President, Illinois Council of health-System Pharmacists, LovesPark, ILLike last year, this promises to be an energetic and robust discussioncentered on recommendations of the PTCB CRESTSummit and the sundry differences in certification/licensurerequirements between pharmacists and technicians. This is amust attend networking session for those who have purview ofand/or interest in pharmacy technician issues!Discussion Topics:u “Discussing the Summit – Have We Reached the CREST Yet?”u “The Standard Is – We Have No Standard”11:15am – 12:15pm Mandalay Bay D, Level 2a Developing informal Leaders to DrivePractice Model AdvancementNetworking Session Hosted by the Section of PharmacyPractice Managers’ Advisory Groups on Pharmacy PracticeModel Initiative and Leadership DevelopmentFacilitators: Anita Harrison, PharmD, BCPS, ClinicalPharmacy Specialist, SICU, PGY1 Residency Director,Methodist Dallas Medical Center, Dallas, TX; Kelly Martin,PharmD, MS, Manager, Inpatient Pharmacy Services, VirginiaCommonwealth University Health System, Richmond, VAThis networking event is intended for anyone interested inlearning more about how to drive practice advancement.Groups will discuss how various types of informal leaders influencechange and how to become, or influence others tobecome, informal leadersDiscussion Topics:u Discuss how informal leaders influence changeu Discuss how to implement transitions of changeu Discuss strategies to build effective multidisciplinary relationshipsto foster practice model advancements47th ASHP Midyear Clinical Meeting and Exhibition51

pharmacy practice sections networking sessions11:15am – 12:30pm Reef D, Level 2a Ambulatory Care PharmacistReimbursement opportunities: Hospital-Based, Physician-Based and RetailPharmacy-BasedNetworking Session Hosted by the Section of Ambulatory CarePractitioners’ Advisory Group on Clinical Business DevelopmentFacilitator: Mary Ann Kliethermes, BS, PharmD, Vice-ChairAmbulatory Care, Associate Professor, Chicago College ofPharmacy, Midwestern University, Downers Grove, ILDiscussion Topics:u Describe the current Medicare billing models for clinical pharmacyservices and the rules and regulations for each settingu Describe state based Medicaid billing models for clinicalpharmacy services in states where models have been successfullyimplementedu List commercial payers that have mechanisms for clinicalpharmacy service payment for their enrollees and describe theprogramsu Describe emerging models of potential payment for clinicalpharmacy services under innovative models associated withhealth care reform11:15am – 12:30pm Palm H, Level 3a The Pharmacist and Meaningful UseNetworking Session Hosted by the Section of PharmacyInformatics and Technology’s Advisory Group on ClinicalInformation SystemsFacilitators: Franklin P. Crownover, RPh, MSHI, PharmacyInformatics Coordinator, Tufts Medical Center, Boston, MA;Maren Everton, RPh, Management Consulting Director, maxITHealthcare, Park City, UTDiscussion Topics:u Meaningful use Stage 1u Decision support in Meaningful Useu Meaningful Use Stage 211:15am – 12:45pm Lagoon G, Level 2a Clinical LeadershipNetworking Session Hosted by the Section of ClinicalSpecialists and Scientists’ Advisory Group on ClinicalLeadershipFacilitator: John S. Clark, PharmD, MS, BCPS, FASHP,Director of Pharmacy Services, University of Michigan, AnnArbor, MIDiscussion Topics:u Is everyone a clinical leader? What makes a clinical leader?u Teambuilding, accountability – Who is responsible?u To measure or not to measure metrics and their impact onclinical leadership11:15am – 12:45pm Mandalay Bay F, Level 2a AnticoagulationNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Lynn Belcher, BS Pharm, Clinical SpecialistAnticoagulation, Legacy Health System,St. Helens, ORDiscussion Topics:u Have your anticoagulation clinics increased the time betweenINR monitoring to 6, 9, 12 weeks? If so have you establishedcriteria for who gets the longer monitoring interval? How areyou documenting rational for increased time for each patient?Are you monitoring outcomes for these patients?u Have sites developed treatment guidelines to reverse bleedingwith new anticoagulants? What agents are being used?u Have new anticoagulants impacted workload in your anticoagulationclinics? Are your clinics working with any patients onnew agents? Monitoring renal function, determining dosing?11:15am – 12:45pm Breakers C, Level 2a Emergency MedicineNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Melinda J. Ortmann, PharmD, BCPS, ClinicalPharmacy Specialist – Emergency Medicine, The JohnsHopkins Hospital, Baltimore, MDDiscussion Topics:u Creative Staffing Options in the Era of Budget Crunching –strategies to help deliver safe and consistent clinical coveragein a 24/7 environmentu Collaborative Practice Agreements in the ED Settingu Education and Training in the ED environment: challenges,learning opportunities, structure and ideas for developing andadvancing training of students and residents12:00pm – 1:30pm Lagoon H, Level 2a Pharmacy Practice Experiences: Studentand Preceptor Partnerships to Maximizethe interactionsHosted by the Section of Inpatient Care Practitioners’ AdvisoryGroup on Pharmacy Practice ExperiencesFacilitator: Lijian (Leo) Cai, PharmD, Director of Pharmacy,Wheaton Franciscan Inc. – Saint Joseph Hospital, Milwaukee, WIEnsuring a positive pharmacy practice experience is the goal ofevery preceptor. Attend this networking session to learn tipsand discuss strategies that facilitate an engaging experiencefor the student and a rewarding experience for the preceptor.Discussion Topics:u Role of Junior Preceptors and the Medical Training Model inPharmacy Practice Experiencesu Student Training: Burden or Benefit?5247th ASHP Midyear Clinical Meeting and Exhibition

5:15pm – 6:30pm Banyan C, Level 3a Critical CareNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Stacey Folse, PharmD, MPH, BCPS, Medical ICUClinical Pharmacy Specialist, Emory University Hospital,Atlanta, GADiscussion Topics:u Dopamine vs Norepinephrine for Septic Shocku Fluid Resuscitation in Severe Sepsisu ARDS: New Definition and Role of NMBAs5:15pm – 6:30pm Lagoon H, Level 2a Primary Care/PharmacotherapyNetworking Session Hosted by the Section of ClinicalSpecialists and ScientistsFacilitator: Kristi W. Kelley, PharmD, BCPS, CDE, AssociateClinical Professor, Department of Pharmacy Practice/ClinicalPharmacist, Auburn University Harrison School of Pharmacy/Continuity Clinics, Baptist Health, Inc., Birmingham, ALDiscussion Topics:u Updates to guidelines and recent key studies significant toprimary careu Response to transitions to care in the primary/ambulatorycare settingu New medications for obesityu Experience with new anticoagulantsu Changes to immunization recommendations and significanceto primary careWEDnESDAY, DECEMBER 511:00am – 12:30pm Lagoon G, Level 2a OR/AnesthesiologyNetworking Session Hosted by the Section of Inpatient CarePractitionersFacilitator: Peggy Bickham, PharmD, Assistant Director,Specialty & Support Services, University of Illinois Hospital andHealth Sciences Center, Chicago, ILAttend this networking session and meet OR/Anesthesiologypharmacists as they discuss contemporary issues and proposedsolutions in this distinct area of practice.Discussion Topics:u New Drugs: Issues and Usageu Electronic Anesthesia Records11:15am - 12:30pm Lagoon H, Level 2a Informatics in Pharmacy PracticeExperiencesNetworking Session Hosted by the Section of PharmacyInformatics and Technology’s Advisory Group on PharmacyInformatics EducationFacilitator: Joe Lassiter, MS, PharmD, BCPS, CPHIMS,Director of Experiential Education, Pacific University School ofPharmacy, Hillsboro, ORDiscussion Topics:u Early exposure to informatics in introductory PharmacyPractice Experiences (IPPE)u Informatics and clinical decision support training duringAdvanced Pharmacy Practice Experiences (APPE)u Assessment of informatics competencies for entry level pharmacistpractice47th ASHP Midyear Clinical Meeting and Exhibition53

EDUCATion CE SESSionsAll rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.Sessions marked with this icon relate to ambulatory care.Please note: All educational sessions listed here are availablefor CE credit unless otherwise noted. Presenter affiliations anddisclosures are located in the Presenter Index on page 116.SunDAY, DECEMBER 29:00am – 11:00am Mandalay Bay B, Level 2a Professional and Academic Publishing:Putting your ideas into Practice 2012Activity #204-000-12-216-L04P/204-000-12-216-L04TLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Jack Bruggeman, MBALearning Objectives:u Describe how to create an effective publishing proposal.u Explain how to evaluate a practice improvement idea for publishingpotential.u Be able to list five keys to turning your idea into a publishedproduct.The Characteristics of a Good Idea, Jack Bruggeman, MBAStart with a Good Proposal, Robin ColemanWriting and Editing: Pitfalls and Pearls, Ruth BloomManaging the Author-Editor Team: Perspectives on theProcess, Joshua Caballero, PharmDBeing an Effective Author in the Marketplace, Mary LynnMcPherson, PharmD, BCPS, FASHPEvaluating Five Ideas, Jack Bruggeman, MBA1:30pm – 3:00pm Mandalay Bay D, Level 2a Making Students indispensable: involvingStudents in Patient Care RolesPlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-243-L04PLevel of Content: General Interest1.5 Contact Hours/Application-basedProgram Chair/Moderator: John S. Clark, PharmD, MS, FASHPLearning Objectives:u Describe services implemented in health systems that have afocus on direct patient care that are provided by students.u Recommend a service that can be provided to patients bystudents.12:30pm – 5:00pm Mandalay Bay L, Level 2a The ASHP Federal ForumViva Federal Pharmacy: The Future is NowProgram Chair: Mike Heath, RPh, MBAPlease note: The full program description can be foundonline, on the Mobile Midyear App, and at the meeting inMidyear News & Views.The Federal Sector has always held a strong leadership positionin its innovative approaches to change and now is the timeto accelerate those innovations and leadership. Advancementsin technology, changes in legislation, patient demands foraccountability and access, and increasing recognition thathealthcare is a team sport have created unprecedenteddemands and opportunities for the pharmacy profession. Thisprogram will focus on strategies being utilized throughout thefederal sector to transform practices and align our rapidlychanging world with the practice vision of the future.Welcome EventActivity #204-000-12-327-L04P/204-000-12-327-L04TLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedModerator: Justin Lusk, PharmD, Captain, U.S. Air ForceKeynote: Carey LohrenzFederal Pharmacy Vision:Report to the U.S. Surgeon generalActivity #204-000-12-328-L04P/204-000-12-328-L04TLevel of Content: General Interest0.75 Contact Hours/Knowledge-basedOpportunities for Federal Pharmacy toLead the ChargeActivity #204-000-12-331-L04P/204-000-12-331-L04TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedKey Challenges: Re-Engineering Initiatives and InnovationsPresenters: COL John Spain, PharmD, BCPS, US Army;Lynn Sanders, PharmD, Department of Veterans AffairsStrategies to Transform the Pharmacy Practice ModelPresenters: Julie Groppi, PharmD, CED, Department ofVeterans Affairs; Anthony Morreale, PharmD, MBA, BCPS,Department of Veterans AffairsIntroduction/Introductory Pharmacy Practice Experience,Paul C. Walker, PharmD, FASHPTransitions of Care: Working With Students, Meghan DavlinSwarthout, PharmD, MBAMaking Students Indispensible Example and Think/Pair/Share, Diane B. Ginsburg, MS, RPh, FASHP5447th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

2:00pm – 4:00pm Mandalay Bay B, Level 2a More Creative Techniques to Engage YourAudience in Active LearningActivity #204-000-12-326-L04P/204-000-12-326-L04TLevel of Content: General Interest2.0 Contact Hours/Application-basedPresenter: Jennifer D. Goldman-Levine, PharmD, CDEFacilitators: David Schnee, PharmD; Dhiren K. Patel,PharmD, CDE, BD-ADM; Johannah Heaphy, PharmD; RickyThumar, PharmDLearning Objectives:u Identify small and large audience challenges and opportunitiesto engage and improve participant outcomes.u Describe creative techniques to capture attention, enhanceparticipation, and foster learning.u Apply at least two techniques to transform content laden, lecture-basedprograms into participant-centered, active experiences.u Describe techniques that could be used in multiple situationssuch as the classroom, medical rounds, P&T committee meetingsor any other seminar or teaching situation.MonDAY, DECEMBER 37:30am – 9:00am Mandalay Bay D, Level 2a 340B Program Update: Transitioning fromAccess to integrityActivity #204-000-12-315-L04P/204-000-12-315-L04TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Christopher A. Hatwig, MS, RPh,FASHPLearning Objectives:u Describe the roles, priorities, and current activities of HRSA’sOffice of Pharmacy Affairs and its contractors in supportingnew integrity initiatives.u Discuss HRSA’s, pharmaceutical manufacturers’, and entity’sperspectives on 340B integrity and the audit process.u Describe leading practices used by a recently-audited 340Bcompliant program.OPA Update, Krista M. Pedley, PharmD, MSGet Prepared: Audit Readiness for 340B Pharmacies,Michelle Herzog; Jason Atlas, RPh, MBA; Marcus Farbstein,RPh, MBAApexus Update and Wrap Up, Christopher A. Hatwig, MS,RPh, FASHP11:15am – 12:45pm Banyan C, Level 3a ACPE Update 2012Presenters: Robert S. Beardsley, RPh, PhD; Michael J.Rouse, BPharm (Hons.), MPS; Peter H. Vlasses, PharmD, DSc(Hon.), BCPS, FCCPPlease Note: CE is not offered with this sessionACPE Board and Staff will provide an update regarding theprofessional degree program and continuing pharmacy educationaccreditation matters and will address your questions.Specific topics for discussion include: findings from ACPEInvitational Conference, CPE monitor, international initiatives,and inter-professional education.For presenter affiliations see Presenter Index1:30pm – 3:00pm Banyan C, Level 3a The Art of Precepting:It’s not as Easy as it LooksPlanned in cooperation with the American Association ofColleges of PharmacyActivity #204-000-12-289-L04PLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Leigh Ann Ross, PharmD, FCCP,FASHPPresenter: Craig D. Cox, PharmD, BCPSLearning Objectives:u Describe effective teaching strategies to engage students onpharmacy practice experiences.u Describe innovative ways to provide orientation and feedbackto students during their pharmacy practice experiences.u Identify practical solutions to theoretical student-teacherissues through challenging case scenarios.Please Note: 1:30pm - 2:00pm is an American Association ofColleges of Pharmacy (AACP) business meeting. ContinuingEducation Credit is only offered from 2:00pm -3:00pm2:00pm – 3:00pm South Seas H, Level 3a Process improvement Essentials forPharmacy TechniciansActivity #204-000-12-330-L04TLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedPresenter: Richard C. Ponder, Jr., MBA, CMRPLearning Objectives:u Describe process improvement methods (such as LEAN) andtechniques.u Discuss applications to pharmacy practice; including improvingoperational efficiencies and cost containment.2:00pm – 3:30pm South Seas D, Level 3a The Emily Jerry Story:Lessons Learned from aFatal Medication ErrorActivity #204-000-12-214-L05P/204-000-12-214-L05TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedModerator: Douglas J. Scheckelhoff, MSLearning Objectives:u Describe how poorly designed medication systems can contributeto serious, even fatal, errors.u Distinguish ways institutions can respond to errors and how itinfluences patients, caregivers, future error reporting, and systemimprovements.u Define just culture and the influence that culture can have onimproving the safety of patient care.The Emily Jerry Story, Christopher S. JerryThe Events of February 26, 2006, Eric J. Cropp, BS PharmLessons Learned: Analysis of Contributing Factors andResponse to Errors, Michael R. Cohen, RPh, MS, ScD (hon)47th ASHP Midyear Clinical Meeting and Exhibition55

MManagement of Delirium in the ICU, John W. Devlin, PharmDeducation CE sessions2:00pm – 3:30pm Breakers C, Level 2a Pain, Sedation, and Delirium in the iCU:Cutting-Edge UpdatesPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-229-L01PLevel of Content: Advanced1.5 Contact Hours/Application-basedProgram Chair/Moderator: Kevin Anger, PharmD, BCPSLearning Objectives:u Evaluate recent literature on the management of pain, sedation,and delirium in the ICU.u Discuss key concepts in the selection of sedatives, analgesics,and anti-psychotic agents in critically ill patients.u Describe key pharmacotherapy concepts and barriers to optimizingpain, sedation, and delirium pharmacotherapy in criticallyill patients.Management of Pain in the ICU, Gilles L. Fraser, PharmD,FCCMManagement of Sedation in the ICU, Joseph F. Dasta, MSc2:00pm – 3:30pm Mandalay Bay L, Level 2a Domo Arigato, Mr. Roboto: AdvancingTechnician Roles Through iV RoomTechnology & Quality AssurancePlanned in cooperation with the ASHP Section of PharmacyInformatics and TechnologyActivity #204-000-12-236-L04P/204-000-12-236-L04TLevel of Content: Intermediate1.5 Contact Hours/Application-basedProgram Chair/Moderator: Chad S. Stashek, PharmD, MSLearning Objectives:u Identify how the ASHP Pharmacy Practice Module Initiative(PPMI) promotes pharmacy technician career advancementthrough increased involvement with technology.u Describe how an institution has improved resource allocationby shifting responsibilities to pharmacy technicians that havetraditionally been the responsibilities of pharmacists and pharmacymanagers.u Develop a departmental action plan for technician-driven,quality assurance testing of compounded sterile products (CSPs).u Evaluate ways to advance pharmacy technician roles throughthe use of IV room technologies, quality assurance testing, andreporting responsibilities.PPMI: Technicians, Technology, and Quality Assurance,Chad S. Stashek, PharmD, MSCase Studies: IV Room Technologies and QualityAssurance, Chad S. Stashek, PharmD, MS; Caryn Domenici-Belisle, RPh2:00pm – 3:30pm Reef D, Level 2a What is the Pharmacy Enterprise?A Framework for Success and for theFuture of the ProfessionPlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-259-L04PLevel of Content: Intermediate1.5 Contact Hours/Knowledge-basedMonDAY, DECEMBER 3continuedProgram Chair: Rick Couldry, MS, RPh, FASHPModerator: Michael F. Powell, BS Pharm, MS Pharm, FASHPLearning Objectives:u Describe the significance of the Pharmacy Enterprise.u Define key aspects of the Pharmacy Enterprise.u Relate the importance of defining the pharmacy enterprise tocurrent dynamics in healthcare and future success ofpharmacy.Introducing the Concept of the Pharmacy Enterprise,Michael F. Powell, BS Pharm, MS Pharm, FASHPKey Aspects of the Pharmacy Enterprise, Scott Knoer, MS,PharmD, FASHPPharmacy Enterprise Concept and Future Success, RickCouldry, MS, RPh, FASHP2:00pm – 3:30pm South Seas J, Level 3a Expecting the Unexpected: Treatment ofOpiate Dependence in PregnancyPlanned in cooperation with the College of Psychiatric andNeurologic PharmacistsActivity #204-000-12-285-L01PLevel of Content: Advanced1.5 Contact Hours/Application-basedProgram Chair/Moderator: Sarah T. Melton, PharmD, BCPPPresenter: Susan C. Sonne, PharmD, BCPPLearning Objectives:u Evaluate evidence-based literature regarding treatment ofopioid dependency during pregnancy with buprenorphine ormethadone.u Contrast the benefits and disadvantages associated with useof buprenorphine or methadone in pregnant women.u Discuss the management of intrapartum and postpartum painin opioid dependent patients.u Examine the incidence and treatment of neonatal abstinencesyndrome associated with buprenorphine and methadone usein pregnancy.2:00pm – 4:00pm Mandalay Bay F, Level 2a Are You Prepared? Excelling in JointCommission Surveys5647th ASHP Midyear Clinical Meeting and ExhibitionActivity #204-000-12-218-L03P/204-000-12-218-L03TLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: John P. Uselton, RPh, BSLearning Objectives:u Develop strategies on how to prepare for tracers and othersurveyor activities during an accreditation survey.For presenter affiliations see Presenter Index

Sessions marked with this icon relate to ambulatory care.u Work with nursing to successfully prepare a strategy forMedicare’s new interpretation of their 30-minute rule for drugadministration.u Describe how to comply with hospital-wide standards thataffect all departments including pharmacy.u Identify potential problematic areas prior to surveys anddevelop an action plan for success.Overview of What’s New, John P. Uselton, RPh, BSMaking Sense Of Pharmacy-Related Issues, Robert Jordin,RPhWorking With Nursing to Solve Medication ManagementIssues, Patricia C. Kienle, BSc Pharm, MPAMeeting Requirements for Hospital-Wide Standards, Lee B.Murdaugh, BS Pharm, PhDPutting It All Together, John P. Uselton, RPh, BS2:00pm – 4:00pm South Seas E, Level 3a Safety & Quality Pearls 2012Planned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-231-L05P/204-000-12-231-L05TLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Jorge D. Carrillo, PharmD, MS, BCPSLearning Objectives:u Describe three examples of interventions that have improvedsafety or quality of patient care in health systems.u List steps for implementation of at least one safety improvementprogram.u Explain how to apply three strategies for preventing patient harm.Development of an Assessment Tool for Evaluation ofMedication Safety Risks and Opportunities forImprovement in a Ten-Hospital Health System, JosephHooley, BSUsing Near Miss Tracking to Promote Medication Safety,Jules M. Trahan, PharmD, RPhUse of Data from Failure Mode Effects Analysis (FMEA)and Medication Error Reporting Systems to DriveRedesign of Medication Management Systems, DonaldMcKaig, RPh, CDOESeeing Double: Avoiding Therapeutic Duplication Errors,Deborah R. Saine, MS, RPh, FASHPDevelopment and Evaluation of Safety Interventions toReduce Distractions During Medication AdministrationProcess, Alina D. Bulgar, PharmD, PhDImproving Your Odds - How to Safely Manage Patients withPulmonary Hypertension, Molly Leber, PharmD, BCPSTeam building with TeamSTEPPS, Julia F. Gannon, BS PharmDoes Your Game Plan Include a Safety Huddle? Perry Allen,PharmDStandard vs Dilute - The End of an Error, Jennifer Sterner-Allison, PharmDApplying Smart Pump Data to Improve Safety at theBedside, Marie Link, PharmD, RPhAn LTG of Med Safety, Mary Rebo, PharmDYour Data is Your Best Friend, Aki Singam, PharmDPop that Amp! Introduction to Medication Safety forClinical Anesthesia First-Year Residents, Peggy Bickham,BS Pharmacy, PharmDMinding Your Q’s and R’s - Controlled SubstanceMonitoring, Timothy Ekola, PharmDYes We (Nar)can: Pharmacy-Led Multidisciplinary Team toAddress Naloxone Usage, Nicole J. Clark, PharmD, BCPSAssuring Safe Substitutions During Drug Shortages,Brenda A. Egan, PharmD, BCPSAre You Feeling Like Henny Penny? See How These HENsCan Help! Lynn Eschenbacher, PharmD, MBA2:00pm – 4:00pm Mandalay Bay H, Level 2a A ‘Bloody’ Debate - Which Agent is Bestto Prevent Stroke in a Treatment naiveAtrial Fibrillation Patient?Activity #204-000-12-250-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Michael P. Gulseth, PharmD,BCPS, FASHPLearning Objectives:u Evaluate and pick an appropriate therapy for a patient whohas new atrial fibrillation and needs a medication for strokeprophylaxis.u Recommend what agent may be preferred in special patientpopulations (examples: renal dysfunction, interacting medications,etc.)for stroke prophylaxis in atrial fibrillation.u Interpret the scientific literature supporting the approval of theagents used to prevent stroke in atrial fibrillation by identifyingthe strengths and weaknesses of each study.Debate #1: Dabigatran Etexilate is the Preferred Agent toPrevent Stroke Due to Atrial Fibrillation in a TreatmentNaive Patient, Michael P. Gulseth, PharmD, BCPS, FASHPDebate #2: Rivaroxaban is the Preferred Agent to PreventStroke Due to Atrial Fibrillation in a Treatment NaivePatient, Nathan Clark, PharmD, BCPSDebate #3: Apixaban is the Preferred Agent to PreventStroke Due to Atrial Fibrillation in a Treatment NaivePatient, Edith A. Nutescu, PharmD, FCCPDebate #4: Warfarin is the Preferred Agent to PreventStroke Due to Atrial Fibrillation in a Treatment NaivePatient, William E. Dager, PharmD, BCPS, FASHPDebate Rebuttals, Michael P. Gulseth, PharmD, BCPS,FASHP; Nathan Clark, PharmD, BCPS; Edith A. Nutescu,PharmD, FCCP; William E. Dager, PharmD, BCPS, FASHPCase Discussions (Focus on Special Patient Populations),William E. Dager, PharmD, BCPS, FASHP; Michael P. Gulseth,PharmD, BCPS, FASHP; Edith A. Nutescu, PharmD, FCCP;Nathan Clark, PharmD, BCPSFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition57

education CE sessions2:00pm – 4:00pm Mandalay Bay D, Level 2a Update in Emergency DepartmentPractice: Service optimization &Collaborative PracticeActivity #204-000-12-258-L04PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Heather Draper Eppert, PharmD,BCPSLearning Objectives:u Based on identified barriers and challenges, develop strategiesfor integration of the pharmacist into the interdisciplinaryED team.u Based on the unique characteristics associated with patientcare in the ED, develop a triage system for pharmacy servicesin the ED.u Given limited time and resources, develop a strategy to optimizethe type and level of pharmacy services provided in the ED.u Develop innovative collaborative practice agreements to beimplemented in the ED.Integrating into the ED Team, Alison M. Jennett Reznek,PharmD, BCPSDeveloping a Triage System, Renee Petzel Gimbar, PharmDOptimizing Pharmacy Services, Heather Draper Eppert,PharmD, BCPSCollaborative Practice Agreements, Heather Draper Eppert,PharmD, BCPS2:00pm – 4:00pm Mandalay Bay J, Level 2a Emerging Strategies for neonatalInfectionsPlanned in cooperation with the Pediatric Pharmacy AdvocacyGroupActivity #204-000-12-295-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Sherry A. Luedtke, PharmDLearning Objectives:u Optimize the antibiotic regimen for a premature infant diagnosedwith sepsis.u Describe how to utilize biological markers to identify neonateswith sepsis.u Recommend the appropriate use of granulocyte colony-stimulatingfactor and intravenous immune globulin in the managementof neonatal infections.u Identify a neonate with disseminated intravascular coagulationand evaluate the role of antithrombin III.u Define hypotension in the preterm infant and recommendmanagement.Neonatal Sepsis – Optimization of Antimicrobial Therapy/Trends in Diagnosis and Management, Peter Gal, PharmD,BCPS, FASHPManagement of Progressing Neonatal Sepsis, ChristopherMcPherson, PharmDMonDAY, DECEMBER 3continued2:00pm – 5:00pm South Seas B, Level 3a Perspectives on internationalCollaboration in Pharmacy EducationActivity #204-000-12-217-L04PLevel of Content: General Interest2.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: William Zellmer, BS (Pharmacy),MPHLearning Objectives:u Identify the major factors that cause variability in the nature ofpharmacy education around the world.u List the main reason that colleges of pharmacy are interestedin international collaborations.u Summarize the most important success factors in establishingsuccessful cross-border collaborations in pharmacy education,including experiential education and residency training.u Describe worldwide efforts to foster quality improvement inpharmacy education.Challenges and Opportunities in Pharmacy EducationAround the World, Claire Anderson, PhDU.S. Perspectives on International Collaborations inPharmacy Education, Rosalie Sagraves, PharmDCase Study in Collaboration: The U.S. - Thai Consortium inPharmacy Education, Bernard Sorofman, RPh, PhDGlobal Perspectives on Quality Assurance in PharmacyEducation, Michael Rouse, BPharm (Hons), MPSThis session will conclude with the Donald E. Francke MedalLecture.Donald E. Francke Medalist, Henri R. Manasse, Jr., PhD,ScD, FFIP, Retired ASHP Chief Executive Officer/ExecutiveVice President and current Professional Secretary of theInternational Pharmaceutical Federation (FIP), will present alecture titled, “Perspectives on the Global Evolution andDevelopment of Pharmacy.” The Donald E. Francke Medalwas established to honor individuals who have made significantinternational contributions to hospital pharmacy.All attendees of this session are invited to join Dr. Manasseafter his lecture to offer congratulations at a special receptionfor International Registrants. The reception is an opportunity tonetwork with your friends and colleagues from around theworld. Light refreshments will be served.For more information on the Francke Medalist and the InternationalRegistrants Gathering and Reception, see pages 27-28.3:00pm – 4:00pm South Seas H, Level 3a Optimizing Medication Safety: The Role ofPharmacy TechniciansActivity #204-000-12-329-L04TLevel of Content: General Interest1.0 Contact Hours/Knowledge-basedPresenters: Mark Brunton, CPhT; Nick Barkley, CPhTLearning Objectives:u Identify at least two opportunities to prevent adverse medicationevents in your health-system.u Discuss strategies to enhance medication safety during andafter implementation of information technology and automation.5847th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

education CE sessions MonDAY, DECEMBER 3continuedImplementation of Risk Evaluation and MitigationStrategy Programs in a Health System: FromProcess Development to Monitoring ComplianceActivity #204-000-12-352-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Mandy C. Leonard, PharmD, BCPS; Katie L. Stabi,PharmD, BCPSLearning Objectives:u Describe a process that can be implemented to ensure allREMS requirements for a medication are addressed.u Explain the benefit of identifying a REMS coordinator in ahealth system.u List potential roadblocks to the implementation of a REMSprogram.4:00pm – 5:00pmSouth Pacific F, Lower Level,North Convention Centera Antimicrobial Safety: Spare the KidneysActivity #204-000-12-206-L01PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Annie Wong-Beringer, PharmDLearning Objectives:u Identify risk factors that predispose to the development ofantibiotic-induced acute kidney injury (AKI).u Evaluate a monitoring plan to facilitate early detection of AKI.u Develop an alternative treatment plan in the event AKI develops.4:00pm – 5:00pm South Seas D, Level 3a Medical Marijuana: Rational Medicine orPotential Medication Misadventure?Activity #204-000-12-220-L01PLevel of Content: Advanced1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Laura Borgelt, PharmDLearning Objectives:u Evaluate and discuss clinical studies performed in patientswith various conditions to determine the effectiveness of medicalmarijuana (MMJ).u Identify adverse effects, psychiatric implications, and potentialdrug interactions that may occur with the use of MMJ.Pharmacology and Therapeutic Uses of Medical Marijuana,Laura Borgelt, PharmDAdverse Effects and Drug Interactions for Medical Marijuana,Lawrence Cohen, PharmD, BCPP, FASHP4:00pm – 5:00pm Banyan C, Level 3a Transplant Pharmacy: Paving the Wayto a Practice Model of ExcellencePlanned in cooperation with the American Society ofTransplantation Pharmacist Community of PracticeActivity #204-000-12-246-L04PLevel of Content: Intermediate1.0 Contact Hours/Knowledge-based6047th ASHP Midyear Clinical Meeting and ExhibitionProgram Chair: Eric M. Tichy, PharmD, BCPSModerator: Lonnie Smith, PharmDLearning Objectives:u Describe the CMS requirements for transplant pharmacists inthe phases of transplant.u List the fundamental and desirable activities of the transplantpharmacist on the multidisciplinary transplant team.u Differentiate between methods for billing transplant pharmacyservices.u List 5 actionable methods for increasing revenue or cost savingstrategies that can be used to justify and support transplantpharmacy services.The Transplant Pharmacy Practice Model: A CMS Mandate,Eric M. Tichy, PharmD, BCPSBilling for services/ Medicare Cost Report: Coverage ofPharmacy Services, Eric M. Tichy, PharmD, BCPSTransplant Specialty Pharmacy: A Revenue Stream, DavidJ. Taber, PharmD, BCPSPatient Education: Impact on Length of Stay and Readmission,David J. Taber, PharmD, BCPS4:00pm – 5:00pm Mandalay Bay L, Level 2a Hitting the Trifecta: improving Safety andQuality Without Breaking the BudgetPlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-270-L05PLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Molly Billstein Leber, PharmD, BCPSLearning Objectives:u Summarize key National quality and safety initiatives thatpharmacy has the opportunity to impact.u Examine innovative strategies to implement into daily practiceand within your pharmacy budget.u Describe strategies to improve adverse event and near missreporting.u Identify pharmacy responsibilities that could be managedthrough telepharmacy or remote verification and what regulatoryissues must be addressed.Role of Pharmacy in Improving Safety and Quality, MollyBillstein Leber, PharmD, BCPSUse of Pharmacy Residents and Technicians for Value-Based Purchasing Metrics and Decreasing 30-day Re-Admissions, Maribeth A. Cabie, PharmD, BCPSImplementing Telepharmacy, Mike Brownlee, PharmD, MSImproving Reporting and Using Data from MedicationErrors and Near Misses, Jacob Thompson, PharmD, MS4:00pm – 5:00pm Breakers C, Level 2a Bring it on! Alternative opinions on aControversial Pain TopicPlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersActivity #204-000-12-280-L01PLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedFor presenter affiliations see Presenter Index

Program Chair/Moderator: Chris M. Herndon, PharmD,BCPS, FASHPLearning Objectives:u Following presentation of available evidence, develop a positionon the possibility that opioids cause cancer to grow andfurther metastasize.u Evaluate the data and develop personal opinions on thereported risk of opioids causing increased morbidity in cancerpatients using analgesics.Opioids Increase Mortality in Cancer, Jennifer Strickland,PharmDOpioids Do NOT Increase Mortality in Cancer, Mary LynnMcPherson, PharmD, BCPS, FASHP4:30pm – 5:00pm South Seas J, Level 3a Management Case Studies BPreparing for Precepting: Establishing a SharedOrientation Plan for Multiple LearnersActivity #204-000-12-353-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Kate Farthing, PharmD, BCPS; Kristine B.Marcus, BSPharm, BCPSModerator: Chelsea Sealey, PharmD CandidateLearning Objectives:u Describe key agenda topics and products of an initial preceptormeeting to design a shared orientation program.u Explain the benefits to learners of creating a shared orientationprogram.u Explain the benefits to preceptors of creating a shared orientationprogram.TUESDAY, DECEMBER 48:00am – 9:00am South Seas H, Level 3a Management Case Studies F: Parts 1 & 2Moderator: Charlene A. Hope, PharmD, BCPSImplementation of Automated DispensingCabinets (ADCs) at a Large Academic MedicalCenter: A Project Management ApproachActivity #204-000-12-360-L04P/204-000-12-360-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenter: Gajendra A. Gharia, RPh, MPHLearning Objectives:u Describe a framework for creating a multi-stakeholder projectteam with defined roles and responsibilities.u Illustrate communication strategies employed within andacross departments impacted by an HIT projectimplementation.u Present mechanisms for project wrap-up and ensuring ongoingmaintenance and optimization.Streamlining the Stat Medication Processthrough an observational Study and Utilizationof Automated Dispensing Cabinets (ADCs):An interdisciplinary Quality improvementProject in an Academic Medical CenterFor presenter affiliations see Presenter IndexActivity #204-000-12-361-L04P/204-000-12-361-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Denice L. Duda, MHA, RN, CPHQ; Jennifer V.Gillespie, PharmD, MBA; Melinda D. Sawyer, MSN, RN, CNS-BCLearning Objectives:u Describe steps in the stat medication order process that canbe removed to decrease waste.u Explain the benefits of automated dispensing cabinets(ADCs) as a means to help decrease missing medications andimprove turnaround time.u Identify lessons learned from an interdisciplinary observationalstudy effort to improve the stat medication process.8:00am – 9:00am Reef D, Level 2a Is natural Better? nutraceuticals in theTreatment of PainPlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersActivity #204-000-12-204-L01PLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Jennifer Rosselli, PharmD, BCPSLearning Objectives:u Given specific patient cases, identify natural products used inthe treatment of common pain disorders.u Summarize mechanism, dosing, efficacy, and safety concernsof nutraceuticals used in pain management.u Identify references containing quality information pertaining tocomplementary and alternative therapies.Nutraceutical Treatment of Peripheral Neuropathy andArthritis, Jennifer Rosselli, PharmD, BCPSNutraceutical Treatment of Headache and Acute MusculoskeletalPain; CAM Resources, Julie P. Karpinski, PharmD, BCPS8:00am – 9:15am Breakers C, Level 2a Productivity and Benchmarking:More than Just Doses DispensedPlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-260-L04PLevel of Content: Intermediate1.25 Contact Hours/Knowledge-basedProgram Chair/Moderator: Jay P. Rho, PharmD, FASHPLearning Objectives:u Describe the different types of metrics used in clinicaldevelopment.u Define methods for ensuring the metrics chosen are bothvalid and relevant.u Describe current challenges in collecting cognitive productivitymeasures in clinical pharmacy services.u Identify components of the automated productivity tool applicablefor their institution.Strategies for the Development of Clinical ProductivityMetrics and Benchmarks, Jay P. Rho, PharmD, FCCP, FASHPAutomating Productivity Metrics of Clinical PharmacyServices, Tanya Y. Barnhart, PharmD, BCPS47th ASHP Midyear Clinical Meeting and Exhibition61

8:00am – 9:30am Mandalay Bay J, Level 2a PGY1s, PGY2s, and Students, oh My!Tools for Effective Precepting and TrainingPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-211-L04PLevel of Content: General Interest1.5 Contact Hours/Application-basedProgram Chair/Moderator: J. Russell May, PharmD, FASHPLearning Objectives:u Compare and contrast expected and ideal preceptor characteristicsbased upon the student survey results.u Given a patient care scenario, design the preceptor’sapproach for a PGY-1 versus a student.u Given a patient care scenario, design the preceptor’sapproach for a PGY-2 versus a PGY-1.Precepting Pharmacy Students on APPEs: Perfecting theProcess, Rony Zeenny, PharmDPrecepting PGY-1 Pharmacy Residents: Above andBeyond APPE Precepting, Michelle W. McCarthy, PharmD,FASHPPrecepting PGY-2 Pharmacy Residents: Above andBeyond PGY-1 Precepting, Brian L. Erstad, PharmD, FASHP8:00am – 9:30am Mandalay Bay B, Level 2a Critical Updates in Pediatrics, Part 1:Guidelines on UTI, Pneumonia, andCardiovascular RiskPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-296-L01PLevel of Content: Advanced1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Kim W. Benner, PharmD, BCPS,FASHPLearning Objectives:u Identify three new guidelines relative to the care of pediatricpatients.u Summarize the new recommendations from these guidelinesas related to pediatric pharmaceutical care.u Recommend pharmacotherapy for provided pediatric patientcases in relation to pneumonia, urinary tract infections and preventionof cardiovascular disease.New Pediatric Guidelines on Community-AcquiredPneumonia, Kim W. Benner, PharmD, BCPS, FASHPNew Pediatric UTI Guidelines, Lea S. Eiland, PharmD,BCPS, FASHPNew Pediatric CV Risk Reduction Guidelines, DonardHuynh, PharmD, MA6247th ASHP Midyear Clinical Meeting and ExhibitionT8:00am – 10:00am Banyan C, Level 3education CE sessions TUESDAy, DECEMBER 4continueda Innovations in Drug information Practiceand Research 2012Activity #204-000-12-210-L04PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Patrick M. Malone, PharmD, FASHPLearning Objectives:u List and recommend new services and methods used by druginformation specialists and centers.u Explain how to design a system to incorporate new druginformation services at your practice setting.u Evaluate the importance and relevance of these services andmethods in your practice.Butler University Adverse Drug Reaction CausalityAssessment Tool (BADCAT), Amy S. Peak, PharmDManaging Risk Evaluation and Mitigation Strategies in aHealth-System Setting, Katie L. Stabi, PharmD, BCPSNew York State Medicaid Prescriber Education Programand Drug Information Response Center, Drew Lambert,PharmD; Linda Catanzaro, PharmD; Holly V. Coe, PharmD;Irene S. Hong, PharmD, BCPSUse of Social Media and Perspectives on E-professionalism,Amy Heck Sheehan, PharmD; Genevieve Ness, PharmDImpact of Allocation Concealment on Study Outcomes inClinical Trials Evaluating Dietary Supplements, Darren Hein,PharmDAssessment of Medical Resident Drug Information Skills atan Academic Medical Center, Gregory J. Hughes, PharmD,BCPS; Priti N. Patel, PharmD, BCPS; Christopher Mason, DO8:00am – 10:00am Mandalay Bay F, Level 2a First Do no Harm: Prevention, Detection &Management of Drug-Induced DiseasesActivity #204-000-12-222-L01PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: James Tisdale, PharmD, BCPSLearning Objectives:u Improve participants’ clinical skills in detecting and managingdrug-induced diseases through interactive case examples anddiscussion.u Evaluate evidence that pharmacists can improve patienthealth care outcomes by preventing and detecting druginduceddiseases.u Identify major drug classes associated with drug-induceddiseases.u Identify common organ systems affected by drug-induceddiseases.Overview of Drug-Induced Diseases: Epidemiology, PublicHealth Impact, and Evidence That Pharmacists May Havean Impact on Prevention and Management, James E. Tisdale,PharmD, BCPSEvaluating Your Patient for Drug-Induced Diseases, DouglasA. Miller, PharmDDrug-Induced Diseases Interactive Case Discussions,James E. Tisdale, PharmD, BCPS; Douglas A. Miller, PharmDFor presenter affiliations see Presenter Index

8:00am – 11:00am South Seas B, Level 3OncologY PHARMACY SPECiALTY SESSionS 2012: Advanced Topics in Practice Part 1Planned in cooperation with the Hematology/Oncology Pharmacy Association and the American College of Clinical PharmacyProgram Chair/Moderator: Ryan N. Bookout, Pharm.D.,BCPS, BCOPPlease note: If you are attending this program for BCOP recertification,there are different instructions for claiming CE fromthose attending only for ACPE credit.ACPE Credit Only: Instructions for claiming CE will be availablein the session room. CE will be provided by the Hematology/Oncology Pharmacy Association (HOPA).BCOP Recertification: These sessions are part of the professionaldevelopment program for recertification of Board CertifiedOncology Pharmacists (BCOPs), approved by the Board ofPharmaceutical Specialties (BPS). Part 2 will be presented onTuesday, December 4, 2:00pm – 5:00pm BCOPs must attendall six hours of programming to be eligible to complete theWeb-based post-test for oncology recertification credit. Partialcredit is not available for recertification, but is available forACPE credit.In the session room, you must complete a paper registrationform and sign in and out in both the morning and afternoonsessions as you enter and exit the session room.post-test fee is $45. After The Midyear, program participantswill receive email instructions to purchase and access the test,as well as claim ACPE credit. The post-test examination mustbe completed and submitted by December 31, 2012.8:00am – 9:00ama Therapy of T-Cell and CutaneousLymphomas: There’s More than Just B CellsUAN# 0465-9999-12-017-L01-PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Patrick J. Kiel, PharmD, BCPSLearning Objectives:u Compare and contrast the outcomes of standard therapy toregimens that incorporate novel agents into treatment of T-celland cutaneous lymphoma.u Assess the toxicities associated with the use of novel agentsin the treatment of T-cell and cutaneous lymphoma.u Differentiate between the toxicities associated with the use ofnovel agents in the treatment of T-cell and cutaneous lymphoma.u Analyze the role of stem cell transplant in this patientpopulation.9:00am – 10:00ama Neuroendocrine Cancers: A Focus onRecent Advances in PharmacotherapyUAN# 0465-0000-12-012-L04-PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Julian H. Slade, PharmD, BCOPLearning Objectives:u Differentiate the pathogenesis of neuroendocrine tumorsfrom other abdominal malignancies.u Develop a treatment algorithm for neuroendocrine tumorsincorporating newly approved drugs.u Assess monitoring parameters and patient-specific factors todetermine when a change in treatment is necessary.u Distinguish between tumor related symptoms and treatmentrelated adverse effects and create a patient specific therapeuticplan of symptom management.10:00am – 11:00ama Bone Health in the oncology PopulationUAN# 0465-0000-12-019-L01-PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Chad M. Barnett, PharmD, BCOPLearning Objectives:u Compare and contrast the mechanism of action, efficacy,and toxicity of pharmacological therapies for management ofcancer treatment-induced bone loss (CTIBL) and reductionskeletal-related events (SREs) in patients with metastatic cancerto the bone.u Analyze current data to support anticancer properties relatedto bone-modifying therapies.u Discuss novel agents to reduce the incidence of SREs inpatients with metastatic cancer to the bone and for the managementof CTIBL.8:15am – 9:15am South Seas J, Level 3a Hepatitis C in 2012: The ClinicalPharmacist’s Role in Successful TreatmentActivity #204-000-12-205-L01Level of Content: Intermediate1.0 Contact Hours/Application-basedProgram Chair/Moderator: Linda M. Spooner, PharmD, BCPSLearning Objectives:u Evaluate treatment options for managing Hepatitis C Virus(HCV) infection in 2012.u Identify key considerations in counseling patients with HCVinfection, including adverse effect management, adherenceconcerns, and avoidance of drug interactions.u Plan how to incorporate HCV management into pharmacypractice.Overview of Current HCV Management: Administration,Adverse Effects, and Drug Interactions, Linda M. Spooner,PharmD, BCPSIncorporating HCV Management into Your PharmacyPractice, Jacqueline L. Olin, PharmD, MSFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition63

education CE sessions TUESDAy, DECEMBER 4continued8:30am – 9:30am Mandalay Bay D, Level 2a Strategies for Reducing AnesthesiaMedication ErrorsActivity #204-000-12-287-L05P/204-000-12-287-L05TLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Patricia C. Kienle, RPh, MPA, FASHPPresenter: Lebron Cooper, MDLearning Objectives:u State the incidence of medical errors and the portion of whichare drug-related.u List the incidence and types of medication errors inanesthesia.u Explain the process for reporting medication errors inanesthesia.u Describe three priorities to improve medication safety inanesthesia.9:00am – 11:00am South Seas E, Level 3a Management Pearls 2012Planned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-232-L04PLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Thomas E. Kirschling, PharmD, MSLearning Objectives:u Identify opportunities to improve pharmacy services in varioushealth-system settings.u Describe steps for implementation of one pharmacy improvementopportunity.u Discuss human resource opportunities that have been successfullyimplemented.Raising the Bar on Accountability: Implementing a PeerReview Process in an Inpatient and Ambulatory PharmacyPractice Setting, Trish H.J. Hessling, PharmDDischarging Patients on the Right Foot: Implementing aPharmacy Delivery to Bedside Service, Samuel Calabrese,MBA, RPhI’m Not Just a Bill: Pharmacy Patient Bill of Rights, Jeff Little,PharmD, MPHTexas One Step Protocol, Nancy M. Wyatt, PharmDChanging Culture in the ED, Philip W. Rioux, BS PharmMove, Shoot, Communicate: Establishment of a PharmacyCall Center at a Military Community Hospital, Eric M. Maroyka,PharmD, BCPSFrom Soup to Nuts: Preventing Readmissions through aComprehensive Transitions of Care Initaitive, KatherinePalmer, PharmD“I’m So Busy. . .I’m So Bored. . .I’m So Busy” - Taking theHighs and Lows Out of IV Technician Workload, BrianPeters, PharmD, MSImplementation of an IV Workflow Manager at an AcademicMedical Center:What it Taught Us About the Errors WeMight Have Been Making! Heather Kokko, PharmD, MBAAlerting Providers that Need to be Alerted: Use of aDirected Notification Tool to Communicate Drug Shortages,Berook Addisu, PharmD, BCPSClosing the Loop: Pharmacist Involvement in Post DischargePhone Calls, Rebecca A. Taylor, PharmD, MBAIDS: We Love Logistics, Christopher Lowe, PharmD, BCPSPharmacy Safety Committee: A Multidisciplinary Collaborationto Improve Pharmacy Staff Health and Well Being,Mark Sullivan, PharmD, MBAConcentrating on the Pediatric Perspective, Richard K.Ogden, PharmDUsing Your EHR as Your Pharmacist Intervention DocumentationTool, Lourdes M. Cuellar, MS, FASHPEasing the Transition to a VA Facility - Description of aPharmacist Run New Patient Clinic, Susan Joyce, PharmD,BCPSTips and Tools on Implementing a Hazardous PharmaceuticalWaste Disposal Program, Elaine R. Mebel, PharmD, MSSo, You Don’t Like the Law? Change It! Scott Knoer, MS,PharmD, FASHP9:00am – 11:00am South Seas D, Level 3a Ambulatory guideline Roulette:Place Your BetsPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-244-L01PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Joel C. Marrs, PharmD, BCPSLearning Objectives:u Review changes to the national guidelines on hypertension,dyslipidemia, and chronic obstructive pulmonary disease.u Interpret and apply the new guidelines to the management ofpatients with hypertension, dyslipidemia, and chronic obstructivepulmonary disease in specific patient population.u Identify clinical controversies regarding the benefits of treatinghypertension, dyslipidemia, and chronic obstructive pulmonarydisease.u Evaluate challenges with the application of the updatedguidelines when treating hypertension, dyslipidemia, andchronic obstructive pulmonary disease.Hypertension Guideline Update (JNC-8), Joseph J. Saseen,PharmD, BCPS, FASHPChronic Obstructive Pulmonary Disease Guideline Update(ACP/ACCP/ATS/ERS), Joseph Vande Griend, PharmDDyslipidemia Guideline Update (NCEP ATP IV), Joel C.Marrs, PharmD, BCPS6447th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

9:15am – 11:00am Mandalay Bay L, Level 2a Success Strategies for implementing anElectronic Health RecordPlanned in cooperation with the ASHP Section of PharmacyInformatics and TechnologyActivity #204-000-12-238-L04P/204-000-12-238-L04TLevel of Content: Intermediate1.75 Contact Hours/Knowledge-basedProgram Chair/Moderator: Wayne Bohenek, PharmD, MS,FASHPLearning Objectives:u Describe key strategies for a successful implementation of anEHR in a multi-hospital system and an academic medicalcenter.u Describe key strategies for shared ownership with otherhealthcare providers necessary for a successful EHRimplementation.u Discuss common pitfalls of EHR implementation.Introduction and Overview, Wayne Bohenek, PharmD, MSPre Go-Live: Lessons Learned from the Battlefield, SusanMashni, PharmD, BSThe Go-Live: How to Get an A, Kelly Turner, PharmDPost Go-Live: The Work and Fun Starts Now, Jack Temple,MS, PharmDComments and Strategies from a Consultants Perspective,Kevin Marvin, MS, FHIMSS, FASHP9:30am – 10:30am South Seas H, Level 3a Management Case Studies g: Parts 1 & 2Moderator: Julie Dagam, PharmD, BCPSCentralized to Decentralized: The Centralization of OrderProcessing Across a Health System to Support the PPMIActivity #204-000-12-362-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Allan Loeb, MS, RPh; Brian Olender, PharmDLearning Objectives:u Describe the challenges to centralizing order processingacross multiple hospitals.u Describe the development and implementation of the centralizedorder processing project.u Describe the monitoring process for centralized orderprocessing.Implementation of a Clinical Pharmacy PracticeModel initiative through Alignment of ClinicalMetrics and Executive incentivesActivity #204-000-12-363-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Steven G. Pickette, PharmD, BCPS; Stephen E.Stoner, PharmD, BCPSLearning Objectives:u Identify appropriate outcome measures to assess the effectivenessof a clinical pharmacy practice model initiative.u Describe the steps to include in implementation of a clinicalpharmacy practice model initiative.u Describe methods to align incentives with senior leadershipto ensure successful implementation of a clinical pharmacypractice model.9:30am – 11:00am Mandalay Bay H, Level 2a Bet on Red: new Challenges andTherapies for BleedingActivity #204-000-12-251-L01PLevel of Content: Advanced1.5 Contact Hours/Application-basedProgram Chair/Moderator: Asad E. Patanwala, PharmD,BCPSLearning Objectives:u Recommend strategies for the reversal of oral anticoagulantssuch as direct thrombin inhibitors and factor Xa inhibitors.u Develop a plan for bleeding cessation due to traumatic hemorrhageand in the perioperative setting.u Evaluate dosing considerations for factor products such asprothrombin complex concentrate and factor VIIa.Reversal of New Oral Anticoagulants, William E. Dager,PharmD, BCPS, FASHPNew Therapies for Traumatic and Surgical Bleeding, RobertMacLaren, PharmD, FCCMOptimizing the Use of Factor Products, Asad E. Patanwala,PharmD, BCPS9:30am – 11:00am Reef D, Level 2a What You need to Know to get Started:Opportunities in Medical WritingActivity #204-000-12-286-L04P/204-000-12-286-L04TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Gayle Nicholas Scott, PharmD, BCPSLearning Objectives:u Describe regulations and guidelines governing medicalpublications.u Differentiate between ghostwriting and professional medicalwriting.u List resources for current and aspiring medical writers.Opportunities in Medical Communications, Lana Vegman,PharmDEthical Publication Practices, Aruna Seth, PhD, CMPPWorking with Medical Writers, Charles (Kurt) Mahan,PharmD, PhCEducation, Organizations, Certifications in Medical Communications,Gayle Nicholas Scott, PharmD, BCPSFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition65

T2:00pm – 3:15pm Mandalay Bay D, Level 2a Are You Ready?Preparing and Responding to CodesPlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-254-L01PLevel of Content: Intermediate1.25 Contact Hours/Knowledge-basedProgram Chair/Moderator: Wes Pitts, PharmD, BCPSLearning Objectives:u Summarize recent updates to ACLS and PALS guidelines.u Explain practical tips that can be applied to be a more effectivemember of the resuscitation team.u Define simulation training and review its components withemphasis on the role of the pharmacist.u Explain how to advocate for pharmacist involvement in simulationbased training and education.ACLS and PALS Update with Practical Tips for CodeResponse, Asad E. Patanwala, PharmD, BCPSUse of Simulation in Advanced Cardiopulmonary Life Support,Michael J. Cawley, PharmD, RRT2:00pm – 3:30pm South Seas J, Level 3a Critical Roles for Certified PharmacyTechnicians in Practice Model ChangePlanned in cooperation with the Pharmacy TechnicianCertification BoardActivity #204-000-12-225-L04P/204-000-12-225-L04TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedProgram Chair: Angela T. Cassano, PharmD, BCPSModerator: Megan Coder, PharmDLearning Objectives:u Explain new or modified roles that have been developed or expandedto assist in achieving PPMI recommendations and goals.u List steps to integrate remote supervision of pharmacy techniciansand describe the impact on patient care.u Identify training, certifications, and competencies needed toenhance pharmacy technician roles.u Discuss the PTCB C.R.E.S.T. Initiative and how it relates to PPMI.Telepharmacy: A Board of Pharmacy Perspective, MarkHardy, PharmDTelepharmacy: A Health-System Perspective, ShelleyJohnsen, RPhPharmacy Technicians: A Critical Element of Practice ModelChange, Megan Coder, PharmD2:00pm – 3:30pm South Seas E, Level 3a Improving Patient outcomes: Highlightsfrom the ASHP-APhA MedicationManagement in Care Transitions ProjectActivity #204-000-12-262-L04PLevel of Content: Intermediate1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Cynthia Reilly, BS PharmFor presenter affiliations see Presenter IndexLearning Objectives:u Define the need for improved transitions of care and opportunitiesfor pharmacists to engage in this work.u Identify key characteristics associated with successful caretransitions models.u Describe potential barriers to care transitions models and recommendstrategies to overcome these barriers.Overview of the ASHP-APhA Medication Management inCare Transitions Project, Cynthia Reilly, BS PharmLeadership for High-Value Health Care: Improving CareTransitions, Kristine Gullickson, PharmD, FASHPEinstein Healthcare Network: Medication REACH program,Deborah Hauser, RPh, MHA; Mariel Sjeime, PharmDProject PRIMED: Pharmacist Reconciliation of Medicationsand Education at Discharge, Anne Szulczewski, PharmD2:00pm – 3:30pm Banyan C, Level 3a Help, i Can’t Afford My Drugs!Emerging opportunities in Caringfor indigent PatientsActivity #204-000-12-319-L04PLevel of Content: Intermediate1.5 Contact Hours/Knowledge-basedProgram Chair: Anna Mangum, MPH, MSWModerator: Maureen Testoni, JDLearning Objectives:u Provide an overview of emerging issues and opportunities inproviding care to indigent patients for 340B hospitals and othersafety net providers.u Describe innovations, strategies and tactics in providing suchcare.u Describe resources available to assist 340B hospitals on thistopic.Introduction/Context, Maureen Testoni, JDCase Study: LA County, Amy Gutierrez, PharmDCase Study: Carolinas Health System, Fern E. Paul-Aviles,PharmD, MS2:00pm – 3:45pm Mandalay Bay L, Level 2a Advancing Pharmacy Practice& Medication Safety ThroughMedical Device integrationPlanned in cooperation with the ASHP Section of PharmacyInformatics and TechnologyActivity #204-000-12-239-L04P/204-000-12-239-L04TLevel of Content: Intermediate1.75 Contact Hours/Knowledge-basedProgram Chair/Moderator: Mark Siska, RPh, MBA/TMLearning Objectives:u Identify the medication infusion therapy safety gaps notaddressed by stand-alone smart pumps.u Summarize the benefits of medical device integration acrossthe medication-use continuum.u List some of the key drivers for medical device integration.Current & Future State of Device Integration, Mark Siska,RPh, MBA/TMcontinues >47th ASHP Midyear Clinical Meeting and Exhibition67

Leveraging Device Integration to Improve Pharmacy OperationalEfficiencies, Donald L. Gerhart, RPhThe Last 100 Feet of Data Integration at the Point of Care,Steven B. Ward, PharmDImproving Medication Therapy Management Servicesthrough Device Integration, Amanda Brummel, PharmDT2:00pm – 4:00pm Mandalay Bay J, Level 2education CE sessions TUESDAy, DECEMBER 4continued2:00pm – 5:00pm South Seas D, Level 3An Afternoon of infectious Diseases2:00pm – 3:00pmClostridium Difficile infections: new Drugs andNew StrategiesActivity #204-000-12-253-L01PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Kevin W. Garey, PharmD, MS, FASHPLearning Objectives:u Identify modifiable risk factors that increase a patient’s riskfor C. difficile infection or CDI.u Develop a treatment plan for the first episode of CDI basedon disease severity and underlying risk factors.u Describe methods to decrease the likelihood of CDI recurrence.3:00pm – 4:00pmAntibiotic Stewardship: get on Board Before WeDrown in Bacterial ResistanceActivity #204-000-12-255-L04PLevel of Content: Intermediate1.0 Contact Hours/Application-basedPresenter: Marc H. Scheetz, PharmD, MScLearning Objectives:u Given a specific hospital scenario, identify factors thatincrease injudicious use of antimicrobials.u Design a scheme to analyze the data that captures antimicrobialutilization at a hospital.u Utilize clinical decision support (CDS) techniques to the fullestcapability.4:00pm – 5:00pmCrisis in Medical Mycology: The Urgent need toAdjust Antifungal BreakpointsActivity #204-000-12-269-L01PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Nathan P. Wiederhold, PharmDLearning Objectives:u Given a specific patient case, identify factors that increase apatient’s risk of treatment failure.u Describe the rationale for the change in antifungal clinicalbreakpoints.u Determine if the fungal isolate is resistant and explain whattreatment options exist.a Preparing for 2013 - Congress,Agencies, and the States: What’s inStore for Health-System PharmacyActivity #204-000-12-223-L03P/204-000-12-223-L03TLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair: Brian M. Meyer, MBAModerator: Kasey K. Thompson, PharmD, MSLearning Objectives:u Identify current federal regulatory and legislative issuesimpacting health-system pharmacists in a variety of settings.u Discuss current regulatory and legislative issues in the statesthat impact health-system pharmacists.u Identify the grassroots actions attendees can take at theirpractice sites to advocate before policymakers.Preparing for the 2013 Policy Environment and the PoliticalLandscape from the November Election, Brian Meyer, BA, MBAThe 113th Congressional Agenda and the Impact for HealthSystem Pharmacy, Joseph Hill, MAThe 2013 Federal Regulatory Agencies Agenda, ChristopherTopoleski, BAState Legislative and Regulatory Issues for 2013, KarenNoonan, MA2:00pm – 4:00pm Mandalay Bay H, Level 2a Clinical Pearls 2012Planned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-233-L01PLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair: Ericka L. Breden, PharmD, BCPPModerator: Bruce R. Canaday, PharmD, FAPhA, FASHPLearning Objectives:u Discuss three clinical scenarios that might not be widelyknown or published.u Identify novel clinical practice options for patient care in varioushealth-system settings.u Describe medication management strategies in difficult orcontroversial patient care situations.u Identify clinical information that can be applied to your worksetting.Don’t Let Weight Loss Surgery Bypass You! Robert A. Lucas,PharmD, BCPSBetter Living through Nebulization, Kevin McDonough,PharmD, MPAWould You Like That Blended or on the Rocks? FecalTransplant as an Alternative for Recurrent Clostridium Difficile,Nick Bennett, PharmD, BCPSWhen Does “S” Really Mean “R”? William L. Musick,PharmD, BCPS (AQ-ID)Carbapenems Causing Seizures? A Valproate InteractionIncognito..., Nicole Bohm, PharmDP-Glycoprotein, Role of the “Cellular Vacuum Cleaner” inDrug Interactions, Gayle Nicholas Scott, PharmD, BCPS6847th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

Monthly Menstrual Migraine Miniprophylaxis: An AlliterativeNew Role for Triptans? Sarah L. Anderson, PharmD,BCPSLithium Toxic Patients: The SILENT Type, Jonathan G.Leung, PharmDGetting to the Heart of the Matter: Citalopram, Steven C.Stoner, PharmD, BCPPChad on CHA2DS2-VASc: A Novel Stroke Risk AssessmentTool in Atrial Fibrillation, Chad Coulter, PharmDPentoxifylline: It’s Not Just for Claudication Anymore! TimothyReilly, PharmD, BCPSInsulin U-500: Why is it so Hard to Concentrate, MatthewStrum, PharmD, BCACPWhat to Testify When You’re Testifying: A Primer for PharmacistsServing as Expert Witnesses, Gary Milavetz, BS,PharmDDon’t Hold the Salt...Impact of Hyponatremia on Growth inInfants Receiving Adequate Calories, Kathleen M. Gura,PharmD, BCNSP, FASHPBaby Vaccine Blues, Amy Holmes, PharmDLyse to Live: Alteplase for Pulmonary Embolism AssociatedCardiac Arrest, Sarah Nelson, PharmD, BCPSMyth-Busting Auto-Anticoagulation, Brian Watson, PharmD,BCPSStumped with an Enoxaparin Anti-Xa Level? Consult YourPharmacist! Jenna Huggins, PharmD, BCPS2:00pm – 5:00pm South Seas B, Level 3OncologY PHARMACY SPECiALTY SESSionS 2012: Advanced Topics in Practice Part 2Planned in cooperation with the Hematology/Oncology Pharmacy Association and the American College of Clinical PharmacyProgram Chair/Moderator: Ryan N. Bookout, Pharm.D.,BCPS, BCOPPlease note: If you are attending this program for BCOP recertification,there are different instructions for claiming CE fromthose attending only for ACPE credit.ACPE Credit Only: Instructions for claiming CE will be availablein the session room. CE will be provided by theHematology/Oncology Pharmacy Association (HOPA).BCOP Recertification: These sessions are part of the professionaldevelopment program for recertification of BoardCertified Oncology Pharmacists (BCOPs), approved by theBoard of Pharmaceutical Specialties (BPS). Part 2 will be presentedon Tuesday, December 4, 2:00pm – 5:00pm BCOPsmust attend all six hours of programming to be eligible to completethe Web-based post-test for oncology recertificationcredit. Partial credit is not available for recertification, but isavailable for ACPE credit.In the session room, you must complete a paper registrationform and sign in and out in both the morning and afternoonsessions as you enter and exit the session room.The post-test fee is $45. After The Midyear, program participantswill receive email instructions to purchase and accessthe test, as well as claim ACPE credit. The post-test examinationmust be completed and submitted by December 31, 2012.2:00pm – 3:00pmTreatment Progress for Advanced non-Small CellLung CancerUAN# 0465-9999-12-027-L03-PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Christine M. Walko, PharmD, BCOPLearning Objectives:u Design a first-line treatment plan for a patient with metastaticnon-small cell lung cancer (NSCLC) based on histology.u Evaluate the role of mutation testing in metastatic NSCLC.u Compare different maintenance therapies utilized in the managementof metastatic NSCLC based on efficacy and toxicity.3:00pm – 4:00pmTrends in oncology Drug Expenditures andPractical Cost-Management StrategiesUAN# 0465-9999-12-028-L01-PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: James M. Hoffman, PharmD, MSLearning Objectives:u Analyze trends and project future costs for health care overall,for cancer care, and for oncology drugs.u Assess key implications of healthcare reform on oncologydrug costs, especially the future role of biosimilars.u Implement effective formulary and other strategies to managecancer drug costs to maintain a quality oncology practice.4:00pm – 5:00pmThe Emergence of Adolescent and Young AdultOncologyUAN# 0465-9999-12-028-L01-PLevel of Content: Advanced1.0 Contact Hours/Application-basedPresenter: Kerry Parsons, PharmD, BCOPLearning Objectives:u Assess the different characteristics and concerns that separatethe AYA population from the adult and pediatric sectors ofmedicine.u Discuss potential causes of outcome disparities in the AYApopulation.u Evaluate current and future treatment regimens of the AYApopulation for specific cancersu Review the future of AYA Oncology as a medical specialty.For presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition69

education CE sessions2:00pm – 4:00pm Mandalay Bay F, Level 2a Soothing the Savage Beast: Vignettes inComplicated Pain ManagementPlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersActivity #204-000-12-281-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Ernest J. Dole, PharmD, BCPS,FASHPLearning Objectives:u Recognize the impact that comorbid conditions such as hypothyroidismand low vitamin D can have on the response to opiatetherapy and be able to develop a medication regimen thatreflects application of the best evidence and current guidelines.u Describe common symptoms of PTSD in a patient withchronic pain and develop a medication regimen that reflectsapplication of the best evidence ad current guidelines.u Develop a medication regimen that reflects application of thebest evidence and current guidelines in a patient with sleepapnea who is receiving opiates.u Describe the risk of opiate overdose in patients receiving highdose opiates.Overview of Effect of Comorbid Disorders on OpiateResponse, Mary Lynn McPherson, PharmD, BCPS, FASHPOverview of the Effect of PTSD on Chronic Pain, Ernest J.Dole, PharmD, BCPS, FASHPOverview of the Impact That Sleep Apnea Can Have onOpiate Response, Christopher M. Herndon, PharmD, BCPS,FASHPOverview of the Use of High Dose Opiate Therapy and OpiateOverdose, Michele L. Matthews, PharmD, CPE2:00pm – 5:00pm Reef D, Level 2a Developing Ambulatory CareClinical Services: Financial incentivesand Service ValuePlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersActivity #204-000-12-263-L04PLevel of Content: Intermediate3.0 Contact Hours/Application-basedProgram Chair/Moderator: Seena L. Haines, PharmD, BCACPLearning Objectives:u Explain the key elements necessary when conducting aneeds assessment to include: initial scope of services, role ofstudents/residents, and interdisciplinary patient centered carewhen developing a business proposal.u List the critical components necessary for sustainability andexpansion of pharmacist clinical services through a strategicplanning process.u Compare other methods of offering financial value to create asustainable program through cost-avoidance, pay-for-qualityinitiatives (PCMH, ACO), state Medicaid programs that havepharmacist provider status.7047th ASHP Midyear Clinical Meeting and ExhibitionTUESDAy, DECEMBER 4continuedu Discuss financial incentives available by payors for establishedclinics with collaborative drug therapy management (CDTM).Needs Assessment and Business Proposal with HIT, KellyT. Epplen, PharmD, BCACPStrategic Planning and Clinical Expansion with HIT, Amy L.Stump, PharmD, BCPSFinancial Value and Sustainability with HIT, Sandra Leal,PharmD, FAPhAFinancial Incentives with HIT, Betsy Bryant Shilliday,PharmD, CDE3:00pm – 5:00pm Breakers C, Level 2a Corporate Pharmacy: ManagingPharmacy Across an integratedMulti-Hospital networkActivity #204-000-12-261-L04PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Gregory C. Gousse, BSPharmacy, MS Pharmacy, FASHPLearning Objectives:u Describe the steps involved with the successful functioningof a collaborative pharmacy committee within an integratedhospital network.u Identify the key elements to achieve success given the challengesof formulary management across a network.u Recommend a system-wide pharmacy approach includingintegration with other disciplines in the prevention of readmissionsthat addresses value-based purchasing and healthcarereform.u Describe the challenges and opportunities facing a newlyappointed corporate director.Perspectives of a New Corporate Director, Demetris Butler,PharmDCoordinating a Corporate Pharmacy Executive Committee,Margaret ClappPharmacy and Therapeutics Committee Network Coordination,James A. Jorgenson, RPh, MS, FASHPPlanning Challenges in a Value-Based Purchasing Environment,Bonnie L. Senst, MS, RPh, FASHP3:30pm – 5:00pm South Seas H, Level 3a Management Case Studies H: Parts 1, 2 & 3Moderator: Deborah A. Brown, MS, PharmDPotential Strategy for implementing a CareTransition Service with Existing ResourcesActivity #204-000-12-364-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Allison E. Burnett, PharmD, PhC; RichardD’Angio, PharmD; Melanie Dodd, PharmDLearning Objectives:u Describe the valuable role that pharmacy residents and studentscan have in care transitions.u Describe key steps in development and implementation of apharmacy-driven care transitions service.For presenter affiliations see Presenter Index

Introduction, implementation and impact of aPharmacist-Driven Transitional Care ModelActivity #204-000-12-365-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Rowell Daniels, PharmD, MS; Robert Granko,PharmD, MBA; Scott Savage, PharmD, MSLearning Objectives:u Describe overall development and resources needed for apharmacy-driven transitional care model.u Define core metrics around this model.u Discuss limitations and next phases for the launching ofCarolina Care at Home.Pharmacist Role in Accountable CareOrganizations – Transition of CareActivity #204-000-12-366-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Haley Holtan, PharmD; Bruce R. Thompson, RPh,MSLearning Objectives:u Explain the concepts needed to implement a transitional caremodel.u Describe the roles of Pharmacists in transitional care.u Explain the complexity of transition of care in a teaching hospital.3:30pm – 5:00pm Lagoon K, Level 2a Compounding Conundrums:Outsourcing Shortages, Clean RoomDesign, and Hazardous DrugsActivity #204-000-12-288-L04P/204-000-12-288-L04TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Patricia C. Kienle, RPh, MPA,FASHPLearning Objectives:u State the process to assess the appropriate use of an outsourcedsterile compounding pharmacy.u List components of a process to assess appropriateness of avendor new to the organization.u List common issues that cause a clean room to fail a certificationtest.u List the concerns of occupational exposure healthcare workersto hazardous drugs.u Identify The National Institute for Occupational Safety andHealth (NIOSH), Occupational Safety Health Administration(OSHA), and accreditation organization activities in reducinghazardous drug exposure in healthcare workers.Outsourcing, Shortages, and Issues with CleanroomDesign, Eric S. Kastango, MBA, RPh, FASHPHazardous Drugs, Luci Power, BS MSFor presenter affiliations see Presenter Index3:30pm – 5:00pm Mandalay Bay B, Level 2a Critical Updates in Pediatrics, Part 2: CHF,Cystic Fibrosis, and Traumatic Brain injuryPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-297-L01PLevel of Content: Advanced1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Elizabeth Anne Farrington,PharmD, BCPSLearning Objectives:u Explain the current guidelines for infants and children withcystic fibrosis.u Evaluate the current literature regarding the efficacy andsafety of VX-770 (KalydecoTM) in combination with VX-809 anew agent-in-development, for the treatment of cystic fibrosis.u Describe the pathophysiology and treatment of pediatric heartfailure and how it differs from adult heart failure.u Describe the causes of traumatic brain injury (TBI) based onthe age of the patient and how this changes empiric testing ormedication management.u Review the new SCCM pediatric TBI guideline and applicationof key changes to the treatment of the pediatric patient.New Treatment Options for the Patient with Cystic Fibrosis,Kimberly Novak, PharmD, BCPSUpdate in the Treatment of Congestive Heart Failure inChildren, Jason A. Corcoran, PharmD, BCPSHighlights of the New Pediatric Traumatic Brain InjuryGuidelines, Elizabeth A. Farrington, PharmD, BCPS4:00pm – 5:00pmSouth Pacific D, Lower Level,North Convention Centera Management Case Studies D: Parts 1 & 2Moderator: Juliana Chan, PharmDImprovement in Smart Pump Utilization with anInfusion Pump PharmacistActivity #204-000-12-356-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Tina B. Aramaki, PharmD; Beth Johnson, RPh;Scott Milner, PharmD, MBALearning Objectives:u Explain the difficulties in maintaining a drug library.u Describe the workflow of a pump pharmacist.u Describe the complexity of smart pumps.Getting the Most from Your Chemo Robot – FirstYear Experience in a Hospital-Based AmbulatoryInfusion PharmacyActivity #204-000-12-357-L04P/204-000-12-357-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenter: Angela W. Yaniv, PharmD, BSLearning Objectives:u Describe the challenges to optimal robot through put in anambulatory infusion pharmacy setting.u Identify two strategies that can enhance robot use and through put.u Discuss human-factor issues to address when implementingan IV robot.47th ASHP Midyear Clinical Meeting and Exhibition71

Teducation CE sessions TUESDAy, DECEMBER 4continued4:00pm – 5:00pm South Seas J, Level 3 4:00pm – 5:00pm Mandalay Bay L, Level 2a Management Case Studies E: Parts 1 & 2 a Integrated Precepting: MaximizingModerator: Nicole J. Clark, PharmD, BCPSLearning for Both Students and ResidentsMedication History Technician Supervision:Activity #204-000-12-212-L04PRecommendations for Establishing EffectiveLevel of Content: General InterestAccountability1.0 Contact Hours/Knowledge-basedActivity #204-000-12-358-L04P/204-000-12-358-L04TProgram Chair/Moderator: Debbie C. Byrd, PharmD, BCPSLevel of Content: General InterestLearning Objectives:0.5 Contact Hours/Knowledge-basedu Design strategies to integrate pharmacy student and residentPresenters: DeAnne L. Brooks, PharmD; Julie B. Cooper,learners into practice.PharmD, BCPSu Evaluate current pharmacy services that could be extendedthrough use of pharmacy students and residents.Learning Objectives:u Identify quality metrics for a medication history program.Integrating Learners into Practice, Shaunta’ M. Ray,u Evaluate essential components of a Medication HistoryPharmD, BCPSStandard and technician evaluation rubric as a foundation of a Expanding the Role of Learners in Patient Care, Sarahmedication history accountability program.Nisly, PharmD, BCPSu Explain the value of direct observation in the supervision of amedication history technician.4:00pm – 5:00pm Banyan C, Level 3Successes and Challenges with implementationand Expansion of Pharmacy Technicians ina Therapy Updates: The Risks and BenefitsMedication History Roleof immunosuppression in the Modern EraActivity #204-000-12-359-L04P/204-000-12-359-L04TPlanned in cooperation with the ASHP Section of InpatientLevel of Content: General InterestCare Practitioners0.5 Contact Hours/Knowledge-basedActivity #204-000-12-215-L01PPresenter: Jeanne R. Ezell, MS, BS, FASHPLevel of Content: IntermediateWLearning Objectives:1.0 Contact Hours/Knowledge-basedu Describe how to obtain support and approval for medicationProgram Chair/Moderator: Terri Albarano, PharmD, MSreconciliation technician positions.u List key factors for success with implementation and expansionof medication reconciliation pharmacy technicians. u Identify pharmacotherapeutic strategies for the manipulationLearning Objectives:u Explain how to collect meaningful data for quality assessment of the human immune system after transplantation.of medication and allergy histories performed by pharmacy u Illustrate treatment strategies for post-transplant rejection.technicians.u Distinguish treatment options for transplant-relatedcomorbidities.4:00pm – 5:00pm Mandalay Bay F, Level 2Risk-Based Approach to Maintenance Immunosuppression,Christopher R. Ensor, PharmD, BCPS-CVa Providing Care Beyond Cure:Immunosuppression Manipulation for Rejection/AdverseTransitioning Patients to Palliative CareEffects, Edward T. Horn, PharmD, BCPSPlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersWEDnESDAY, DECEMBER 5Activity #204-000-12-203-L01P8:00am – 9:30am Banyan C, Level 3Level of Content: Intermediate1.0 Contact Hours/Application-baseda Management Case Studies i: Parts 1, 2 & 3Program Chair/Moderator: Lee A. Kral, PharmD, BCPSModerator: Barbara Giacomelli, PharmD, MBA, FASHPLearning Objectives:Communication Strategy to Educate Healthcareu Given a description of a specific patient, determine what theProviders about Drug Shortages in a Multi-Facilitygoals of care are when transitioning to a palliative care approach.Academic Medical Centeru Create a list of drug-related problems.Activity #204-000-12-367-L04P/204-000-12-367-L04Tu Develop and present recommendations to address the drugrelatedproblems.Level of Content: General Interest0.5 Contact Hours/Knowledge-basedIntroduction to the Palliative Care Transition, Lee Kral,Presenters: Ellena Anagnostis, PharmD, BCPS; Anne MariePharmD, BCPSValorie-Oberle, PharmD, BCOP; John Williamson, PharmD,Transition to Palliative Care: Pain Management, Lee Kral, MBA, BCPSPharmD, BCPSLearning Objectives:Transition to Palliative Care: Symptom Management, u Identify pharmacy staff to contribute to the design of a communicationplan for drug shortages.Pamela Moore, BCPS, CPE7247th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

u List opportunities to educate providers through face-to-facecommunication regarding drug shortages.u Describe options for communicating information electronicallyto prescribers.Process for Addressing Drug Shortages in aTwo-Hospital SettingActivity #204-000-12-368-L04P/204-000-12-368-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenter: Jill M. Strykowski, MS, RPhLearning Objectives:u Describe the importance of assessing supply chain andinventory during a time of critical drug shortages.u Describe the role of key team members in averting drugshortages.u Given that drug shortages are an everyday occurrence,explain the difference between managing through a drug shortageversus addressing a shortage that is of an immediate criticalpatient care nature.Reimbursement for Medication TherapyManagement Clinic (MTMC)Activity #204-000-12-369-L04PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Anna Markel Vaysman, PharmD, BCPS; MansiShah, PharmD; Jessica J. Tilton, PharmD, BCACPLearning Objectives:u Define various options for billing of medication therapy managementservices.u Design a process to implement billing opportunities.u Describe the barriers encountered when billing for MTMCservices.8:00am – 9:30am South Seas B, Level 3a Management Case Studies L: Parts 1, 2 & 3Moderator: Brad Myers, PharmD, MBA, BCPSUsing Failure Mode Effects Analysis (FMEA) toImprove Controlled Substances Processes inInpatient AreasActivity #204-000-12-374-L05PLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Leigh DeMarco, PharmD, MS; Carolyn Kowalchik,RPh, MSs; Linda S. Tyler, PharmD, FASHPLearning Objectives:u Describe the steps of a FMEA.u List three system vulnerabilities for handling controlled substancesthat can be identified through a FMEA process.u Identify three factors to make a FMEA project moresuccessful.Pharmacy Lessons Learned from a Disaster - TheJoplin StoryActivity #204-000-12-375-L04P/204-000-12-375-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Sarah Boyd, PharmD, BCPS; Jonathan Lakamp,PharmD, BCPSLearning Objectives:u Describe the disaster preparedness plan at Mercy HospitalJoplin prior to May 22, 2011.u Review the immediate response.u Identify strategies for re-establishment of pharmacy services.Calling a Blitz: Utilization of a Rapid ProcessImprovement Tool to Enhance MedicationDistribution ProcessesActivity #204-000-12-376-L04P/204-000-12-376-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Berook Addisu, PharmD, BCPS; Carol Munch, BSPharm; Andrew Wilcox, PharmDLearning Objectives:u Describe the purpose of a kaizen blitz.u Describe the potential framework of a kaizen blitz.u Describe how to select members of a kaizen blitz Project Team.8:00am – 9:30am Reef D, Level 2a Case-Based Approach to insulin initiationand intensificationPlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersActivity #204-000-12-282-L01PLevel of Content: Intermediate1.5 Contact Hours/Application-basedProgram Chair/Moderator: Gina Ryan, PharmD, BCPSLearning Objectives:u Describe the normal physiological insulin release and pharmacokineticprofiles of the following insulin regimens: basalonly, 70/30 twice a day, and basal-bolus insulin.u Appropriately adjust insulin based on a patient’s self-bloodglucose monitoring results.Brief Basic Diabetes Background and Description ofPatients in Insulin Cases, Melody L. Hartzler, PharmD, AE-CNormal Physiology of Insulin Release, Melody L. Hartzler,PharmD, AE-CInsulin Pharmacokinetics, Basal vs. Bolus Types, Melody L.Hartzler, PharmD, AE-CInsulin Level Curves and Limitation for Common Regimens,Candis M. Morello, PharmD, CDETarget Blood Glucose Levels, Candis M. Morello, PharmD, CDEInsulin Cases, Gina J. Ryan, PharmD, CDE8:00 a.m. – 9:30 a.m. Breakers C, Level 2a A Compounding Tragedy —A national ResponseActivity #204-000-12-275-L03P/204-000-12-275-L03TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedThis session will provide an update from ASHP, federal officials,and other experts on emerging developments related topreventing contaminated drug products from entering the drugsupply chain.For presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition73

8:00am – 9:30am Mandalay Bay L, Level 2a PPMI, iT, & Automation: How to Develop aMedication-Use System Strategic PlanActivity #204-000-12-299-L04P/204-000-12-299-L04TLevel of Content: Intermediate1.5 Contact Hours/Application-basedProgram Chair: Allen Flynn, PharmDModerator: Mike J. Wisz, MBALearning Objectives:u Describe what is included in the outline of a medication-usesystem strategic plan for pharmacy.u Apply medication-system automation and information technologyto the medication-use cycle in your organization.u Explain how enabling technologies can facilitate practicemodel advancement in key focal PPMI areas of telepharmacy,mobile workflow, pharmacist documentation and continuity of care.Big Picture View of Medication-Use Systems, Mike J. Wisz,MBAWhat’s in a Medication-Use System Strategic Plan, Mike J.Wisz, MBASetting Your Medication-Use System Plan Objectives,Cedric A. Terrell, PharmDHow to Build Support for Your Plan, Cedric A. Terrell, PharmDTech-Enabled Practice Model Advancement Opportunities,Cedric A. Terrell, PharmD8:00am – 9:45am South Seas E, Level 3a Emergency Medicine Pearls 2012Planned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-234-L01PLevel of Content: General Interest1.75 Contact Hours/Knowledge-basedProgram Chair/Moderator: Daniel Hays, PharmD, BCPSLearning Objectives:u Discuss clinical practice in the Emergency Department.u Explain applications of clinical pharmacotherapy in theEmergency Department.u Discuss how to apply clinical pharmacotherapy to unique circumstancesand clinical presentations.Attack of the Killer Migraine! Droperidol to the Rescue!Megan Musselman, PharmD, BCPSIntranasal Midazolam, Kimberly Glasoe, PharmD[Don’t] Take My Breath Away: The Role of Glucagon inAcute Asthma Exacerbation, Nadia I. Awad, PharmDThe Use of Richmond Agitation Sedation Scale (RASS) forAlcohol Withdrawal Assessment in the Emergency Department,Lauren Elizabeth King, PharmDHeart to Heart: Recognizing Undiagnosed CongenitalHeart Disease in the ED, Leah M. Hatfield, PharmD, BCPSAlternative Dosing of Adenosine: Does Size Really Matter?Daniel H. Jarrell, PharmDPropofol for Alcohol Withdrawal Syndrome: Imitation is theSincerest Form of Flattery, Darrel W. Hughes, PharmD, BCPSEbbing the Flow in Trauma-Induced Coagulopathy, BrittanyR. Traylor, PharmDWUncommon Pediatric Treatments in Traumas - Avoiding the“I wish I Had Known That” Moment, Shannon Manzi, PharmDeducation CE sessions WEDNESDAy, DECEMBER 5continuedWhen the Pain is Skin Deep, Courtney McKinney, PharmD, BCPSA Look into Wilderness Medicine - HAPE and HACE,Pamela Walker, PharmD, BCPSPhysostigmine: It’s Back, Nicole M. Acquisto, PharmD, BCPSTPA for the PE in PEA, Alison M. Jennett Reznek, PharmD,BCPSIntranasal Medication Delivery in the Emergency Department,Renee Petzel Gimbar, PharmDNebulized Narcan: A Kinder, Gentler Awakening, HeatherSchumann, PharmDPulling Bedside Tricks, Part II, Joanne Witsil, PharmD, RN8:00am – 9:45am Mandalay Bay B, Level 2a Lytes off in Vegas!The Acute Management ofPotassium and Calcium DisordersActivity #204-000-12-242-L01PLevel of Content: Intermediate1.75 Contact Hours/Application-basedProgram Chair/Moderator: Michael C. Thomas, PharmD, BCPSLearning Objectives:u Design a plan to replace and monitor potassium.u Recommend a comprehensive treatment approach for thepatient with hyperkalemia.u Incorporate knowledge about treatments for calcium disordersinto the therapeutic plan for a patient.Low K May Not be Okay, Philippe Mentler, PharmD, BCPSHyperkalemia - Protect, Shift, and Eliminate, Michael C.Thomas, PharmD, BCPSBad to the Bone: Acute Calcium Disorders, Megan Corrigan,PharmD, BCPS8:00am – 9:45am Mandalay Bay J, Level 2a Innovative Practice: SustainableApproaches for Reducing30-Day Hospital ReadmissionsPlanned in cooperation with the ASHP Section of AmbulatoryCare Practitioners and the ASHP Section of Inpatient CarePractitionersActivity #204-000-12-265-L04PLevel of Content: Intermediate1.75 Contact Hours/Application-basedProgram Chair/Moderator: Richard L. Stambaugh, PharmD, MSLearning Objectives:u Identify and describe effective programs and services thathave reduced preventable readmissions to hospital.u Develop a plan to incorporate new practice models, programs,services and/or pharmacist interventions to reduce hospitalreadmissions in the inpatient, outpatient and transitionalcare settings.u Identify how to gather return on investment data for reducingreadmissions and creating sustainable services.7447th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

Pharmacy’s Role in Reducing Readmissions: A Review ofEstablished Programs and Outcomes, Steven M. Riddle,PharmD, BCPS, FASHPHeart Failure, Respiratory Disease, and Readmission,Joseph M. Dula, PharmDPreventing Readmissions, Joanne Doyle Petrongolo, PharmDCare Transitions and Reducing Readmissions, Paul Glynn,PharmD, BCPS, CGP8:00am – 9:45am South Seas J, Level 3a Transforming Care: Results from thePartnership for Patients initiativeActivity #204-000-12-266-L05P/204-000-12-266-L05TLevel of Content: General Interest1.75 Contact Hours/Knowledge-basedProgram Chair/Moderator: Brian J. Isetts, PhD, BCPSLearning Objectives:u Equip participants with the measures and best practices toengage their institution in achieving bold national medicationsafety aims.u Describe strategies to optimize patient participation in improvingcare and outcomes.u Discuss ASHP collaborations to promote quality improvementand to align the work of members in measuring decreases inadverse drug events and hospital readmissions.Overview of National Medication Safety, Brian J. Isetts, PhD,BCPSPrinciples for Partnering with Patients to Achieve Goals ofTherapy, Regina HollidayThe Urgent National Call to Action, Tom C. Evans, MD, FAAFPAlignment of ASHP Priorities with National MedicationSafety Aims, Kasey K. Thompson, PharmD, MSMeasures and Best Practices for Decreasing High ImpactADEs, Monica Barrington, RPh, MPH8:00am – 9:45am Mandalay Bay D, Level 2a Residency Precepting:Strategies Worth SharingActivity #204-000-12-271-L04PLevel of Content: General Interest1.75 Contact Hours/Application-basedProgram Chair/Moderator: John E. Murphy, PharmD, FCCP,FASHPLearning Objectives:u Refine your own orientation programs to enhance positiveexperiences for residents using examples provided during thissession.u Assess the outcomes and likelihood that institutions will adoptrecommended changes based upon the results of residencyprojects.u Evaluate current approaches to resident assessment andrevise strategies to improve processes.u List key strategies to fast-track changes for success.Effectively Orienting Residents to Your Program, Brian L.Erstad, PharmD, FASHPCreating Residency Projects that Make a Difference, JohnE. Murphy, PharmD, FCCP, FASHPAssessment that Improves Outcomes, Beth B. Phillips,PharmD, BCPSFor presenter affiliations see Presenter Index8:00am – 9:45am South Seas H, Level 3a Troubled Teen 101:Topics in Adolescent PsychiatryActivity #204-000-12-283-L01PLevel of Content: Intermediate1.75 Contact Hours/Application-basedProgram Chair/Moderator: Julie A. Dopheide, PharmD, BCPPLearning Objectives:u Explain how the development of the brain progresses fromchildhood into adulthood and how this ongoing brain developmentimpacts attention, mood and behavior.u Recognize signs and symptoms of psychiatric disorders,including ADHD, substance abuse, eating disorders, mood andpsychotic disorders, in adolescents.u Given a case of an adolescent prescribed an antipsychotic,mood stabilizer or antidepressant, determine which adverseeffects are most problematic and recommend managementand counseling.Case Presentation, Julie Dopheide, PharmD, BCPPThe Adolescent Brain, Elizabeth Sowell, PhDRecognizing and Managing Psychiatric Disorders in Youth,Julie Dopheide, PharmD, BCPP8:00am – 9:45am South Seas D, Level 3a From Drug Shortage to order Entry Errorto Device Failure: Managing a TPn Eventin a Large Health SystemActivity #204-000-12-284-L05P/204-000-12-284-L05TLevel of Content: General Interest1.75 Contact Hours/Application-basedProgram Chair/Moderator: Bonnie Levin, PharmD, MBALearning Objectives:u Identify common pharmacy human factors failure pointswhich could lead to extensive system errors.u Analyze process improvements which can be used to effectivelyprevent the identified potential failures.u Describe the safety processes which should be required toreplace drugs that cannot be obtained due to shortage.u Describe leadership strategies and tactics to effectively handlea serious medication error or other patient safety event.u Evaluate the use of the “Just Culture” concept and its implementationduring a serious medication error.Error Description, Bonnie Levin, PharmD, MBAImmediate Corrective Action: Communication and PatientMonitoring, Bonnie Levin, PharmD, MBAISMP’s Assessment and Corrective Action Planning,Michael R. Cohen, RPh, MS, ScD (hon)Human Factors Engineering Assessment and CorrectiveAction Planning, Rollin (Terry) J. Fairbanks, MD, MSOther Consultants’ Assessments, Corrective ActionPlanning and Leadership Strategy; Full Disclosure withPhysicians, Patients, Boards of Pharmacy, Bonnie Levin,PharmD, MBA47th ASHP Midyear Clinical Meeting and Exhibition75

education CE sessions WEDNESDAy, DECEMBER 5continued8:30am – 9:30am Lagoon K, Level 2a Resisting inertia: Approaches toManaging Resistant HypertensionActivity #204-000-12-256-L01PLevel of Content: Intermediate1.0 Contact Hours/Application-basedPresenter: Joel C. Marrs, PharmD, BCPSLearning Objectives:u Identify risk factors for the development of resistant hypertension.u Evaluate specific antihypertensive agents to treat hypertensiveresistant patients using current guidelines and evidence-basedpractice.u Compare and contrast the mechanisms of action, role in therapy,benefits and risks, and special considerations with antihypertensiveagents that are used in the management of resistanthypertension.10:00am – 11:00am Mandalay Bay F, Level 2a Spotlight on ScienceNanotechnology in Medicine:How Very Tiny Solutions can Impact Big ProblemsActivity #204-000-12-325-L01P/204-000-12-325-L01TLevel of Content: General Interest0.75 Contact Hours/Knowledge-basedFeatured Speaker: Mansoor M. Amiji, PhDFor more information on Dr. Amiji, see page 30.Learning Objectives:u Describe nanotechnology and its relevance in diseasemanagement.u Recognize the differences in nanotechnology and their therapeuticrelevance.u Give examples of future uses of nanotechnology in medicineand pharmacy.Hazardous Medication Handling:Implications for Pharmacy Compoundingand identification of Alternative TherapiesActivity #204-000-12-371-L03P/204-000-12-371-L03TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Kathryn Clark McKinney, PharmD, BCPS;Michael W. Cunningham, PharmDLearning Objectives:u Identify characteristics that would lead to the classification ofa medication as hazardous.u Differentiate between the health-systems Level 1 and Level 2hazardous medications.u Discuss the systems methodology for identification of alternativesto avoid disruption of solid dosage formulations of hazardousmedications outside of pharmacy.2:00pm – 3:00pm Mandalay Bay J, Level 2a Strategies to Createa More Collaborative WorkplacePlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-272-L04P/204-000-12-272-L04TLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Matthew W. Eberts, PharmD, MBALearning Objectives:u Identify the characteristics of a culture that supports and fosterscollaboration.u Explain the process for building a culture of collaboration.u Identify multi-disciplined patient centered services that can bedeveloped within a culture of collaboration.Practice Example-Building Patient Centered Coalitions byBreaking Down Barriers, John S. Clark, PharmD, MS, FASHPCreating a Culture of Collaboration, Matthew W. Eberts,PharmD, MBA2:00pm – 3:30pm Mandalay Bay L, Level 22:00pm – 3:00pm Banyan C, Level 3a Management Case Studies J: Parts 1 & 2Moderator: John S. Clark, PharmD, MS, FASHPImplementation of Resource ConservationRecovery Act (RCRA) Hazardous PharmaceuticalWaste Disposal PracticesActivity #204-000-12-370-L03P/204-000-12-370-L03TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Gayle Cotchen, PharmD, MBA; RosellaHoffmann, RPh; Elaine R. Mebel, PharmD, MSLearning Objectives:u Explain the Resource Conservation Recovery Act regulations.u Describe processes for compliance with RCRA medicationdisposal in health-systems.u Identify barriers that can hamper implementation of RCRAcompliance projects.7647th ASHP Midyear Clinical Meeting and Exhibitiona The Tortoise and the Hareof Chronic Kidney Disease:Slowing Disease ProgressionActivity #204-000-12-201-L01PLevel of Content: Intermediate1.5 Contact Hours/Application-basedProgram Chair/Moderator: Thomas C. Dowling, PharmD, PhDLearning Objectives:u Using a set of criteria, evaluate a patient’s comprehensivekidney function.u Recommend strategies for slowing the progression of renaldisease in patients with diabetic nephropathy in light of currentcontroversies in the literature.u Recommend strategies for slowing the progression of renaldisease in patients with hypertensive nephropathy.Update on Estimating GFR and Renal Biomarkers, ThomasDowling, PharmD, PhDHypertensive Nephropathy and Ethnicity, Chanel Agness,PharmD, BCPSApproaches to Slowing Diabetic Nephropathy, MaryOnysko, PharmD, BCPSFor presenter affiliations see Presenter Index

2:00pm – 3:30pm South Seas H, Level 3a 2012 ASHP national Survey Results:Implications and Trends for Today’s PracticePlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-224-L04P/204-000-12-224-L04TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Douglas J. Scheckelhoff, MSLearning Objectives:u Describe how the ASHP National Survey results can be usedto effect change in your organization.u List the most significant practice trends identified in the 2012ASHP National Survey.u Describe the practice trends that deviate from establishedbest practices.Patient Monitoring and Education, Craig A. Pedersen, PhD,FAPhAImportant Trends and Strategic Initiatives, Philip J. Schneider,MS, FASHPPharmacy Practice Model Initiative (PPMI) National Dashboard,Douglas J. Scheckelhoff, MS2:00pm – 3:30pm South Seas D, Level 3a Hot Topics in Emergency MedicinePlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-267-L01PLevel of Content: Advanced1.5 Contact Hours/Application-basedProgram Chair/Moderator: Daniel Hays, PharmD, BCPSLearning Objectives:u Discuss the current therapeutic regimens/options given apatient with pulmonary embolism.u Develop a treatment regimen based on best practices in apatient with a polysubstance overdose.u Evaluate a treatment regimen based on best practices in apatient with a calcium channel blocker/beta blocker.tPA for PE, Daniel Hays, PharmD, BCPS, FASHPHyperinsulinemia for Overdose, Philippe Mentler, PharmD,BCPSLipid Rescue for Overdose, Zlatan Coralic, PharmD2:00pm – 3:30pm Lagoon K, Level 2a Top Ten Medication Safety issues Relatedto Hospital Accreditation StandardsPlanned in cooperation with the Institute for Safe MedicationPracticesActivity #204-000-12-314-L03P/204-000-12-314-L03TLevel of Content: General Interest1.5 Contact Hours/Knowledge-basedPresenter: Darryl S. Rich, PharmD, MBA, FASHPLearning Objectives:u List the top ten medication safety issues in hospitals thatdirectly relate to the Joint Commission’s medication standardsand National Patient Safety Goals.For presenter affiliations see Presenter Indexu Cite the corresponding Joint Commission standard and elementof performance number for each issue, citing at least oneexample of a common practice that is an issue for eachstandard.u List at least one reason why medication safety is negativelyimpacted for each of these ten issues.u Describe at least one strategy or set of strategies for improvingmedication safety for each issue that also meets therequirements of each standard.u Cite at least two resources for improving medication safety inthese areas.2:00pm – 3:45pm South Seas J, Level 3a Reimbursement 2013: Unique andCompelling opportunitiesPlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-264-L04PLevel of Content: Intermediate1.75 Contact Hours/Application-basedProgram Chair/Moderator: Bonnie Kirschenbaum, MS,FCSHP, FASHPLearning Objectives:u Explain 2013 changes to Medicare reimbursement and identifyoperational changes required to implement them.u Evaluate three Medicare reimbursement challenges and complexitiesin your practice setting.u List the compliance requirements for Medicare and how theyapply to the 2013 changes to Inpatient Prospective (IPPS) andOutpatient Prospective (OPPS) Payment Systems.u Describe the role of pharmacy leaders in educating theirhealth systems on the impact of IPPS and OPPS changes.Strategies that Determined 2013 Reimbursement, Beth L.Roberts, JDQuirks, Responsibilities and Compliance Drive Reimbursement,Bonnie Kirschenbaum, MS, FCSHP, FASHP2:00pm – 4:00pm Reef D, Level 2a Transitioning Through ADHD:Pharmacotherapeutic Management fromChildhood to AdulthoodActivity #204-000-12-200-L01PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: David G. Fuentes, PharmD, BCPPLearning Objectives:u Apply patient-specific adherence barriers and the co-morbiditiesto the selection of the most beneficial attention deficithyperactivity disorder (ADHD) treatment options.u Design a patient-specific treatment plan for the managementof the presenting ADHD symptoms/chief complaint.u Evaluate a patient’s ADHD medication regimen customized topersonal adherence practices, labs, and concurrent medicalillnesses.u Interpret population safety data to determine the use of themost optimal agents for the management of a health system’sADHD medication formulary. continues >47th ASHP Midyear Clinical Meeting and Exhibition77

education CE sessions WEDNESDAy, DECEMBER 5continuedIntroduction to ADHD Pharmacotherapy and Considerations,David Fuentes, PharmD, BCPPRecommendations for Adding a Second Agent Differentiating(Comparing and Contrasting) Between Childhood andAdulthood Symptoms of ADHD, Clayton D. English, PharmD,BCPPRecommendations for Adding a Second Agent for TreatingPatients Already Using an Agent for ADHD, Joshua Caballero,PharmDRecommendations on Treating Adult ADHD Patients withCommon Comorbid Axis I Disorders, Bridget Bradley, RPh,PharmD2:00pm – 4:00pm South Seas E, Level 3a Informatics Pearls 2012: Bytes ofInformaticsPlanned in cooperation with the ASHP Section of PharmacyInformatics and TechnologyActivity #204-000-12-235-L04P/204-000-12-235-L04TLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Laura L. Tyndall, BS, PharmDLearning Objectives:u Identify how pharmacy informatics programs can be utilizedin your hospital system to improve patient care.u Describe one way a hospital has made better use of its clinicalinformation system and how it may be implemented in yourhospital.u Compare various pharmacy informatics initiatives and howthey improve the medication-use system.Can We Make Smart Pumps Smarter? Silvana Balliu,PharmD, RPhLeveraging Existing Hospital RFID Asset Tracking Technologyfor Pharmacy Applications, Richard Capps, PharmDElectronic Prescriptions for Controlled Substances – AFederal Agency’s Perspective on Implementation, RobertSilverman, PharmDUsing an Electronic Medication Build Checklist, Jeff Chalmers,PharmDLessons learned and Actions Taken After Discovery ofUndetected Information Technology (IT) Hazards Within anElectronic Medication Reconciliation Pathway: Is YourSystem at Risk? Donald McKaig, RPh, CDOEChemotherapy CPOE: Safety in Numbers, James L. Besier,PhD, RPh, FASHPWorking Smarter with “Dummy Drugs” - Improving VancomycinSafety, Melissa C. Frank, PharmDSurvey Says! Don’t Feud Among the Family…14 SurveyQuestions as Part of a Pharmacist-Physician Warning AlertProject, Burl Beasley, BS Pharm, MS PharmAlert Fatigue with DDI Clinical Decision Support: Is TurningOff Alerts the Answer? John Horn, PharmDTo Suppress or to Not Suppress – That is the Question:A Clinical Decision Support Tool to Help Decide WhichAlerts to Suppress, Victoria Noonkester, PharmDAre Your Drug Levels Timed Correctly? Pharmacist Timingof Therapeutic Drug Levels in a CPOE System, Gregory P.Burger, PharmDThe Role of Informatics Pharmacy and Patient Safety inInterfacing Vendor Software Functionality into the ElectronicHealth Record, Nancy R. Smestad, MS, RPhGet Your Vendors “Talking”- Developing an InterfaceBetween Your Online Ordering System and Your Robot,Andrew Trella, PharmDEducate as You Medicate, Loan M. Vu, PharmD, MBAMaking the Transition: Using CDS in CPOE to Move fromHospital to Home, Vanitra R. Richards, PharmDVirtual Ambulatory Consult: One Small Step Towards aCollaborative Practice, Kathy Yount, BS Pharm, RPh2:00pm – 4:00pm Mandalay Bay B, Level 2a A Smooth Transition: Moving PainManagement from Here to TherePlanned in cooperation with the ASHP Section of AmbulatoryCare PractitionersActivity #204-000-12-268-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Virginia L. Ghafoor, PharmDLearning Objectives:u Utilize practice models that integrate prescription monitoringprograms and practice protocols for transitions of care.u Determine appropriate drugs and devices for pain managementthat can be used across the continuum of care for intravenous,subcutaneous, epidural and intrathecal routes.u Collaborate on developing an interdisciplinary model for communicatingthe pain treatment plan across multiple practice settingsincluding the medical home.u Advocate for strategies to overcome barriers with prescribinglimitations, access to pain specialists, and insurance coverage.Preventing Pain Management Emergencies, AnthonyPazanese, PharmDConnecting Missing Links from Admission to Discharge,Virginia L. Ghafoor, PharmDAdvancing into the Medical Home, Barbara J. Petroff, BS,MS, FASHPRemoving Barriers to Chronic Pain Management, Ernest J.Dole, PharmD, BCPS, FASHP7847th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

2:30pm – 4:30pm Breakers C, Level 2a Evidence Based Approaches toPharmacokinetic Dilemmas 2012Activity #204-000-12-227-L04PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: John E. Murphy, PharmD, FCCP,FASHPLearning Objectives:u Discuss controversial issues in the literature related togeneric substitution of anti-epileptic drugs.u Evaluate the use of the MDRD equation for dosing medicationsin the presence of diminished renal function.u Describe debates in the literature on the use of weight estimatesfor drug dosing.u Identify issues about the pharmacokenetics of drug-druginteractions.Generic Substitution of Antiepileptic Drugs is a Safe Practice,Michael E. Winter, PharmD, FASHPThe MDRD Equation Should Replace Cockroft-Gault forDetermining Doses of Drugs in Renal Dysfunction, ThomasC. Dowling, PharmD, PhDPharmacokinetic Drug-Drug Interactions are Mostly ofTheoretical Rather Than Practical Importance to PatientSafety, John E. Murphy, PharmD, FCCP, FASHPThe Best Size Descriptor for Drug Dosing in ObesePatients is not Ideal Body Weight as Determined by theDevine Method, Mary Ensom, PharmD, FCCP, FASHP3:00pm – 5:00pm South Seas B, Level 3a Beers, Antihypertensives, and MedicalHome: An Update in geriatric PracticePlanned in cooperation with the ASHP Section of InpatientCare PractitionersActivity #204-000-12-226-L04PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Susan J. Skledar, RPh, MPH, FASHPLearning Objectives:u Explain pertinent updates to recently published guidelines forensuring safe use of medications in the elderly (Beers criteria)in comparison to the 2003 version.u Apply current literature on the use and effectiveness of antihypertensivesin older adults.u Identify and potentially prevent negative outcomes related tothe transition of care process.u Develop strategies for improving the quality of care forseniors in the patient-care medical home.Updates from the Revised Beers Criteria: Where Are We 10Years Later? Sunny Linnebur, PharmD, CGPHypertension Management in the Elderly Patient, EmilyPeron, PharmD, MSUsing Your Pharmacy Geriatric Pharmaceutical Services,Christine M. Ruby, PharmD, BCPSImproving Quality of Care for Seniors in the Patient-CenteredMedical Home, Mollie Ashe Scott, PharmD, BCACP3:30pm – 4:30pm Banyan C, Level 3a Management Case Studies K: Parts 1 & 2Moderator: Stewart R. Wirebaugh, PharmDUtilization of novel informatics Solutions toPromote Pharmaceutical Cost Reduction StrategiesActivity #204-000-12-372-L04P/204-000-12-372-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: Lindsay Hovestreydt, PharmD, BCPS; RuchiTiwari, PharmD, MSLearning Objectives:u Analyze comparative data to illustrate end goals and opportunitiesfor systems improvement to key stakeholders.u Describe novel ways to utilize existing resources to promotepharmaceutical budget reduction strategies.u Assess methods to optimize CPOE clinical decision supporttools to promote pharmaceutical care and drive effective medicationutilization.Negotiating a Wholesaler Prime Vendor Contractfor a Diverse Member networkActivity #204-000-12-373-L04P/204-000-12-373-L04TLevel of Content: General Interest0.5 Contact Hours/Knowledge-basedPresenters: David Hardy, MS; Richard Paul, RPh; Craig A.Pedersen, PhD, FAPhALearning Objectives:u Describe an RFP process that guides your IDN during wholesalerselection.u Describe how pricing models affect your cost of goods.u List contract elements that can be advantageous and disadvantageousto your IDN.3:30pm – 5:00pm Mandalay Bay J, Level 2a Driving Qualitywith Real-Time DashboardsPlanned in cooperation with the ASHP Section of PharmacyPractice ManagersActivity #204-000-12-298-L04PLevel of Content: Intermediate1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Thomas E. Kirschling, PharmD,MSLearning Objectives:u Outline the reasons why the electronic dashboard and patientscorecards will significantly contribute to the future practicemodel.u Discuss the development of an electronic pharmacy dashboardand patient scorecard system.u Identify various operational and clinical metrics to incorporatewith these systems.u Describe the utilization of the system and improved outcomesseen by pharmacy leadership.Driving Quality with Information, Scott M. Mark, FASHPDriving Quality with Visual Management, Scott Knoer, MS,PharmD, FASHPFor presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition79

education CE sessions WEDNESDAy, DECEMBER 5continued4:00pm – 5:00pm Mandalay Bay D, Level 2a Antimicrobial Dosing in obesity:Finding the Holy ScaleActivity #204-000-12-209-L01PLevel of Content: Advanced1.0 Contact Hours/Knowledge-basedPresenter: Manjunath P. Pai, PharmDLearning Objectives:u Given a specific obese patient case, evaluate the effects ofbody size descriptors on the estimate of kidney function.u Interpret the population pharmacokinetic model to aid estimationof the optimal dose in an obese patient.u Recommend an appropriate dose of an antimicrobial agentfor an infected patient with chronic kidney disease where noguidance is available for dose modification.4:00pm – 5:00pm South Seas H, Level 3a Antipsychotics for the non-PsychiatricPharmacist: Across the AgesPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-213-L01PLevel of Content: Intermediate1.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Ericka L. Breden, PharmD, BCPPLearning Objectives:u Recognize and evaluate adverse events of antipsychotics inchildren and elderly admitted to a non-psychiatric floor.u Manage adverse events of antipsychotics in specialpopulations.u Discuss appropriate indications for antipsychotics in pediatricpatients.u Explain the CMS statement regarding over-utilization of antipsychoticsin the long-term care setting and efforts to improvedementia care.Antipsychotic Use in Pediatric Cases, Julie Dopheide,PharmD, BCPPAntipsychotic Use in Geriatric Cases, Christopher J.Thomas, PharmD, BCPP, FASHPTHURSDAY, DECEMBER 69:00am – 11:00am Mandalay Bay L, Level 2a Hot off the Press...New Hypertensionand Dyslipidemia guidelinesActivity #204-000-12-257-L01PLevel of Content: Intermediate2.0 Contact Hours/Application-basedProgram Chair/Moderator: Joseph J. Saseen, PharmD, FASHPLearning Objectives:u Describe clinical controversies related to the treatment ofhypertension and dyslipidemia.u Summarize the JNC 8 and NCEP ATP 4 guidelines for themanagement of hypertension and dyslipidemia.8047th ASHP Midyear Clinical Meeting and Exhibitionu Identify how clinical trials evidence support recommendationsin the JNC 8 and NCEP ATP 4 guidelines.u Evaluate therapy that effectively implements new JNC 8 andNCEP ATP 4 guidelines.Overview of CVD and Hypertension Guidelines, Joseph J.Saseen, PharmD, BCPS, FASHPDyslipidemia Guidelines, Joel C. Marrs, PharmD, BCPS9:00am – 11:45am Reef D, Level 2a Problem Solving 101: Why going Backto Basics Yields Better ResultsActivity #204-000-12-293-L04P/204-000-12-293-L04TLevel of Content: General Interest2.75 Contact Hours/Application-basedPresenter: Leslie A. Stein, BSMany individuals and organizations jump right into brainstormingsolutions before they’ve clearly identified the problem. Thismay lead to solutions that aren’t as strong as they could be orworse yet, total failure. Come hear about the most overlookedsteps in problem solving, why doing them could help youbypass failure, & how to turn around the projects that feel likethey’ve got failure knocking at the door like the Grim Reaper.Learning Objectives:u Identify the most overlooked steps in problem solving.u Apply one 4-step problem solving approach to current issuesthey face in their projects and/or teams.u Utilize activities and examples they will see demonstrated inthe session to help resolve issues on their own teams.9:30am – 11:30am Mandalay Bay J, Level 2a Strategies Worth Sharing:Practice innovationsPlanned in cooperation with the ASHP Sections, Forums, andPPMI Joint Coordination CommitteeActivity #204-000-12-228-L04P/204-000-12-228-L04TLevel of Content: General Interest2.0 Contact Hours/Knowledge-basedProgram Chair/Moderator: Jennifer M. Edwards-Schultz,PharmD, FASHPLearning Objectives:u Identify and describe methods utilized to highlight whichPPMI recommendations receive priority and resources.u Describe common barriers that affect PPMI advancement.u Identify and recommend effective strategies utilized to implementPPMI recommendations.The Electric Slide from Inpatient to Outpatient, TimothyBrown, PharmD, BCACP, FASHPA Team-Based Approach to Pharmacy Practice ModelDevelopment, John S. Clark, PharmD, MS, FASHPPharmacy Tech Advancement: Facilitation of Prior AuthorizationProcess and Patient Assistance Programs, Scott B.Silverstein, MS, RPhWe want YOU! A Discussion of How Informatics PharmacistsImpact PPMI and Vice Versa, Kevin C. Marvin, MS,FHIMSS, FASHPEvolution of Providing Consistent Clinical Services, RitaShane, PharmD, FCSHP, FASHPFor presenter affiliations see Presenter Index

W9:30am – 11:30am Mandalay Bay D, Level 2Your Student is Doing What?! PPMI with APPEs, Ashley M.Overy, PharmDFrom Defense to Offense: PPMI from the Frontlines, AudreyKennedy, PharmD, BCPSa Controversial iCU Prophylactic DrugTherapies: Playing With a Royal Flush orBluffing on a Busted HandActivity #204-000-12-240-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Mitchell Buckley, PharmD, FCCMLearning Objectives:u Design an evidence-based pharmacotherapy regimen forstress ulcer prevention in the critically ill patient.u Compare the efficacy of novel pharmacologic agents versusstandard therapies in the prophylaxis of atrial fibrillation aftercardiac surgery.u Evaluate the different approaches to providing thromboprophylaxisin the critically ill.u Evaluate the literature for post-traumatic seizure prophylaxisfocusing on the safety and effectiveness of newer anti-epilepticmedications.Reducing the Stressed Stomach: Optimal Stress UlcerProphylaxis Strategies, Mitchell S. Buckley, PharmD, FCCMGetting the Heart Out of the Fast Lane: Novel Therapies inPreventing Postoperative Atrial Fibrillation, Brian J. Barnes,PharmD, MSPreventing VTE: Keeping the Blood Flowing, William E.Dager, PharmD, BCPS, FASHPNovel Anti-Epileptic Medications for Seizure Prevention inPatients with Traumatic Brain Injury, Stacy Voils, PharmD,BCPS2:00pm – 4:00pm Mandalay Bay J, Level 2a Advanced Topics: Treating Your Patientwith novel oral AnticoagulantsActivity #204-000-12-241-L01PLevel of Content: Advanced2.0 Contact Hours/Application-basedProgram Chair/Moderator: Maureen Smythe, PharmD, FCCPLearning Objectives:u Compare and contrast dabigatran, rivaroxaban and apixabantherapy for stroke prevention in patients with atrial fibrillation.u Discuss strategies for peri procedural management with thenewer agents.u Explain the impact of renal dysfunction of the safety and efficacyof the newer agents.u Outline considerations for transitions of care and patienteducation.u Discuss approaches to and limitations of laboratory monitoringwith newer agents.Patient Case, Maureen Smythe, PharmD, FCCPDifferentiating New Oral Anticoagulants for Stroke Prevention,Edith Nutescu, PharmD, FCCRenal Impairment and Laboratory Monitoring: What CliniciansShould Know, Maureen A. Smythe, PharmD, FCCPOptimizing Transitions of Care, Lynda J. Thomson, PharmD,FCCP2:15pm – 3:30pm Mandalay Bay D, Level 2a Frontline Pharmacists Make a Differencefor PatientsActivity #204-000-12-247-L04PLevel of Content: Intermediate1.25 Contact Hours/Knowledge-basedProgram Chair/Moderator: Shekhar Mehta, PharmD, MSLearning Objectives:u Identify four evidence-based domains where frontline pharmacistscan directly improve patient care and clinical outcomes.u Examine specific clinical activity and outcome measures toimprove glycemic control in your diabetic patients.u Discuss strategies to efficiently and effectively implement theuse of these metrics to exceed patient care and organizationalleadership goals.Accountability: Why Pharmacists? Why Now? Mary A.Andrawis, PharmD, MPHClinical Analysis and Metric Dashboards for Diabetes, JannetM. Carmichael, PharmD, BCPSQuality Measure Domains and Families, Shekhar Mehta,PharmD, MS2:15pm – 4:00pm Reef D, Level 2a Office Anthropology: new Ways toApproach Team Conflict for Better ResultsActivity #204-000-12-294-L04P/204-000-12-294-L04TLevel of Content: General Interest1.75 Contact Hours/Application-basedPresenter: Leslie A. Stein, BS“But what if my way really IS better?” We’ve all thought it.And maybe your way IS, in fact, better. That and $4 might getyou a cup of coffee these days. Instead of trying to prove ourselvesright or make sure our value is known, the questions wemight want to ask are things like:“How does my way help or hurt the team?”“What do I like about other peoples’ ideas?”“What does my way look like to people who aren’t in my head?”By stepping back to approach your team & your role within itlike an anthropologist (instead of just being caught up in theoffice drama), you might find things you’ve never discoveredbefore. Learn to separate fact form feelings, shift competitioninto collaboration, & create an environment where you, yourteam, & your organization can thrive.Learning Objectives:u Identify behaviors that make teams less effective (their ownAND others).u Apply a variety of perspectives to see their team(s) from differentvantage points, creating new opportunities for growth.u Utilize questioning techniques to create a more collaborativeteam environment.For presenter affiliations see Presenter Index47th ASHP Midyear Clinical Meeting and Exhibition81

education CE sessions WEDnESDAY, DECEMBER 5continued2:30pm – 4:00pm Mandalay Bay L, Level 2a Optimizing Antimicrobial Therapy forGram-Negative infectionsPlanned in cooperation with the ASHP Section of ClinicalSpecialists and ScientistsActivity #204-000-12-207-L01PLevel of Content: Advanced1.5 Contact Hours/Knowledge-basedProgram Chair/Moderator: Douglas Slain, PharmD, BCPS,FASHPLearning Objectives:u Identify clinical situations that would warrant double coverageof Gram-negative infections.u Explain the role of double coverage and/or combination therapyin empiric therapy.u Evaluate population pharmacokinetics/pharmacodynamics(PK/PD) modeling approaches used for dose optimization ofantimicrobial therapy for Gram-negative infections.u List advantages to applying PK/PD principles in the treatmentof Gram-negative infections specifically related to extendedinfusion -lactams.u Describe systematic approaches to implementing antimicrobialPK/PD dosing strategies in a clinical setting.Optimizing Gram-Negative Therapy PK/PD, Marc H.Scheetz, PharmD, MScCombination Therapy for Gram-Negative Infections, DouglasSlain, PharmD, BCPS, FASHPG O T H EDISTANCEW I T H O U T L E A V I N GHOME.YOU ALREADY WORK HARD AT YOUR CAREER.But to stay ahead in the rapidly changing field ofhealth-system pharmacy, you also need to workhard on your career.Introducing ASHP eLearning: a revolutionarylearning management system that’s online, on yourtime, from the experts you trust.Pharmacists and pharmacy technicians atevery level, both brand-new and more experienced,now have 24/7 continuing education at theirfingertips, with access to the leading names inthe industry, anytime, anywhere. Soon directorsof pharmacy will be able to assess staff and trackprogress with this secure, flexible, centralizedmanagement tool.Easy to use at home, at work, and on theroad, ASHP eLearning personalizes the trainingprocess, while making it efficient and affordable.Go to elearning.ashp.org to browse ourrapidly growing onlinecatalog, and see how easywe’ve made it to get ahead.Your portal to successeLearning.ashp.orgCopyright 2012 American Society of Health-System Pharmacists8247th ASHP Midyear Clinical Meeting and ExhibitionFor presenter affiliations see Presenter Index

InDUSTRY-SUPPoRTED SYMPosiaThe following industry-supported educational symposia havebeen scheduled in conjunction with The Midyear 2012. For moreinformation, contact the company and/or individual listed. Listingis current as of October 3, 2012. For an up-to-date listing, visitour website at http://connect.ashp.org/midyear2012/Symposiaor check the onsite program.Satellite SymposiaNote: Check the hotel reader boards for room locations.SunDAY, DECEMBER 26:15am - 7:45amMandalay Bay Hotela CE in the Mornings –Managing Postoperative ComplicationsRelated to AnesthesiaSupported by Merck, Inc. Contact Erika Thomas, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists6:15am - 7:45amMGM Granda CE in the Mornings – ReducingCardiovascular Risk: Evidence-basedStrategies for Managing DyslipidemiaSupported by Merck, Inc. Contact Erika Thomas, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists2:00pm - 5:00pmMandalay Bay Hotela Pharmacy Leadership Forum - Pharmacyand the new Health Care Model: Rolesand Responsibilities for PharmacistsSupported by Baxter Healthcare Corporation. Contact ErikaThomas, ASHP Advantage; 301-664-8653. CE Provider:American Society of Health-System Pharmacists5:30pm - 8:00pmMandalay Bay Hotela Clinical Pearls to improve Safety andPatient Care in the Hospital Setting:Addressing Challenges of insulin TherapySupported by Novo Nordisk Inc.. Contact Laurie Ermentrout,E&S MedEd Group, Inc.; 215-453-9164. CE Provider:American Academy of CME Inc6:00pm - 8:00pmMandalay Bay Hotela Clinical Decisions in the Treatment ofMRSA infections: issues and AnswersContact Colleen McQuone, MedEDirect; 850-385-2187. CEProvider: MedEDirectMonDAY, DECEMBER 36:15am - 7:45ama CE in the Mornings – ManagingPostoperative Complications Relatedto AnesthesiaMGM GrandSupported by Merck, Inc. Contact Erika Thomas, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists6:15am - 7:45amMandalay Bay Hotela CE in the Mornings – ReducingCardiovascular Risk: Evidence-basedStrategies for Managing DyslipidemiaSupported by Merck, Inc. Contact Erika Thomas, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists6:45am - 8:45amMandalay Bay Hotela Postoperative Pain and Patient-ControlledAnalgesia: Evaluating Current andEvolving ModalitiesSupported by Incline Therapeutics, Inc.. Contact Lori Marrese,201-799-4832; 201-799-4820. CE Provider: University ofWisconsin School of Pharmacy7:00am - 8:30amMandalay Bay Hotela Emerging Solutions in Pulmonary ArterialHypertension: Empowering Pharmacists inTreatment DecisionsSupported by Actelion Pharmaceuticals US, Inc. Contact MajaDrenovac, Vemco MedEd; 908-704-2400. CE Provider: Centerfor Independent Healthcare Education7:30am - 8:30amMandalay Bay Hotela Evolving Therapeutic Targets in AdvancedProstate Cancer: Current Trends inOptimizing outcomesSupported by Janssen Biotech, Inc. Contact Kimberly Lynch,Plexus Communications; 856-727-8335. CE Provider: GeorgiaSociety of Health System Pharmacists5:30pm - 7:30pmMandalay Bay Hotela Examining the Role of DPP-4 inhibitors inSpecial PopulationsSupported by Boehringer Ingelheim . Contact Kristin Ciszeski,NACCME; 609-371-1137. CE Provider: NACCME47th ASHP Midyear Clinical Meeting and Exhibition83

industry-supported symposiaTUESDAY, DECEMBER 46:15am - 7:45amMandalay Bay Hotela CE in the Mornings – ManagingPostoperative Complications Related toAnesthesiaSupported by Merck, Inc. Contact Erika Thomas, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists6:15am - 7:45amMGM Granda CE in the Mornings – optimizingImmunization Strategies for Adult Patientsacross the Health SystemSupported by Merck, Inc. Contact Kristi Hofer, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists6:15am - 7:45amMandalay Bay Hotela The Pharmacist’s Role in implementingthe new Pain, Agitation, and DeliriumGuidelines in the Critical Care Setting(Available via Live Webcast)Supported by Hospira, Inc. Contact Kristi Hofer, ASHPAdvantage; 301-664-8773. CE Provider: American Society ofHealth-System Pharmacists5:30pm - 7:00pmMandalay Bay Hotela Achieving Hemostasis in the SurgicalField: a multidisciplinary Team Approachto PharmacotherapySupported by The Blood CME Center. Contact Jodi Andrews,The Blood CME Center; 973-588-1407. CE Provider:Postgraduate Institute for MedicineWEDnESDAY, DECEMBER 56:15am - 7:45amMGM Granda CE in the Mornings – ManagingPostoperative Complications Related toAnesthesiaSupported by Merck, Inc. Contact Erika Thomas, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists6:15am - 7:45amMandalay Bay Hotela CE in the Mornings – The nextGeneration: Exploring Current andEmerging Therapies for Type 2 DiabetesSupported by Merck, Inc. Contact Kristi Hofer, ASHPAdvantage; 301-664-8891. CE Provider: American Society ofHealth-System Pharmacists8447th ASHP Midyear Clinical Meeting and Exhibition

Midday SymposiaNote: All Midday Symposia are located in the Mandalay BayHotel’s North Convention CenterMonDAY, DECEMBER 03, 201211:30am - 1:30pma The Pharmacist’s Role inACS Management: TranslatingData into PracticeSouth Pacific BSupported by AstraZeneca. Contact Rebecca Weaver, CreativeEducational Concepts, Inc.; 859-260-1717. CE Provider:Creative Educational Concepts, Inc.11:30am - 1:30pmSouth Pacific Da 340B Audits: Learn about compliancerequirements of the 340B Drug PricingProgram as well as how to prepare forand what to expect during a 340B audit.Supported by AmerisourceBergen Drug Corporation. ContactCarla Frehn, AmerisourceBergen; 610-727-2490. CE Provider:Pharmacy Healthcare Solutions Ltd.11:30am - 1:30pmSouth Pacific Fa Infusion Management Technology: Real-World Lessons to Demonstrate Value (AlsoAvailable via Live Webinar)Supported by Hospira. Contact Gail Townley, ProCE, Inc.;630-540-2848. CE Provider: ProCE, Inc.11:30am - 1:30pmSouth Pacific Ja Reducing iV Admixture Related SafetyRisks: A Review of the iSMP SterilePreparation Compounding guidelinesSupported by Baxter Healthcare Corporation. Contact RachelCohen, ISMP; 215-947-7797. CE Provider: EducationalReview Systems, Inc.11:30am - 1:30pmIslander Fa Appropriate Dosing & Administration ofIntraoperative iV opioids During generalAnesthesiaSupported by Mylan Specialty. Contact Jennifer Lapidus,Integrity Continuing Education; 732-212-9777. CE Provider:Postgraduate Institute for Medicine11:30am - 1:30pma Preparing for Biosimilars: Scientific,Regulatory, and Practice ManagementIssues for PharmacistsIslander HSupported by an educational donation provided by Amgen andby an educational grant from Pfizer, Inc. Contact Erika Thomas,ASHP Advantage; 301-664-8653. CE Provider: AmericanSociety of Health-System Pharmacists11:30am - 1:30pmIslander Ia Emerging Treatment options for theReversal of oral Anticoagulant Therapy(Available via Live Webcast)Supported by CSL Behring. Contact Carla Brink, ASHPAdvantage; 301-664-8825. CE Provider: American Society ofHealth-System PharmacistsTUESDAY, DECEMBER 0411:30am - 1:30pma Management of Hyponatremiain Hospitalized Patients:The Key Role of PharmacistsSouth Pacific BSupported by Otsuka America Pharmaceutical, Inc.. ContactMary Stanley, Potomac Center for Medical Education; 443-909-7903. CE Provider: Potomac Center for Medical Education11:30am - 1:30pmSouth Pacific Da Managing oncology in a Health SystemSupported by AmerisourceBergen Drug Corp.. Contact CarlaFrehn, AmerisourceBergen; 610-727-2490. CE Provider:Pharmacy Healthcare Solutions Ltd.11:30am - 1:30pmSouth Pacific Fa Surface contamination with antineoplasticagents: Where Are We a Decade Later?Supported by BD. Contact Laura De La Rosa, STATManagement; 201-847-5783. CE Provider: STAT Management11:30am - 1:30pmSouth Pacific Ja Traveling optimal Pathways for ManagingStable ischemic Heart DiseaseSupported by Gilead Sciences Medical Affairs. Contacttthompson@voxmedia.us, Voxmedia, LLC; 973-467-0500. CEProvider: Neomed11:30am - 1:30pma PAH Pharmacotherapy:Progress in the Modern Treatment EraIslander FSupported by Actelion Pharmaceuticals. Contact Gail Townley,ProCE, Inc.; 630-540-2848. CE Provider: ProCE, Inc.11:30am - 1:30pmIslander Ha Evaluating new Pharmaceutical Productsat Your Health System: Maximizing Valuewith Medication-use EvaluationsSupported by Cadence Pharmaceuticals. Contact Carla Brink,ASHP Advantage; 301-664-8825. CE Provider: AmericanSociety of Health-System Pharmacists47th ASHP Midyear Clinical Meeting and Exhibition85

industry-supported symposia11:30am - 1:30pma The 2012 Landscape of i.V. MedicationSafety: Processes, Tools, and Training(Available via Live Webcast)Islander ISupported by Hospira, Inc. Contact Kristi Hofer, ASHPAdvantage; 301-664-8773. CE Provider: American Society ofHealth-System Pharmacists11:30am - 1:30pmIslander Ga Challenges in Managing Acute Bleedingin Patients with Hemophilia (Available viaLive Webcast)Supported by Novo Nordisk Inc. Contact Carla Brink, ASHPAdvantage; 301-664-8825. CE Provider: American Society ofHealth-System PharmacistsWEDnESDAY, DECEMBER 5Follow ASHP at @ashpofficial:Use #ashpmidyearShare pictures!Set up meetings!Win prizes!11:30am - 1:30pma Health iT and Hospital Pharmacy:The Time is now (Also Available viaLive Webinar)South Pacific DSupported by Hospira. Contact Gail Townley, ProCE, Inc.; 630-540-2848. CE Provider: ProCE, Inc.8647th ASHP Midyear Clinical Meeting and Exhibition

PoSTER PRESEnTATionsGain insight into successful programs from health-systems in the U.S. and around the world! Below are the scheduledtimes for poster presentations.Professional poster presentations are listed below; Student and Resident/Fellows presentations are listed online at http://connect.ashp.org/midyear2012/Education/Posters.Poster Hall Bayside B, Level 1a Professional and ASHP Fellows Posters*Monday, December 3Tuesday, December 42:00pm – 4:30pm2:00pm – 4:30pm*Fellows will present on Monday and Tuesday in the Professional Poster sessions. Check the website for a listing.a Student PostersMonday, December 38:15am – 9:15am11:30am – 12:30pmTuesday, December 411:30am – 12:30pma Resident PostersWednesday, December 58:30am – 9:30am10:00am – 11:00am11:30am – 12:30pm1:00pm – 2:00pm2:30pm – 3:30pma You’RE nEEDED! You’RE WanTED! You’RE INVITED—to be a Poster Mentor. Share an hour of your time with Student or Resident poster presenters during The Midyear and you’ll be givinga much-needed boost to the rising stars of our profession. Stop by the Poster Hall during any one of the Student or ResidentPoster sessions and ask about being a mentor at the Poster Information booth.TUESDAY, DECEMBER 411:15am – 12:30pm Bayside Foyer, Level 1Special Poster SessionIntroducing an Emergency Pharmacist into Your Institution: An ASHP Patient Care Impact Program TM 2012The participants of this 6-month education program collaborated with mentors to introduce the role of the emergency pharmacist intotheir institutions. Stop by and view the results of their important work in this special poster session.47th ASHP Midyear Clinical Meeting and Exhibition87

ProFESSionAL PoSTERSPriMARY AUTHoR inDEXName Day Board#Abaskharoun, Mena Tuesday 5-184Abbas, Cheryl Monday 3-174Abdallah, Jad Tuesday 5-180Adamson, Robert Monday 3-136Afolarin, Helen Tuesday 5-100Agarwal, Nitika Monday 3-156Ahmed, Ebtesam Monday 3-183Ahn, Seong-Sim Tuesday 5-057Akel, Marwan Monday 3-008Monday 3-034Albert, Mila Monday 3-002Ali, Fatima Tuesday 5-172Al-Khani, Salma Tuesday 5-192Amaral, Renata Tuesday 5-120Ambury, Matthew Monday 3-150Andrade, Diana Monday 3-141Anger, Kevin Monday 3-132Anicete, Charity Monday 3-049Aramvareekul, Varintorn Tuesday 5-214Armstrong, Norma Tuesday 5-014Arnold, Alana Monday 3-153Arrison, Charles Tuesday 5-148Augustine, Jill Tuesday 5-116Aungst, Timothy Monday 3-189Awad, Nadia Monday 3-159Baker, Matt Monday 3-200Baker, Shannon Tuesday 5-002Balasubramanian, Ramadas Monday 3-070Tuesday 5-198Beckley, Jozef Monday 3-027Belovsky, Alla Monday 3-065Belusko, Kathleen Tuesday 5-063Bender, Fredrick Tuesday 5-253Benson, John Monday 3-064Berdougo, Brice Tuesday 5-077Berger, Reisel Monday 3-030Berkland, Allison Monday 3-045Bernbaum, Lauren Tuesday 5-155Biehle, Karen Tuesday 5-087Bishop, Mark Tuesday 5-208Blakely, Teresa Monday 3-054Bloodworth, Lauren Tuesday 5-119Bonilla, Macarena Tuesday 5-058Borja-Hart, Nancy Monday 3-202Bork, Sara Tuesday 5-132Bott, Quinn Monday 3-154Bou Raad, Etwal Monday 3-148Bowen, Danielle Monday 3-126Brahim, Amanda Monday 3-201Brandt, Jennifer Tuesday 5-027Tuesday 5-241Brown, Meagan Monday 3-041Brownlee, Seth Monday 3-166Buckley, Thomas Monday 3-028Bulgar, Alina Tuesday 5-213Bulone, Dominick Tuesday 5-122Bundeff, Andrew Monday 3-023Burch, Kelly Monday 3-133Burris, Alexandra Monday 3-152Butts, Allison Monday 3-013Caccioppoli, Victoria Tuesday 5-234Cappelletti Galante, Mariana Monday 3-031Cernik, Brent Monday 3-157Chahine, Bahia Monday 3-062Chan, Esther Tuesday 5-085Chehab, Fadi Tuesday 5-065Chen, Shih-Yin Tuesday 5-070Tuesday 5-071Chen, Jack Tuesday 5-176Tuesday 5-177Chiu, Allison Monday 3-169Cho, Nam Tuesday 5-047Choi, Mi Hye Monday 3-172Chong, Yun Yee Tuesday 5-088Chow, Elaine Tuesday 5-026Choy, Samantha Tuesday 5-073Christian, Michaela Tuesday 5-149Chu, Chau Monday 3-097Chu, Stephen Tuesday 5-218Chung, Tiffany Monday 3-171Clapp, Margaret Monday 3-010Cohen, Dmitri Tuesday 5-030Confer, Jennifer Monday 3-176Conway, Kathleen Tuesday 5-113Cooper, Maryann Monday 3-180Monday 3-181Cooper, Julie Tuesday 5-202Corrado, Michelle Tuesday 5-105Cortejoso, Lucia Monday 3-177Tuesday 5-059Tuesday 5-060Couch, Kimberly Tuesday 5-134Tuesday 5-159Tuesday 5-225Crader, Marsha Tuesday 5-093Crawford, Stephanie Tuesday 5-224Crisp, Brett Tuesday 5-031Crow, Leah Tuesday 5-231Tuesday 5-233Cruz, Maria Tuesday 5-032Curtis, Kelley Monday 3-122Tuesday 5-033Dadayan, Sara Monday 3-050Daley, Douglas Tuesday 5-034Das, Rolee Tuesday 5-209Daubert, Eliza Monday 3-194Dauterman, Tonya Tuesday 5-161Dave, Nidhi Monday 3-206Davis, Larry Tuesday 5-025DeGrado, Jeremy Tuesday 5-049DeGrote, Shannon Monday 3-221Dekmak, Asia Monday 3-089Denaburg, Michael Monday 3-1958847th ASHP Midyear Clinical Meeting and Exhibition

DeRemer, Christina Tuesday 5-021DeWitt, Mindee Tuesday 5-104DeYoung, Jaculin Tuesday 5-004Tuesday 5-207Dick, Travis Tuesday 5-229Dietrick, David Tuesday 5-091Dolley, Stephen Tuesday 5-179Donofrio, Christopher Tuesday 5-146Doten, Amy Monday 3-036Downer, Karen Tuesday 5-062Edwards, Christopher Tuesday 5-079Efejuku, Rosebel Monday 3-077Egbunike-Chukwuma, Ifeanyi Tuesday 5-068Tuesday 5-102Tuesday 5-103Eiland, Edward Monday 3-139El Masri, Randa Monday 3-209Elmore, Lindsey Tuesday 5-174Elsey, Rachel Monday 3-003Elson, Elysha Tuesday 5-197Ensign, Richard Monday 3-131Eriksen, Christina Tuesday 5-199Eroschenko, Kathy Monday 3-144Ertel, Ginger Tuesday 5-243Evans, John Monday 3-130Fercocq, Chloe Tuesday 5-066Ferrell, Sarah Monday 3-118Flinn, Melanie Monday 3-096Flores, Brannon Monday 3-170Flox, Pilar Tuesday 5-005Fondriest, Mark Tuesday 5-141Fossaceca, Carl Monday 3-129Fouad, Mohamed Monday 3-082Frinzi, Kristina Tuesday 5-125Fung, Po Ying Tuesday 5-048Gao, Tingting Tuesday 5-190Garcia, Adrianna Monday 3-026Garst, Mary Monday 3-218Garvey, Michael Monday 3-107Tuesday 5-081Geibig, Charles Tuesday 5-023Gettys, Suzanne Monday 3-057Gianakopoulos, Steve Tuesday 5-121Gibson, Matthew Monday 3-215Girardeau, Caroline Tuesday 5-042Tuesday 5-043Gitman, Brenda Tuesday 5-139Glasoe, Kimberly Tuesday 5-082Glowczewski, Jason Monday 3-014Glowczewski, Julia Monday 3-015Gopalani, Radhan Tuesday 5-094Gow, Edna Tuesday 5-035Grajzl, Barbara Tuesday 5-211Groenkjaer, Louise Monday 3-111Grossomanides, John Monday 3-214Guharoy, Roy Monday 3-161Tuesday 5-098Tuesday 5-164Gundrum, Todd Monday 3-004Gunter, J. Ashley Monday 3-121Tuesday 5-036Gupta, Vasudha Monday 3-040Gwak, Hyesun Tuesday 5-236Ha, David Monday 3-207Hammerquist, Rhonda Tuesday 5-185Harsanye, Jason Tuesday 5-242Haselden, Molly Monday 3-042Hassan, Mariam Monday 3-063Hassan, Erkan Tuesday 5-050Tuesday 5-051Hassett, Leza Tuesday 5-186Hata, Micah Tuesday 5-162Heger, Margaret Tuesday 5-123Hein, Bradley Monday 3-083Monday 3-143Monday 3-220Helmons, Pieter Tuesday 5-249Hendrick, Lynn Monday 3-117Hickman, Skip Monday 3-009Hindahl, Cortney Monday 3-116Hollins, Randy Monday 3-147Holm, Michelle Monday 3-185Holte, Lindsay Monday 3-055Hong, JiEun Monday 3-187Hope, Charlene Monday 3-066Horton, Evan Tuesday 5-170Hosokawa, Mio Tuesday 5-227Hovestreydt, Lindsay Monday 3-011Hoying, Michael Tuesday 5-250Huggins, Jenna Tuesday 5-017Hughes, Peter Monday 3-073Hughes, Kacie Monday 3-193Hurrell, Michelle Monday 3-108Huynh, Trina Monday 3-216Hyduk, Amy Monday 3-155Hylton Gravatt, Leigh Monday 3-081Ikesue, Hiroaki Monday 3-168Ishida, Takuya Monday 3-075Ives, John Tuesday 5-244Tuesday 5-245Jacobs, Ashley Tuesday 5-011Jacobs, Tibb Tuesday 5-173Jadid, Lina Monday 3-210Jarvis, Courtney Monday 3-047Jastorff, Wesleigh Monday 3-098Monday 3-151John, Isha Tuesday 5-219Johnson, Cathy Tuesday 5-110Juska, Alicia Monday 3-101Monday 3-102Kabbara, Wissam Monday 3-093Kanawati, Lama Tuesday 5-226Kaplan, Blair Tuesday 5-016Kasimatis, Helen Monday 3-105Kats, Diana Tuesday 5-189Kauzlarich, Kimberly Monday 5-178Kayser, Megan Tuesday 5-129Kellner, Curtis Tuesday 5-008Kellner, Francia Tuesday 5-086Kelly, Linda Tuesday 5-009Kelly, Kimberly Tuesday 5-012Kendrach, Michael Monday 3-061Kim, Sowall Monday 3-087KIM, KH Monday 3-125King, Amber Tuesday 5-152Klein, Miriam Tuesday 5-216Knoblock, Amy Tuesday 5-029Knudsen, Jasen Monday 3-18447th ASHP Midyear Clinical Meeting and Exhibition89

professional posters primary author indexKoenig, Sara Monday 3-078Koh-Pham, Tsingyi Monday 3-056Tuesday 5-133Kumar, Ruchira Tuesday 5-203Kwak, Namhee Monday 3-205L. Griffith, Niesha Tuesday 5-239Laille, Eric Tuesday 5-138Lam, Lee Monday 3-106LaMori, Joyce Tuesday 5-019Tuesday 5-150Langley, Andrew Monday 3-038Leahy, Angela Monday 3-037Leandro, Ana Tuesday 5-061Tuesday 5-153Lee, Pei-Yu Monday 3-029Lee, Sang Tuesday 5-137Leelum, William Monday 3-109Lepage, Jayne Tuesday 5-171Li, Julius Tuesday 5-154Lian, Vivian Monday 3-044Lim, Soyoung Monday 3-173Lindsey, Wesley Monday 3-072Lo, Melissa Monday 3-032Lockwood, Allen Monday 3-186Lovely, Jenna Tuesday 5-040Lustig, Ahuva Tuesday 5-183Ly, Tiep Tuesday 5-076MacDonald, Elyse Tuesday 5-115MacKay, Mark Monday 3-199Madduri, Ajay Tuesday 5-083Maglinte, Gregory Tuesday 5-157Malaeb, Diana Monday 3-092Monday 3-149Malone, Richard Monday 3-162Malsin, Luanne Tuesday 5-200Mang, William Monday 3-146Manton, Fancy Tuesday 5-201Marin, Carlos Monday 3-006Marini, Erica Monday 3-213Marjanovic, Helena Monday 3-076Markakis, Emmanuel Tuesday 5-210Marraffa, Rebecca Tuesday 5-028Martin, Michelle Monday 3-051Monday 3-052Marxen, Terri Monday 3-022McDonough, Kevin Monday 3-124McDougall, Karen Monday 3-007McIntyre, Megan Monday 3-012McKaig, Donald Tuesday 5-194McMillin, Tara Tuesday 5-015Meisinger, Stephanie Tuesday 5-013Merandi, Jenna Tuesday 5-246Migaki, Gerry Monday 3-001Mikrut, Michael Monday 3-113Milane, Aline Tuesday 5-230Miller, Amber Monday 3-085Miller, Jessica Tuesday 5-131Milner, Scott Tuesday 5-112Mitchell, Jennifer Tuesday 5-135Moffett, Brady Tuesday 5-126Tuesday 5-127Tuesday 5-128Moore, Jessica Monday 3-192Moore, Heather Tuesday 5-143Moore, Wayne Tuesday 5-232Moran, Kelly Tuesday 5-056Morrill, Haley Monday 3-0219047th ASHP Midyear Clinical Meeting and ExhibitionMorris, David Monday 3-067Morton, Ted Monday 3-140Murase, Tetsuya Monday 3-059Musselman, Megan Tuesday 5-169Nasrallah, Rabih Tuesday 5-237Neill, Kathryn Tuesday 5-007Nelson, Winnie Tuesday 5-018Nelson, Scott Tuesday 5-191Nguyen, Maileah Monday 3-019Nguyen, Connie Monday 3-048Nguyen, Bao Monday 3-086Nguyen, Thom Monday 3-127Nikstad, Timothy Monday 3-103Nkemdirim Okere, Arinze Monday 3-197Monday 3-198O’Dell, Kate Monday 3-068Oishi, Ryozo Monday 3-178Onder, Erin Tuesday 5-092Ong, Karen Tuesday 5-003Onisk, Mallory Monday 3-188Ortiz Blanco, Erin Tuesday 5-142Palli, Swetha Tuesday 5-147Pandya, Dehuti Tuesday 5-238Parker, Amanda Tuesday 5-181Pasquale, Margaret Monday 3-203Patel, Dhiren Monday 3-020Patel, Gita Monday 3-134Monday 3-135Patel, Darshika Tuesday 5-001Patel, Shreya Tuesday 5-175Pedersen, Craig Monday 3-017Perez, Ann-Lori Tuesday 5-074Perry, Elizabeth Monday 3-212Perry, Trevor Tuesday 5-046Pesa, Jacqueline Monday 3-095Phuoc Lynsey, Le Phuoc Tuesday 5-196Pippins, Corinda Tuesday 5-095Pitts, Patricia Tuesday 5-108Pong, Krystal Tuesday 5-206Portillo, Juan Monday 3-191Powichrowski, Anna Tuesday 5-022Pressiat, Claire Tuesday 5-064Propes, Denise Tuesday 5-144Prunty, Leesa Tuesday 5-075Pugh, Thomas Tuesday 5-006Pulver, Lisa Monday 3-088Qaqundah, John Monday 3-182Rainville, Ed Monday 3-071Rampe, Nancy Tuesday 5-247Reardon, David Tuesday 5-024Rhea, Gene Tuesday 5-069Rigelsky, Frank Monday 3-069Ring, Kathryn Monday 3-043Robey-Gavin, Erin Tuesday 5-080Ross, Leigh Ann Tuesday 5-240Rozenberg- Ben-Dror, Karine Monday 3-137Rudfeld, Mariya Monday 3-138Rueter, John Monday 3-164Ruspantini, William Tuesday 5-041Ryman, William Tuesday 5-145Saad, Aline Monday 3-053Salomo Azevedo, Tuesday 5-096Maria FernandaSan Jose, Begona Tuesday 5-053Sanders, MaRanda Tuesday 5-215

Santos, Valter Monday 3-160Tuesday 5-055Tuesday 5-107Schmier, Jordana Tuesday 5-111Schnee, David Monday 3-024Shank, Brandon Tuesday 5-158Sharma, Milan Tuesday 5-160Sheikh-Taha, Marwan Tuesday 5-020Shepard, Tanya Monday 3-039Sholy, Lydia Tuesday 5-140Sidawy, Emil Tuesday 5-195Silva, Matthew Tuesday 5-165Simpson, Karen Tuesday 5-101Slika, Rania Monday 3-090Monday 3-091Smelser, Jamie Monday 3-058Smith, Ashley Monday 3-211Smith, Cynthia Tuesday 5-204Solem, Caitlyn Monday 3-104Soleymani, Mahnoush Tuesday 5-106Soric, Mate Monday 3-119Monday 3-190Spence, Nathan Tuesday 5-052Stabi, Katie Monday 3-074Steinberg, Michael Monday 3-179Tuesday 5-117Tuesday 5-118Stinnett, Ashley Tuesday 5-045Stitt, Danni Tuesday 5-067Stuckey, Nate Tuesday 5-248Stumpf, Janice Monday 3-167Swan, Joshua Tuesday 5-044Sweeney, Marc Monday 3-016Szkiladz, Andrew Tuesday 5-187Taber, David Tuesday 5-228Tackett, Kimberly Tuesday 5-097Tan, Edwin Monday 3-115Tang, Fletcher Tuesday 5-163Tauman, Allison Monday 3-112Taylor, Erin Monday 3-060Taylor, Ruston Tuesday 5-235Thi, Winnie Tuesday 5-151Thomas, Richard Tuesday 5-078Thomas, Michael Tuesday 5-168Thomas, Kelly Tuesday 5-217Thompson, David Monday 3-204Tonnu-Mihara, Ivy Monday 3-046Tran, Uyen Monday 3-100Trenkler, Karen Tuesday 5-038Tuesday 5-039Triglia, Sara Tuesday 5-090Troendle, Shelby Tuesday 5-254Trytten, Jennifer Tuesday 5-221Tulolo, Amanda Monday 3-079Tung, Dennis Tuesday 5-156Turberville-Vega, Vicky Tuesday 5-037Tuttle, Christopher Tuesday 5-205Ursan, Iulia Monday 3-219Vander Schoor, Jenny Monday 3-033VanSickle, Stacey Tuesday 5-084Vu, Kieu-Loan Tuesday 5-251Tuesday 5-252Walter, Andrea Monday 3-035Wang, Linda Tuesday 5-072Ware, Kenric Monday 3-120Waugh, Shaviller Tuesday 5-124Waxlax, Theresa Tuesday 5-212Wells, Elizabeth Tuesday 5-089Werling, Matthew Tuesday 5-130Wieloch, Linda Tuesday 5-220Tuesday 5-223Wiemer, Dawn Monday 3-005Williams, Jonathan Monday 3-018Williamson, James Monday 3-217Wilson, Alexander Tuesday 5-054Wirick, Nathan Monday 3-145Wong, Bruce Tuesday 5-188Wong, Kok Thong Tuesday 5-193Wong, Audrey Tuesday 5-222Woo, Hee Kyung Monday 3-094Woodward, John Monday 3-110Woolley, Adam Monday 3-123Xu, Ran Monday 3-158Yagi, Tatsuya Monday 3-196Yamreudeewong, Weeranuj Monday 3-099Yaniv, Angela Tuesday 5-114Yu, Crystal Monday 3-208Yuschock, Zachary Tuesday 5-010Zaer, Azita Monday 3-025Zeenny, Rony Monday 3-080Zendel, Laura Monday 3-163Tuesday 5-182Ziegenbusch, Kristi Tuesday 5-099Zillmer, Rhonda Monday 3-114Tuesday 5-136Fellows Primary Author indexAbe, Andrew Tuesday 5-263Acheampong, Frank Tuesday 5-258Ahmed, Tasfia Tuesday 5-286Alam, Shushama Tuesday 5-259Aseeri, Mohammed Tuesday 5-277Balint, Justin Tuesday 5-267Bradshaw, Laura Tuesday 5-270Buchta, Michael Tuesday 5-261Camuso, Michael Tuesday 5-269Carou, Susanna Tuesday 5-265Comer, Dominique Tuesday 5-276Dilworth, Thomas Tuesday 5-273Enrique, Martinez Tuesday 5-284Gonzalez, Danny Tuesday 5-268Greenberg, Noah Tuesday 5-271Hajar, Zaher Tuesday 5-257Haney, Owen Tuesday 5-279Hensley, Brett Tuesday 5-272Hulvershorn, Sarah Tuesday 5-288Juan Enrique, Martinez Tuesday 5-285Kaur, Rajbir Tuesday 5-255Kiser, Jessica Tuesday 5-260Ling, Hua Tuesday 5-264Lopatto, Jessica Tuesday 5-280Lu, Jackie Tuesday 5-287Luder, Heidi Tuesday 5-275Luther, Megan Tuesday 5-282Morrill, Haley Tuesday 5-281Rosenwasser, Rebecca Tuesday 5-256Schnur, Evan Tuesday 5-289Shah-Mohammadi, Ali-Reza Tuesday 5-278Thompson, Nathan Tuesday 5-290Villanueva, Mara Tuesday 5-266Wilson, Tiffany Tuesday 5-262Yeste_Gomez, Ines Tuesday 5-283Zasowski, Evan Tuesday 5-27447th ASHP Midyear Clinical Meeting and Exhibition91

ProFESSionAL PoSTERSMonday, December 32:00pm – 4:30pmCategories: Administrative Practice /Financial Management /Human Resources, Ambulatory Care, Automation Informatics,Chronic/Managed Care, Clinical Services Mangement, Drug-Use Evaluation, General Clinical Practice, Geriatrics, IVTherapy/Infusion Devices, Infectious Diseases, InvestigtionalDrugs, Leadership, Nutrition Support, Oncology, OperatingRoom Pharmacy, Pain Management, Pharmacokinetics,Practice Research/Outcomes Research/Pharmacoeconomics,Small and Rural Pharmacy Practice, ToxicologyAdministrative Practice / FinancialManagement / Human ResourcesSession-Board#3-001 Development and implementation of a drug shortagemitigation strategy for a regional healthsystem,Gerry Migaki, Steve Stoner, Elva Van devender,Linh Nguyen3-002 Importance of safety stock in pharmacy inventorymanagement with drug shortages, Mila Albert,Isabel Sanvanson, Sharon Aaron3-003 Quantifying the impact of drug shortages at a universityhospital, Rachel Elsey, Malia Manning, TomieAnn Boackle, Tom Comer3-004 Reliability of an approach to resident selectioninterviews, Todd Gundrum, Michael Peeters, MichelleSerres3-005 Implementation of the serving leadership practicemodel in a community hospital inpatient pharmacydepartment, Dawn Wiemer, Jason Milner3-006 CMS reimbursement of drug waste: a quantitativeanalysis at one medical center, Carlos Marin,Patrick Curtin3-007 Resident practice management project focusingon the implementation of a mobile medication systemat a rural VA, Karen McDougall, Bonnie Walno3-008 A study of stress and coping strategies inLebanese pharmacy students, Marwan Akel, JihanSafwan, Rama Srour, Ali Baydoun3-009 Establishing a network pharmaceutical sourcingposition, Skip Hickman3-010 Wholesaler conversion: strategies for success,Margaret Clapp3-011 Utilization of informatics systems to leverage costreduction initiatives, Lindsay Hovestreydt, RuchiTiwari3-012 Developing a post graduate year two health systempharmacy administration residency program,Megan McIntyre3-013 Pharmacy residency program director approachesto assessing applicants’ communication and interpersonalskills, Allison Butts, Kelly Smith3-014 Under-reporting of interventions made by pharmacistsin a community hospital setting, JasonGlowczewski, Melissa Ruminski, Mate Soric, RachaelLerman3-015 Incorporation of interview skills training into experientialstudent rotations, Julia Glowczewski3-016 Hospital employee prescription costs may bereduced by using a transparent PBM, MarcSweeney, Rebecca Grant3-017 Exposing wholesaler prime vendor contracts:Lessons learned by a diverse member network,Craig Pedersen, Richard Paul, Glenn Adams, PennyReher, Leslie Hanson3-018 Development and implementation of objective performancemeasures for pharmacy technicians,Jonathan Williams, Samuel CalabreseAmbulatory Care3-019 Pharmacist interventions in a heart failure transitionsclinic, Maileah Nguyen3-020 Case report of a unique drug-drug interaction withan oral contraceptive and lamotrigine, Dhiren Patel,David Schnee, Jennifer Goldman-Levine3-021 Effectiveness of gemfibrozil versus fish oil in loweringtriglycerides in patients currently on backgroundsimvastatin therapy, Haley Morrill, ChristineHuber, Bradley Peterson3-022 Utilization of oral anticoagulation selection criteriafor patients in a warfarin clinic, Terri Marxen3-023 Impact of clinical pharmacists’ recommendationson a proton pump inhibitor taper protocol in anambulatory care practice, Andrew Bundeff, KathyZaiken, Gary Tataronis3-024 Case report of dysgeusia secondary to metformintherapy, David Schnee, Dhiren Patel, JenniferGoldman-Levine3-025 Impact of group diabetes education classes ondiabetes knowledge, program satisfaction andclinical parameters, Azita Zaer, Renu Singh, PantehaKelly, Jan Hirsch, Yelena Wood3-026 Impact of pharmacist involvement on chronicobstructive pulmonary disease management inpatient aligned care teams, Adrianna Garcia, RachelBurke, Michaela Hrdy, Ly Nguyen3-027 Effects of insulin injection site on short-term glycemiccontrol in adult patients with type 2 diabetesmellitus: a prospective clinical case series,Jozef R. Beckley, Daniel Longyhore9247th ASHP Midyear Clinical Meeting and Exhibition

3-028 Delivering culturally appropriate care to optimizemedication use in the elderly, Thomas Buckley,Mary Scully3-029 Adherence rates and outcomes of patients prescribeddabigatran at a Veterans Affairs medicalcenter, Pei-Yu Lee, Sora Han, Randell Miyahara3-030 Evaluation of primary care provider pharmacistrun shared medical appointments for patients withdiabetes, Reisel Berger, Lorraine Wang, Jennifer Chen3-031 Assessment of the use of clopidogrel associatedwith gastroprotective medications in outpatients,Mariana Cappelletti Galante, Valter Garcia Santos,George Wasington Bezerra da Cunha3-032 Dabigatran etexilate: prescribing practice, safety,adherence, and patient satisfaction in ambulatorypatients, Melissa Lo, Paula Brown, ArtemisDiamantouros3-033 Evaluation of colchicine therapy using facilityapprovedrestrictions at VA Central IowaHealthcare System, Jenny Vander Schoor, KarmenJorgensen, Allison Berkland, Noelle Johnson, RachelDigmann3-034 Constipation management in Lebanese communitypharmacies, Marwan Akel, Jihan Safwan3-035 Assessment of group-based diabetes educationusing the medication conversation map in the veteranpopulation, Andrea Walter, Julie Stading,Yongyue Qi3-036 Implementation of dabigatran use in a rural VA setting,Amy Doten, Iman Badawy3-037 Activities and impact of a clinical pharmacist in apatient-centered medical home (PCMH) practicewithin an integrated healthcare system: a threemonthreview, Angela Leahy, Maureen Lloy Groux,Steven Smith, Denis Ishisaka, David Hickman3-038 Implementation of contract pharmacy services in ahospital outpatient hemophilia and thrombosiscenter utilizing the 340B drug pricing program,Andrew Langley, Christine Collins, Edward Aberger,Tracey Wallace, Geoffrey Allen3-039 Evaluating time in therapeutic range of warfarinpatients self testing with point of care (POC)devices, Tanya Shepard, Jason Bandy, TeresaKwong, Veronica Bandy, Lin Wan3-040 Evaluation of differences in percent of INRs inrange between pharmacist-led and physician-ledanticoagulation management service (AMS),Vasudha Gupta, Sarah Thompson, Stephen Kogut3-041 Impact of pharmacist education and/or medicationreconciliation on proton pump inhibitor use postdischarge, Meagan Brown, Megan Crete, RobertDufresne, Bradley Peterson3-042 Outcome of a standardized conversion protocol inveteran patients receiving simvastatin and gemfibrozil,Molly Haselden, Thomas Worrall, Dorothy Jenrette3-043 Expanded outpatient pharmacist role in preventivecare and chronic condition monitoring, KathrynRing, Scott Shattuck, Sandra Dahl, Nancy Lee3-044 The impact of collaboration between clinical pharmacistsand nurse care managers on diabeticpatients with hemoglobin A1c above 9%, VivianLian, Shirley Chao, Phillip Chiao3-045 Implementation of pharmacy medication therapymanagement (MTM) services in the patient alignedcare team (PACT) model and the impact on dyslipidemia,Allison Berkland, Rachel Digmann, RichardDouglas, Karmen Jorgensen, Noelle Johnson3-046 Telequit CRAVES: counseling referrals and abstinencefor veterans enrolled in smoking cessation,Ivy Tonnu-Mihara, Grant Kim, Thao Nguyen3-047 Pharmacist analysis of a quality improvement registryto identify possible interventions in a patientcentered medical home, Courtney Jarvis, MatthewSilva, Stephanie Conway3-048 Comparison of efficacy and tolerability betweenniacin extended-release and sustained-release niacinafter formulary conversion, Connie Nguyen,Yong Moon, Mike Juzba, Josephine Tran3-049 Evaluation of the maintenance of glycemic controlin veterans discharged from a pharmacist-manageddiabetes clinic, Charity Anicete, SeemaKapadia, Mansi Patel, Anthony Tardi3-050 Evaluation of outcomes of two anticoagulationmanagement services, Sara Dadayan, Holly Chiu3-051 Patient satisfaction with liver clinic health careproviders during hepatitis C virus management,Michelle T. Martin, Donna M. Faber3-052 Retrospective review of vitamin D levels, supplementation,and early virological response in hepatitisC genotype 1 patients on dual and triplemedication therapy, Michelle T. Martin, ElzbietaStarzycka, Patrick Zueger, Krystyna Khopta,Alexander B. Chew3-053 Use of over-the-counter medications and dietarysupplements among elderly in the Lebanese population,Aline Saad, Marwan AkelAutomation / informatics3-054 Implementing a downtime contingency plan forcarousel dispensing technology (CDT) in a communityhospital inpatient pharmacy, Teresa Blakely,Melissa Frank, Steve Carlson3-055 Evaluating the implementation of drug monographdecision support software for warfarin criticaldrug interactions, Lindsay Holte, Maureen Boro,Audrey Lee, J Ben Davoren3-056 Pharmacists use of iPads to facilitate decentralizedpharmacy services, Tsingyi Koh-Pham, CrystalTom, Peter Lutz, Alana Arnold, Al Patterson3-057 Continued analysis of smart pump safety softwareimplementation: evaluation of soft and hard limitsfor medications, Suzanne Gettys, Shea Polk, ClintShadinger, Maury Donovan47th ASHP Midyear Clinical Meeting and Exhibition93

professional posters3-058 Automated computer alerts to improve warfarinprescribing and monitoring among hospitalizedpatients, Jamie Smelser, Michele Fang, JeffreyWilson, Boulos Nassar, Ryan Hobbs3-059 Pharmacists and technicians receive the medicalproducts storage temperature log in pharmacyautomatically by using e-mail system, TetsuyaMurase, Hiroaki Ikeda, Yongxin Shen, SatoruIzumitani, Kenji Kihira3-060 Reduction of pharmacy technician dispensingerrors through utilization of bar code scanning atthe point of delivery to automated dispensing cabinets(BADC), Erin Taylor, Shawn Roggie, Mark Heelon3-061 Impact of technology on student perceptions inhigher learning, Michael Kendrach, Scott KeithChronic / Managed Care3-062 Efficacy of angiotensin-receptor blockade versusconverting enzyme inhibition in delaying progressionof macroalbuminuria in type two diabetesmellitus, Bahia Chahine, Nancy Nasser, Etwal BouRaad, Diana Malaeb3-063 Economic Burden of cardiometabolic disordersassociated with comonly-used atypical antipsychoticsamong patients with schizophrenia in theU.S., Mariam Hassan, Shien Guo, Luis Hernandez,Julia Green, Vamsi BolluClinical Service Management3-064 Creating a role for pharmacy externs in an antimicrobialstewardship program, John Benson, CamilleMingo-Aguilar, Karen Brainard3-065 Pharmacy practice change: moving in the rightdirection, Alla Belovsky, Nilam Gandhi, CarolynWoodley, Ellen Rudnick, Mark Sinnett3-066 Creation of a patient registry to track performanceof clinical pharmacy services added to a hospitaldiabetes self-management training/education program,Charlene Hope, Izabella Wentz3-067 Development and implementation of a vancomycincollaborative practice agreement at a communityhospital, David Morris, Christopher Carlisle, Pete VanAarle, Robb Dengg, Carrie Dunford3-068 Impact of a pharmacist on HCAHPS PerformanceMeasures, Kate O’Dell, Matthew J. Serna3-069 Implementation of the pharmacy practice modelinitiative (PPMI) in a community hospital and thepharmacists role in heart failure hospital qualitymeasures and readmission rates, Frank Rigelsky,Michael A. Jakubecz3-070 Assessment of the 4 Ts scoring system to predictthe likelihood of positive antibody-titer for heparin-inducedthrombocytopenia (HIT) as a screeningtool in adult inpatients in a communityhospital, Ramadas Balasubramanian, Scott Perkins,Ashish Patel, Sridhar Pal, Santosh Gopalakrishnan3-071 Impact on pharmacist interventions by implementingpharmacy practice model changes, EdRainville, Jerry Storm, Vern Johnson, Mike Hawley9447th ASHP Midyear Clinical Meeting and ExhibitionDrug information3-072 Bioterrorism drill collaboration between druginformation centers and the Alabama Departmentof Public Health, Wesley Lindsey, Maisha KellyFreeman, John Hooper, Charles Thomas3-073 Assessment of attitudes toward the iPad and patternsof use among pharmacy faculty members,Peter Hughes, Jeffrey Kyle, Logan Norman3-074 Creation of a peer reviewed drug information frequentlyasked questions database for internal usein a health care system pharmacy, Katie Stabi,Mandy Leonard, Janine Douglas, Matthew Miller3-075 Trends in drug recalls in pharmaceutical manufacturersin Japan, Takuya Ishida, Takafumi Naito,Takashi Osawa, Kasumi Yamakawa, JunichiKawakami3-076 Chronic obstructive pulmonary disease (COPD):inhalation technique and information about drugtreatment effects - a task for clinical pharmacists?,Helena Marjanovic, Jolene HenriksenDrug-Use Evaluation3-077 Meperidine medication use evaluation for 2 to 3days of therapy, Rosebel Efejuku, Pamela Murphy,Nancy Chapman, Yi Wang3-078 Evaluation of the appropriateness of dabigatranuse and follow-up events, Sara Koenig, EvelynHermes-DeSantis3-079 Clinical and economic evaluation of rivaroxabanfor prophylaxis of venous thromboembolism inpatients undergoing total hip or knee replacementsurgery with implications for the MassHealth budget,Amanda Tulolo, Amanda Slowinski, JenniferEspiritu, Jennifer Weiner, Ian Fitts3-080 Assessing benzodiazepines use and dispensingprocedures in a Lebanese community pharmacy,Rony Zeenny, Lydia Sholy, Antoine Gebrayel, PiaMhanna3-081 Evaluation of hypoglycemia after implementationof a revised insulin protocol, Leigh Anne HyltonGravatt, Amanda Dubil3-082 Evaluation of appropriate use of micafungin at acommunity hospital, Mohamed Fouad, Samia Fawzi,Radhika Pisupati, Mitch Sobel3-083 Iron sucrose medication use evaluation, BradleyHein, Myanh Lai3-084 Evaluation of intravenous acetaminophen use insurgical patients, George Udeani, Robert Eschbach,Lisa Sprenger, Chris Miller, Joseph High3-085 Evaluation of appropriate use of carbapenems atan acute-care community hospital, Amber Miller,Julie Snyder, Jill Bennett, Gene Borrelli, Evelyn Elliott3-086 Implementation of a clinical decision support systemand its impact on alvimopan usage in a communityhospital, Bao Nguyen, Andrew Gifford,Makenzie Nye, Danny McNatty

3-087 Evaluation risk of fracture associated with longterm proton pump inhibitors therapy in the elderlyin veterans health service medical center, Seoul,South Korea, Sowall Kim, Sun young Min, Jeong hoHong, Hyokeun Jeong, Jaegon Ryu3-088 Discharge management of acute coronary syndromes(DMACS) toolkit: the Australian experience,Lisa Pulver, Kate Oliver, Susan Tett3-089 Is there any role for the clinical pharmacist inLebanon?, Asia Dekmak, Fatima Awada, Etwal BouRaad, Diana Malaeb3-090 Pegfilgrastim use evaluation in a tertiary care hospitalin the United Arab Emirates (UAE), RaniaSlika, Lina Wehbe, Nicole Gebran, Aref Alam3-091 Retrospective review of rituximab use in an oncologycenter in UAE, Rania Slika, Nicole Gebran,Khaled Al Qawasmeh, Kholoud Jamal, Aref Alam3-092 Effects of colistin therapy on renal function in criticallyill Lebanese patients, Diana Malaeb, KatiaIskandar3-093 Evaluation of the appropriate use of imipenem/cilastatin in a tertiary care hospital: indication,dose, dose adjustment in renal impairment, andseizure risk, Wissam Kabbara, George Na’was3-094 A retrospective analysis on potential drug use inhyperbilirubinemia, Hee Kyung Woo, Young HeeChoi, Hye Sook Lee, Sang Geon Kim3-095 Adherence to medication treatment regimensamong schizophrenia patients treated with paliperidonepalmitate in community mental healthcenters, Jacqueline Pesa, Cynthia Schmeichel-Mueller, Jennifer Liang3-096 Impact of a daptomycin prescribing restriction at acommunity hospital: six months before and afterintervention, Melanie Flinn, Jacqueline Pitts3-097 Economic implications of the misuse of protonpump inhibitors for stress ulcer prophylaxis inhospitalized patients, Chau Chu, Michael Huang,Patrick Brennan, Fayth Edillor, Grace Hwang3-098 Medication use evaluation of ipratropium inchronic obstructive pulmonary disease, WesleighJastorff, Kelly Moran, Tiffany Jastorff GilliesGeneral Clinical Practice3-099 Case report: asymptomatic bradycardia possiblyassociated with travoprost therapy, WeeranujYamreudeewong3-100 Use of calculated FRAX score to assess clinicalreadiness for discontinuation of alendronate therapyin a male veteran population, Uyen Tran, CarolBotelho, Bradley Peterson3-101 Evaluation of the rates of proton pump inhibitoruse, documentation of proper indications, andpossible proton pump inhibitor associated risks ata community hospital, Alicia Juska, Zoon Park,Ramesh Patel3-102 Implementation of a pharmacist managed insulinprotocol: five years later, Alicia Juska, Zoon Park,Ramesh Patel3-103 Implementation and results of a pharmacistdirected inpatient hyperglycemia management service,Timothy Nikstad, Kay Palmer3-104 Disease trajectory and treatment practice forchronic obstructive pulmonary disease (COPD):results from a nationally representative physiciansurvey, Caitlyn Solem, Lavanya Sudharshan, ShawnSun, Cynthia Macahilig, Monica Katyal3-105 Pharmacy clinical video telehealth (CVT): developmentand implementation of services within aVeterans Affairs health care system, HelenKasimatis, Donna Leslie, Nicole Olson, Khyati Patel,Danielle Alsip3-106 Student pharmacist interventions on a generalmedicine advanced pharmacy practice experience,Lee Lam, Angie Koo, Peter Ambrose3-107 Utilizing a clinical pharmacist to impact the safetyand quality of care in the medication reconciliationprocess, Michael Garvey, Plante Elena, VincentLudewig3-108 Evaluation of an inpatient alcohol withdrawal protocol,Michelle Hurrell, Leah Ann Durham3-109 Pharmacists interventions do affect patient care: astudy of interventions utilizing selected but clinicallysignificant drug-drug interactions as a therapeuticmeasure, William Leelum3-110 Pharmacy consultancy service in medical practicesin Australia, John Woodward, Lisa Pulver3-111 Introducing clinical pharmacists at the acute medicineadmission ward at Odense UniversityHospital, Denmark, led to implementation of severalinterventions, Louise Groenkjaer3-112 Implementation of an inhaler optimization programacross three health-systems: infection rates andfinancial outcomes, Allison Tauman, MichelleCorrado, Kimberly Curry, Robert Ritchie, Scott Neel3-113 Implementation of an electronic alert to improvethromboembolism prophylaxis at a communityteaching hospital, Michael Mikrut, Sonali Muzumdar3-114 Development and implementation of a nursedriven pneumococcal and influenza vaccinationprotocol in a community hospital, Rhonda Zillmer,Lynn Eschenbacher3-115 Pharmacist interventions provided in family practice:a systematic review, Edwin Tan, Kay Stewart,Rohan Elliott, Johnson George3-116 Assessment of the presence and quality of osteoporosisprevention education among at-risk internalmedicine patients, Cortney Hindahl, JenniferShulha, John O’Meara, Melody Berg3-117 Improving glycemic control: pharmacy protocolfor the transition of intravenous insulin infusion tosubcutaneous insulin, Lynn Hendrick, Dave Kanyer47th ASHP Midyear Clinical Meeting and Exhibition95

3-147 Clinical and economic evaluation of tenofovir/emtricitabine for pre-exposure prophylaxis of HIVin men who have sex with men with implicationsfor the MassHealth perspective, Randy Hollins,Kelly Gehman, Laura Van Alsten, Aura Neidhardt,Mary Rezk3-148 Assessing the adherence to the idsa guidelinesfor empiric treatment of community acquiredpneumonia in intensive care unit patients at threeLebanese university hospitals, Etwal Bou Raad,Diana Malaeb, Taghrid Suleiman, Maraim Nasser3-149 Evaluation of pharmacist role on antimicrobialsurgical prophylaxis in a Lebanese hospital, DianaMalaeb, Katia Iskandar, Zeinab Abbass3-150 Conflicting vancomycin minimum inhibitory concentration(MIC) susceptibility reporting of staphylococcusaureus isolates; an evaluative study toimprove clinical practice at a state hospital,Matthew Ambury, David Berkowitz, Carol Aboud,Faramarz Jamshidi, Matthew Tonon3-151 Retrospective evaluation of intravenous vancomycinuse in a rural Veterans Affairs hospital,Wesleigh Jastorff, Kelly Moran, Sarah Opitz, TiffanyJastorff Gillies, Michael Lemon3-152 Validation of a vancomycin dosing nomogram in acommunity hospital, Alexandra Burris, Estella Davis,David Schmidt, Ryan Dull3-153 Safety of cidofovir in pediatric patients with viralinfection, Alana Arnold, Sarah Jones, Al Patterson3-154 Cost-effectiveness of fidaxomicin for the treatmentof severe Clostridium difficile infection in hospitalizedpatients in North America, Quinn Bott, LibbiRice, John Oh, Veejaye Sinha, Nohemie Boyer3-155 Evaluation of a pharmacy-monitored procalcitoninprotocol in community-acquired pneumonia, AmyHyduk, Gordon Bokhart, Gloria Huynh, Angel Heyerly3-156 Impact of antibiotic stewardship program on thetreatment of asymptomatic bacteriuria at an inpatientrehabilitation hospital, Nitika Agarwal, MaryMekheil, Steven Lewis, Susan Isenberg, Xiao Yuan3-157 Evaluating the appropriateness of an antimicrobialintravenous to oral conversion protocol comparedto antimicrobial stewardship recommendations ina veterans affairs health care system, Brent Cernik,Pamela Foral, Michaela Hardy, Chris Destache3-158 Outcomes following implementation of an antimicrobialstewardship program in a 154-bed communityhospital, Ran Xu, Mona Kapadia, KarenSimpson, Kaye Rathmann, Laura Meadows3-159 Evaluation of the appropriateness of antimicrobialdosing in critically ill patients receiving continuousrenal replacement therapy, Nadia Awad, WendyLam, Jodie Skayhan, Evelyn Hermes-DeSantis3-160 Evaluating the correction of antibiotics usinginformation in a public pharmacy (Mongagua,Brazil), Valter Santos, Solange Bricola, AlessandraKoukdjian, Bruna Abreu, Luciana Camargo3-161 Financial impact of multi-disciplinary team ledantimicrobial stewardship initiative, Roy Guharoy,Elizabeth Radigan, Gail Scully, Jennifer DalyInvestigational Drugs3-162 Quantifying the financial impact of investigationaldrug services in a large, not for profit, tertiary academicmedical center, Richard MaloneLeadership3-163 Use of interactive polling to incorporate multipleperspectives into the pharmacy practice model initiative(PPMI) hospital self assessment, LauraZendel, Justin Sebakijje, Jay Barbaccia3-164 Collaboration between South Sudanese immigrantsand American health care workers resultsin a proposal with potential international impact,John Rueter, Jennifer Barnes, Ashley Cobb, ErinNystrom, Ashokakumar Patel3-165 Implementation of an innovative seminar coursefor third professional year pharmacy students,Lydia Sholy, Rony Zeenny3-166 Development of a structured, university-supportedprogram to assist students in the post-match residencyscramble, Seth Brownlee, Timothy Ulbrich,Laura Cessna, Kyle Gustafson, Richard KasmerNutrition Support3-167 Retrospective assessment of the efficacy of a pancreaticenzyme protocol for clearing occludedenteral tubes, Janice Stumpf, Jennifer Vuong,Rebecca Kurian, Kimberlyn Dang, Michael KraftOncology3-168 Antiemetic efficacy and safety of aprepitant inmultiple-day chemotherapy for hematologicalmalignancies, Hiroaki Ikesue, Mayako Uchida,Toshihiro Miyamoto, Nobuaki Egashira, Ryozo Oishi3-169 Assessment of compliance with American Societyof Clinical Oncology (ASCO) guidelines for thescreening and management of bone health inbreast cancer patients, Allison Chiu, Bryna Ewachiw,Ilene Browner3-170 Development of an antibiotic algorithm for febrileneutropenia, Brannon Flores, Barry Diamond3-171 Identifying medical oncology patients at high-riskfor venous thromboembolism in the outpatientsetting, Tiffany Chung, Beth Keeney, Joyce Lin3-172 Evaluation of carboplatin dosing methods in pediatricpatients undergoing autologous stem celltransplantation, Mi Hye Choi, Go Wun Choi, YongHwa Lee, Hye Suk Lee, Kyung Duk Park3-173 Analysis of prescription errors through carefulreview on chemotherapy regimen, Soyoung Lim,Sujin An, Heesu Chang, Hyokeun Jung, Jaegon Ryu3-174 The use of glucarpidase as adjunctive treatmentfor a patient with delayed methotrexate elimination,Cheryl Abbas, Anne Marie Valorie-Oberle47th ASHP Midyear Clinical Meeting and Exhibition97

professional posters3-175 Retrospective review of carboplatin dosing inpatients with low serum creatinine, Linh Phan,Tiffany Dea, Nelson Chee3-176 Significant cisplatin toxicity in a patient with testicularseminoma with retroperitoneal metastases,Jennifer Confer, Jeremy Prunty, Jon Wietholter, ChrisLarck, Arif Goreja3-177 Pharmacogenetic biomarkers for predisposition totoxicity with irinotecan or oxaliplatin-containingregimes in colorectal cancer patients, LuciaCortejoso, Maria Isabel Garcia-Garcia, Pilar Garcia-Alfonso, Silvia Manrique-Rodriguez, Luis AndresLopez-Fernandez3-178 Concentration-dependent venous irritationinduced by bendamustine injection, Ryozo Oishi,Hiroyuki Watanabe, Hiroaki Ikesue, Kenichiro Nagata,Nobuaki Egashira3-179 Effect of an oncology pharmacy elective courseon fostering interest in oncology pharmacy as acareer specialty, Michael Steinberg, Maryann Cooper3-180 Knowledge of cancer screening recommendationsamong health fair attendees, Maryann Cooper,Carroll-Ann Goldsmith, Cheryl Durand, HelenPervanas, Michael Steinberg3-181 Knowledge of healthy habits in cancer preventionamong health fair attendees, Maryann Cooper,Carroll-Ann Goldsmith, Cheryl Durand, HelenPervanas, Michael Steinberg3-182 Hybrid-dosing ondansetron vs. standard palonosetronin the treatment of chemotherapy-inducednausea and vomiting - a retrospective review, JohnQaqundah, Thomas Pham, Bill Tan, Robert Romanelli3-183 An elective in advanced therapeutic managementof oncology patients, Ebtesam Ahmed, Damary C.Torres, Tina Kanmaz3-184 Electronic medical record messaging can changeclinical practice and lead to reduction in the use ofgranulocyte-colony stimulating factor withoutcompromising quality care, Jasen Knudsen,Mohamed Sallout, Dan Colley, Brad Halverson,Nagendra TirumaliOperating Room Pharmacy3-185 Development of a clinical operating room surgicalrotation, Michelle Holm, John Rueter3-186 Detection of narcotic diversion using an auditreview of anesthesia records, Allen Lockwood,Dietrich Gravenstein, Patrick Tighe, Michael Mahla,Tammy Euliano3-187 Performance analysis of automated anesthesiadispensing system, JiEun Hong, Janet Kozakiewicz,Paul RochefortPain Management3-188 Characterization of chronic opioid monitoringpractices using urine and serum drug testing atthe VA Maryland Health Care System (VAMHCS),Mallory Onisk, Amy Ives, Robert Lavin, ChristopherGallagher3-189 Ketamine infusion for loin pain hematuria syndromeexacerbation refractory to opioid therapy: a twopatientcase study, Timothy Aungst, Robert Menak,Ric Baxter, AnnElise Collier3-190 Implementation of a pharmacist led pain consultservice utilizing electronic order entry in a communityhospital, Mate Soric, Jason Glowczewski,Rachael Lerman, Brandon Mottice3-191 Patient satisfaction with intravenous acetaminophentreatment: A meta-analysis of randomized,placebo-controlled, repeated dose studies in theacute postoperative setting, Juan Portillo, PoorviDalal, Sergio Bergese3-192 Effect of patient controlled analgesia lockout intervalon patient safety and pain control, JessicaMoore, Lori Reisner, Sheri VanOsdolPharmacokinetics3-193 Pharmacokinetic characterization of extendedreleasetopiramate (USL255) compared to immediate-releasetopiramate after single- andmultiple-dose administration, Kacie Hughes,Lawrence Lambrecht, Tricia Braun, W Mark Todd,Mark Halvorsen3-194 Evaluation of transdermal absorption of ketoprofenin a rabbit model, Eliza Daubert, Christina Inteso,Manuel Isherwood, Trey Tietz, Arthur Kibbe3-195 Development and Implementation of a PhenytoinTraining Manual for Pharmacists at UAB Hospital,Michael Denaburg, Deborah Como, Trisha Patel,Shilpa Shah, Alice Ookeditse3-196 Impact of concomitant magnesium oxide administrationon oral bioavailability of gabapentin in cancerpatients with neuropathic pain, Tatsuya Yagi,Takafumi Naito, Yasuaki Mino, Kazuo Umemura,Junichi KawakamiPractice Research / outcomes Research /Pharmacoeconomics3-197 Development and validation of a survey to assesspatient knowledge about medications and confidencein their use, Arinze Nkemdirim Okere, ColleenRenier, Jacqueline Morse3-198 The Impact of pharmacist-led medication reconciliationservice (MRS) in the reduction of emergencyroom (ER) readmissions, Arinze Nkemdirim Okere,Colleen Renier, James Tomsche3-199 Physical and chemical stability of injectable acetaminophen,Mark MacKay, Chenelle Stidham,Jacquelyn Ouellette, Sabrina Boehme, CollinAnderson3-200 Does early antibiotic administration decrease theoverall length of stay in acute exacerbation ofchronic obstructive pulmonary disease?, MattBaker, Stacey Kwan3-201 Impact on outcomes with inpatient pharmacy practicemodel change, Amanda Brahim, William Kernan,Osmel Delgado9847th ASHP Midyear Clinical Meeting and Exhibition

3-202 Simulating Framingham risk reductions to assessapplicability as a global study endpoint: reportfrom the P.A.T.H. steering committee, Nancy Borja-Hart, Steven Smith, Audrey Wooten, Tara Lukawski,Benjamin Epstein3-203 Evaluating the impact of a pay-for-outcomes programrewarding primary care physicians for optimalLDL-C management, Margaret Pasquale, YihuaXu, Christine Divers, Michael Bullano, Jennifer Weber3-204 Economic evaluation of fingolimod with budgetimplications for MassHealth, David Thompson,Connie Cheng, Anne Coz, David Dreissen, NehaKashalikar3-205 Clinical and economic evaluation of bortezomibfor salvage therapy in relapsed or refractory multiplemyeloma patients with implications for theMedicare budget, Namhee Kwak, Stephanie Belair,Kathy Ching, John Komry, Anna Moulton3-206 Clinical and economic evaluation of ivacaftor fortreatment of cystic fibrosis patients with implicationsfor the MassHealth budget, Nidhi Dave,Aneeqa Islam, Colleen Martin, Lindsey Pelletier,Jasmine Wing-Choi3-207 Estimated cost avoidance associated with a pharmacist-CDEled diabetes intense medical managementand education clinic, David Ha, Jan Hirsch,Christine Cadiz, Anisa Arjmand, Candis Morello3-208 Economic implications of liraglutide for a statehealth insurance program for low-to-middleincome residents, Crystal Yu, Daniel Felix, EmilyHeath, Amber Ladak, Elizabeth Haftel3-209 Pharmacist counseling versus leaflet education inimproving awareness in vitamin D deficientLebanese patients, Randa El Masri, Lina Jadid,Diana N. Malaeb, Etwal Bou Raad3-210 Vitamin D status in healthy Lebanese pharmacystudents, Lina Jadid, Randa El Masri, Diana N.Malaeb, Etwal Bou Raad3-211 Clinical and economic evaluation of cholinesteraseinhibitors for behavior symptom managementof Alzheimers patients with implications for theVeterans Administration budget, Ashley Smith,Kaylee Marino, His An Chang, Tanmayi Gupta, TaylorNelson3-212 Student pharmacists’ perceived level of confidencebefore and after a medical outreach elective,Elizabeth Perry, Amanda Storer, Roy Parish3-213 Clinical and economic evaluation of hepatitis Ctreatments with implications for the VeteransHealth Administration budget, Erica Marini, AektaVasavada, Sonya Gusinov, Jan Michael Bumatay,Cheyanne Freeman3-214 Evaluation of adherence and persistence of antimuscarinicmedications for overactive bladder,John Grossomanides, Carl Possidente3-215 Impact of pharmacist-based heart failure counselingon 30-day readmission rates, Matthew Gibson,Christopher Tuttle, Jason Milner3-216 Discrepancies of medication name, dose, route,and frequency in primary care clinics, Trina Huynh,Grace KuoSmall and Rural Pharmacy Practice3-217 Pharmacist usage of a medication interventionsheet for nitrofurantoin, metformin, and trimethoprim/sulfamethoxazole(smx-tmp)in a smallrural community hospital, James Williamson, GingerBain3-218 Efforts to reduce clostridium difficile infections ina rural community, Mary Jo Garst, Marti Heinze3-219 Trends in pharmacy practice in Illinois small andrural hospitals over the past two decades, IuliaUrsan, Glen Schumock, Surrey Walton, StephanieCrawford, Andrew DonnellyToxicology3-220 Retrospective analysis of the prevention and treatmentof alcohol withdrawal at a large communityteaching institution, Bradley Hein, Michelle Bilinski3-221 Arizona poison and drug information center(APDIC) quality improvement project: qualityassurance guideline to monitoring and improvingrecording errors (QUAGMIRE), Shannon DeGrote,Steven Boyles, Michael Herman, Charles McFarlan,Keith BoesenTuesday, December 42:00pm – 4:30pmCategories: Administrative practice / Financial Management /Human Resources, Automation/Informatics,Cardiology/Anticoagulation, Chronic/Managed Care,Clinical Services Mangement, Critical Care , DrugInformation, Drug-Use Evaluation, EmergencyMedicine/Emergency Room, General Clinical Practice,Homecare, Infectious Diseases, Investigtional Drugs,Leadership, Operating Room Pharmacy,Pediatrics,Pharmacokinetics, Pharmacy Law/Regulatory/Accreditation, Pharmacy Technicians, PracticeResearch/Outcomes Research/Pharmacoeconomics,Preceptor Skills, Psychopharmacy/Neurology, QualityAssurance/Medication-Use Safety, Small and RuralPharmacy Practice, Toxicology, Transplant/Immunology, Women’s HealthAdministrative practice / FinancialManagement / Human ResourcesSession-Board#5-238 Capturing pharmacy interventions without the useof external documentation software, DehutiPandya, Sarah Lake-Wallace, Lourdes Cuellar5-239 Formulary selection criteria for biosimilars: considerationsfor health-system pharmacists, NieshaL. Griffith, Jim Stevenson, Ali McBride, Larry Green5-240 Developing a residency program through a community-basedresearch project, Leigh Ann Ross,Lauren Bloodworth, Justin Sherman, LaurieWarrington47th ASHP Midyear Clinical Meeting and Exhibition99

professional posters5-241 Communities of pharmacy: collaboration forsafety, quality, and efficiency in a multi-hospitalhealth system, Jennifer Brandt, Bonnie Levin,Marybeth Kazanas5-242 Implementation of a unit-dose topical repackagingservice in a tertiary care academic medical center,Jason Harsanye, Todd Donnelly, Jeffrey Rosner, SamCalabrese5-243 Cost benefit analysis of a universal needlelessadaptor system for reconstitution and transfer ofsterile medications in two hospital settings, GingerErtel, Brandi Strader, Kristine Valenti, Ryan Birk5-244 Economic impact of a dexmedetomidine order setin a community hospital, John Ives, Craig Miller,Catherine Leventis, Valerie Sheehan, Dave Ehlert5-245 Economic impact of a therapeutic interchange forparenteral iron in a community hospital, John Ives,Craig Miller, Catherine Leventis, David Baribeault,Dave Ehlert5-246 Medication event huddles: effect of an electronicdatabase on intervention follow-up in a pediatrichospital, Jenna Merandi, Shelly Morvay5-247 Development and implementation of a techniciancareer ladder in a community hospital, Nancy Rampe5-248 Buying-in: devising a purposeful staff educationalplan to increase knowledge of healthcare regulationsand improve employee engagement, Nate Stucky5-249 Improved formulary compliance by implementinga comprehensive formulary management system,Pieter Helmons, Charles E. Daniels5-250 Using performance improvement tools and staffinvolvement to optimize neonatal pharmacy services,Michael Hoying, Jacob Zapolnik5-251 Cost effectiveness of an antimicrobial stewardshipprogram in a community hospital, Kieu-Loan Vu5-252 Creating a new model for pharmacy/nursing partnershipin a community acute care hospital setting,Kieu-Loan Vu5-253 Evaluation of a new pharmaceutical waste disposalsystem (Cactus Smart Sink®), Fredrick H.BenderAutomation / informatics5-001 Transition to a paperless clinical monitoring processto support pharmacy practice modelchanges, Darshika Patel, Osmel Delgado, WilliamKernan, Martha Espinosa-Friedman5-002 Implementing an electronic chemotherapy statusboard (eCSB) to improve communication anddecrease patient wait times, Shannon Baker, LouisPalmisciano II, Jennifer Ferolito, Christine Collins5-003 Concordance with prescribing indications enteredinto the computerized prescriber order entry(CPOE) system, Karen Ong, Monique Pitre, JohnMurdoch, Gary Wong5-004 The impact of computerized provider order entry(CPOE) on adverse events as measured by theInstitute for Healthcare Improvement (IHI) GlobalTrigger Tool, Jaculin DeYoung, Brian Gugerty, PeterLundeen, Neil Carlson, Nathan Mosurinjohn5-005 Pilot study results of an automated system preparingintravenous admixtures in a hospital pharmacyaseptic unit, Pilar Flox, Ana Herranz, Rosa Romero,Patricia Perez, Silvia Manrique5-006 Evaluation of effectiveness of real time outpatientpharmacy printing of savings estimation forpatients with mail order incentive, Thomas Pugh,Robert Kawashima, Amar Prasad5-007 Use of an internet-based education managementsystem to track ICU pharmacists interventions,Kathryn Neill, Kendrea Jones, Allison Hollis, AshleyStinnett5-008 Impact on nurse satisfaction after converting froma centralized cart fill drug distribution model usingmedication carts to a decentralized model usingautomated dispensing cabinets, Curtis Kellner,Robert DembickiCardiology / Anticoagulation5-009 Monitoring achievement of adequate heparin levelsin adult patients receiving heparin infusions: adrug use evaluation of an adult weight based heparininfusion protocol, Linda Kelly, Josie Saldana,Yousuf Shakir, J. Randle Adair5-010 Clinical and economic evaluation of rivaroxabanfor stroke prophylaxis in patients with atrial fibrillationwith implications for the Veterans Affairsbudget, Zachary Yuschock, Maria-Elena DiMaria,Charles Berds, Cristina Tran, Eric Conover5-011 Evaluating the reasons for dabigatran discontinuationin a community hospital and anticoagulationclinic, Ashley Jacobs, Brook Sipe, Dustin Linn, AngelHeyerly, Gordon Bokhart5-012 Assessment of the use of a novel method to educateclinical staff pharmacists on 2012 CHESTguidelines, Kimberly Kelly, Lynn Eschenbacher5-013 Impact of receiving target dose angiotensin convertingenzyme (ACE) inhibitor/angiotensin IIreceptor blocker (ARB) or beta-blocker therapy onfollow-up care in patients with heart failure,Stephanie Meisinger, Paul Dobesh, Donald Klepser5-014 Retrospective drug utilization evaluation to validatethe use of a weight-based heparin protocolfor initiation of a heparin infusion in the treatmentof venous thromboembolism and cardiac indications,Norma Armstrong, Emily Martinez5-015 Evaluation of compliance and validation of aninstitution specific weight based heparin nomogram,Tara McMillin, Jaculin DeYoung, Steven Hixson5-016 Factors affecting heart failure readmission rates inJesse Brown VA medical center patients, BlairKaplan, Clare Bergman, Grazina Janeliauskaite10047th ASHP Midyear Clinical Meeting and Exhibition

5-017 Impact of pharmacist discharge education andinterventions on publically reported heart failuremeasures, Jenna Huggins, Janice Pan, KimberlyFordham, Haywood Rhodes, Chris Lynch5-018 Most frequent medical conditions concomitantwith atrial fibrillation in men and women and useof anticoagulation in the ORBIT-AF registry, WinnieNelson, Jeffrey Schein, Chandrasekharra Damaraju,Jonathan Piccini, Eric Peterson5-019 Prevalence, associated comorbidities, and burdenof a prior myocardial infarction among patientswith venous thromboembolism, Joyce LaMori,Hillary Gross, Marco DiBonaventura, BrahimBookhart, Brahim Bookhart, Jeffrey Schein5-020 Evaluation of proper prescribing of cardiac medicationsat hospital discharge for patients withacute coronary syndromes (ACS) in two Lebanesehospitals, Marwan Sheikh-Taha, Zeinab Hijazi5-021 Occurrence of venous thromboembolism despiteprophylaxis in an obese patient population at anacademic medical center, Christina DeRemer,Justina Damiani, Trisha Branan, J. Kimble Keller5-022 Warfarin discharge counseling pilot evaluation,Anna Powichrowski, Katie Greenlee, Jeff Ketz5-023 Transforming anticoagulant patient education,Charles Geibig, Susan Tripp, Jerry Lopez, Kern Low5-024 Recombinant factor VII activated and prothrombincomplex concentrate use at a tertiary academicmedical center, David Reardon, Paul Szumita, Julie Atay5-025 Development of an oral anticoagulant coagulopathy/bleedingmanagement protocol based on limitedevidenced based medicine, Larry Davis, CindyWilliams, Lindsay Enzor5-026 Extended anti-Xa monitoring of low-molecularweightheparin in end-stage renal disease: a casereport, Elaine Chow, Andrea Hall5-027 Early experience with dabigatran at a large, tertiarycare hospital, Jennifer Brandt, JosephBarbaccia, Mary Turner5-028 Anticoagulation management and valvular thrombosisin a toddler: a case report, Rebecca Marraffa,Andrea Hall5-029 Tirofiban use in a community-based hospital, AmyKnoblock, Shelby Troendle5-030 Implementation of a heart failure readmissionreduction initiative in a rural healthcare system,Dmitri Cohen, William Seavey, Bethany Lessard5-031 Implementation of a pharmacist-driven anticoagulationdischarge counseling process at an academicmedical center, Brett Crisp, Robert Granko,Rowell Daniels5-032 Difference in initial activated clotting time afterbivalirudin bolus during PCI in obese versus nonobesepatients, Maria C. Cruz, Jenna M. Huggins, J.Erin AllenderChronic/Managed Care5-033 The impact of pharmacist involvement in associatebenefit design programs, Kelley Curtis, LarryClark, Kelly Carstens, Mercedes Dombi, Peter WongClinical Service Management5-034 Integration of value added clinical responsibilitiesfor decentralized unit based pharmacists in a communityhospital setting, Douglas Daley, DanielNewberg, Betty Li5-035 Implementation of a pharmacy driven inpatientdiabetes service improves inpatient glycemic control,Edna Gow, Eric Fleischbein, Mary Green,Emanuel Decquir, Patricia Montgomery5-036 Successful credentialing and privileging of pharmacistsin a community hospital, J. Ashley Gunter,Eric Maroyka5-037 Continuity of care: an innovative approach to anadvanced pharmacy practice experience within alarge community hospital, Vicky Turberville-Vega,Anees Kanorwala5-038 Evolution of the role of pharmacy in optimizationof transitions of care in heart failure patients,Karen Trenkler, Justin Schneider, Zahra Khudeira5-039 Novel PGY1 residency learning experience encompasseshealth system’s pharmacist role in thetransitions of care, Karen Trenkler, Justin Schneider,Tejal Patel, Jonathan Murray5-040 Glycemic evaluation and feasibility of collaborativepractice model for colorectal surgery patients,Jenna Lovely, Joseph Herges, Benjamin Dreesman,David Larson5-041 Application of an interdisciplinary protocol to successfullyconvert enterally incompatible drugswith enteral nutrition from the intravenous or inappropriateenteral route to an appropriate enteraladministration time in critical care tube fedpatients at a major medical center, WilliamRuspantini, Edwina Rich, Andy Chu, Asha BhallaCritical Care5-042 Wake up and wean protocol, Caroline Girardeau,Cheryl Reilly, Ashley Liggins, Ashley Sweeney, JackieEveridge5-043 Continuous renal replacement therapy: movingpractice forward with new technology, CarolineGirardeau, Rhonda Vincent, Michael Casey, ElizabethNeuffer, Cheryl Reilly5-044 Distinguishing comatose from non-comatoseimproves validity of delirium screening with theConfusion Assessment Method for the IntensiveCare Unit (CAM-ICU), Joshua Swan, Tiffany Ho,Diana Luong5-045 Nosocomial clostridium difficile infection in ICUpatients receiving acid suppressive therapy,Ashley Stinnett, Christine Browning47th ASHP Midyear Clinical Meeting and Exhibition101

professional posters5-046 Effect of sedation medication and daily awakeningon delirium in the mechanically ventilated criticallyill patient: a descriptive pilot study, TrevorPerry, Julie Moon, Harminder Sikand5-047 Medication shortages: are alternative agents tofacilitate mechanical ventilation safe?, Nam Cho,Cathy Hirokawa, Huan (Mark) Nguyen5-048 Continuous intravenous infusion of furosemide: isone electrolyte replacement protocol appropriatefor all critically ill patients?, Po Ying Fung, CathyHirokawa, Huan (Mark) Nguyen5-049 Evaluation of spontaneous awakening trials in themedical intensive care unit at a tertiary academicmedical center, Jeremy DeGrado, Megan Colwell,Megan Colwell, Paul Szumita, Anthony Massaro5-050 Clinical and financial evaluation of a tele-ICUbased pharmacy program on stress ulcer prophylaxis(SUP): A pilot project, Erkan Hassan, PaigeCuellar, Steven Klahn, Holly Chavez5-051 Effect of sedation tapering as part of a multi-professionalpain, agitation and delirium program onICU outcomes, Erkan Hassan, Michael DePietro,Marc Zubrow, Anita Witzke, Megan FarrajDrug information5-052 Compliance with location- and service-based formularyrestrictions using computerized providerorder entry, Nathan Spence, Christopher Wisniewski,Kelli Garrison5-053 Key characteristics for the administration of drugsthrough feeding tubes, Begona San Jose, LauraSerrano, Alazne Bustinza, Zurine Baskaran, IdoiaBilbao5-054 Cost-effectiveness and implementation of a druginformation center in the Bahamas and surroundingCaribbean islands, Alexander Wilson, JohnRedwanski5-055 Importance of pharmaceutical care regarding theuse of ascorbic acid (vitamin C), Valter Santos,Solange Bricola, Felicia Abraho, Mariana Gaeta,Stefanie GaldinoDrug-Use Evaluation5-056 Evaluation of pioglitazone use in a rural VA healthcaresystem, Kelly Moran5-057 Drug use evaluation of sitagliptin in patients withrenal impairment, Seong-Sim Ahn, Eun-hee Kim,Soon-Joo Kim, Hyen-Oh La5-058 Use of cabazitaxel for metastatic prostate cancerin clinical practice, Macarena Bonilla, Eva Castillo,Blanca Rodriguez, Marta Hernandez5-059 Acyclovir and hyponatremia: a case report, LuciaCortejoso, Maria Gomez-Antunez, Maria EstherDuran-Garcia, Silvia Manrique-Rodriguez, MariaSanjurjo-Saez5-060 Anti-angiogenic drugs and cardiogenic shock: acase report, Lucia Cortejoso, Javier Garcia-Lledo,Alvaro Gimenez-Manzorro, Silvia Manrique-Rodriguez, Maria Sanjurjo-Saez5-061 Risk assessment associated to natalizumab therapy,Ana Leandro, Paula Santos, Armando Alcobia5-062 Evaluation of a clinical pharmacist intervention toindividualize pancreatic enzyme therapy to thelowest effective dose, Karen Downer, DorothyJenrette5-063 Clinical and economic evaluation of roflumilast forsevere COPD patients with implications for theVeterans Administration budget, Kathleen Belusko,Ashley Doyle, Lindsey Williamson5-064 Retrospective study of the use of ipilimumab in aFrench University hospital, Claire Pressiat, CharlesEsquirol, Philippe Arnaud, Emmanuelle Papy5-065 Outpatient pharmacist academic detailing reducesprescribing of non-preferred drugs and improvesquality and cost, Fadi Chehab, Suzanne Gauen5-066 Prescription of fractional doses of solid oral drugsin hospital: a qualitative and quantitative description,Chloe Fercocq, Kivan Long, Emmanuelle Papy,Philippe Arnaud5-067 Evaluation of initial vancomycin trough concentrationsin obese patients receiving vancomycin,Danni Stitt, Andy Grimone5-068 An evaluation of pharmacy and nursing complianceto the weight based heparin protocol in acommunity teaching hospital, Ifeanyi Egbunike-Chukwuma, Joseph Norbert Ngwa Nforbi, KevinSchnupp5-069 Evaluation of the implementation of an automatictherapeutic substitution to 3mL rapid and shortacting insulin vials, Gene Rhea, Matthew Kelm,Kirby Davis5-070 Severe hypoglycemic events associated with nonguideline-concordantoral anti-diabetic drug treatmentsin patients with type 2 diabetes andmoderate to severe chronic kidney disease: findingsfrom a U.S. commercially-insured population,Shih-Yin Chen, Yuan-chi Lee, Veronica Alas, JosephBiskupiak, Mallik Angalakuditi5-071 Association of severe hypoglycemic risk withpackage insert recommended renal dose adjustmentsfor oral anti-diabetic drug treatmentsamong commercially insured patients with type 2diabetes, Shih-Yin Chen, Yuan-chi Lee, VeronicaAlas, Diana Brixner, Mallik Angalakuditi5-072 Treatment of recurrent Clostridium difficile infectionsin hospitalized patients with implications for theVeterans Administration budget, Linda Wang, ViktoriaArons, Katie Trotta, Sagar Vegesna, Kimberly Wan10247th ASHP Midyear Clinical Meeting and Exhibition

5-073 Clinical and economic evaluation of etanercept fortreatment of patients with rheumatoid arthritis withimplications on the MassHealth budget (2011),Samantha Choy, Alexandra Cote, Victoria Getty, KatePark, Cassandra Petty5-074 Implementation of a pharmacist driven erythropoietinstimulating agent program, Ann-Lori Perez,Janelle Berg, Michaela Christian5-075 Effect of obesity on continuous weight-based heparininfusions, Leesa Prunty, Sharon Jones5-076 Evaluation of acetaminophen prescribing & administrationin a level 1 trauma center, Tiep Ly,Harminder Sikand5-077 One-day focus on antivitamins K (AVK) drug interactions:pathing the way for a computerizedassisted prescription, Brice Berdougo, MurielleDalle, Catherine Divine, Muriel PaulEmergency Medicine / Emergency Room5-078 Parent and staff saftisfaction with local anesthesiapriot to IV starts in a pediatric emergency room,Richard Thomas, Cydney Greenhalgh, Jared Cash5-079 The emergency pharmacist as influenza immunizationofficer, Christopher Edwards, Katherine Hiller,Uwe Stolz, Janet Kerrigan, David Peirce5-080 Impact of clinical pharmacists on initiation of postintubationanalgesia in the emergency department,Erin Robey-Gavin, Lamies Abuakar5-081 Utilization of a clinical pharmacist to enhance thesafety and quality of medication reconciliation initiatedin the emergency care center, MichaelGarvey, Elana Plante, Vincent Ludewig5-082 Development of a standardized emergency departmentorder set for initiation of high-dose insulintherapy for beta-blocker and calcium channelblocker overdose, Kimberly Glasoe, StaceyVanSickle5-083 Assessing the time to antibiotic administration inseptic shock patients with pharmacy services inthe emergency department, Ajay Madduri, EvelynHermes DeSantis, Patrick Bridgeman5-084 High-dose insulin therapy for beta-blocker andcalcium channel blocker overdose: case series,Stacey VanSickle, Kimberly Glasoe5-085 IV droperidol and olanzapine as adjuncts to midazolamfor the acutely agitated patient: a multicentre,randomised, double-blind,placebo-controlled, clinical trial, Esther Chan,David Taylor, David Kong, Jonathan Knott, GeorginaPhillips5-086 Compliance with pneumonia core measures in theemergency department: it takes a village, FranciaKellner, Christopher Freer, Doreen Dutchak, MarilynRoque-Ammirata5-087 Antimicrobial surveillance program by clinicalpharmacists in the emergency departmentenhances treatment of urinary tract infections,Karen Biehle, Sean Tran, Remco Witteveen, AllenGandhi, Reno Law5-088 Implementation of pharmacy services to a freestanding emergency department using on sitepharmacist and remote support from a hospitalpharmacy, Yun Yee Chong, Nisha Patel, Sharon Lu,Vafa Aflatooni, Christian Hamm5-089 Expansion of emergency medicine pharmacy servicesin a tertiary academic medical center,Elizabeth Wells, Matthew Campbell, Brian Pettry,David Tietz, Jonathan Williams5-090 Impact of a clinical pharmacist on emergencymedicine services, Sara Triglia, Kristen Longstreth,Maria Pusnik5-091 Implementation and impact of 24 hour hospitalpharmacy services and emergency departmentclinical services: a combined role, David Dietrick,Linda Higginson, Brent DammeierGeneral Clinical Practice5-092 Impact of a pharmacist-driven discharge counselingprogram in a community hospital setting, ErinOnder, Kimberly Czajka, Thomas Bauer5-093 Impact of a residency antimicrobial stewardshiprotation on pharmacist initiated interventions,Marsha Crader, Andrea Cavenaugh, Sarah Cochran,Cynthia Garris5-094 Reduction of alvimopan use by implementing arestriction protocol in a community hospital,Radhan Gopalani, Erika Dittmar, Ken Kepler5-095 Competing priorities in a community hospitalemergency department: whats a newly deployed,rotating pharmacist to do?, Corinda Pippins, BethDixon, Dave Merryfield5-096 Situational analysis of the vancomycin use monitoringprocedure, Maria Fernanda Salomo Azevedo,Mayra Ribeiro, Carlos Henrique Cunha, DeboraCarvalho, Maria Beatriz Souza Dias5-097 Problem based learning in an elective course toassociate treatment principles between acute andambulatory patient care, Kimberly Tackett, C. ScottLancaster5-098 Utilization of automatic stop order practice amongacademic medical centers, Roy Guharoy, KarenSmethers, Christian Hartman5-099 Pharmacists impact on decreasing length of stayin a collaborative care unit, Kristi Ziegenbusch,Nathan Ash, Cory Werts, Thomas Spallinger5-100 Darbepoetin alfa protocol implementation in aninpatient rehabilitation hospital: the pharmacist’simpact, Helen Afolarin, Nitika Agarwal5-101 A pilot of pharmacist counseling patient on newmedications prior to discharge in a 154-bed communityhospital, Karen Simpson, Ran Xu, KayeRathmann, Brenda Harvey-Traylor, Jennifer Squyres47th ASHP Midyear Clinical Meeting and Exhibition103

professional posters5-102 Evaluation of the 4Ts clinical pre-test scoring systemfor the diagnosis of heparin-induced thrombocytopeniain a community teaching hospital,Ifeanyi Egbunike-Chukwuma, Jackie Tran, BonnieEnwezor, Aruna Pokharel, Rahel Goitom5-103 Implementation of a medication reconciliation processin a community teaching hospital: a pilotstudy focused on patients at high risk for hospitalreadmission, Ifeanyi Egbunike-Chukwuma, KevinSchnupp, Sai Nimmagadda5-104 Impact of the pharmacist in the patient-centeredmedical home, Mindee DeWitt, Diane Cantwell, TinaLee, Nancy Louie Lee5-105 Outcome of a pharmacist discharge counselingprogram for congestive heart failure (CHF)patients, Michelle Corrado, Nicole Clark5-106 Effect of delayed prophylaxis on increase ofVenous thromboembolism in post orthopedic surgerypopulation, Mahnoush Soleymani5-107 Pharmaceutical attention showing improvement inmedical adherence and glycated hemoglobin(HbA1C) reduction in diabetic patients., ValterSantos, Solange Bricola, Mariana Garcia, JulioOliveira, Debora Sitnik5-108 Preparing to be an international relief pharmacist:lessons learned from post-quake Haiti, PatriciaPitts, Elena Chidlowsky5-109 Endeavor for greater pharmacy heartburn interventionthrough development and widespreademployment of heartburn screening surveys,Nyemachi Ejiowhor, Tamara Foreman, Kathleen MichelHome Care5-110 Clinical problems identified with a screening toolfor patients starting home infusion therapy, CathyJohnson, Malathi CrossleyI.V. Therapy / infusion Devices5-111 Hospital infusion center costs for anti-tumornecrosis factor agents, Jordana Schmier, Mary Cifaldi,James Shaw, Michael Halpern, Nancy Nickman5-112 Evaluation of an infusion pump pharmacist, ScottMilner, Beth Johnson, Tina Aramaki5-113 Creating monthly clean room cleaning assignments,Kathleen Conway, Angela Yaniv5-114 Verification activities for a hazardous IV compoundingrobot, Angela YanivInvestigational Drugs5-115 Establishing an investigational drug service atIntermountain Medical Center, Elyse MacDonald,Krystal MoormanLeadership5-116 Review of pharmacy careers: advice for pharmacystudents, Jill Augustine, Annesha Lovett, Gina Ryan,Hong Xiao, Sam Peasah5-117 Evaluation of the preparative and reflectivethoughts of post-graduate biopharmaceuticalindustry fellows teaching experiences in a Doctorof Pharmacy elective course, Michael Steinberg,Maryann Cooper5-118 Impact of conducting admission interviews on facultyof a school of pharmacy, Michael Steinberg,Evan Horton, Kristine Willett5-119 Student pharmacists perception of a service learningexperience at a charity pharmacy, Lauren Bloodworth,Meagan Brown, Courtney Davis, Leigh Ann RossNutrition Support5-120 Evaluation of parenteral nutrition prescription:pharmaceutical interventions, Renata Amaral, DirceAkamine, Michel Kfouri, Carmem PeresOperating Room Pharmacy5-121 Effectively communicating the current status ofdrug shortages in an operative setting, SteveGianakopoulos, Peggy Bickham, Julie Golembiewski5-122 Use of tranexamic acid in orthopedic joint arthoplasty,Dominick BulonePediatrics5-123 Impact of an intermittent pediatric antimicrobialstewardship program on pharmacist interventionsat a children’s hospital, Margaret Heger, AaronHarthan, Julie Giddens, KanokpornMongkolrattanothai5-124 Early experience with intravitreal bevacizumabcompared to laser treatment for retinopathy of prematurity,Shaviller Waugh, Kimberly Le, JenniferGardner, Lingkun Kong, Paul Steinkuller5-125 Optimization of the vancomycin dosing nomogramin the regional neonatal intensive care unit, KristinaFrinzi, Kimberly Ross Wurst, Corinne Smith5-126 Utility of early vancomycin monitoring to preventacute kidney injury in critically ill pediatricpatients, Brady Moffett, Michelle Pharm, Sara Bork,Jeanine Graf5-127 Non-antimicrobial medication allergies in pediatricinpatients, Brady Moffett, Genevieve Echeta, JoanShook5-128 Beta-blocker associated hypoglycemia in pediatricinpatients, Brady Moffett, Susan Abraham, Roy Chacko,David Ung, Antonio Cabrera5-129 Review of pediatric vancomycin dosing regimens,Megan Kayser, Kelly Matson, Andrew Hatt5-130 Implementation of a pediatric decentralized pharmacytechnician service to facilitate patientaccess to discharge medications, verify dischargemedication reconciliation and increase pharmacistinvolvement in the discharge process, MatthewWerling, Andrea Zuckerman, Rachel Lovria, MarciaWhite, Laura Tietz10447th ASHP Midyear Clinical Meeting and Exhibition

5-131 Pharmacy student-led inpatient medication educationrounds in a pediatric teaching hospital,Jessica Miller, Jennifer Anderson, Brittany Oswald, YinWong, Judy Yu5-132 Utilization of a smart pump bolus feature in a pediatricintensive care unit at a large children’s hospital,Sara Bork, Erin McDade, Shahnaz Zakeri, HilelFrankenthal5-133 Hepatitis associated with single dose administrationof micafungin in a pediatric transplant patient,Tsingyi Koh-Pham, Yin Wong, Courtney Fratto5-134 Clostridium difficile infection in an 11 month oldchild, Kimberly Couch, Brenda Johnson, MeridethBrown, Lucy Schwobel, George Schwobel5-135 Neonatal intensive care unit antimicrobial stewardship:early onset sepsis in neonates, Jennifer Mitchell,Julie Kasap, Sarah Engberg, Kamlesh Macwan5-136 Intranasal fentanyl versus intravenous morphinefor acute pain in the pediatric emergency department,Rhonda Zillmer, Tracy CuppPharmacokinetics5-137 Status and improvement of blood sampling errorsby clinical pharmacokinetic consultation services,Sang Y. Lee, Ji Y. Park, Jin K. Kim, Hae J. Park5-138 Pharmacokinetics (PK) of different formulations oforal azacitidine (CC-486) and the effect of food onPK in patients with hematologic malignancies, EricLaille, Michael Savona, Bart Scott, Thomas Boyd,Barry Skikne5-139 Improvement of vancomycin utilization in a communityteaching hospital, Brenda Gitman, RaniPatel, Mini Varghese, Sonia Patel, Ashmi PhilipsPharmacy Law / Regulatory /Accreditation5-140 Assessing the impact of a law case assignmentfor third professional year pharmacy students,Lydia Sholy, Rony Zeenny5-141 Utilizing technology in the development of ananesthesia auditing program, Mark Fondriest,Michael Marchionda, Michelle Homner-LeanzaPharmacy Technicians5-142 Using web based open-source software to organize,expand, and manage pharmacy techniciantraining within a health-system program, Erin OrtizBlanco, Rebecca A. Taylor, Joston T. Da Grava,William E. Ryman, Scott Visker5-143 Medication reconciliation in the emergency roomand continued patient education regarding homemedications before discharge, Heather Moore,Angela Smith, Deborah Laughter, Jessica Garner5-144 An innovative role for pharmacy technicians: formaleducation and training of pharmacy students,Denise Propes, Rivka Siden, Kimberly Redic, DanaDeJohn5-145 Examining the value of accredited pharmacy techniciantraining by comparing organizational pharmacycalculations competency assessmentswithin a health-system, William E. Ryman, Erin M.Ortiz Blanco, Rebecca A. Taylor, Joston T. Da Grava,Scott Visker5-146 Analysis of refill times and par levels to best utilizestaff resources in a community health system,Christopher Donofrio, Thomas Cerbone, MichelleCorrado, Nicole ClarkPractice Research / outcomes Research /Pharmacoeconomics5-147 Cost drivers associated with clostridium difficileinfection in a hospital setting, Swetha Rao Palli,Marcie Strauss, Ralph Quimbo, Sheila Thomas5-148 Impact of extended infusion piperacillin-tazobactam(PT) on length of stay (LOS) and PT utilization at acommunity hospital, Charles Arrison, Kimberly LaPointe5-149 Pharmacists intervention on improving medicationside effect scores in a community hospital setting,Michaela Christian, Janelle Berg5-150 Inpatient resource utilization for acute coronarysyndrome: an analysis using the healthcare costand utilization project (HCUP) databases, JoyceLaMori, Kellie Dudash, Omar Shoheiber, Samir Mody,Concetta Crivera5-151 A phase III prospective analysis of outcomes seenwith the implementation of a new alcohol withdrawalprotocol within a large teaching institution,Winnie Thi, Felipe Gutierrez, Harminder Sikand5-152 Clinical and economic evaluation of vemurafenibin metastatic melanoma patients with implicationsfor the MassHealth budget, Amber King, JenniferSet, Lauren Escobar, Olena Lyashchenko, Alby Jacob5-153 Cost-efficacy analysis of cabazitaxel for the treatmentof hormone-refractory metastatic prostatecancer patients, Ana Leandro, Armando Alcobia5-154 Clinical and economic implications of substitutingdexmedetomidine for propofol in patients during arecent national drug shortage: examination of hospitalpatients undergoing uncomplicated coronaryartery bypass graft (CABG) surgery, Julius Li, CaraMcDaniel, Brandi Thoma, Laura Pizzi5-155 Clinical and economical evaluation of 17 hydroxyprogesteronecaproate for the prevention of pretermlabor in women with prior preterm labor andimplications for the MassHealth budget, LaurenBernbaum, Andrea Mark, Andrew Marsella, CarolPoskay, Raul Santiago5-156 Clinical and economic evaluation of riluzole foramyotrophic lateral sclerosis (ALS) with implicationsfor the Veterans Administration budget,Dennis Tung, Nicole East, Felicia Cheng, Andrea Susi,Dave Patel47th ASHP Midyear Clinical Meeting and Exhibition105

professional posters5-157 Hemoglobin and darbepoetin alfa dosing trends inhospital-based dialysis centers: 2010-2011,Gregory Maglinte, Matthew Gitlin, Chun-Lan Chang,Jerrold Hill, Jeffrey Petersen5-158 Pharmacoeconomic evaluation of transplantrelatedcytomegalovirus hyperimmune globulinuse at a large academic medical center, Brandon R.Shank, Kate Jeffers, Michael Spinner, Mathew Jones,Christopher Ensor5-159 Economic impact of common canister forms ofinhaled anticholinergic treatments, Kimberly Couch,Merideth Moody, Lucy Schwobel, George Schwobel5-160 Cost effectiveness of rivaroxaban compared withwarfarin and dabigatran for stroke prevention inmoderate-to-high risk nonvalvular atrial fibrillationpatients, Milan Sharma, Caitlin Snyder, BridgetChisholm, Olivia Chirsky, Won Yang5-161 Improving health care literacy awareness andempathy among pharmacy students through ahealth literacy gap academic assignment, TonyaDauterman, Laura Perry, Lori Ernsthausen5-162 Who, what, where, and how? Preparing studentpharmacists for health fairs, Micah Hata, PatrickChan, Michael Trillanes, Julie Hoang, Maianh Nguyen5-163 Clinical and economic evaluation of indacaterolmaleate for moderate to severe COPD patientswith implications on the MassHealth budget,Fletcher Tang, Shamir Patel, Alana Gruszecki,Matthew Lord, Harrison Jaffess5-164 Financial impact of lean process improvement ontargeted drugs in the oncology population in anacademic medical center, Roy Guharoy, KarenSmethers, Christian Hartman5-165 Pens or syringes? A time savings evaluation,Matthew Silva, Brett Rollins, Diana Lee5-166 The risk of hypotension following co-administrationof macrolide antibiotics and calcium-channelblockers in Korea, Ji-Young Choi, Hyun Jung Lee,Jae Yeon Kim, Young Cheon SongPreceptor Skills5-168 A novel approach to integrating advanced pharmacypractice experience rotations in emergency andinternal medicine, Michael Thomas, Kimberly Tackett5-169 Survey assessment of pharmacy resident and preceptorperceptions of feedback, Megan Musselman,Amber Lucas, Jill Robke5-170 Development of a pharmacy-school affiliated longitudinaladvanced pharmaceutical practice experienceat a large academic institution, Evan Horton,Jason Cross, Katherine Carey, Kathleen Kopcza, ErinTaylor5-171 Implementation of a faculty-precepted institutionaladvanced pharmacy practice experience at a largeacademic medical center, Jayne Lepage, CherylDurand, Catherine Simonian, Kristin Tuiskula, KarynSullivan5-172 Resident teaching certificate program at RooseveltUniversity College of Pharmacy, Fatima Ali, MeghanaAruru, Cara Brock, Tara Dymon, David Fuentes5-173 Implementation of a clinical pharmacy careerdevelopment course for P2 and P3 students interestedin post-graduate residency training, TibbJacobs, Jamie Terell, Amy Kerkemeyer5-174 Impact of a required indigent care APPE rotationon perceptions of the underserved in a cohort ofstudent pharmacists, Lindsey Elmore, PatriciaBaldone Naro, Angela Roberts Thomason5-175 Pilot for an innovative teaching certificate programat a new college of pharmacy, Shreya Patel,Maureen Sullivan, Nataliya ShinkazhPsychotherapy / neurology5-176 ANCHOR-CD (AbobotulinumtoxinA neurotoxin:clinical and health economics outcomes registryin cervical dystonia): a multicenter, observationalstudy of dysport in cervical dystonia: baselinedata and cycle one outcomes data, Jack Chen,Richard M. Trosch, Cynthia L. Comella, Steven B.Hall, Yavuz Silay5-177 ANCHOR-CD (AbobotulinumtoxinA neurotoxin:clinical and health economics outcomes registryin cervical dystonia): a multicenter, observationalstudy of dysport in cervical dystonia: patientdemographic, history, and health economics data,Jack Chen, Richard M. Trosch, Cynthia L. Comella,Steven B. Hall, Yavuz Silay5-178 Role of buprenorphine and naloxone in VA MedicalCenter opioid treatment programs, KimberlyKauzlarich, Ronald Brown5-179 Assessment of concomitant antipsychotic therapyat an inpatient psychiatric service, Stephen Dolley,Anna Morin, Boris Lorberg5-180 Evaluation of the pharmacotherapy of Parkinsonsdisease in a tertiary care Lebanese hospital, JadAbdallah, Reina SkaffQuality Assurance / Medication Safety5-181 Impact of a pharmacist-led adverse drug reaction(ADR) surveillance program in a pediatric medicalcenter, Amanda Parker, Tracy Sandritter, MollyCamis, Jennifer Lowry5-182 Pharmacy and nursing collaboration to improvemedication availability, Laura Zendel, Cynthia Willis,Rikki-Leigh Gaudet, Youngmy Kim, Cory Johnson5-183 Impact of drug shortages on Israeli hospitals,Ahuva Lustig5-184 The effect of day two vaccination on pneumococcalvaccine administration core measure compliance,Mena Abaskharoun, Sherry Ninni, Cindy Dugan5-185 Effect of computerized provider order managementon reported medication variances relating to anticoagulation,Rhonda Hammerquist, Sara Fowler,Michael Gulseth10647th ASHP Midyear Clinical Meeting and Exhibition

5-186 Reducing missed doses events in admitted patientsusing pre-admission medication reconciliation,Leza Hassett, Siobhan deUrioste, Siobhan deUrioste,Theodore Mitchell, Theodore Mitchell, Ann Osborne5-187 Creation of a standardized USP 797 training processand lab practicum examination for certifiedpharmacy technicians, Andrew Szkiladz, MelissaMariani, Pauline Pietrzykowski, Shawn Roggie,Kathleen Kopcza5-188 A multidisciplinary approach to improving medicationsafety, Bruce Wong, Yelena Mikheyeva5-189 Detection and analysis of errors in prescriptionsfor discharged patients, Diana Kats, Hana Polachek,Roza Zalesin, Tamar Shechter, Rimona Rotem5-190 Admission medication reconciliation utilizing apharmacy technician and pharmacist team in theemergency department: a pilot study, Tingting Gao,Bonnie Pitt, Deb Saine, Justin Hoppes5-191 Quality assurance for parenteral nutrition usinglaboratory analysis of electrolytes, Scott Nelson,Jason Barrows, Michael Helm, Angela Wolsey, MarkMacKay5-192 Outcome of medication safety officer preparatorycourse a Saudi experience, Salma Al-Khani, TahirKhan, Hisham Aljadhey5-193 Pharmacists’ perceptions on pediatric medicineuse in Malaysia, Kok Thong Wong, Jeff Jiang FoongKong, Elitsa Nikolaeva Ivanova5-194 Lessons learned and actions taken after discoveryof undetected information technology (IT) hazardswithin an electronic medication reconciliationpathway: is your system at risk?, Donald McKaig,Christine Collins, Jim Smith, Kimberley Rodrigues5-195 Implementation of antimicrobial stewardship programin a community hospital, Emil Sidawy, SafyJohn, Meisam Ashkezary5-196 Optimizing smart infusion pump functionality toincrease safety at point of administration in neonataland pediatric populations, Le Phuoc Lynsey,Tara DeCerbo, Lindsey Klish, Craig Senholzi, CindyWordell5-197 Continuity of care: unintentional discontinuationof chronic medications related to intensive careunit admission, Elysha Elson, David Weetman5-198 Assessment of venous thromboembolism prophylaxisin adult medical inpatients after implementationof the computerized prescriber order entry(CPOE) system in a community hospital, RamadasBalasubramanian, David Bilotta, Scott Perkins, JeffreyAndrievk5-199 Increased quality in documentation of medicationreviews by use of a national database and a locallydeveloped registration tool, Christina Eriksen, LeneRavn-Nielsen5-200 Implementation of a drug safety alert program(DSAP) at Marshfield Clinic, Luanne Malsin, SaraGriesbach, Gary Plank, Theodore Praxel5-201 Smart infusion pump continuous quality improvementin a specialty hospital, Fancy Manton5-202 Expansion of a system-wide standardized pharmacymedication history program to all emergencydepartment visits: a baseline evaluation,Julie Cooper, Clayton Nance II5-203 Implementation of a pharmacist-managed medicationorder and compounding card filing system toreduce missing doses in an urban tertiary teachinghospital, Ruchira Kumar5-204 Implementation of outpatient pharmacy near-missmedication errors documentation program, CynthiaSmith5-205 Implementation of a pharmacist-based medicationreconciliation program upon discharge in patientsadmitted with heart failure to a community teachinghospital, Christopher Tuttle, Matthew Gibson,Jason Milner5-206 Incidence of thromboembolic events after the useof recombinant factor VIIa at a veterans affairsmedical center, Krystal Pong, Lisa Tong, JanellKobayashi5-207 Reduction of adverse events as measured by theInstitute of Healthcare Improvement (IHI) GlobalTrigger Tool in a pediatric and two adult hospitalsover two years, Jaculin DeYoung, Morgan Cole5-208 Bar-code medication administration: pharmacy’skey role in the medication safety process, MarkBishop, Jennifer Raynor, Karen Michaels, JasmineSudhakar5-209 Role of pharmacy students to improve screeningfor vaccination, Rolee Das, Radhika Pisupati5-210 Impact of a pharmacist on a core measures team,Emmanuel Markakis, Barbara Hammer, Jennifer Kim5-211 911: Re-dispense with discretion, Barbara Grajzl,Neelam Vyas5-212 Benefits of performing a thorough formulary reviewprior to barcode implementation, Theresa Waxlax5-213 Development and evaluation of safety interventionsto reduce distractions during medicationadministration process, Alina Bulgar5-214 Impact of executive support on medication safetyand regulatory compliance in hospital clinics,Varintorn Aramvareekul, Geoffrey Cox, NyemachiEjiowhor, Corinthians Hughey5-215 Evaluating the impact of pharmacist led medicationreconciliation on 30 day post discharge emergencydepartment visits and hospital readmissions,MaRanda Sanders, Niki Carver5-216 Drilling down on hydromorphone and its globalmedication safety issues reports, Miriam Klein,Christopher Russo, Jalil Minhas47th ASHP Midyear Clinical Meeting and Exhibition107

5-263 Analysis of drug information resources utilization:development of a drug information impact factorfor tertiary resources, Andrew M. Abe, Philip J.Gregory, Darren J. Hein, Zara Risoldi Cochrane, AmyF. Wilson5-264 A novel strategy for smoking cessation: wheredoes your butt go?, Hua Ling, Megan Nicklaus,Tammy Burns5-265 Pharmaceutical Industry and Health AuthoritiesUse of Data Mining as a Pharmacovigilance Toolfor Drug Safety Signal Detection, Susanna Carou5-266 Impact of an elective medical writing course onacademic performance, Mara Villanueva, Evelyn R.Hermes-DeSantis5-267 The Impact of Industry-Based Experienceand Student Involvement on Obtaining aPharmaceutical Industry Fellowship, Justin Balint,Kyechen Chen, Justin Kwiatek, Eric Zhao, MichaelToscani5-268 Use of social media strategies among the top10 pharmaceutical companies in 2012, Danny S.Gonzalez, Bernadette Chan, Katherine Gorcyca, HirenKachhia, Bijan Bandani5-269 Pharmaceutical industrys adoption of the FDAsguidance on the evaluation of QT/QTc prolongationduring drug development, Michael Camuso,Donato Forlenza, Yunji Kim, Amol Parekh, Priti Patel5-270 Understanding the value of PerformanceImprovement based Continuous MedicalEducation (PI-CME) to enhance Health CareProviders (HCP) performance and improve patienthealth outcomes, Laura Lee Bradshaw5-271 How do priority and orphan status designationsaffect review times for new oncology indicationsapproved through a supplemental application? Aretrospective analysis, Noah L. Greenberg, SanchaliKasbekar, Vishal V. Patel5-272 Association between insurance coverage andopportunistic infections among HIV-infectedpatients at a university hospital, Brett DavidHensley, Mara Villanueva, Evelyn Hermes-DeSantis5-273 Impact of a pharmacy adherence clinic on humanimmunodeficiency virus (HIV) medication takingself-efficacy: a single-group, pretest-postteststudy., Thomas Dilworth, Lindsey Mascarenas,Matthew Borrego, Renee-Claude Mercier5-274 Pharmacodynamic profiling of intraperitonealadministration of ceftazidime, Evan Zasowski, KatieE. Cardone, Darren W. Grabe, Zach Merry, Thomas P.Lodise5-275 Cues to Action that Predict Enrollment in aCommunity Pharmacy Diabetes and HypertensionCoaching Program, Heidi Luder, Stacey M. Frede,James Kirby, Pamela C. Heaton5-276 Identifying medication discrepancies throughlinked administrative pharmacy claims, DominiqueComer, Joseph Couto, Daniel Elliott5-277 Analysis of the multiple risks involving the use ofintravenous fentanyl, Mohammed Aseeri5-278 Analysis of perceived barriers encountered bymanagement within pharmacy workflow due tointermittent Family and Medical Leave Act (FMLA)leave at a governmental teaching hospital, Ali-RezaShah-Mohammadi, Ekere J. Essien, Lou V. Gould,Ryan K. Roux, Susan M. Abughosh5-279 Data mining of observational and spontaneousdatabases for safety assessment, Owen Haney,Lauren Remkus, Heather Strandberg5-280 Comparing Italian and American RadiationOncologists use of androgen deprivation therapyin the treatment of prostate cancer post-prostatectomy,Jessica Lopatto, Marco Lupattelli, Timothy N.Showalter, Zoe Clancy, Vittorio Maio5-281 Use of pharmacy residents (PGY1) and studentsas a conduit for an antimicrobial stewardship programat a small teaching hospital, Haley J. Morrill,Jonathan Dworkin, Kerry LaPlante5-282 Evaluating activity of daptomycin or linezolidin combination with rifampin or gentamicin onEnterococcus faecium in an in vitro pharmacodynamicmodel using simulated endocardial vegetations,Megan Luther, Kayla Babcock, Kerry LaPlante5-283 Excess of oral anticoagulation in hospitalizedpatients in a tertiary hospital., Ines Yeste-Gomez,Monica Ferrit-Martin, Raquel Garcia-Sanchez, SilviaManrique-Rodriguez, Maria Sanjurjo-Saez5-284 Local treatment of choroid melanoma hepaticmetastases by injection of irinotecan loadedbeads, Martinez Plata Enrique, Ferrit Martin Monica,Pardo Moreno Pedro, Vallejo Rodriguez Inmaculada,Calleja Hernandez Miguel Angel5-285 Local treatment of choroid melanoma hepaticmetastases by injection of irinotecan loadedbeads, Martinez de la Plata Juan Enrique, MonicaFerrit Martin, Inmaculada Vallejo Rodriguez, PedroPardo Moreno, Miguel Angel Calleja Hernandez5-286 Tennessee pharmacists’ attitudes toward theincreased number of graduates and its impacton career outlook, Tasfia Ahmed, Katherine Marks,Camille Hill, Jennifer Moll5-287 Empower your patients: evaluating the two-yearclinical outcomes of a pharmacist-led diabetesmedication management program, Jackie Lu,Kangho Suh, Tricia Tabor, Paul Godley5-288 Evaluation of factors affecting blood pressuregoal achievement, Sarah Hulvershorn, Kangho Suh,Karen Rascati, Paul Godley, Karim Prasla5-289 Post-graduate opportunities at national pharmacyassociations: a qualitative review, Evan S. Schnur,Whitney Cowart, Krystalyn K. Weaver, Alex J. Adams5-290 The Economic Burden of Drug Acquisition DuringPeriods of Reported Medication Shortages, NathanThompson, Victor Boey, Matthew Scanlon47th ASHP Midyear Clinical Meeting and Exhibition109

ACKnoWLEDgEMEnTSASHP Officers and Board of DirectorsKathryn R. Schultz, PresidentGerald E. Meyer, President-ElectStanley S. Kent, Immediate Past PresidentPhilip J. Schneider, TreasurerPaul W. Abramowitz, Chief Executive OfficerPaul W. BushLarry C. ClarkChristene M. JolowskyThomas J. JohnsonSteve RoughMichael D. SanbornJames A. TrovatoKathleen S. Pawlicki, Board-ElectKelly M. Smith, Board-ElectASHP Section and Forum Executive CommitteesASHP Section of Clinical Specialistsand ScientistsLea S. Eiland, ChairErin Fox, Immediate Past ChairJill S. Bates, Chair-ElectTricia Meyer, Director-at-LargeMichelle E. Allen, Director-at-LargeDaniel P. Hays, Director-at-Large-ElectJames A. Trovato, Board LiaisonAngela Raval, Section DirectorASHP Section of Ambulatory CarePractitionersSteven Riddle, ChairPamela L. Stamm, Immediate Past ChairSeena Haines, Chair-ElectCathy Johnson, Director-at-LargeGloria Sachdev, Director-at-LargeSandra Leal, Director-at-Large-ElectChristene Jolowsky, Board LiaisonJustine Coffey, Section DirectorASHP Section of inpatient CarePractitionersLynn Eschenbacher, ChairJennifer Edwards Schultz, Immediate Past ChairNoelle RM Chapman, Chair-ElectJoanne Kowiatek, Director-at-LargeEmily Alexander, Director-at-LargeLois F. Parker, Director-at-Large-ElectSteve Rough, Board LiaisonAnthea V. Francis, Section DirectorASHP Section of informatics andTechnologyKevin Marvin, ChairAllen Flynn, Immediate Past ChairMichael D. Schlesselman, Chair-ElectSylvia M. Thomley, Director-at-LargeGwen Volpe, Director-at-LargeTrinh Le, Director-at-Large-ElectLarry Clark, Board LiaisonKarl Gumpper, Section DirectorASHP Section of Pharmacy PracticeManagersPatricia Killingsworth, ChairMichael F. Powell, Immediate Past ChairTodd Karpinski, Chair-ElectLaura Mark, Director-at-LargeJames Hoffman, Director-at-LargeRick Couldry, Director-at-Large-ElectThomas J. Johnson, Board LiaisonDavid Chen, Section DirectorASHP new Practitioners ForumKatherine Palmer, ChairChristina Martin, Vice ChairHolly CauseyLuke MarkhamArpit MehtaPaul Bush, Board LiaisonJill Haug, Forum DirectorASHP Pharmacy Student ForumLisa Scherkenbach, ChairThomas Achey, Vice ChairSamar ChakarJacalyn JonesThomas LuptonMichael Sanborn, Board LiaisonDiana Dabdub, Forum Director11047th ASHP Midyear Clinical Meeting and Exhibition

2011-2012 Section Educational Steering Committees2011-2012 SectionEducational SteeringCommitteesASHP Section of Clinical Specialistsand ScientistsPaul M. Szumita, ChairEricka L Breden, Vice ChairKim W. BennerKimberli M BurgnerChad J. CoulterFreddy CreekmoreJennifer HardestyDaniel P HaysJoel C MarrsJ. Russell MayDouglas SlainMatthew W. StrumMichelle “Shelly” WiestMichael VozniakJill Bates, Council on Therapeutics LiaisonJoAnn Harris, Educational ServicesAngela Raval, Section DirectorASHP Section of AmbulatoryCare PractitionersJennifer A. Buxton, ChairTracy A. Martinez, Vice ChairPaige CarsonKevin ChamberlinLindsey ElmoreMelody L. HartzlerDavid HoangJeannie K. LeeLisa M. LundquistGina RyanAnne TeichmanPamela Stamm, Executive CommitteeLiaisonBarbara B. Nussbaum, EducationalServicesJustine Coffey, Section DirectorASHP Section of informaticsand TechnologyRobert Christiansen, ChairArmen Simonian, Vice ChairAlan ChungChristopher FortierJohn ManzoMichael SchlesselmanLaura TyndallKevin Marvin, Executive CommitteeLiaisonMichelle Abalos, Educational ServicesKarl Gumpper, Section DirectorASHP Section of inpatientCare PractitionersLois F. Parker, ChairWes Pitts, Vice ChairTerri AlbaranoLori DupreeShishir GuptaSum LamTyrone LinDarlette G. LukeJacqueline L. OlinRichard PacittiKimberly PesaturoElizabeth McGowan ReboRonald SetoMichelle L. ShahSusan Jean SkledarLinda SpoonerLori TsukijiJoanne Kowiatek, Executive CommitteeLiaisonMichelle Abalos, Educational ServicesPamela Hsieh, AJHPAnthea V. Francis, Section DirectorASHP Section of PharmacyPractice ManagersThomas E. Kirschling, ChairRebecca Taylor, Vice ChairRyan A Forrey, Immediate Past ChairJohn A. ArmitsteadJohn S. ClarkTammy CohenDoina DumitruMatthew W EbertsNancy A HuffStephanie PeshekJohn D PastorJay P. RhoDeepak R SisodiyaMichelle Abalos, Educational ServicesDavid Chen, Section DirectorFederal Forum PlanningCommitteeWilliam M. (Mike) Heath, Colonel (Ret)Captain Justin LuskChristina HubbleLieutenant Laura ModafferiAnthony P. MorrealeLieutenant Kendall Van TyleLieutenant Jefferson FredyJulie A. GroppiMajor James MastersonSPECiAL ACKnoWLEDgEMEnTSASHP would like to thank these organizations for their assistance in planning educational sessions:American Association of Colleges of Pharmacyu The Art of Precepting: It’s Not as Easy as it Looksu Starting Your Career as a Pharmacy Faculty MemberAmerican Pharmacists Associationu Super Sunday: Ambulatory Care Review Course IntensivesAmerican Society of Transplantation PharmacistCommunity of Practiceu Transplant Pharmacy: Paving the Way to a Practice Model ofExcellenceCollege of Psychiatric and Neurologic Pharmacistsu Expecting the Unexpected: Treatment of Opiate Dependencein PregnancyHematology/Oncology Pharmacy Association and theAmerican College of Clinical Pharmacyu Oncology Pharmacy Specialty Sessions 2012: AdvancedTopics in Practice, Parts 1 & 2Institute for Safe Medication Practicesu Top Ten Medication Safety Issues Related to HospitalAccreditation StandardsPediatric Pharmacy Advocacy Groupu Emerging Strategies for Neonatal InfectionsPharmacy Technician Certification Boardu Critical Roles for Certified Pharmacy Technicians in PracticeModel Change47th ASHP Midyear Clinical Meeting and Exhibition111

acknowledgementsThe Midyear 2012 Proposal and Poster ReviewersNicole AcquistoGlen AlbrachtMichael AndreskiAlison AppleNathan AshRyan AttwooRamadas BalasubramanianPaul BarrettEmily BartleyJudith BeizerKim BennerMarianne BilleterMelissa BlairLynn BoeclerAmy BoldtPaul BookstaverLaura BorgeltSara BorkHeidi BraggJanet BramellMichael BrennerPatrick BridgemanTim BrownBernadette (Bonnie) BrownDorothy BrownPhil BrummondJessie BurchLakesha ButlerAdriana CabreraTheresa Catalano-ChristouBruce ChaffeeJuliana ChanJack ChenToby ClarkChristine ClarkKevin ClausonMary Petrea CoberCharlie W. ColquittJill ComeauJessica CottreauSteven CrosbyBrian CryderMonica CyrWilliam DagerGary L. DalinMichele DanishGeorge DavisBethany DiPaulaPaul DobeshErnest DoleJennifer DSouzaDoina DumitruSteven DzierbaKim Edmonds-RogersLea EilandMaguy El HajjThomas EllingtonHeather EppertTracy FangJohn FanikosMegan FarrajKate FarthingDeanna FernandesKatie Flowers-ChoateMichael A. FotisMichelle FraleyMaisha FreemanCarla FryeDavid FuentesJulie FuscoPeter GalDianna GattoChristine GegeckasTeresa GeideBrett GeigerJustine GortneyLeAnn T. GrahamBrooke GriffinCindy HalasJessica HallDorothy L. HancockMargaret HegerBethanne Held-GodgluckRobert HenaultStephen HeteyCarol HeunischLisa HeuserMichelle HilaireAngela HillJames HoffmanConstance HogrefeJulie HolstadAntoun HouraniehLindsay HovestreyatJane HughesNga HuynhRami IbrahimEric IpTibb JacobsSamantha P. Jellinek-CohenHeath JenningsDouglas JenningsPaul JensenErwin JeongRita JewThomas JohnsonFrances JordanMilica JovicWissam KabbaraAbir (Abby) A. KahalehSeema KapadiaBeth KeeneyKristi KelleyMichael KendrachAnthony KesselsPatricia C. KienlePolly KintzelBonnie KirschenbaumMark KlangSusannah KoontzJessica LaFosseTim R. LaneseTrisha LaPointeRodna LarsonBrian D. LathamTrinh LeTodd LemkeBonnie LevinRobert H. LevinEdward LozanoLeslie MackowiakEric MacLaughlinLynnae M. MahaneyMark MaleskerPatrick MaloneMary ManningJeannell MansurJoel MarrsCynthia MascarenasHuzefa MasterAli McBrideKatie McClendonChristina MichalekGary MilavetzEryn MiliusKarla MillerSarah MillerDeborah MinorSamir ModyStephen MoerleinKevin MooresAnna MorinRobert MouraAndrew MoyerLee MurdaughYen K. NguyenEllen J. NickelBob S. OakleyCarol OttSharon K. ParkZoon H. ParkSteven PassAsad PatanwalaHina PatelStephen PawloskiWilliam PeppardJennifer PetrieBarbara J. PetroffHanna PhanJen PhillipsJennifer A. PhillipsMarjorie PhillipsJudy PiRadhika PisupatiLinda PopowiskiLuci PowerClaudia RakhmanRobert RappJohn RedwanskiMichael ReedJeffrey ReitzMelinda RobbinsJohn RoefaroMelody RyanMaha SaadCynthia SanoskiJoseph SaseenScott SavageKevin ScheckelhoffLauren SchlesselmanJean ScholtzTerry SchwinghammerNicole ScovisAmy SeybertElizabeth ShermanKelly ShieldsHarminder SikandSusan J. SkledarMaureen SmytheDenise SokosClyde E. SpenceSarah SpinlerDoug St. JohnAaron SteffenhagenMichael SteinbergJoAnn StubbingsJanine ThenDavid TomichKristin TuiskulaSuzanne TurnerLinda TylerLindsey UhrinLaura WachterPaul C. WalkerFei WangDavid WarnerSheila WilhelmPatricia WilkinsonKristine WillettNancy WilliamsSusan WinklerAvin YaldoDaisy YangRony Zeenny11247th ASHP Midyear Clinical Meeting and Exhibition

Sponsors and PartnersASHP would like to extend a special thanks to the following:a SponsorsZ-Card, Meeting & Activities,Recharging Station and Aisle SignsConvention Registration BagsMeeting LanyardsHotel Keysa PartnersIt’sYou’re different here.47th ASHP Midyear Clinical Meeting and Exhibition113

ASHP STAFF in ATTEnDAnCEMichelle Abalos, Director, Educational Programs, EducationalServicesAngela Abraham, Administrative Manager, ResourcesDevelopmentPaul Abramowitz, Chief Executive Officer, Executive OfficeChris Baker, Director, Information Management and Reporting,Information Systems TechnologyBona Benjamin, Director, Medication-Use QualityImprovement, Practice DevelopmentColette Bevis, Manager, Learning Management System,Resources DevelopmentChristine Beyers, Database Administrator, InformationSystems TechnologyKathleen Biesecker, Director, Communications, PublicRelationsBeverly Black, Director, Affiliate RelationsRuth Bloom, Editorial Project Manager, Books and eLearning,Acquisitions and Special PublishingMichelle Bonnarens, Director, Program Development,Resources DevelopmentTyricia Bradley, Manager, Educational Programs, EducationalServicesCarla Brink, Scientific Project Director, ResourcesDevelopmentJack Bruggeman, Director, Acquisitions and SpecialPublishingFran Byrnes, Director of Conference Planning, Conferenceand ConventionKimberly Cackowski, Project Manager, ResourcesDevelopmentDavid Chen, Director, Pharmacy Practice SectionsJustine Coffey, Director, Section of Home, Ambulatory andChronic Care Practitioners, Pharmacy Practice SectionsRobin Coleman, Acquisitions Editor, Acquisitions and SpecialPublishingJessica Cremer, Meetings Manager, Conference andConventionChap Cronquist, Senior Training Manager, InformationSystems TechnologyWhitney Curtiss, Drug Information Analyst, American HospitalFormulary Service Drug InformationKarin Cushman, Marketing Manager, Meetings and DrugInformation, Marketing and SalesDiana Dabdub, Director, Pharmacy Student Forums, MemberRelationsLindsey Daniels, Education Project Assistant, EducationalServicesPete Dejtisakdi, Manager, Help Desk, Information SystemsTechnologyDave Edwards, Vice President and Chief Financial Officer,Finance OfficeBrian Esuchanko, Manager, Educational Programs,Educational ServicesDayna Evans, Director of Exhibits and Sponsorships,Conference and ConventionBasma Fayyad, Administrative Manager, Member RelationsAnthea Francis, Director, Section of Inpatient CarePractitioners, Pharmacy Practice SectionsKatrin Fulginiti, Accreditation Services Associate,Accreditation ServicesBryce Gaylor, Web Developer, Information SystemsTechnologyLaura Gibbs, Director, Executive OfficeVanessa Gripper, Education Project Assistant, EducationalServicesKarl Gumpper, Director, Section of Pharmacy Informatics andTechnology, Pharmacy Practice SectionsAretha Hankinson, Director, Advocacy Communications,Public RelationsKen Harding, Manager, Operations, Resources DevelopmentBrian Harrell, Manager, Network Engineering, InformationSystems TechnologyJoAnn Stacy Harris, Director, Educational ServicesGuy Hasegaga, Senior Editor, Manuscript Development,American Journal of Health-System PharmacyJill Haug, Director, Forums, Member RelationsBruce Hawkins, Editorial Director, Practice StandardsJoseph Hill, Director, Federal Legislative Affairs, GovernmentAffairsAileen Holland, Marketing Manager, Membership, Marketingand SalesPamela Hsieh, Assistant Editor, Manuscript Development,American Journal of Health-System PharmacyCindy Huang, Senior Drug Information Analyst, AmericanHospital Formulary Service Drug InformationCheryl Imirie, Senior Membership Program Manager, MemberRelationsMeredith Jannsen, Director, CareerPharm, Publications andDrug Information SystemsLouise Kelley, Director, OperationsTia Kilpatrick, Customer Relations Analyst, InformationSystems TechnologyCatherine Klein, Director, Education Development andOutcomes, Resources DevelopmentChuck Lebioda, Customer Relations Management Manager,Information Systems TechnologyLinda Leishear, Director, LAN/Desktop Services, InformationSystems TechnologyLily Leu, Oncology Specialist Drug Information Analyst,American Hospital Formulary Service Drug InformationLisa Lifshin, Director Program Services and Coordinator,Technician Program Development, Accreditation ServicesLouise Maitland, Manager, Technology Communications,Educational ServicesDean Manke, Vice President, Marketing and Sales11447th ASHP Midyear Clinical Meeting and Exhibition

Randy Manos, Manager, CareerPharm, American Journal ofHealth-System PharmacyShana Martin, Marketing Manager, Resources DevelopmentDiane McCleskey, Director, e-Learning and Logistics,Resources DevelopmentGerald McEvoy, Assistant Vice President, Drug Information;and Editor-in-Chief, AHFS Drug Info,Shekar Mehta, Director, Clinical Guidelines and QualityImprovement, Practice DevelopmentBrian Meyer, Director, Government AffairsLisa Mihalik, Manager, Educational Programs, EducationalServicesJocelyn Milford, Public Relations Assistant, Public RelationsCarlye Miller, Research Assistant, Marketing and SalesEdward Millikan, Director, Product Development andMaintenance eHealth Solutions, Publications and DrugInformation SystemsMaryam Mohassel, Managing Editor, ManuscriptDevelopment, American Journal of Health-System PharmacyLilliana Morales, Project Manager, Certification Development,Resources DevelopmentBruce Nelson, Operations Director, Accreditation ServicesKaren Noonan, Director, State Affairs and GrassrootsAdvocacy, Government AffairsBarbara Nussbaum, Director, Adult Learning and Education,Educational ServicesSandra Oh Clarke, Senior Director, Certification Developmentand CE Liaison, Resources DevelopmentKevin Parker, Director, Web Development, InformationSystems TechnologyWarren Parris, Senior Administrative Assistant, GeneralCounsel OfficeGiovana Peroni, Assistant Manager, Meetings, Conferenceand ConventionThrity Rangwala, Administrative Assistant, Member RelationsAngela Raval, Director, Section of Clinical Specialists andScientists, Pharmacy Practice SectionsVerna Reed, Director, Customer Relations/Customer Service,Information Systems TechnologyCindy Reilly, Director, Practice DevelopmentTesa Reynolds, Marketing and Sales Coordinator, Marketingand SalesAlicia Ross, Senior Administrative Assistant, Executive OfficeMartha Russell, Senior Director, Project Management,Resources DevelopmentNavili Sandoval, Staff Accountant, Financial ManagementDouglas Scheckelhoff, Vice President, ProfessionalDevelopmentNaomi Schultheis, Director, Standards Development andTraining, Accreditation ServicesJeffery Shick, Senior Director, eHealth Solutions, Publicationsand Drug Information SystemsJack Spencer, Chief Information Officer and Vice President,Operations and Technology OfficeDesiree’ Steele, Administrative Assistant, Conference andConventionAkilah Strawder, Accreditation Services Associate,Accreditation ServicesRichard Talley, Assistant Vice President, PharmacyPublishing; and Editor-in-Chief, American Journal of Health-System Pharmacy,Janet Teeters, Director, Accreditation ServicesErika Thomas, Scientific Project Director, ResourcesDevelopmentKasey Thompson, Vice President, Policy, Planning andCommunicationCheryl Thompson, Director, News Center, Publications andDrug Information SystemsChristopher Topoleski, Director, Federal Regulatory Affairs,Government AffairsKate Traynor, News Writer, News Center, Publications andDrug Information SystemsMichelle Tyler, Manager, Exhibits and Affiliate Events,Conference and ConventionHannah Vanderpool, Vice President, Member RelationsTerry Wang, eHealth Applications Analyst, eHealth Solutions,Publications and Drug Information SystemsJulie Webb, Vice President, Resources DevelopmentEllen Wilcox, Director, Public RelationsCrystal Williams, Manager, Special Projects and QualityAssurance, Information Systems TechnologyTyffani Wingfield, Director, Executive Office Communications,Executive OfficeDavid Witmer, Senior Vice President/Chief Operating Officer,Executive OfficeCarol Wolfe, Vice President, Publications and DrugInformation SystemsTracy Yaklyvich, Assistant Director and Assistant Controller,Financial ManagementVickie Yarborough, Project Manager, Resources DevelopmentBarbara Young, Editor, AHFS Consumer MedicationInformation, American Hospital Formulary Service DrugInformationFern Zappala, Vice President, General Counsel and ChiefCompliance Officer, Executive OfficeCheri Zollicoffer, Education Project Assistant, EducationalServicesDana Zook, Assistant Director, Program Development,Resources DevelopmentASHP Research and EducationFoundationStephen Allen, Executive Vice President and Chief ExecutiveOfficer, ASHP Research and Education FoundationDaniel Cobaugh, Vice President, ASHP Research andEducation FoundationBethany Coulter, Director, Communications and DonorRelations, ASHP Research and Education FoundationBrandi Goswick, Senior Program Coordinator, ASHPResearch and Education FoundationMyrna Petersen, Director of Development, ASHP Researchand Education FoundationRichard Walling, Director, Center for Health-SystemPharmacy Leadership, ASHP Research and EducationFoundation47th ASHP Midyear Clinical Meeting and Exhibition115

PRESEnTER inDEXPresenter and network Facilitator index and Disclosure ListingASHP requires all presenters, Program Chairs, and planning committee members to disclose relevant financial relationships. Anyconflicts of interest are resolved before an individual’s participation is confirmed. None of the presenters listed below have anything todisclose except where noted.AThomas Achey, PharmD Candidate, Auburn University, ViceChair, Pharmacy Student Forum Executive Committee, Helena,AL............................................................................................ 40Nicole M. Acquisto, PharmD, BCPS, Emergency MedicineClinical Pharmacy Specialist, University of Rochester MedicalCenter, Rochester, NY............................................................ 74Berook Addisu, PharmD, BCPS, Associate Chief, William S.Middleton Memorial Veterans Hospital, Madison, WI..... 64, 66, 73Chanel Agness, PharmD, BCPS, Assistant Professor,University of Maryland School of Pharmacy, Baltimore.......... 76Terri Albarano, PharmD, MS, Manager, Pharmacy Operations,Allegheny General Hospital, Pittsburgh, PA............................ 72Perry Allen, PharmD, Pharmacy Manager, Brunswick NovantMedical Center, Boliva, NC..................................................... 57Mansoor M. Amiji, PhD, Co-Director, Nanomedicine Educationand Research Consortium, School of Pharmacy, Bouve Collegeof Health Sciences, Northeastern University, Boston, MA.....30, 76Ellena Anagnostis, PharmD, BCPS, Drug Information Specialist,Thomas Jefferson University Hospital, Philadelphia, PA......... 72Claire Anderson, PhD, Professor of Social Pharmacy,University of Nottingham, Nottingham, UK............................. 58Sarah L. Anderson, PharmD, BCPS, Assistant Professor,University of Colorado Skaggs School of Pharmacy andPharmaceutical Sciences, Aurora, CO.................................... 69Mary A. Andrawis, PharmD, MPH, Field Co-Director,Medication Safety, Center for Medicare & Medicaid Innovation(CMMI)/Centers for Medicare & Medicaid Services (CMS),Baltimore, MD......................................................................... 81Kevin E. Anger, PharmD, BCPS, Clinical Pharmacy Specialist inCritical Care, Brigham and Women’s Hospital, Boston, MA... 56Tina B. Aramaki, PharmD, Director of Pharmacy,Intermountain Healthcare, Salt Lake City, UT......................... 71Jason Atlas, RPh, MBA, Director Ambulatory Pharmacy,Denver Health and Hospital Authority, Denver, CO................ 55Nadia I. Awad, PharmD, PGY-2 Emergency MedicinePharmacy Resident, Robert Wood Johnson University Hospital,New Brunswick, NJ........................................................... 43, 74Phil Ayers, PharmD, BCNSP, FASHP, Chief, Clinical PharmacyServices, Associate Clinical Professor, Mississippi BaptistMedical Center, Jackson, MS................................................. 50BSilvana Balliu, PharmD, RPh, Smart Pump Pharmacist,Cleveland Clinic, Cleveland, OH............................................. 78Nick Barkley, CPhT, Technician Supervisor, Valley HospitalMedical Center, Las Vegas, NV.............................................. 58Alonzo Barnes, Jr., Financial Representative, New EnglandFinancial, Tampa, FL............................................................... 43Brian J. Barnes, PharmD, MS, Associate Dean/AssociateProfessor, The University of Kansas, School of Pharmacy,Lawrence................................................................................ 81Chad M. Barnett, PharmD, BCOP, Clinical PharmacySpecialist, University of Texas M.D. Anderson Cancer Center,Houston................................................................................... 63Tanya Y. Barnhart, PharmD, BCPS, Manager Compliance andClinical Pharmacy Program, Regions Hospital, Department ofPharmacy, Paul, MN............................................................... 61Monica Barrington, RPh, MPH, vice president, engagementand delivery, Partnership fpr Patients, Premier, Inc., Charlotte,NC........................................................................................... 75Robert S. Beardsley, RPh, PhD, Professor, University ofMaryland School of Pharmacy, Baltimore............................... 55Burl Beasley, BS Pharm, MS Pharm, Manager, PharmacyInformatics, Community Health Systems, Franklin, TN.......... 78Robert D. Beckett, PharmD, BCPS, Clinical AssistantProfessor of Pharmacy Practice, Manchester UniversityCollege of Pharmacy, Fort Wayne, IN..................................... 37Lynn Belcher, BS Pharm, Clinical Specialist Anticoagulation,Legacy Health System, St. Helens, OR.................................. 52Robyn Benincasa, ................................................................ 31Kim W. Benner, PharmD, BCPS, FASHP, Professor ofPharmacy Practice, Samford University McWhorter School ofPharmacy, Birmingham, AL..................................................... 62Nick Bennett, PharmD, BCPS, Clinical Pharmacist, SaintLuke’s North Hospital, Kansas City, MO................................. 68Karen Berger, PharmD, BCPS, Neurocritical Care ClinicalPharmacist, New York Presbyterian Hospital, New York........ 37James L. Besier, PhD, RPh, FASHP, Director, Pharmacy Services,Owensboro Medical Health System, Owensboro, KY............. 78Christopher Betz, PharmD, BCPS, Associate Professor,Department of Clinical and Administrative Sciences, SullivanUniversity College of Pharmacy, Louisville, KY....................... 4811647th ASHP Midyear Clinical Meeting and Exhibition

Peggy Bickham, BS Pharmacy, PharmD, Assistant Director,University of Illinois Hospital and Health Sciences System,Chicago............................................................................. 53, 57Molly Billstein Leber, PharmD, BCPS, Clinical PharmacyCoordinator, Yale New Haven Hospital, New Haven, CT... 57, 60Michelle Blair, PharmD, PGY1 Pharmacy Resident, BillingsClinic, Billings, MT................................................................... 41Amie Taggart Blaszczyk, PharmD, CGP, BCPS, AssociateProfessor, Head, Geriatric Division, Texas Tech University HSCSOP, Dallas, VA....................................................................... 33Ruth Bloom, Editorial Project Manager, American Society ofHealth-System Pharmacists, Bethesda, MD........................... 54Wayne Bohenek, PharmD, MS, FASHP, Vice President, CareTransformation, Catholic Health Partners, Cincinnati, OH...... 65Nicole Bohm, PharmD, Assistant Professor, Internal MedicinePharmacy Specialist, South Carolina College of Pharmacy,MUSC Campus, Charleston, SC....................................... 39, 68Joseph Bonnarens, PhD, Associate Dean for Student Affairs,Manchester University College of Pharmacy, Fort Wayne, IN..... 43Ryan N. Bookout, PharmD, BCPS, Clinical Pharmacist II - BMT,Department of Blood and Marrow, H. Lee Moffitt Cancer Center& Research Institute, Tampa, FL....................................... 63, 69Laura M. Borgelt, PharmD, Associate Professor, University ofColorado Anschutz Medical Campus, Aurora......................... 60Catherine Bourg, PharmD, BCPS, BCACP, Clinical AssistantProfessor, University of Georgia College of Pharmacy, Athens,GA........................................................................................... 41Sarah Boyd, PharmD, BCPS, Pharmacy Clinical Manager,Mercy Hospital-Joplin, Joplin, MO.................................... 41, 73Disclosure — Spouse is employee of Sanofi-AventisBridget Bradley, RPh, PharmD, Assistant Professor, PacificUniversity School of Pharmacy, Hillsboro, OR........................ 78Heidi Bragg, MBA, RPh, Director, Regulatory Compliance,Cardinal Health, Houston, TX................................................. 44Disclosure — Employee: Cardinal HealthEricka L. Breden, PharmD, BCPP, Clinical Pharmacy Specialist -Psychiatry, Virginia Commonwealth University Health System,Richmond.......................................................................... 68, 80Elizabeth Breeden, DPh, MS, Assistant Professor, Departmentof Pharmacy Practice Director, Master of Health Care InformaticsProgram, Lipscomb College of Pharmacy, Nashville, TN....... 42DeAnne L. Brooks, PharmD, Director of Pharmacy, ConeHealth, Moses Cone Hospital, Greensboro, NC..................... 72Tyson Brooks, PharmD, BCPS, Advanced ClinicalPharmacist, Intermountain Medical Center, Murray, UT......... 39Deborah A. Brown, MS, PharmD, Market Director ofPharmacy, Cardinal Health, Valrico, FL.................................. 70Timothy Brown, PharmD, BCACP, FASHP, Director of ClinicalPharmacotherapy in Family Medicine, Akron General MedicalCenter, Akron, OH, 44307....................................................... 80Mike Brownlee, PharmD, MS, Director of Pharmacy, OregonHealth & Science University, Portland, OR............................. 60Jack Bruggeman, MBA, Director, Special Publishing, AmericanSociety of Health-System Pharmacists, Bethesda, MD.......... 54Amanda Brummel, PharmD, Director, Clinical AmbulatoryPharmacy Services, Fairview, Minneapolis, MN..................... 68Mark Brunton, CPhT, Pharmacy Technician Program Director,Kaplan College, Las Vegas, NV.............................................. 58Betsy Bryant Shilliday, PharmD, CDE, Assistant MedicalDirector, UNC Internal Medicine, Chapel Hill.......................... 70Beth Bryles Phillips, PharmD, BCPS, Clinical Professor,University of Georgia, Athens..................................... 32, 41, 75Mitchell S. Buckley, PharmD, FCCM, Clinical Pharmacist,Banner Good Samaritan Medical Center, Phoenix, AZ........... 81Alina D. Bulgar, PharmD, PhD, Coordinator, MedicationRegulatory and Accreditation Services, Cleveland Clinic,Cleveland, OH......................................................................... 57Disclosure — Research Grant Recipient: Cardinal HealthFoundationGregory P. Burger, PharmD, Clinical Pharmacist, LawrenceMemorial Hospital, Lecompton, KS......................................... 78Allison E. Burnett, PharmD, PhC, Clinical Pharmacist,University of New Mexico Hospital, Albuquerque, NM............ 70Bradley Burton, PharmD, BCOP, CACP, Clinical PharmacySpecialist, Medical Oncology, The Johns Hopkins Hospital,Baltimore, MD................................................................... 42, 48Michael E. Burton, PharmD, Professor, The University ofOklahoma College of Pharmacy, Oklahoma City.................... 36Demetris Butler, PharmD, Corporate Pharmacy Director,Dimensions Healthcare System, Cheverly, MD...................... 70Debbie C. Byrd, PharmD, BCPS, Professor and AssociateDean, Professional Affairs, University of Tennessee College ofPharmacy, Knoxville................................................................ 72CJoshua Caballero, PharmD, Associate Professor, NovaSoutheastern University, Ft. Lauderdale, FL............... 42, 54, 78Disclosure — Grant Recipient: Health Resources and ServicesAdministrationMaribeth A. Cabie, PharmD, BCPS, Manager, Safety and QualityOutcomes, Yale New Haven Hospital, New Haven, CT.......... 60Lijian (Leo) Cai, PharmD, Director of Pharmacy, WheatonFranciscan Inc. - Saint Joseph Hospital, Milwaukee, WI........ 52Samuel Calabrese, MBA, RPh, Associate Chief PharmacyOfficer, Cleveland Clinic, Cleveland, OH................................ 64Bruce R. Canaday, PharmD, FAPhA, FASHP, Professor and Chair,Department of Pharmacy Practice and Pharmacy Administration,Philadelphia College of Pharmacy, Philadelphia, PA.............. 68Richard Capps, PharmD, Pharmacy Manager - MST,Greenville Hospital System, Greenville, SC............................ 78Ann Carder, PharmD, Staff Pharmacist, Montgomery CountyMemorial Hospital, Red Oak, IA.............................................. 45Jannet M. Carmichael, PharmD, BCPS, VISN 21 Pharmacy Executive,VA Sierra Pacific Network (VISN 21), Reno, NV..... 66, 8147th ASHP Midyear Clinical Meeting and Exhibition117

presenter indexJorge D. Carrillo, PharmD, MS, BCPS, Deputy Director,Military Vaccine Agency, U.S. Army, Falls Church, VA............ 57Donald Carroll, RPh, MHA, Administrator, Cleveland ClinicHome Care Services, Cleveland Clinic, Independence, OH... 59Angela T. Cassano, PharmD, BCPS, President, PharmfusionConsulting, LLC, Midlothian, VA.............................................. 67Linda Catanzaro, PharmD, Clinical Assistant Professor,University at Buffalo School of Pharmacy & PharmaceuticalSciences, Buffalo, NY............................................................. 62Michael J. Cawley, PharmD, RRT, Professor of Clinical Pharmacy,Philadelphia College of Pharmacy, Philadelphia, PA.............. 67Disclosure — Speakers Bureau: CubistSamar Chakar, PharmD Candidate, University of New EnglandCollege of Pharmacy, Member, Pharmacy Student ForumExecutive Committee, Lawrence, MA............................... 41, 42Jeff Chalmers, PharmD, Pharmacy Informatics Manager,Cleveland Clinic, Cleveland, OH............................................. 78Rachel Chambers, PharmD, Pharmacy Specialist, AntimicrobialStewardship, Henry Ford Hospital, Detroit, MI........................ 38Juliana Chan, PharmD, Clinical Pharmacist, University ofIllinois at Chicago, Chicago..................................................... 71Eric L. Chernin, RPh, Pharmaceutical Care Specialist-ORPharmacy, Sarasota Memorial Hospital, Sarasota, FL........... 42Navy Chhay, PharmD, Director of Pharmacy Services, SaukPrairie Memorial Hospital & Clinics, Prairie du Sac, WI.......... 49Kavish Choudhary, PharmD, MS, Director, Pharmacy SupportServices, University of Utah Hospitals & Clinics, Salt Lake City,UT........................................................................................... 49Margaret Chrymko, BS, PharmD, FASHP, Clinical PharmacySpecialist, Erie VA Medical Center, Erie, PA........................... 32Margaret Clapp, Chief Pharmacy Officer, MassachusettsGeneral Hospital, Boston........................................................ 70John S. Clark, PharmD, MS, FASHP, Director of PharmacyServices, University of Michigan, Ann Arbor......... 52, 54, 76, 80Nathan Clark, PharmD, BCPS, Clinical Pharmacy Supervisor,Kaiser Permanente Colorado, Aurora..................................... 57Nicole J. Clark, PharmD, BCPS, Pharmacy Clinical Manager,Hallmark Health System Inc., Medford, MA...................... 57, 72David Cluck, PharmD, Assistant Clinical Professor, EastTennessee State University Gatton College of Pharmacy,Johnson City........................................................................... 39Megan Coder, PharmD, Director of Professional Affairs,Pharmacy Technician Certification Board, Washington, DC... 67Holly V. Coe, PharmD, Clinical Assistant Professor, Universityat Buffalo, School of Pharmacy & Pharmaceutical Sciences,Buffalo, NY.............................................................................. 62Lawrence J. Cohen, PharmD, BCPP, FASHP, Professor/Associate Dean for Clinical Programs/ Chair, Department ofPharmacotherapy, University of North Texas System College ofPharmacy, Fort Worth, TX................................................. 32, 60Disclosure — Speakers Bureau: Sunovion, Forest; Consultant:Mylan Specialty Products11847th ASHP Midyear Clinical Meeting and ExhibitionMichael R. Cohen, RPh, MS, ScD (hon), President, Institutefor Safe Medication Practices, Horsham, PA.................... 55, 75Robin Coleman, Acquisitions Editor, American Society ofHealth-System Pharmacists, Bethesda, MD........................... 54Kevin J. Colgan, MA, FASHP, Corporate Director ofPharmacy, Rush University Medical Center, Chicago, IL........ 59Jill M. Comeau, PharmD, BCOP, Assistant ProfessorHematology/Oncology, University of Louisiana at MonroeCollege of Pharmacy, Gratis Assistant Professor of Medicine,Feist-Weiller Cancer Center and Bone Marrow Transplant Unit,LSUHSC-Shreveport, Shreveport, LA..................................... 43Wayne F. Conrad, PharmD, FASHP, Contract Surveyor, AmericanSociety of Health-System Pharmacists, Bethesda, MD.......... 32Julie B. Cooper, PharmD, BCPS, Clinical Pharmacist, ConeHealth, Greensboro, NC......................................................... 72Lebron Cooper, MD, Chief of Anesthesiology, Medical Directorof Perioperative Services, University of Miami, Miami, FL...... 64Zlatan Coralic, PharmD, Clinical Pharmacist, University ofCalifornia San Francisco School of Pharmacy, San Francisco... 77Jason A. Corcoran, PharmD, BCPS, Clinical Specialist, CardiacIntensive Care, Children’s National Medical Center, Washington,DC........................................................................................... 71Megan Corrigan, PharmD, BCPS, Emergency Medicine ClinicalPharmacist, Advocate Illinois Masonic Medical Center, Chicago...74Gayle Cotchen, PharmD, MBA, Lead Pharmacist, Magee-Womens Hospital of University of Pittsburgh Medical Center,Pittsburgh, PA......................................................................... 76Rick Couldry, MS, RPh, FASHP, Director of Pharmacy, Universityof Kansas Hospital, Kansas City............................................. 56Chad Coulter, PharmD, Assistant Professor, Sullivan University,Louisville, KY.......................................................................... 69Debra L. Cowan, PharmD, FASHP, Director of Pharmacy,Angel Medical Center, Franklin, NC........................................ 45Craig D. Cox, PharmD, BCPS, Associate Professor, PharmacyPractice, Texas Tech University HSC SOP, Lubbock.............. 55Freddy M. Creekmore, PharmD, BCPS, Associate Professor,East Tennessee State University, Johnson City...................... 39Kristine Crews, PharmD, BCPS, Translational ResearchLaboratory Director and Director, PGY2 PharmacogeneticsResidency Program, Pharmaceutical Sciences Department, St.Jude Children’s Research Hospital, Memphis, TN................. 42Eric J. Cropp, BS Pharm, Patient and Caregiver Advocate,The Emily Jerry Foundation, Cleveland, OH........................... 55Franklin P. Crownover, RPh, MSHI, Pharmacy InformaticsCoordinator, Tufts Medical Center, Boston, MA...................... 52Lourdes M. Cuellar, MS, FASHP, Administrative DirectorPharmacy & Clinical Support Services, TIRR MemorialHermann, Houston, TX........................................................... 64Disclosure — Author: American Society of Health-SystemPharmacistsJean Cunningham, PharmD, BCPS, Assistant Professor ofPharmacy Practice, The University of Findlay, Findlay, OH.... 37Michael W. Cunningham, PharmD, Medication SafetyCoordinator, UC Health, Cincinnati, OH.................................. 76

DDiana L. Dabdub, Director, ASHP Pharmacy Student Forum,Bethesda, MD......................................................................... 43Julie Dagam, PharmD, BCPS, Residency Director/ClinicalCoordinator, Aurora Health Care, Milwaukee, WI................... 65William E. Dager, PharmD, BCPS, FASHP, PharmacistSpecialist, University of California Davis Medical Center,Sacramento................................................................. 57, 65, 81June L. Dahl, PhD, Professor of Neuroscience, University ofWisconsin School of Medicine and Public Health, Madison, WI....30Richard D’Angio, PharmD, Clinical Director of Pharmacy,University of New Mexico Hospital, Albuquerque................... 70Rowell Daniels, PharmD, MS, Director of Pharmacy, UNCHealth Care, Chapel Hill, NC.................................................. 71Joseph Dasta, MSc, Adjunct Professor, The University of Texas,Austin...................................................................................... 56Disclosure — Consultant: AcelRx, Cadence, Hospira, Pacira;Speakers Bureau: Cadence, Pacira, France Foundation (CMEfunded by Hospira)Lindsay Davison, PharmD, Health Promotion Officer, Food andDrug Administration, Silver Spring, MD................................... 37Meghan Davlin Swarthout, PharmD, MBA, Division Director,Ambulatory and Care Transitions, The Johns Hopkins Hospital,Baltimore, MD......................................................................... 54Richard F. de Leon, PharmD, Pharmacy Relations andEducation Director, Amgen Inc., ............................................. 66James E. De Muth, PhD, Professor of Continuing EducationDivision, University of Wisconsin, Madison............................. 34Michael DeCoske, PharmD, BCPS, Associate Chief PharmacyOfficer, Ambulatory Services, Duke University Hospital, Durham,NC........................................................................................... 49Dan Degnan, PharmD, MS, CPHQ, Medication Safety Officer,Community Health Network, Carmel, IN................................. 51Leigh DeMarco, PharmD, MS, Pharmacy Manager, HuntsmanCancer Hospital, Salt Lake City, UT........................................ 73Deborah A. DeNure, BS, Chief Learning Officer, DBAssociates of WI LLC, McFarland, WI.................................... 37Disclosure — Consultant: Herrmann International; Employee:DB Associates of WI, LLCJohn W. Devlin, PharmD, Associate Professor of Pharmacy,Northeastern University, Boston, MA...................................... 56Disclosure — Research Grant Recipient and Delivery of CMEPresentations: Hospira PharmaceuticalsJoseph T. DiPiro, PharmD, Executive Dean, Medical Universityof South Carolina, Charleston................................................. 36Disclosure — Author: McGraw-Hill, University of Georgia;Board Member: McGraw-Hill, American Association of Collegesof PharmacyMelanie Dodd, PharmD, Associate Professor of Pharmacy inGeriatrics, University of New Mexico College of Pharmacy,Albuquerque............................................................................ 70Ernest J. Dole, PharmD, BCPS, FASHP, Clinical Pharmacist,Pain Consultation & Treatment Clinic, University of NewMexico Hospitals, Albuquerque......................................... 70, 78Caryn Domenici-Belisle, RPh, Pharmacy Manager SterileProducts and Robotic Services, Brigham and Women’sHospital, Boston, MA............................................................... 56Julie A. Dopheide, PharmD, BCPP, Associate Professor ofClinical Pharmacy, Psychiatry and the Behavioral Sciences,University of Southern California School of Pharmacy, LosAngeles, CA...................................................................... 75, 80Disclosure — Board Member: College of Psychiatric andNeurologic Pharmacists; Author: American Society of Health-System Pharmacists, The Rx ConsultantThomas C. Dowling, PharmD, PhD, Associate Professor andVice Chair, University of Maryland, Baltimore................... 76, 79Disclosure — Board Member: NovartisJoanne Doyle Petrongolo, PharmD, Ambulatory Care Pharmacist,Massachusetts General Hospital, Boston............................... 75Disclosure — Stockholder: CVS & MerckHeather Draper Eppert, PharmD, BCPS, Associate Professor,University of Tennessee College of Pharmacy, Knoxville....... 58Denice L. Duda, MHA, RN, CPHQ, Quality Improvement TeamLeader, Medicine, ED, & Pharmacy, The Johns HopkinsHospital, Baltimore, MD.......................................................... 61Joseph M. Dula, PharmD, Regional Director of ClinicalServices, Pharmacy Systems, Inc., Dublin, OH...................... 75Disclosure — Employee: Pharmacy Systems, Inc.Lori C. Dupree, PharmD, BCPS, President, ClincommConsulting, LLC, Lexington, SC.............................................. 66Rabiah Dys, PharmD, Executive Director, Clinical Program Development,Comprehensive Pharmacy Services, Dracut, MA...... 50EMatthew W. Eberts, PharmD, MBA, Director of Pharmacy,West Penn Allegheny Health System, Pittsburgh, PA............. 76Richard L. Edwards, BS , RPh, CPh, Clinical Pharmacy Manager,Heart of Florida Regional Medical Center, Davenport............ 59Jennifer M. Edwards-Schultz, PharmD, FASHP, PharmacyResidency Director / Clinical Pharmacist, Bozeman DeaconessHealth Services, Bozeman, MT.............................................. 80Brenda A. Egan, PharmD, BCPS, Clinical Manager, BristolHospital, Cardinal Health Solutions, Bristol, CT...................... 57Lea Eiland, PharmD, BCPS, FASHP, Associate Clinical Professor& Associate Department Head of Pharmacy Practice, AuburnUniversity Harrison School of Pharmacy, Huntsville, AL... 41, 62Timothy Ekola, PharmD, Medication Safety Officer, LandstuhlRegional Medical Center, Landstuhl, Germany...................... 57Clayton D. English, PharmD, BCPP, Assistant Professor, AlbanyCollege of Pharmacy & Health Sciences, Colchester, VT....... 78Mary H. H. Ensom, PharmD, FCCP, FASHP, Professor, Universityof British Columbia, Vancouver, British Columbia, Canada.... 79Christopher R. Ensor, PharmD, BCPS-CV, Clinical Specialist,Cardiothoracic and Vascularized Composite Tissue Allotransplantation,The Johns Hopkins Hospital ComprehensiveTransplant Center, Baltimore, MD........................................... 72Kelly T. Epplen, PharmD, BCACP, Assistant Professor of ClinicalPharmacy Practice, James L. Winkle College of Pharmacy,University of Cincinnati, Cincinnati, OH............................ 33, 7047th ASHP Midyear Clinical Meeting and Exhibition119

presenter indexBrian L. Erstad, PharmD, FASHP, Professor, University ofArizona College of Pharmacy, Tucson.................. 37, 38, 62, 75Lynn Eschenbacher, PharmD, MBA, Assistant Director, ClinicalServices, WakeMed Health & Hospitals, Raleigh, NC............ 57Tom C. Evans, MD, FAAFP, President and CEO, IowaHealthcare Collaborative, Des Moines, IA.............................. 75Maren Everton, RPh, Management Consulting Director, maxITHealthcare, Park City, UT........................................................ 52Jeanne R. Ezell, MS, BS, FASHP, Director of Pharmacy,Blount Memorial Hospital, Maryville, TN................................. 72FRollin (Terry) J. Fairbanks, MD, MS, Director, National Centerfor Human Factors Engineering in Healthcare, MedStarInstitute for Innovation, MedStar Health, Washington, DC...... 75Marcus Farbstein, RPh, MBA, Director, 340B Program,Genentech, South San Francisco, CA.................................... 55Disclosure — Employee and Stockholder: GenentechElizabeth A. Farrington, PharmD, BCPS, Pharmacist III -Pediatrics, New Hanover Regional Medical Center, Wilmington,NC........................................................................................... 71Kate Farthing, PharmD, BCPS, FASHP, Clinical PharmacySpecialist, Quality & Patient Safety, Legacy Health, Portland,OR........................................................................................... 32Kate Farthing, PharmD, BCPS, FASHP, Clinical PharmacySpecialist, Quality & Patient Safety, Legacy Health, Portland,OR........................................................................................... 61Denise Fields, PharmD, Director of Pharmacy Services,Decatur County Memorial Hospital, Greensburg, IN............... 45Disclosure — Research Grant Recipient: Indiana Rural HealthAssociation & Office of Rural Health; Board Member: IndianaRural Health AssociationDonald J. Filibeck, PharmD, MBA, National Director, PharmacyServices, Critical Care Systems, Dublin, OH.......................... 51Susan M. Flaker, PharmD, Pharmacy Supervisor, BarnesJewish Hospital, Saint Louis, MO........................................... 66Allen Flynn, PharmD, Solutions Designer, Health PracticeInnovators, Ann Arbor, MI........................................................ 74Stacey Folse, PharmD, MPH, BCPS, Medical ICU Clinical PharmacySpecialist, Emory University Hospital, Atlanta, GA.... 42, 53Brent I. Fox, PharmD, PhD, Associate Professor, AuburnUniversity, Auburn, AL............................................................. 59Anthea Francis, RPh, PharmD, BS, Director, Section ofInpatient Care Practitioners, American Society of Health-System Pharmacists, Bethesda, MD...................................... 44Melissa C. Frank, PharmD, Clinical Coordinator, NortheastGeorgia Medical Center, Gainesville....................................... 78Gilles Fraser, PharmD, FCCM, Clinical Pharmacist in CriticalCare, Maine Medical Center, Portland.................................... 56David G. Fuentes, PharmD, BCPP, Associate Professor &Department Chair, Manchester University College of Pharmacy,Fort Wayne, IN.................................................................. 77, 78Katrin S. Fulginiti, BS Pharm, MGA, Accreditation ServicesAssociate, American Society of Health-System Pharmacists,Bethesda, MD......................................................................... 32GPeter Gal, PharmD, BCPS, FASHP, Director, NeonatalPharmacotherapy Fellowship and NICU PharmacologyResearch Laboratory, Cone Health and Greensboro AHEC,Greensboro, NC...................................................................... 58Julia F. Gannon, BS Pharm, Chief of Pharmacy Services, USArmy Health Clinic, Heidelberg, Germany.............................. 57Kevin W. Garey, PharmD, MS, FASHP, Associate Professorand Chair, University of Houston College of Pharmacy,Houston, TX............................................................................ 68Disclosure — Research Grant Recipient: Merck, Inc.Dawn Knudsen Gerber, PharmD, CGP, FASCP, AssociateProfessor, Midwestern University College of Pharmacy-Glendale, Glendale, AZ........................................................... 50Donald L. Gerhart, RPh, Medication Safety Officer, YorkHospital/WellSpan Health, York, PA........................................ 68Virginia L. Ghafoor, PharmD, Clinical Pharmacy Specialist -Pain Management, University of Minnesota Medical Center,Minneapolis....................................................................... 50, 78Gajendra A. Gharia, RPh, MPH, Pharmacy Manager,NewYork-Presbyterian, New York, NY.................................... 61Barbara Giacomelli, PharmD, MBA, FASHP, ExecutivePharmacist Consultant, McKesson Provider Technology,Vineland, NJ............................................................................ 72Jennifer V. Gillespie, PharmD, MBA, Operations Manager,Adult Inpatient Pharmacy, The Johns Hopkins Hospital,Baltimore, MD......................................................................... 61Diane B. Ginsburg, MS, RPh, FASHP, Clinical Professor &Assistant Dean for Student Affairs, The University of Texas atAustin College of Pharmacy, Austin............................ 30, 32, 54Kimberly Glasoe, PharmD, Emergency Medicine Clinical Pharmacist,Mercy Hospital - Allina Health, Coon Rapids, MN...... 74Paul Glynn, Pharm D, BCPS, CGP, Clinical PharmacyManager, Abbott Northwestern Hospital, Minneapolis, MN..... 75Debra Goff, PharmD, FCCP, Clinical Associate Professor,Infectious Disease Specialist, The Ohio State UniversityWexner Medical Center, Columbus........................................ 37Jennifer D. Goldman-Levine, PharmD, FCCP, Professor ofPharmacy Practice, Massachusetts College of Pharmacy andHealth Sciences, Boston, MA.................................................. 55Gregory C. Gousse, BS, MS, FASHP, ImplementationManager, VHA Inc., Irving, TX................................................. 70Robert Granko, PharmD, MBA, Associate Director ofPharmacy, UNC Health Care, Chapel Hill, NC....................... 71Craig W. Griffis, BS Pharm, Vice President of BusinessDevelopment, Community Health Network, Berlin, WI........... 44James B. Groce, III, PharmD, CACP, Professor, CampbellUniversity College of Pharmacy & Health Sciences, BuiesCreek, NC......................................................................... 39, 59Disclosure — Speakers Bureau: Boehringer Ingelheim12047th ASHP Midyear Clinical Meeting and Exhibition

Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc.,Diagnostica Stago, Inc.Julie Groppi, PharmD, CED, Department of Veterans Affairs, .....54Kristine Gullickson, PharmD, FASHP, Director of Pharmacy,Abbott Northwestern Hospital, Allina Health, Minneapolis, MN... 67Michael P. Gulseth, PharmD, BCPS, FASHP, ProgramDirector for Anticoagulation Services, Sanford USD MedicalCenter, Sioux Falls, SD........................................................... 57Disclosure — Speakers Bureau: Boehringer Ingelheim,Janssen; Consultant: JanssenKathleen M. Gura, PharmD, BCNSP,FPPAG, FASHP, ClinicalPharmacy Specialist, Gastroenterology & Nutrition, BostonChildren’s Hospital, Boston, MA.............................................. 69Amy Gutierrez, PharmD, Chief Pharmacy Officer, Los AngelesCounty Department of Health Services, Los Angeles, CA...... 67HSeena L. Haines, FASHP, BCACP, FASHP, Professor andDean for Faculty, Palm Beach Atlantic University, West PalmBeach, FL................................................................................ 70Stuart T. Haines, PharmD, BCPS, BCACP, Professor and ViceChair for Clinical Services, University of Maryland School ofPharmacy, Baltimore............................................................... 33Jennifer Hamner, PharmD, Manager of ProfessionalDevelopment and Residency Program Director, Children’sHospital Colorado, Aurora, CO............................................... 48Rebekah Hanson, PharmD, BCPS, Clinical LiaisonPharmacist, Specialty Pharmacy Services, University of IllinoisHospital and Health Sciences System, Chicago..................... 59David Hardy, MS, Vice President for Pharmacy Services,Amerinet, Health Resource Services LLC, Seattle, WA.......... 79Mark Hardy, PharmD, Assistant Executive Director, NorthDakota Board of Pharmacy, Bismarck.................................... 67Anita Harrison, PharmD, BCPS, Clinical Pharmacy Specialist,SICU, PGY1 Residency Director, Methodist Dallas MedicalCenter, Dallas, TX................................................................... 51Melody L. Hartzler, PharmD, AE-C, Assistant Professor ofPharmacy Practice, Cedarville University School of Pharmacy,Cedarville, OH......................................................................... 73R. Donald Harvey, PharmD, FCCP, BCOP, Director, Phase 1Clinical Trials Section, Emory University, Atlanta, GA............. 38Leah M. Hatfield, PharmD, BCPS, Clinical PharmacistSpecialist, UNC Healthcare, Chapel Hill, NC.......................... 74Christopher A. Hatwig, MS, RPh, FASHP, Vice President,Apexus, 340B Prime Vendor Program, Irving, TX................... 55Disclosure — Employee: Apexus, Inc.Deborah G. Hauser, RPh, MHA, Network Pharmacy Director,Einstein Healthcare Network, Philadelphia, PA....................... 67Daniel Hays, PharmD, BCPS, FASHP, Clinical Coordinator,University of Arizona Health Network, Tucson.................. 74, 77Johannah Heaphy, PharmD, Pharmacy Specialist, HealthDialog, Bedford, NH................................................................ 55Mike Heath, RPh, MBA, Colonel (RET), U.S. Army, SeniorPartner, Heath Healthcare Consulting, Inc., Martinez, GA...... 54Darren Hein, PharmD, Drug Information Resident, Center forDrug Information & Evidence-Based Practice - CreightonUniversity, Omaha, NE............................................................ 62Christopher M. Herndon, PharmD, BCPS, FASHP, AssociateProfessor, Southern Illinois University, Edwardsville........ 61, 70Michelle Herzog, Deputy Director, Office of Pharmacy Affairs,Health Resources and Services Administration, Rockville, MD......55Mary Hess, PharmD, FASHP, FCCM, FCCP, Associate Dean,Student Affairs, Jefferson School of Pharmacy, ThomasJefferson University, Philadelphia, PA..................................... 41Trish H.J. Hessling, PharmD, Clinical Pharmacist, William S.Middleton VA Hospital, Madison, WI................................. 64, 66Michelle L. Hilaire, PharmD, BCPS, Clinical AssociateProfessor of Pharmacy Practice, University of Wyoming,Laramie, WY........................................................................... 36Joseph Hill, MA, Director, Federal Legislative Affairs, AmericanSociety of Health-System Pharmacists, Bethesda, MD.......... 68Elizabeth B. Hirsch, PharmD, BCPS, Assistant Professor,Northeastern University, Boston, MA...................................... 66Disclosure — Research Grant Recipient: PfizerA.J.M. (Ton) Hoek, MSc Pharmacist, CEO and GeneralSecretary, International Pharmaceutical Federation (FIP) ..... 29James M. Hoffman, PharmD, MS, Medication Outcomes andSafety Officer, St. Jude Children’s Research Hospital,Memphis, TN........................................................................... 69Rosella Hoffmann, RPh, Pharmacy Director, UPMC,Pittsburgh, PA......................................................................... 76Regina Holliday, Founding Artist, The Walking Gallery,Washington, DC...................................................................... 75Amy Holmes, PharmD, Neonatal Clinical Pharmacy Specialist,Forsyth Medical Center, Winston Salem, NC.......................... 69Haley Holtan, PharmD, Ambulatory Pharmacy Manager,Hennepin County Medical Center, Minneapolis, MN.............. 71Irene S. Hong, PharmD, BCPS, Clinical Assistant Professor,University at Buffalo School of Pharmacy and PharmaceuticalSciences, Buffalo, NY............................................................. 62Joseph Hooley, BS, Adverse Drug Event Coordinator,Cleveland Clinic, Cleveland, OH............................................. 57Charlene A. Hope, PharmD, BCPS, Clinical PharmacyManager, Norwegian American Hospital, Chicago, IL............. 61Edward T. Horn, PharmD, BCPS, Clinical PharmacySpecialist, Allegheny General Hospital, Pittsburgh, PA........... 72John Horn, PharmD, Professor of Pharmacy, University ofWashington, Seattle................................................................ 78Lindsay Hovestreydt, PharmD, BCPS, Clinical PharmacyManager, NewYork-Presbyterian Hospital, New York, NY...... 79Jenna Huggins, PharmD, BCPS, Clinical PharmacyCoordinator-Cardiology, WakeMed Health and Hospitals,Raleigh, NC............................................................................. 69Darrel W. Hughes, PharmD, BCPS, Clinical Pharmacist, Emer -gency Medicine, University Health System, San Antonio, TX... 7447th ASHP Midyear Clinical Meeting and Exhibition121

presenter indexGregory J. Hughes, PharmD, BCPS, Assistant ClinicalProfessor, St. John’s University College of Pharmacy andHealth Sciences, Queens, NY................................................ 62Donard Huynh, PharmD, MA, Assistant Professor, Universityof Maryland, Baltimore, MD.................................................... 62I/JBrian J. Isetts, PhD, BCPS, Health Policy Fellow, Centers forMedicare and Medicaid Services, Baltimore, MD................... 75Cherry W. Jackson, PharmD, BCPP, FASHP, Professor ofPharmacy, Auburn University, Auburn, AL............................... 48Daniel H. Jarrell, PharmD, PGY2 - Emergency Medicine,University of Arizona, Tucson.................................................. 74Charles W. Jastram, PharmD, FASHP, Associate Professorand Department Head, Clinical & Administrative Sciences,University of Louisiana at Monroe College of Pharmacy,Monroe.................................................................................... 32Meghan Jeffres, PharmD, Associate Prof of Pharmacy Practice,Roseman University of Health Sciences, Henderson, NV...... 38Disclosure — Consultant: Cubist; Research Grant Recipient:PfizerAlison M. Jennett Reznek, PharmD, BCPS, AssistantProfessor, Massachusetts College of Pharmacy and HealthSciences, Worcester......................................................... 58, 74Heath R. Jennings, PharmD, BCPS, Executive Director ofPharmacy, University of Chicago Medical Center, Chicago, IL.... 34Christopher S. Jerry, President & CEO, The Emily JerryFoundation, Cleveland, OH..................................................... 55Sarah A. Johannes, PharmD, Health-System PharmacyAdministration Resident, University of North Carolina Hospitaland Clinics, Chapel Hill, NC.................................................... 43Shelley Johnsen, RPh, Director of Telepharmacy, ePharmacistDirect / Catholic Health Initiatives, Fargo, ND.................. 67Disclosure — Employee: ePharmacist DirectBeth Johnson, RPh, Pharmacy Operations Manager,Intermountain Healthcare, Salt Lake City, UT......................... 71Diane M. Johnson, PharmD, BCPS, Clinical PharmacySpecialist, VA Hospital, Madison, WI...................................... 66Jacalyn Jones, PharmD Candidate, Northeast Ohio MedicalUniversity College of Pharmacy, Pharmacy Student ForumExecutive Committee, Rootstown, OH.................................... 41Robert Jordin, RPh, Director, Accreditation and MedicationSafety, Cardinal Health Pharmacy Solutions, Houston, TX.... 57Disclosure — Employee: Cardinal HealthJames A. Jorgenson, RPh, MS, FASHP, Vice President, ChiefPharmacy Officer, Indiana University Health, Indianapolis..... 70Susan Joyce, PharmD, BCPS, Clinical Pharmacist, William S.Middleton VA, Madison........................................................... 64KMichael P. Kane, PharmD, FCCP, Professor, Albany College ofPharmacy and Health Sciences, Albany, NY.......................... 59Andrew Kaplan, PharmD, PGY2 Pharmacy Resident, WilliamS. Middleton Memorial Veterans Hospital, Madison, WI......... 66James A. Karboski, PharmD, Clinical Professor, University ofTexas at Austin, Austin............................................................ 32Julie P. Karpinski, PharmD, BCPS, Pharmacist, Drug Policy,Froedtert Hospital, Milwaukee, WI.......................................... 61Eric S. Kastango, MBA, RPh, FASHP, President/CEO, ClinicalIQ, LLC, Madison, NJ.............................................................. 71Disclosure — Board Member: USPLance W. Keilers, MBA, President, National Rural HealthAssociation, Ballinger, TX....................................................... 44Kristi W. Kelley, PharmD, BCPS, CDE, Associate ClinicalProfessor, Department of Pharmacy Practice/ClinicalPharmacist, Auburn University Harrison School of Pharmacy/Continuity Clinics, Baptist Health, Inc., Birmingham, AL......... 53Audrey Kennedy, PharmD, BCPS, Clinical PharmacySpecialist, Cardiology, Children’s Mercy Hospitals and Clinics,Kansas City, MO..................................................................... 81Leslie Kenney, BS Pharm, BCPS, Director Adult ClinicalPharmacy Services, Norton Healthcare, Louisville, KY.......... 34Anthony C. Kessels, PharmD, BCPS, FASHP, Manager ofMedication Safety, Barnes-Jewish Hospital, St. Louis, MO.... 41Nehrin Khamo, PharmD, Clinical Staff Pharmacist, SpecialtyPharmacy Services, Clinical Instructor, College of Pharmacy,University of Illinois, Chicago.................................................. 59Patrick J. Kiel, PharmD, BCPS, Clinical Pharmacy Specialist,Hematology/Stem Cell Transplant, Indiana University Health,IU Simon Cancer Center, Indianapolis.................................... 63Disclosure — Speakers Bureau: Genzyme, Sanofi-Aventis;Consultant: Swedish Orphan BiovitrumPatricia C. Kienle, BSc Pharm, MPA, FASHP, Director,Accreditation and Medication Safety, Cardinal HealthPharmacy Solutions, Laflin, PA................................... 57, 64, 71Disclosure — Employee: Cardinal HealthLauren Elizabeth King, PharmD, PGY-2 Emergency MedicineResident, The Johns Hopkins Hospital, Baltimore, MD.......... 74Shelly King McIntire, PharmD, PGY2 Ambulatory CareResident, University of Georgia and Charlie Norwood VAMedical Center, Athens, GA.................................................... 41Bonnie Kirschenbaum, MS, FCSHP, FASHP, Health CareConsultant, Boulder, CO......................................................... 77Thomas E. Kirschling, PharmD, MS, Director, Acute CarePharmacy, Denver Health Medical Center, Denver, CO... 64, 79Mary Ann Kliethermes, BS, PharmD, Vice-Chair AmbulatoryCare, Associate Professor, Midwestern University ChicagoCollege of Pharmacy, Downer’s Grove, IL........................ 42, 52Scott Knoer, MS, PharmD, FASHP, Chief Pharmacy Officer,Cleveland Clinic, Cleveland, OH................................. 56, 64, 79Heather Kokko, PharmD, MBA, Director of PharmacyServices, Medical University of South Carolina, Charleston... 64Carolyn Kowalchik, RPh, MSs, Director of Pharmacy,University of Utah Hospitals & Clinics, Salt Lake City............. 73Lee A. Kral, PharmD, BCPS, Clinical Pharmacy SpecialistPain Management, The University of Iowa Hospitals & Clinics,Iowa City................................................................................. 7212247th ASHP Midyear Clinical Meeting and Exhibition

Amy G. Krauss, PharmD, BCPS, Clinical Pharmacy Specialist,Solid Organ Transplant, Methodist University Hospital,Memphis, TN........................................................................... 49Christine J. Kubin, PharmD, BCPS (AQ-ID), ClinicalPharmacy Manager, Infectious Diseases, NewYork-Presbyterian Hospital, New York, NY...................................... 38LJonathan Lakamp, PharmD, BCPS, Vice President,Pharmacy, Mercy, St. Louis, MO............................................. 73Simon W. Lam, PharmD, BCPS, Clinical Pharmacy Specialist,Cleveland Clinic, Cleveland, OH............................................. 38Drew Lambert, PharmD, PGY2 PharmacoinformaticsResident, University at Buffalo, Buffalo, NY............................ 62Joe Lassiter, MS, PharmD, BCPS, CPHIMS, Director ofExperiential Education, Pacific University School of Pharmacy,Hillsboro, OR........................................................................... 53Sandra Leal, PharmD, FAPhA, Director of Clinical Pharmacy/Broadway Clinic (Special Populations), El Rio Health Center,Tucson, AZ.............................................................................. 70Todd D. Lemke, PharmD, CDE, Director of Pharmacy Services,Paynesville Area Health Care System, Paynesville, MN........ 45Mandy C. Leonard, PharmD, BCPS, System Director, DrugUse Policy and Formulary Management, Cleveland Clinic,Cleveland, OH......................................................................... 60Anne Lesko, PharmD, Senior Clinical Director, CincinnatiChildren’s Hospital Medical Center, Cincinnati, OH................ 32Jonathan G. Leung, PharmD, BCPS, BCPP, PsychiatricClinical Position, Mayo Clinic, Rochester, MN........................ 69Bonnie Levin, PharmD, MBA, Corporate AVP, PharmacyServices, MedStar Health, Silver Spring, MD................... 50, 75Marie Link, PharmD, RPh, System Medication Safety Officer,University Hospitals, Cleveland, OH................................. 57, 66Disclosure — Employee: CEO, Aspire Resource, LLCSunny Linnebur, PharmD, CGP, Associate Professor,University of Colorado Skaggs School of Pharmacy andPharmaceutical Sciences, Aurora, CO.................................... 79Disclosure — Author and Board Member: American GeriatricsSocietyJeff Little, PharmD, MPH, Assistant Director of Pharmacy,Children’s Mercy Hospital, Kansas City, MO.................... 44, 64Allan Loeb, MS, RPh, Pharmacy Operations Director, AuroraHealth Care, Milwaukee, WI................................................... 65Carey Lohrenz................................................................. 26, 54Christopher Lowe, PharmD, BCPS, Clinical PharmacyManager, IU Health, Indianapolis, IN...................................... 64Robert A. Lucas, PharmD, BCPS, Clinical Pharmacist/ResidencyCoordinator, Blount Memorial Hospital, Maryville, TN............ 68Sherry A. Luedtke, PharmD, FPPAG, Associate Professor,Texas Tech HSC School of Pharmacy, Amarillo................ 42, 58Thomas Lupton, PharmD Candidate, University of Kansas,Member, Pharmacy Student Forum Executive Committee,Lawrence, KS.................................................................... 40, 42MElyse A. MacDonald, PharmD, MS, BCPS, Drug InformationSpecialist, University of Utah Hospitals & Clinics, Salt LakeCity, UT................................................................................... 50Robert MacLaren, PharmD, FCCM, Associate Professor,University of Colorado School of Pharmacy, Aurora............... 65Charles (Kurt) Mahan, PharmD, PhC, Director of OutcomesResearch, New Mexico Heart Institute, Albuquerque............. 65Lynnae M. Mahaney, RPh, MBA, FASHP, Asssitant PharmacyChief, William S. Middleton VA Hospital, Madison, WI............ 66Patrick M. Malone, PharmD, FASHP, Professor and AssociateDean, The University of Findlay College of Pharmacy, Findlay,OH........................................................................................... 62Henri R. Manasse, Jr., PhD, ScD, FFIP, Retired ExecutiveVice President and Chief Executive Officer, American Societyof Health-System Pharmacists, Bethesda, MD........... 27, 29, 58Anna Mangum, MPH, MSW, Director, Programs andMembership, SNHPA, Washington, DC.................................. 67Disclosure — Employee: Safety Net Hospitals forPharmaceutical AccessJeannell Mansur, BS Pharm, PharmD, FASHP, PracticeLeader, Medication Safety, Joint Commission Resources, OakBrook, IL.................................................................................. 45Disclosure — Employee: Joint Commission ResourcesFancy G. Manton, PharmD, Clinical Pharmacy Coordinator,Woman’s Hospital, Baton Rouge, LA...................................... 49Shannon Manzi, PharmD, Team Leader, Emergency Services,Boston Children’s Hospital, Boston, MA................................. 74Kristine B. Marcus, BSPharm, BCPS, Assistant Professor,Pacific University Oregon, Hillsboro, OR................................ 61Scott M. Mark, FASHP, Corporate Vice President, West PennAllegheny Health System, Pittsburgh, PA............................... 79Anna Markel Vaysman, PharmD, BCPS, Clinical Pharmacistand Assistant Professor, University of Illinois, Chicago.......... 73Ryan Markham, PharmD, PGY1 Resident, Oregon Health &Science University (OHSU) Hospitals and Clinics, ................ 41Claire Markway, PharmD, PGY2 Pediatric PharmacyResident, St. Louis Children’s Hospital, St. Louis, MO........... 43Eric M. Maroyka, PharmD, BCPS, Director, Department ofPharmacy, Fort Belvoir Community Hospital, Fort Belvoir, VA.64Joel C. Marrs, PharmD, BCPS, Assistant Professor, Universityof Colorado Skaggs School of Pharmacy and PharmaceuticalSciences, Aurora............................................. 33, 39, 64, 76, 80Disclosure — Board Member: National Lipid AssociationSouthwest ChapterKelly Martin, PharmD, MS, Manager, Inpatient PharmacyServices, Virginia Commonwealth University Health System,Richmond, VA......................................................................... 51Kevin C. Marvin, MS, FHIMSS, FASHP, Consultant, KevinMarvin Consulting, LLC, Burlington, VT...................... 48, 65, 80Disclosure — Consultant: Kevin Marvin Consulting LLCSusan M. Mashni, PharmD, BS, DPD Specialist, CatholicHealth Partners, Cincinnati, OH.............................................. 6547th ASHP Midyear Clinical Meeting and Exhibition123

presenter indexChristopher Mason, DO, Chief Resident, North Shore LIJHealth System, Manhasset, NY.............................................. 62Michele L. Matthews, PharmD, CPE, Associate Professor ofPharmacy Practice, Massachusetts College of Pharmacy andHealth Sciences, Boston......................................................... 70Kimberly M. Mattox, PharmD, Clinical Pharmacy Specialist,Geriatrics, James A. Haley Veterans’ Hospital, Tampa, FL..... 32J. Russell May, PharmD, FASHP, Clinical Professor, Universityof Georgia College of Pharmacy, Augusta.............................. 62Michelle W. McCarthy, PharmD, FASHP, Director, MedicationUse Policy, University of Virginia Health System, Charlottesville....62Kevin McDonough, PharmD, MPA, Clinical PharmacyManager, Cardinal Pharmacy Solutions / East Orange GeneralHospital, East Orange, NJ...................................................... 68Disclosure — Employee: Cardinal Pharmacy SolutionsDonald McKaig, RPh, CDOE, Clinical Pharmacist Specialist,Medication Safety, Rhode Island Hospital, Providence.... 57, 78Courtney McKinney, PharmD, BCPS, Clinical PharmacySpecialist, Intermountain Healthcare, Salt Lake City, UT........ 74Kathryn McKinney, PharmD, BCPS, Assistant Director,Clinical Services and Research, UC Health - UniversityHospital, Cincinnati, OH.......................................................... 76Ian McNicholl, PharmD, FCCP, BCPS (AQ-ID), AAHIVE,Associate Clinical Professor, University of California, SanFrancisco................................................................................ 33Christopher McPherson, PharmD, Clinical Pharmacist,Neonatal ICU, St. Louis Children’s Hospital, St. Louis, MO.... 58Mary Lynn McPherson, PharmD, BCPS, FASHP, Professorand Vice Chair, University of Maryland School of Pharmacy,Baltimore..................................................................... 54, 61, 70Elaine R. Mebel, PharmD, MS, Manager, Clinical Services,West Penn Allegheny Health System, Pittsburgh, PA....... 64, 76Shekhar Mehta, PharmD, MS, Director, Clinical Guidelinesand Quality Improvement, American Society of Health-SystemPharmacists, Bethesda, MD................................................... 81Sarah T. Melton, PharmD, BCPP, Clinical Pharmacist, GattonCollege of Pharmacy, East Tennessee State University,Johnson City........................................................................... 56Philippe Mentler, PharmD, BCPS, Emergency MedicinePharmacist, Durham Regional Hospital, Durham, NC...... 74, 77Brian M. Meyer, BA, MBA, Director, Government Affairs, AmericanSociety of Health-System Pharmacists, Bethesda, MD.......... 68Gary Milavetz, BS, PharmD, Associate Professor, TheUniversity of Iowa College of Pharmacy, Iowa City................. 69Douglas A. Miller, PharmD, Professor, Wayne State University,Detroit, MI............................................................................... 62William A. Miller, PharmD, FASHP, Consultant, Columbus, OH...32Scott Milner, PharmD, MBA, Clinical Pharmacist, IntermountainHealthcare, Salt Lake City, UT................................................ 71Robert Montgomery, Liaison International, LLC, ................. 41Pamela Moore, BCPS, CPE, Clinical Lead Pharmacist - Pain& Palliative Care, Summa Health System, Akron, OH............ 72Candis M. Morello, PharmD, CDE, Associate Professor ofClinical Pharmacy, University of California Skaggs School ofPharmacy, La Jolla.................................................................. 73Anthony Morreale, PharmD, MBA, BCPS, Department ofVeterans Affairs, ..................................................................... 54Kelly Morrison, BA, Director, Product Development, CardinalHealth, Houston, TX................................................................ 44Disclosure — Employee: Cardinal HealthCarol Munch, BS Pharm, Inpatient Supervisor, Madison VA,Madison, WI............................................................................ 73Lee Murdaugh, BS Pharm, PhD, Director Accreditation andMedication Safety, Cardinal Health, Knoxville, TN.................. 57Disclosure — Employee: Cardinal Health; Author: AmericanSociety of Health-System PharmacistsJohn E. Murphy, PharmD, FCCP, FASHP, Professor andAssociate Dean, The University of Arizona College ofPharmacy, Tucson............................................................ 75, 79Disclosure — Author: American College of Clinical PharmacyWilliam L. Musick, PharmD, BCPS (AQ-ID), Clinical Specialistin Infectious Diseases, The Methodist Hospital, Houston, TX..... 68Megan Musselman, PharmD, BCPS, Clinical PharmacySpecialist- Emergency Medicine, The University Of KansasHospital, Kansas City, MO...................................................... 74Brad Myers, PharmD, MBA, BCPS, System Director, SentaraHealthcare, Norfolk, VA........................................................... 73NMark D. Nelson, RPh, Director of Pharmacy, Fairview LakesHealth Services, Wyoming, MN.............................................. 44Sarah Nelson, PharmD, BCPS, Critical Care Specialist, MayoClinic, Rochester, MN............................................................. 69Genevieve Ness, PharmD, Regulatory Pharmaceutical Fellowin Drug Information, Purdue University / Eli Lilly and Company /FDA, Indianapolis, IN.............................................................. 62Brad Nieder ..................................................................... 26, 40Sarah Nisly, PharmD, BCPS, Assistant Professor, Departmentof Pharmacy Practice, Butler University, Indianapolis, IN....... 72Michael Nnadi, PharmD, MHS, Corporate Vice President /Chief Pharmacy Officer, Novant Health, Winston-Salem, NC..... 42Karen Noonan, MA, Director of State Affairs and GrassrootsAdvocacy, American Society of Health-System Pharmacists,Bethesda, MD......................................................................... 68Victoria Noonkester, PharmD, PGY-2 Informatics, NorthShoreUniversity HealthSystem, Evanston, IL................................... 78Kimberly Novak, PharmD, BCPS, Clinical PharmacySpecialist-Pulmonary Medicine, Nationwide Children’s Hospital,Columbus, OH........................................................................ 71Edith A. Nutescu, PharmD, FCCP, Clinical Professor, Universityof Illinois at Chicago, College of Pharmacy, Chicago....... 57, 81Disclosure — Research Grant Recipient: Janssen; Consultant:Janssen, Daiichi Sankyo12447th ASHP Midyear Clinical Meeting and Exhibition

ORichard K. Ogden, PharmD, Manager, Pharmacy Critical CareServices, Children’s Mercy Hospital and Clinics, Kansas City,MO.......................................................................................... 64Brian Olender, PharmD, Specialty Pharmacy Coordinator,Aurora Health Care, Milwaukee, WI........................................ 65Jacqueline L. Olin, PharmD, MS, Associate Professor ofPhar macy, Wingate University School of Pharmacy, Wingate,NC..................................................................................... 63, 66Carrie Oliphant, PharmD, BCPS (AQ Cardiology), CardiologyClinical Specialist, Methodist University Hospital, Memphis, TN....39Mary Onysko, PharmD, BCPS, Assistant Clinical Professor ofPharmacy Practice, University of Wyoming, Denver, CO....... 76Brandon J. Ordway, PharmD, MS, Pharmacy OperationsManager, St. Joseph’s Hospital-HealthEast Care System, St.Paul, MN................................................................................. 49Anne Ormerod, PharmD, Clinical Pharmacy Specialist:Hematology and Bone Marrow Transplant, Indiana UniversityHealth, Indianapolis................................................................ 39Melinda J. Ortmann, PharmD, BCPS, Clinical PharmacySpecialist - Emergency Medicine, The Johns Hopkins Hospital,Baltimore, MD................................................................... 42, 52Ashley M. Overy, PharmD, Pharmacy Administration Resident,Cleveland Clinic, Cleveland, OH............................................. 81PManjunath P. Pai, PharmD, Associate Professor, AlbanyCollege of Pharmacy and Health Sciences, Albany, NY......... 80Disclosure — Grant Recipient: Pfizer Inc., Roche Laboratories Inc.Katherine Palmer, PharmD, Pharmacy Program Coordinator,Cedars-Sinai Medical Center, Los Angeles............................. 64Lois Parker, BS, Clinical Lead, Pediatrics, MassachusettsGeneral Hospital, Boston........................................................ 44Kerry Parsons, PharmD, BCOP, Pediatric OncologyPharmacist, Children’s of Alabama, Birmingham.................... 69Disclosure — Speakers Bureau: Sigma Tau PharmaceuticalsSteven Pass, PharmD, FCCM, Associate Professor and ViceChair for Residency Programs, Texas Tech University HealthSciences Center School of Pharmacy, Dallas......................... 32Asad E. Patanwala, PharmD, BCPS, Assistant Professor,University of Arizona, Tucson................................ 37, 38, 65, 67Adam Pate, PharmD, Assistant Professor, University ofLouisiana at Monroe College of Pharmacy, Monroe, LA......... 43Kristen Pate, PharmD, Clinical Assistant Professor, Universityof Louisiana at Monroe College of Pharmacy, Monroe, LA..... 43Dhiren K. Patel, PharmD, CDE, BC-ADM, Assistant Professorof Pharmacy Practice, Massachusetts College of Pharmacyand Health Sciences, Boston.................................................. 55Priti N. Patel, PharmD, BCPS, Associate Clinical Professor, St.John’s University, Queens, NY................................................ 62Richard Paul, RPh, Manager, Inpatient Pharmacy Services,Virginia Mason Medical Center, Seattle, WA........................... 79Fern E. Paul-Aviles, PharmD, MS, Pharmacy Manager,Carolinas Medical Center, Charlotte, NC................................ 67Anthony Pazanese, PharmD, Clinical Pharmacy Specialist,Lakeland Regional Medical Center, Lakeland, FL................... 78Amy S. Peak, PharmD, Director of Drug Information Services,Butler University, Indianapolis, IN........................................... 62Craig A. Pedersen, PhD, FAPhA, Manager, Pharmacy Services,Valley General Hospital, Monroe, WA............................... 77, 79Krista M. Pedley, PharmD, MS, Director, Office of PharmacyAffairs, HRSA, Rockville, MD.................................................. 55Emily Peron, PharmD, MS, Assistant Professor, VirginiaCommonwealth University, Richmond.................................... 79Brian Peters, PharmD, MS, Director of Pharmacy, CommunityHealth Network, Indianapolis, IN............................................. 64Barbara J. Petroff, BS, MS, FASHP, Performance ImprovementChair, Student Mentor, Critical Care Systems, Wixom, MI...... 78Renee Petzel Gimbar, PharmD, Assistant Clinical Professor,Emergency Medicine/Medical Toxicology Clinical Pharmacist,Director PGY-2 EM Pharmacy Residency, University of IllinoisCollege of Pharmacy, Chicago.......................................... 58, 74Steven G. Pickette, PharmD, BCPS, System Director, ClinicalPharmacy, Providence Health and Services, Renton, WA...... 65Wes C. Pitts, PharmD, BCPS, Clinical Pharmacy Specialist/Manager, North Mississippi Medical Center, Tupelo......... 44, 67Jason M. Pogue, PharmD, BCPS-ID, Clinical Pharmacist,Infectious Diseases, Sinai-Grace Hospital, Detroit MedicalCenter, Detroit, MI................................................................... 39Disclosure — Speakers Bureau: Merck, Forest, Pfizer, Cubist,Astellas; Research Grant Recipient: MerckRichard C. Ponder, Jr., MBA, CMRP, Division PharmacyInventory and Procurement Analyst, Parallon Supply ChainSolutions, Covington, LA......................................................... 55Lindsey B. Poppe, PharmD, MS, Clinical Manager, Universityof North Carolina Hospitals, Chapel Hill.................................. 38Michael F. Powell, BS Pharm, MS Pharm, FASHP, ExecutiveDirector, Pharmaceutical & Nutrition Care, The NebraskaMedical Center, Omaha.......................................................... 56Disclosure — Education Grant: AmgenLuci Power, BS MS, Senior Pharmacy Consultant, PowerEnterprises, San Francisco, CA.............................................. 71Disclosure — Consultant: Intelligent Hospital Systems, S.E.A.Medical; Stockholder: S.E.A. Medical; Speakers Bureau:ProCE, Inc.; Scientific Advisory Board member: IntelligentHospital SystemsAmanda E. Prusch, PharmD, BCPS, Clinical PharmacySpecialist-Medication Safety, Lancaster General Health,Lancaster, PA.......................................................................... 42RJohn J. Radosevich, PharmD, PGY2 - Critical Care,University of Arizona, Tucson.................................................. 38Shaunta’ M. Ray, PharmD, BCPS, Associate Professor,University of Tennessee College of Pharmacy, Knoxville....... 7247th ASHP Midyear Clinical Meeting and Exhibition125

presenter indexMary Rebo, PharmD, Medication Safety Manager, Novant Health,Winston Salem, NC................................................................. 57Brendan Reichert, MS, RPh, Assistant Director of Med UseInformatics, The Johns Hopkins Hospital, Baltimore, MD....... 41Cynthia Reilly, BS Pharm, Director, Practice DevelopmentDivision, American Society of Health-System Pharmacists,Bethesda, MD......................................................................... 67Timothy Reilly, PharmD, BCPS, Clinical Assistant Professor,Ernest Mario School of Pharmacy, Piscataway, NJ................ 69Disclosure — Spouse is an employee and shareholder ofJohnson & JohnsonJay P. Rho, PharmD, FCCP, FASHP, Senior Director, KaiserPermanente, Downey, CA....................................................... 61Denise Rhoney, PharmD, FCCP, Associate Professor andChair, University of North Carolina Eshelman School ofPharmacy, Chapel Hill............................................................. 59Disclosure — Speakers Bureau and Research Grant Recipient:VimpatDarryl S. Rich, PharmD, MBA, FASHP, Medication Safety Specialist,Institute for Safe Medication Practices, Horsham, PA.... 77Vanitra R. Richards, PharmD, Pharmacy Informatics Resident,Vanderbilt University Medical Center, Nashville, TN............... 78Daniel M. Riche, PharmD, BCPS, Assistant Professor,University of Mississippi, Jackson........................................... 59Steven M. Riddle, PharmD, BCPS, FASHP, Vice President ofClinical Affairs, Pharmacy OneSource/Wolters Kluwer Health,Seattle, WA............................................................................. 75Philip W. Rioux, BS Pharm, Director of Pharmacy, CentralMaine Medical Center, Lewiston............................................. 64Beth L. Roberts, JD, Partner, Hogan Lovells US LLP,Washington, DC...................................................................... 77George A. Robinson, RPh, Senior Product Manager, FDB(First Databank, Inc.), Indianapolis, IN.................................... 51Mary Roederer, PharmD, BCPS, Assistant Professor, TheUniversity of North Carolina at Chapel Hill School of Medicine,Chapel Hill, NC....................................................................... 33Carol J. Rollins, MS, PharmD, Coordinator, Nutrition SupportTeam, The University of Arizona Medical Center, Tucson....... 37Leigh Ann Ross, PharmD, FCCP, FASHP, Associate Dean forClinical Affairs, Chair and Associate Professor, Department ofPharmacy Practice, The University of Mississippi School ofPharmacy, Jackson, MS......................................................... 55Jennifer Rosselli, PharmD, BCPS, Clinical AssistantProfessor, Pharmacy Practice, Southern Illinois UniversityEdwardsville, Edwardsville...................................................... 61Michael J. Rouse, BPharm (Hons), MPS, Assistant ExecutiveDirector, Professional Affairs & Director International Services,Accreditation Council for Pharmacy Education, Chicago, IL.....55, 58Gina J. Ryan, PharmD, CDE, Cllinical Associate Professor,Mercer University, Atlanta, GA................................................ 73Disclosure — Research Grant Recipient: Merck; CE grant:Astella PharmaceuticalSRosalie Sagraves, PharmD, Consultant on Global PharmacyEducation, American Assocation of Colleges of Pharmacy,Alexandria, VA......................................................................... 58Deborah R. Saine, MS, RPh, FASHP, Medication SafetyManager, Winchester Medical Center, Winchester, VA..... 44, 57Disclosure — Consultant: Health Care LogisticsLynn Sanders, PharmD, Department of Veterans Affairs, .... 54Joseph J. Saseen, PharmD, BCPS, FASHP, Professor andVice Chair, University of Colorado, Aurora........................ 64, 80Disclosure — Board Member: Board of Pharmacy Specialities,National Lipid AssociationScott Savage, PharmD, MS, Assistant Director of Pharmacy,University of North Carolina Health Care, Chapel Hill...... 38, 71Melinda D. Sawyer, MSN, RN, CNS-BC, Assistant Director ofPatient Safety, Armstrong Institute for Patient Safety & Quality,Johns Hopkins Medicine, Baltimore, MD................................ 61Jason J. Schafer, PharmD, BCPS, AAHIVP, Assistant ProfessorPharmacy Practice, Jefferson School of Pharmacy, ThomasJefferson University, Philadelphia, PA................... 36, 37, 41, 51Douglas J. Scheckelhoff, MS, Vice President, ProfessionalDevelopment, American Society of Health-System Pharmacists,Bethesda, MD................................................................... 55, 77Kevin Scheckelhoff, BS Pharm, MBA, Area Vice President,McKesson Corporation, San Francisco, CA............................ 59Disclosure — Employee: McKesson CorporationMarc H. Scheetz, PharmD, MSc, Associate Professor,Midwestern University, Downers Grove, IL....................... 68, 82Disclosure — Research Grant Recipient: TriaxPharmaceuticals; Consultant: CepheidLisa Scherkenbach, PharmD Candidate, University of Minnesota,Chair, Pharmacy Student Forum Executive Committee, St. Paul,MN.......................................................................................... 40David Schnee, PharmD, Associate Professor, MassachusettsCollege of Pharmacy and Health Sciences, Boston, MA........ 55Philip J. Schneider, MS, FASHP, Professor and Associate Dean,University of Arizona College of Pharmacy, Phoenix.............. 77Garrett E. Schramm, PharmD, BCPS, Coordinator - PharmacyEducation and Training, Mayo Clinic, Rochester, MN............. 38Kathryn R. Schultz, PharmD, MPH, FASHP, President, AmericanSociety of Health-System Pharmacists, Bethesda, MD.......... 29Heather Schumann, PharmD, Associate Professor, CaliforniaNorthstate University College of Pharmacy, Rancho Cordova.......74Terry L. Schwinghammer, PharmD, BCPS, FASHP, Chair andProfessor, Department of Clinical Pharmacy, West VirginiaUniversity School of Pharmacy, Morgantown......................... 36Gayle Nicholas Scott, PharmD, BCPS, Principal MedicalWriter, UBC-Envision Group, Southport, CT..................... 65, 68Disclosure — Employee: UBC-Envision GroupMollie A. Scott, PharmD, BCACP, Regional Associate Dean,University of North Carolina Eshelman School of Pharmacy,Asheville.................................................................................. 7912647th ASHP Midyear Clinical Meeting and Exhibition

Chelsea Sealey, PharmD Candidate, Farm Fresh Pharmacy,Hampton, VA........................................................................... 61Saranyu Selvanathan, PharmD, PGY1 Pharmacy Resident,Thomas Jefferson University Hospital, Philadelphia, PA......... 41Bonnie L. Senst, MS, RPh, FASHP, Director of Pharmacy,Allina Health, Minneapolis, MN............................................... 70Aruna Seth, PhD, CMPP, Scientific Team Lead, UBC-EnvisionGroup, Southport, CT.............................................................. 65Disclosure — Employee: UBC-Envision GroupMansi Shah, PharmD, Clinical Pharmacist and AssistantProfessor, University of Illinois, Chicago................................. 73Rita Shane, Pharm.D., FCSHP, FASHP, Director, PharmacyServices, Cedars-Sinai Medical Center, Los Angeles, CA...... 81Amanda Shearin, PharmD, Clinical Assistant II, University ofArizona, Tucson...................................................................... 37Amy Heck Sheehan, PharmD, Associate Professor ofPharmacy Practice, Purdue University College of Pharmacy,Indianapolis, IN....................................................................... 62Robert Silverman, PharmD, Program Manager, Pharmacy BenefitsManagement, Department of Veterans Affairs, Hines, IL..... 78Scott B. Silverstein, Director of Pharmacy Services, HuntsmanCancer Hospital, Dept of Pharmacy, Salt Lake City, UT......... 80Janet Silvester, RPh, MBA, FASHP, Director of Pharmacy andEmergency Services, Martha Jefferson Hospital,Charlottesville, VA................................................................... 30Aki Singam, PharmD, Medication Safety Manager, U.S.Department of Defense, Belvoir, VA........................................ 57Mark Siska, RPh, MBA/TM, Assistant Director Informatics &Technology Pharmacy Services, Mayo Clinic Rochester,Rochester, MN........................................................................ 67Debbie Cameron Sisson, RPh, MS, PharmD, Clinical Pharmacist,St. Luke’s Hospital, and Assistant Professor, University ofMinnesota College of Pharmacy, Duluth, MN......................... 42Mariel Sjeime, PharmD, Transition of Care Pharmacist, EinsteinHealthcare Network Philadelphia, Philadelphia, PA................ 67Susan J. Skledar, RPh, MPH, FASHP, Associate Professor,School of Pharmacy and; Director, Pharmaamcy Drug Use andDisease State Management Progr, University of Pittsburgh,Pittsburgh, PA......................................................................... 79Brock Slabach, MPH, FACHE, Senior Vice-President for MemberServices, National Rural Health Association, Kansas City, MO......45Julian H. Slade, PharmD, BCOP, Clinical Pharmacist,Methodist Dallas Medical Center, Dallas, TX.......................... 63Douglas Slain, PharmD, BCPS, FASHP, Associate Professor& Infectious Diseases Clinical Specialist, West VirginiaUniversity, Morgantown........................................................... 82Nancy R. Smestad, MS, RPH, Pharmacist Consultant, VeteransHealth Administration, Fargo, ND........................................... 78Andrew Smith, PharmD, Clinical Assistant Professor, Universityof Missouri - Kansas City School of Pharmacy, Kansas City.... 59Kelly M. Smith, PharmD, BCPS, FASHP, FCCP, AssociateDean, Academic and Student Affairs Associate Professor,Department of Pharmacy Practice and Science, University ofKentucky College of Pharmacy, Lexington, KY....................... 42Lonnie Smith, PharmD, Manager , Department of Solid OrganTransplant, University of Utah, Salt Lake City......................... 60Maureen A. Smythe, PharmD, FCCP, Professor (Clinical),Pharmacy Practice, Wayne State University, Detroit, MI........ 81Disclosure — Speakers Bureau: JanssenSusan C. Sonne, PharmD, BCPP, Associate Professor ofPsychiatry, Medical University of South Carolina, Charleston..... 56Bernard Sorofman, RPh, PhD, Professor and Chair, PharmacyPractice and Science, The University of Iowa, Iowa City Iowa.... 58Elizabeth Sowell, PhD, Professor of Pediatrics, University ofSouthern California/Children’s Hospital Los Angeles, LosAngeles................................................................................... 75COL John Spain, PharmD, BCPS, U.S. Army ...................... 54Linda M. Spooner, PharmD, BCPS, Associate Professor ofPharmacy Practice, Massachusetts College of Pharmacy andHealth Sciences, Worcester.................................................... 63Katie L. Stabi, PharmD, BCPS, Drug Information Pharmacist(REMS), Cleveland Clinic, Cleveland, OH........................ 60, 62Richard L. Stambaugh, PharmD, MS, Chief, Pharmacy Service,St. Cloud VA Healthcare System, St. Cloud, MN.................... 74Chad S. Stashek, PharmD, MS, Medication Safety & TechnologyManager, Brigham & Women’s Hospital, Boston, MA............. 56Molly E. Steed, PharmD, Clinical Assistant Professor, InfectiousDiseases, The University of Kansas School of Pharmacy,Lawrence................................................................................ 39Leslie A. Stein, BS, Coach, Full Circle Inspiration, Inc., LasVegas, NV......................................................................... 80, 81Jennifer Sterner-Allison, PharmD, Pharmacy Clinical Manager,Children’s Healthcare of Atlanta, Atlanta, GA.......................... 57James G. Stevenson, PharmD, FASHP, Chief Pharmacy Officer,University of Michigan Health System, Ann Arbor................... 59Richard F. Stomackin, BS Pharm, Director of Pharmacy,Lewistown Hospital, Lewistown, PA........................................ 44Stephen E. Stoner, PharmD, BCPS, Regional Director, ClinicalPharmacy Services, Providence Health and Services - Oregon,Portland................................................................................... 65Steven C. Stoner, PharmD, BCPP, Chair and Clinical Professor,Department of Pharmacy Practice and Administration, UMKCSchool of Pharmacy, Kansas City, MO................................... 69Disclosure — Speakers Bureau: Astra Zeneca PharmaceuticalsJennifer M. Strickland, PharmD, Pain and Palliative CareSpecialist / Research Scientist and Clinical Research Educator,Millennium Research Institute / Millennium Laboratories,Lakeland, FL........................................................................... 61Disclosure — Employee: Millennium Research InstituteMatthew W. Strum, PharmD, BCACP, Clinical AssistantProfessor, University of Mississippi School of Pharmacy,University.................................................................... 39, 59, 69Jill M. Strykowski, MS, RPh, Director, Allina Health, Fridley,MN.......................................................................................... 73JoAnn Stubbings, BSPharm, MHCA, Assistant Director,Specialty Pharmacy Services, University of Illinois at ChicagoCollege of Pharmacy, Chicago................................................ 5947th ASHP Midyear Clinical Meeting and Exhibition127

presenter indexAmy L. Stump, PharmD, BCPS, Clinical Pharmacy Specialist,Ambulatory Care, Indiana University Health, Indianapolis...... 70Mark Sullivan, PharmD, MBA, Director, VUH PharmacyOperations, Vanderbilt University Hospital, Nashville, TN...... 64Anne Szulczewski, PharmD, Clinical Pharmacy Manager,Froedtert Hospital, Milwaukee, WI.......................................... 67TDavid J. Taber, PharmD, BCPS, Director of Clinical Research,Division of Transplant Surgery, Medical University of SouthCarolina, Charleston............................................................... 60Helen R. Tamer, PharmD, Clinical Pharmacist, InvestigationalDrug Service, University of Michigan Hospital, Clinical AssistantProfessor, University of Michigan College of Pharmacy, AnnArbor, MI................................................................................. 48Rebecca A. Taylor, PharmD, MBA, Pharmacy EducationManager, Cleveland Clinic, Cleveland, OH............................. 64Jack D. Temple, MS, PharmD, Manager, Information Technologyand Medication Use Systems, Univeristy of Wisconsin Hospitalsand Clinics, Madison............................................................... 65Cedric A. Terrell, PharmD, District Director, Pharmacy Services,Palomar Health, Escondido, CA.............................................. 74Maureen Testoni, JD, Assistant General Counsel, Safety NetHospitals for Pharmaceutical Access, Washington, DC.......... 67Disclosure — Employee: Safety Net Hospitals forPharmaceutical AccessChristopher J. Thomas, PharmD, BCPP, FASHP, ResidencyProgram Director of PGY-1 and PGY-2 (Psychiatry) Programs,Chillicothe VA Medical Center, Chillicothe, OH....................... 80Michael C. Thomas, PharmD, BCPS, Assistant Professor,South University School of Pharmacy, Savannah, GA............ 74Sylvia Thomley, PharmD, MS, Director, IT Clinical Informatics,Sanford Health, Sioux Falls, SD............................................. 48Bruce R. Thompson, BSPharm, MS, Director of PharmacyServices, Hennepin County Medical Center, Minneapolis, MN... 71Jacob Thompson, PharmD, MS, Associate Director of Pharmacy,UHS Wilson Medical Center, Binghamton, NY................. 43, 60Kasey K. Thompson, PharmD, MS, Vice President, Office ofPolicy, Planning and Communications, American Society ofHealth-System Pharmacists, Bethesda, MD..................... 68, 75Lynda J. Thomson, PharmD, CACP, Advance PracticePharmacist, Anticoagulation, Thomas Jefferson UniversityHospital, Philadelphia, PA....................................................... 81Disclosure — Consultant: JanssenRicky Thumar, PharmD, Adjunct Professor, MassachusettsCollege of Pharmacy, Boston, MA.......................................... 55Eric M. Tichy, PharmD, BCPS, Senior Clinical PharmacySpecialist, Yale-New Haven Hospital, New Haven, CT........... 60Jessica J. Tilton, PharmD, BCACP, Clinical Pharmacist andAssistant Professor, University of Illinois, Chicago................. 73Joyce Tipton, BS Pharmacy, MBA, FASHP, Director ofPharmacy and Respiratory Care, Memorial Hermann MemorialCity Medical Center, Houston, TX........................................... 6612847th ASHP Midyear Clinical Meeting and ExhibitionJames E. Tisdale, PharmD, FCCP, Professor, Purdue University,Indianapolis, IN....................................................................... 62Disclosure — Author: American Society of Health-SystemPharmacists, Postgraduate Healthcare Education, LLCRuchi Tiwari, PharmD, MS, Pharmacy Manager, NewYork-Presbyterian, New York........................................................... 79Christopher Topoleski, BA, Director, Federal RegulatoryAffairs, American Society of Health-System Pharmacists,Bethesda, MD......................................................................... 68Jeff Tracta ............................................................................. 31Jules M. Trahan, PharmD, RPh, Medication Safety Fellow,Saint Vincent Hospital, Worcester, MA.................................... 57Brittany R. Traylor, PharmD, Emergency Medicine Pharmacist,UC Davis Medical Center, Sacramento, CA............................ 74Laura M. Traynor, PharmD, BCPS, Assistant Professor,Concordia University Wisconsin School of Pharmacy andAmbulatory Pharmacist, Columbia-St. Mary’s Hospital-Ozaukee, Mequon, WI............................................................ 49Andrew Trella, PharmD, Director of Pharmacy, Lehigh ValleyHealth Network, Bethlehem, PA.............................................. 78Dennis A. Tribble, PharmD, FASHP, Director, Medical Affairs,Baxter Healthcare Corporation, Deerfield, IL.................... 59, 66Disclosure — Employee: Baxter Healthcare Corporation, BaxaCorporationBrad Trom, RPh, MBA, CEO, Lovelace Pharmacy, LovelaceHealth Systems, Albuquerque, NM......................................... 59Eric Truvillion, Financial Representative and FinancialAdvisor, New England Financial, Tampa, FL........................... 43Kelly Turner, PharmD, Director Clinical Systems, Pharmacy,Mercy Hospital, St Louis, MO................................................. 65Linda S. Tyler, PharmD, FASHP, Administrative Director,Pharmacy Services, University of Utah Hospitals & Clinics, SaltLake City................................................................................. 73Laura L. Tyndall, BS, PharmD, Pharmacy Product Advisor,QuadraMed, Coopersburg, PA................................................ 78Disclosure — Employee: QuadraMedU/VJohn P. Uselton, RPh, BS, VP Professional Services, CardinalHealth, Houston, TX.......................................................... 56, 57Disclosure — Employee: Cardinal Health; Author: AmericanSociety of Health-System PharmacistsAnne Marie Valorie-Oberle, PharmD, BCOP, AdvancedPractice Pharmacist, Oncology, Thomas Jefferson UniversityHospital, Philadelphia, PA....................................................... 72Joseph Vande Griend, PharmD, Assistant Professor,University of Colorado Skaggs School of Pharmacy andPharmaceutical Science, Aurora............................................. 64Jason M. Vaughn, PhD, Director, Formulation and ProcessDevelopment, Patheon Pharmaceuticals, Cincinnati, OH....... 32Lana Vegman, PharmD, Client Solutions Team Lead, UBC-Envision Group, Southport, CT............................................... 65Peter H. Vlasses, PharmD, DSc (Hon.), BCPS, FCCP,Executive Director, Accreditation Council for PharmacyEducation (ACPE), Chicago, IL............................................... 55

Stacy Voils, PharmD, BCPS, Clinical Pharmacy Specialist,Virginia Commonwealth University Health System, Richmond......81Kieu- Loan M. Vu, PharmD, MBA, Director of PharmacyServices, NA, Swarthmore, PA............................................... 78WPamela Walker, PharmD, BCPS, Clinical Coordinator - EmergencyMedicine Pharmacy Services, University of Michigan Hospital,Ann Arbor................................................................................ 74Paul C. Walker, PharmD, FASHP, Clinical Professor, Director ofExperiential Education, and Manager of Pharmacy PatientOutcomes, The University of Michigan College of Pharmacyand Health System, Ann Arbor................................................ 54Disclosure — Author: American Pharmacists Association;Board Member: Michigan Pharmacists AssociationChristine M. Walko, PharmD, BCOP, Assistant Professor,University of North Carolina, School of Pharmacy, Chapel Hill... 69Disclosure — Research Grant Recipient: Myriad Genetics,GenzymeRichard Walling, BS Pharmacy, Director, Center for Health-System Pharmacy Leadership, ASHP Research and EducationFoundation, Bethesda, MD..................................................... 66Steven B. Ward, PharmD, Senior Director, General Manager,Cerner Corporation, Kansas City, MO.................................... 68Disclosure — Employee and Stockholder: Cerner Corporation,Cerner CorporationDavid J. Warner, PharmD, Associate Chief Pharmacy Officer,Duke University Hospital, Durham, NC............................. 32, 41Brian Watson, PharmD, BCPS, Clinical Manager, ComprehensivePharmacy Services, Greater Baltimore Medical Center,Baltimore, MD......................................................................... 69Robert Weber, PharmD, MS, FASHP, Senior Director,Pharmaceutical Services, Wexner Medical Center at The OhioState University, Columbus..................................................... 59Trish Wegner, BS Pharm, PharmD, FASHP, Vice-President,Illinois Council of Health-System Pharmacists, Loves Park, IL... 51Sara J. White, MS, (Ret.) Director of Pharmacy, StanfordHospital and Clinics, Palo Alto, CA......................................... 38Nathan P. Wiederhold, PharmD, Associate Professor,University of Texas at Austin, Austin....................................... 68Disclosure — Research Grant Recipient: Astellas, Merck;Consultant: ViametAndrew Wilcox, PharmD, Chief of Pharmacy, William S.Middleton VA Hospital, Madison, WI................................. 66, 73John Williamson, PharmD, MBA, BCPS, Assistant Director,Pharmacoeconomics and Clinical Effectiveness, ThomasJefferson University Hospital, Philadelphia, PA....................... 72Michael E. Winter, PharmD, FASHP, Professor Emeritus,University of California, San Francisco, School of Pharmacy,San Francisco......................................................................... 79Stewart R. Wirebaugh, PharmD, Director of Pharmacy Services,St. David’s South Austin Medical Center, Austin, TX................... 79Mike J. Wisz, MBA, Principal, Mike Wisz & Associates, SanDiego, CA................................................................................ 74Joanne Witsil, PharmD, RN, Clinical Pharmacist, Cook CountyHospital (Stroger), Chicago, IL................................................ 74Daniel M. Witt, PharmD, BCPS, Sr. Manager Clinical PharmacyResearch & Applied Pharmacogenomics, Kaiser Permanente,Aurora, CO.............................................................................. 39Disclosure — Research Grant Recipient: CSL BehringThomas W. Woller, MS, FASHP, Senior Vice President,Pharmacy Services, Aurora Health Care, Milwaukee, WI....... 34Eric Wombwell, PharmD, BCPS, Clinical Assistant Professor,University of Missouri - Kansas City, School of Pharmacy,Kansas City, MO..................................................................... 37Annie Wong-Beringer, PharmD, Associate Professor, Universityof Southern California School of Pharmacy, Los Angeles....... 60Disclosure — Research Grant Recipient: Pfizer Inc., Forest Inc.Christopher Wood, PharmD, Associate Professor, Universityof Tennessee College of Pharmacy, Memphis........................ 59John L. Woon, PharmD, FASHP, Pharmacy Informatics Manager,Providence Sacred Heart Medical Center, Spokane, WA....... 32Disclosure — User Advisory Board: TalystJohn Worden, PharmD, MS, BCPS, Director of Pharmacy,McPherson Hospital, McPherson, KS............................... 44, 45Nancy M. Wyatt, PharmD, Operations Manager, MemorialHermann The Woodlands Hospital, The Woodlands, TX........ 64Y/ZAngela W. Yaniv, PharmD, BS, Assistant Director, ClevelandClinic, Cleveland, OH.............................................................. 71Disclosure — Scientific Collaboration Agreement: ClevelandClinic Pharmacy and IV LogicsKathy Yount, BS Pharm, RPh, Clinical Pharmacist Analyst,Carilion Clinic, Roanoke, VA................................................... 78Rony Zeenny, PharmD, Clinical Assistant Professor, LebaneseAmerican University - School of Pharmacy, Byblos, Byblos,Lebanon.................................................................................. 62William Zellmer, BS (Pharmacy), MPH, President, PharmacyForesight, Bethesda, MD.................................................. 58, 66David A. Zilz, MS, RPh, FASHP, Clinical Professor Emeritus,University of Wisconsin School of Pharmacy, Madison.......... 66Lisa G. Hall Zimmerman, PharmD, BCPS, BCNSP, DetroitMedical Center, Detroit, MI..................................................... 5047th ASHP Midyear Clinical Meeting and Exhibition129

SHUTTLE SCHEDULEDECEMBER 1-6, 2012Shuttle Service to/from Mandalay Bay Convention CenterFrequency of Service: Every 15-20 MinutesSERVICE BEGINSLast Bus DepartsHotel Hotel Convention CenterSaturday 12/1 7:00am 4:30pm 5:30pmSunday 12/2 7:00am 5:00pm 6:00pmMonday 12/3 6:30am 5:00pm 6:00pmTuesday 12/4 7:00am 5:00pm 6:00pmWednesday 12/5 7:00am 4:30pm 5:30pmThursday 12/6 8:00am 3:30pm 4:30pma Breakfast Symposia Shuttle – Sunday-Wednesday, 5:30am - 6:30amLimited Service (Frequency of Service: Every 20 Minutes)a Wednesday Evening Event at Mandalay Bay, Featuring Jeff Tracta, 7:00pm – 10:30pmASHP official HotelsName Boarding Route #MGM Grand South Conference Center Entrance 1The Signature at MGM Grand Walk to MGM Grand South Conference Center Entrance 1Aria Tour Bus Area 2New York-New York Zumanity Theater Entrance 2Mandalay Bay Hotel Walking Distance to Mandalay Bay Convention Center WalkTHEhotel at Mandalay Bay Hotel Walking Distance to Mandalay Bay Convention Center WalkLuxor Walking Distance to Mandalay Bay Convention Center WalkWheelchair accessible transportation is available during hours of operation.Call toll free (866) 439-8563 to schedule (allow 30 minutes).Shuttle Service Managed and Operated byTransportation Management Services13047th ASHP Midyear Clinical Meeting and Exhibition

W HARMON AVEASHP oFFiciAL HoTELSARIARUE DE MONTE CARLOLUXorNEWyork,neWyorkE RENO AVEL A S V E G A S B L V D L A S V E G A S B L V DTROPICANAN BLVDTHEsignatureAT mgm agrandMGMgrandGILES STKOVAL LANETHEhotelW HACIENDA AVEmandalay bayMANDALAYBAY HOTELEVENTSCTRNORTHCONVCTRShuttleStopDrop-off/pick-upmccarraninternationalairportSOUTHCONVCTR47th ASHP Midyear Clinical Meeting and Exhibition131

Use these pages during sessions with color-card audience participation activities.AYESTRUEThe famous“Welcome TO Las Vegas”sign was createdin 1959by Betty Willis.13247th ASHP Midyear Clinical Meeting and Exhibition

BNOFALSEThe famous Las Vegas strip isfor the most part, not withinthe city limits of Las Vegas.The majority of the strip isLOCATED within Clark County.47th ASHP Midyear Clinical Meeting and Exhibition133

Use these pages during sessions with color-card audience participation activities.CHoward HughesSTAYED AT the Desert Innfor so long THAT heWAS asked TO leave.He bought the hotel.13447th ASHP Midyear Clinical Meeting and Exhibition

DSeventeenof the 20 biggesthotels in the U.S.are in Las Vegas.47th ASHP Midyear Clinical Meeting and Exhibition135

Thank you for making PPS a Success.CareerPharm’s Personnel Placement Service isan important event for ASHP. A unique recruitingvenue, PPS remains the best resource for pharmacycandidates and recruiters to meet face to face inone location.PPS would not take place without the support ofour loyal employers and advertisers. Special thanksto our platinum, gold, and silver participants.Employer RecognitionPlatinum PartiCiPantSRutgers University, Institute forPharmacy Industry FellowshipsKaiser PermanenteThe Cleveland ClinicGold PartiCiPantSMayo ClinicThe Johns Hopkins HospitalSilver PartiCiPantVidant HealthcareBronze PartiCiPantSHealix Infusion Therapy, Inc.Georgetown University Hospitalcareer advice | job search strategies | interview skills